0001140361-24-013522.txt : 20240315 0001140361-24-013522.hdr.sgml : 20240315 20240315163828 ACCESSION NUMBER: 0001140361-24-013522 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240315 DATE AS OF CHANGE: 20240315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VirnetX Holding Corp CENTRAL INDEX KEY: 0001082324 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 770390628 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33852 FILM NUMBER: 24755441 BUSINESS ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 BUSINESS PHONE: (831) 438-8200 MAIL ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 FORMER COMPANY: FORMER CONFORMED NAME: PASW INC DATE OF NAME CHANGE: 20001109 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC SOFTWORKS INC DATE OF NAME CHANGE: 19990322 10-K 1 ef20015315_10k.htm 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2023

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                    to                   

Commission File Number: 001-33852

graphic
VirnetX Holding Corporation
(Exact name of registrant as specified in its charter)

Delaware
 
77-0390628
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)

308 Dorla Court, Suite 206
Zephyr Cove, Nevada
 
89448
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: 775-548-1785
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
 
VHC
 
NYSE

Securities registered pursuant to section 12(g) of the Act:
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes  No 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
Accelerated filer
Non-accelerated filer
Emerging growth company 
Smaller reporting company
 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2023, was $29,557,799 based upon the closing price of the common shares of the registrant on June 30, 2023. This calculation does not reflect a determination that certain persons are affiliates of the registrant for any other purpose.

3,681,970 shares of the registrant’s Common Stock were outstanding as of March 8, 2024.

DOCUMENTS INCORPORATED BY REFERENCE
 
The information required by Part III of this Annual Report on Form 10-K, to the extent not set forth herein, is incorporated by reference from the registrant’s definitive proxy statement to be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2023 relating to the registrant’s 2024 Annual Meeting of Stockholders.



INDEX

   
Page
 
PART I
 
     
Item 1.
2
Item 1A.
9
Item 1B.
22
Item 1C.
23
Item 2.
24
Item 3.
24
Item 4.
24
     
 
PART II
 
     
Item 5.
25
Item 6.
26
Item 7.
26
Item 7A.
31
Item 8.
31
Item 9.
54
Item 9A.
54
Item 9B.
54
Item 9C.
55
     
 
PART III
 
     
Item 10.
55
Item 11.
55
Item 12.
55
Item 13.
56
Item 14.
56
     
 
PART IV
 
     
Item 15.
56

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS

We have included or incorporated by reference in this Annual Report on Form 10-K (this “Report”), and from time to time we may make statements that may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements are based upon our current expectations, estimates, assumptions, and beliefs concerning future events and conditions and may discuss, among other things, anticipated future performance (including sales and earnings), products, expected growth, future business plans and costs, the impact of potential and ongoing litigation, the expectation of future stockholder distributions, statements regarding the Company’s efforts and ability to maintain compliance with the New York Stock Exchange (“NYSE”) continued listing standard, our beliefs and statements regarding general industry and market conditions and growth rates, as well as general domestic and international economic conditions. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “will be,” “will continue,” “will likely result in,” and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are necessarily subject to risks, uncertainties, and other factors, many of which are outside our control, which could cause actual results to differ materially from such statements and from our historical results and experience. These risks, uncertainties and other factors include, but are not limited to those described in Item 1A - Risk Factors of this Report and elsewhere in this Report and those described from time to time in our reports filed with the Securities and Exchange Commission (the “SEC”). Readers are cautioned that it is not possible to predict or identify all the risks, uncertainties and other factors that may affect future results and that the risks described herein should not be considered a complete list. Any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Among others, the forward-looking statements appearing in this Report that may not occur include statements that:

We have undertaken activities to commercialize our products and patent portfolio in and outside the United States including VirnetX One™, War Room™, VirnetX Matrix™, GABRIEL Connection Technology™ and our Secured Domain Name Registry and Technology. These statements may imply that the worldwide market for our commercialized products is large and will result in significant future revenue for us. However, commercialization of products such as ours is subject to significant obstacles and risks and may prevent significant future revenues for us.

EXCEPT AS REQUIRED BY LAW, WE UNDERTAKE NO OBLIGATION TO UPDATE OR REVISE ANY FORWARD- LOOKING STATEMENT AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE.

PART I

Item 1.
Business

The Company

We are an Internet security software and technology company with patented technology for Zero Trust Network Access (“ZTNA”) based secure network communications. VirnetX’s software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One™, War Room™, VirnetX Matrix™, and GABRIEL Connection Technology™, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services, and critical infrastructures. Our technology generates secure connections on a “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.

Our product portfolio includes sophisticated technologies, products and services that are available for sale worldwide. Our next-generation, VirnetX One™ platform builds upon our patented Secure Domain Name Registry and Technology and GABRIEL Connection Technology™ to further enhance the security and efficiency of our patented secure communication links. VirnetX One™ is a security-as-a-service platform that protects enterprise applications, services, and infrastructure from cyber-attacks. Our platform allows businesses and other enterprises of all sizes to add a “security umbrella” as an added layer on top of their existing infrastructure to further reduce risk and bolster security against ever-growing cyberthreats to data, operating systems, other infrastructure products and gateway security controllers.

Our War Room™ software product provides safe and secure video conferencing meeting environment where sensitive communications and data is invisible to those not authorized to view it. War Room™ validates permissions of all the users, and devices requesting access to any secure meeting room prior to granting access. We believe our War Room™ will be an attractive solution for government and law enforcement agencies as well as all professional sectors such as legal, financial, and medical where limiting access to confidential data is a critical requirement.

Our VirnetX Matrix™ product provides superior security for internet-enabled enterprise applications and their connected devices, and for control systems currently deployed by those enterprises (e.g., file servers, data back-up systems, VPN/firewalls). VirnetX Matrix™ provides a true “zero-trust” access protection, “single-click” ease of use, and is a highly-effective added layer of protection that is deployed simply, without the need for changes to an enterprise’s existing, in-place infrastructure. We believe VirnetX Matrix™ is an attractive solution for all businesses, cloud and on-premise application service providers, and original equipment manufacturers (“OEMs”), looking to improve visibility and management of their networks to mitigate morphing attacks on their networks and for real time access and control of their users.

Our GABRIEL Collaboration Suite™ is a set of communication applications and tools that use our GABRIEL Secure Communication Platform™. It enables seamless and secure cross platform communications between devices that are enrolled in our “VIRNETX SECURED” network and have our software installed. Effective May 31, 2023 we have ended the support for our GABRIEL Collaboration Suite™. All the existing customers and partners have been notified of this announcement.

We have undertaken activities to commercialize our products and intellectual property in and outside the United States including VirnetX One™, War Room™, VirnetX Matrix™, GABRIEL Connection Technology™ and our Secured Domain Name Registry and Technology. We believe our product portfolio to secure devices and systems are suitable in areas such as City, County and State Governments, Healthcare, Finance, Legal, Oil and Gas, Medical, Law Enforcement, National Defense and related support industries. We continue to actively pursue new sales opportunities in and outside of United States.

During 2023, we actively engaged in discussions with certain third-parties to pitch the capabilities of VirnetX One™. As a result of our efforts, we made a series of announcements with Solution Synergy, WeSecure, Samsung, Envoy Data Corporation, and Object Security. We also announced new deployments of our VirnetX Matrix™ product at City of Bridgeport, International Association of Certified ISAOs (IACI) and SkinWalker Ranch. Although there can be no assurance in this regard, the Company believes that there are opportunities for Company products’ sales directly to, resale arrangements with and/or adoption as vendor standards by, one or more of these third parties.

We invested in two companies in the artificial intelligence (“AI”) sector partnering with them to augment the Company’s strategy to provide secure AI to the marketplace. The first investment was with L2 Holdings, LLC (“OmniTeq”), an AI, machine learning (“ML”) and predictive analytics-based solutions provider with a primary focus on selling into the space and defense sectors. Under the terms of our agreement, OmniTeq will deploy and integrate our VirnetX One™ family of products at SkinWalker Ranch to secure their data and protect against cyber hackers. Our second investment was with OP Media, Inc, a dynamic software platform provider, addressing a critical market requirement for transforming static infrastructure processes and knowledgebases into digital processes that can be continuously optimized using AI, ML, and blockchain technologies for making informed decisions and creating streamlined workflows in real-time, without requiring coding or programming skills. Further, under the terms of our respective agreements, both OmniTeq and OP Media have agreed to integrate our VirnetX One™ family of products and services into their solutions and to resell them to their current and future customers. Both companies have committed to using VirnetX as their exclusive global cybersecurity solution provider and go-to-market partner.

We have an ongoing licensing program under which we offer licenses to our technology, software, and some of our patented inventions, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. Our GABRIEL Connection Technology™ License is offered to OEM customers who want to adopt the GABRIEL Connection Technology™ as their solution for establishing secure connections using secure domain names within their products. We have developed GABRIEL Connection Technology™ Software Development Kit  to assist with rapid integration of these techniques into existing software implementations.

Our employees include the core development team behind our inventions, technology, and software. Some members of this team have worked together for over twenty years and were on the same team that invented and developed this technology while working at Leidos. The team has continued its research and development work to refine our unique network security technology and make it more secure and easy to deploy.

Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 205 total patents and pending applications, including 72 U.S. patents/patent applications and 133 foreign patents/validations/pending applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, and related services, and is used in all our technology and products, some of which were acquired by our principal operating subsidiary; VirnetX, Inc., from Leidos, Inc., or Leidos, (f/k/a Science Applications International Corporation, or SAIC) in 2006.

We expect to continue to launch new and enhanced security platforms, software products, and services based on our GABRIEL Connection Technology™. We will provide updates to new and existing customers as they are released to the public. Many small and medium businesses have installed our software products in their corporate networks. We intend to continue to expand our customer base with targeted promotions and direct sales initiatives to large enterprise and governmental organizations.

Industry Overview & Trends

We believe that the rapid growth in remote work has accelerated digital business transformation initiatives that would have taken years, into a matter of months. The demand to work remotely, explosive growth of video conferencing tools and rapid growth in the cloud has created an opportunity to secure communications regardless of a user’s location, network, or BYOD (bring your own device).

The shift to remote work and expansion of the enterprise network perimeter has driven the growth of ZTNA solutions. The Zero Trust concept treats all networks like the Internet, where all users and devices are untrusted by default. Their location within the network is not a factor for deciding trust. Each user and device on the network requires authentication and authorization, based on policy, prior to accessing any applications or resources on the network. ZTNA facilitates security around remote work, because Zero Trust policies enable granular access control, end-to-end encryption of network communications and remove application visibility from the public Internet which reduces the potential attack surface. Based on our estimates, using publicly available market data, we believe that the Zero Trust security market size is projected to grow from $24.8 billion in 2022 to over $60 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 19.4% during the forecast period. We believe Zero Trust represents a growing market and an ideal fit for our technology and products.

Cloud computing growth has rapidly expanded as enterprises continue to move applications and services to the cloud. The cloud offers scalability, operations and development efficiency and remote access benefits for their workforce. The cloud technology adoption is expected to continue to increase quite significantly in industries where the work-from-home initiative is helped to sustain enterprise business functions. However, shifting critical data to the cloud has resulted in security concerns and the need for enterprises to control access and gain visibility into how information is being used, who is accessing it and where it is going. Based on our estimates, using publicly available market data, we believe that the global cloud computing security market size is expected to grow from approximately $43.6 billion in 2022 to over $92.7 billion by 2028, at a CAGR of 13.4% during the forecast period. We believe our scalable technology allows enterprises to secure applications and services regardless of whether hosting is on-premise or in the cloud.

As billions of connected Internet of Things (“IoT”) devices come online in support of enterprise operations, products, and industrial controls they will need to be secured and integrated into the enterprise. Facilitated by advancements in 4G/Advanced LTE and high-speed 5G networks, IoT devices will be able to operate from any network, transmit higher volumes of data including video streaming and sensor data collection and require real-time decisions based on that data. Without next generation security, these IoT devices represent a large attack surface that manages and controls critical enterprise infrastructure. These IoT devices can operate from anywhere, and will need to be secured with the same level of network security and ZTNA solutions enterprises are already deploying for their remote workforce. We believe that the market opportunity for our software and technology solutions is large and expanding as secure domain names are now an integral part of securing the next generation 5G and 4G/LTE Advanced wireless networks and IoT communications. Based on our estimates, using publicly available market data, we believe that the size of the global Industrial IoT security market size is projected to grow from $4.76 billion in 2022 to approximately $23.17 billion by 2028 at a CAGR of 30.2% during the forecasted period with a growing investment in securing the infrastructure around these devices.

Our Approach & Strategy

We believe that VirnetX One™ software products are positioned to help enterprises adapt to the rapidly evolving threat landscape in work environments and the growing need to secure communications regardless of a user’s location, network, or device using our GABRIEL Connection Technology™.

VirnetX One™ products deliver ZTNA, allowing enterprises to secure their information, control access and gain visibility into how information is being used, who is accessing it and where it is going. Our patented technology allows enterprises to license our technology for integration into their products and services, easily deploy our technology through our VirnetX One™ family of products for endpoint security or securing their communications with our mobile and desktop applications.

Our strategy is to become the market leader in securing real-time communications over the Internet and to establish our VirnetX One™ and GABRIEL Connection Technology™ as the industry standard security platforms. Key elements of our strategy are to:

 
Direct sales efforts with larger users, particularly those engaged in defense and others govermental or national initiatives.


Actively recruit partners in various vertical markets, including healthcare, finance, legal, government to help us expand our enterprise customer base.


Promote our next-generation VirnetX One™ platform as a solution for delivering ZTNA, and securing enterprise applications, services, and infrastructure.


Combine with VirnetX One™ platform with technologies from the companies we have invested in, namely OmniTeq and OPMedia, to enhance their offerings and provide supplemental sales channels for VirnetX One™


Continue to grow our technology licensing program to commercialize our intellectual property, including our GABRIEL Connection Technology™.


Grow registration of VirnetX Secure Domain Names as the network segmentation component of our ZTNA solution. Establish VirnetX as the exclusive, universal registry of secure domain names and enable our customers to act as registrars for their users and broker secure communication between devices.


Promote War RoomTM video conferencing product in the general market for sale to end-user enterprises, directly and with partners, with targeted promotions and other marketing programs to assist remote workers and offer an industry leading secure meeting solution.


Promote VirnetX Matrix™ enterprise applications, services, and infrastructure.

Competitive Strengths

We believe the following competitive strengths will enable our success in the marketplace:


Unique patented technology. We are focused on developing innovative technology for securing real-time communications over the Internet and establishing the exclusive secure domain name registry in the United States and other key markets around the world. Our unique solutions combine industry standard encryption methods and communication protocols with our patented techniques for automated DNS lookup mechanisms. Our technology and patented approach enable users to create a secure communication link by generating secure domain names. We currently own approximately 205 total patents and pending applications, including 72 U.S. patents/patent applications and 133 foreign patents/validations/pending applications. Our portfolio includes patents and pending patent applications in the United States and other key markets that support our secure domain name registry service for the Internet.


Scalable licensing business model. We are actively engaged in pursuing additional licensing agreements with industry participants OEMs, service providers and system integrators within the IP-telephony, mobility, mobile-to-mobile communications, fixed-mobile convergence, and unified communications end-markets.


Highly experienced research and development team. Our research and development team is comprised of nationally recognized network security and encryption technology scientists and experts that have worked together as a team for over ten years. During their careers, this team has developed several cutting-edge technologies for U.S. national defense, intelligence, and civilian agencies, many of which remain critical to our national security today. Prior to joining VirnetX, our team worked for Leidos, during which time they invented the core technology that is the foundation of our current technology and software. Based on the collective knowledge and experience of our development team, we believe that we have one of the most experienced and sophisticated groups of security experts researching vulnerability and threats to real-time communication over the Internet and developing solutions to mitigate these problems.

License and Service Offerings

We offer a diversified portfolio of licenses, software and service offerings focused on securing real-time communications over the Internet. We believe software products will allow enterprises to seamlessly integrate ZTNA protection into their networks to secure their applications, services, virtualized resources, and data as it moves into the cloud. Enterprises can quickly deploy VirnetX One software products to protect legacy applications, secure new cloud-based services and remove application visibility from the public Internet. Enterprises can move towards more granular network access control to protect their network at the edge and away from legacy VPN technologies. VirnetX One family of software products enables remote employees to securely interact with on-premise and cloud-based applications, regardless of their location. Enterprises can use VirnetX One platform to secure open-source applications powering communications, data and analytics, infrastructure, and business services with a focus on making those applications easier to secure, access and manage.

We believe our software products and technologies provide the foundation for securing real-time communications and collaboration applications for the enterprise remote workforce. We are exploring creating a marketplace of applications secured by our VirnetX One platform. This approach will allow us to offer a portfolio of certified applications that can be deployed by the enterprise customers in their business networks with confidence in keeping their confidential data and communications secure. This marketplace strategy will allow us to offer more flexible licensing options to solve specific customer use-cases, align with partner product offerings and create upsell opportunities for our products.

Customers

We have undertaken activities to commercialize our products and intellectual property in and outside the United States including VirnetX OneTM, War RoomTM, VirnetX MatrixTM, GABRIEL Connection TechnologyTM and our Secured Domain Name Registry and Technology. We believe our product portfolio to secure devices and systems are stable in areas such as City, County and State Governments, Healthcare, Finance, Legal, Oil and Gas, Medical, Law Enforcement, National Defense and related support industries. We continue to actively pursue new sales opportunities in and one of United States.


During 2023, we actively engaged in discussions with certain third-parties to pitch the capabilities of VimetX OneTM. As a result of our efforts, we made a series of announcements with Solution Synergy, WeSecure, Samsung, Every Data Corporation, and Object Security We also announced new deployments of our VimetX MatrixTM product at City of Bridgeport, International Association of Certified ISAOs (IACI) and SkinWalker Ranch. Although there can be no assurance in this regard, the Company believes that there are opportunities for Company products' sales directly to, resale arrangements with and/or adoption as vendor standards by, one or more of these third parties.


We have signed Patent License Agreements with Aastra USA, Inc. Avaya, Inc., Microsoft Corporation, Mitel Networks Corporation, NEC Corporation and NEC Corporation of America, Siemens Enterprise Communications GmbH & Co. KG, and Siemens Enterprise Communications Inc. to license certain of our patents, for a one-time payment and an ongoing royalty for all future sales through the expiration of the licensed patents with respect to certain current and future IP-encrypted products.

We are seeking further licensing of our technology, to developers and original equipment manufacturers, or OEMs, of chips, servers, Desktop, mobile devices such as smart phones, tablets, laptops, net books, and other devices, within the IP-telephony, mobility, fixed- mobile convergence, and unified communications markets including 5G and 4G/LTE. We have published our royalty rates and guidelines on our website. All forward moving licenses have adhered to these guidelines and have met or exceeded these rates and we will use these rates and guidelines in all future license negotiations.

Marketing and Sales

We employ a leveraged, partner-oriented marketing and sales strategy for software product and services offerings. We have successfully signed several Resellers & Managed Service Provider Agreements in various market segments, including healthcare, finance, legal, government, etc., to assist us in selling our software products to their customers. We plan to directly market our software products, domain name registry services to large enterprises and government organizations along with our service provider and system integrator customers.

We believe significant opportunities exist for our VirnetX One™, War Room™, VirnetX Matrix™ products and services in areas such as Local and State Governments, Power and Energy generation, Healthcare, Finance, Legal, Oil and Gas, Medical, Law Enforcement, National Defense and related support industries. We are actively pursuing a number of sales opportunities, in and outside the United States, for as we seek to extend out our customer base globally. We expect to leverage our relationship with OmniTeq and Op Media to extend our offering to departments and agencies within the federal government.

We added a Chief Operating Officer to our Japanese team to further our technology licensing efforts in Japan. We have signed a non-exclusive Distribution and Service Agreement with IP Dream, a Japanese based strategic technology developer and service provider, to sell our software products as well as VirnetX’s Secure Domain Name technology to its clients in Japan and greater Asia. Jointly with IP Dream, we are currently pursuing several OEM opportunities with some of the largest services providers in Japan. Along with our efforts with IP Dream, we continue to explore alternative strategies to pursue opportunities to work with other third parties in Japan, and elsewhere, using an approach that will seek to capitalize on these opportunities in part by placing more emphasis on the use of our own employees.

We intend to continue to license our patent portfolio, technology, and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. We intend to seek further license of our technology and software products, to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, Desktop, mobile devices such as smart phones, tablets, laptops, net books, and other devices, within the IP-telephony, mobility, fixed- mobile convergence, and unified communications markets including 5G and 4G/LTE.

Intellectual Property and Patent Rights

Our intellectual property is primarily comprised of trade secrets, patented know-how, issued and pending patents, copyrights and technological innovation.

We currently own approximately 205 total patents and pending applications, including 72 U.S. patents/patent applications and 133 foreign patents/validations/pending applications. Our portfolio includes many patents that describe unique systems and methods for securing real- time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our software and technology solutions also may have additional applications relating to operating systems and network security. A complete list of our U.S. patents is available on our website located at http://www.virnetx.com. Each patent is publicly accessible on U.S. Patent and Trademark Office website at http://www.uspto.gov. Some of our issued U.S. and foreign patents expire at various times during the period from 2023 to 2034.

Notwithstanding anything to the contrary set forth in any of our filings under the Securities Act or the Exchange Act that might incorporate future filings, the information set forth on the United States Patent and Trademark Office (the “USPTO”) website, shall not be deemed to be a part of or incorporated by reference into any such filings. We do not warrant the accuracy, completeness or adequacy of the USPTO website, and expressly disclaim liability for errors or omissions on such website.

Assignment of Patents

Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Leidos, pursuant to an Assignment Agreement dated December 21, 2006, and a Patent License and Assignment Agreement dated August 12, 2005, as amended on November 2, 2006, including documents prepared pursuant to the November amendment, and as further amended on March 12, 2008. We recorded the assignment from Leidos, with the U.S. Patent Office on December 21, 2006.

Key terms of these agreements are as follows:


Patent Assignment. Leidos, unconditionally and irrevocably conveyed, transferred, assigned, and quitclaimed all its right, title, and interest in and to the patents and patent applications, as specifically set forth in the assignment document recorded with the U.S. Patent Office, including, without limitation, the right to sue for past infringement.


License to Leidos, Outside the Field of Use. Effective March 12, 2008, we granted to Leidos, a non-exclusive, royalty free, fully paid, perpetual, worldwide, irrevocable, sub licensable and transferable right and license permitting Leidos, and its assignees to make, have made, import, use, offer for sale, and sell products and services covered by, and to make improvements to, the patents and patent applications we acquired from Leidos, solely outside our field of use.


Compensation Obligations. As consideration for the assignment of the patents and for the rights we obtained from Leidos, as amended, we are required to make payments to Leidos, based on cash or certain other values generated from those patents. The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations. In 2010, we met our maximum royalty payment requirement; however, Leidos is also entitled under certain circumstances to receive a portion of the proceeds paid to us for certain acquisitions of VirnetX and the settlement of certain patent infringement claims of ours.

Government Regulation

We are subject to various federal, state, local, and foreign laws and regulations, including those relating to privacy, data protection and security, intellectual property, employment and labor, workplace safety, consumer protection, anti-bribery, import and export controls, immigration, federal securities, and tax. Additional laws and regulations relating to these areas likely will be passed in the future, and these or existing laws and regulations may be interpreted or enforced in new or expanded manners, each of which could result in significant limitations on how we operate our business.

In particular, the laws governing online secure communications remain unsettled in various respects, even in areas where there has been legislative action. Uncertainty regarding the interpretation and enforcement of laws governing matters such as intellectual property, privacy, data protection and libel in the context of online communications and media is likely to remain. New and existing legislation, or changes in its interpretation and enforcement, may interfere with the growth in use of online secure communications and decrease the acceptance of online secure communications as a viable solution, which could adversely affect our business.

Due to the Internet’s increasing and evolving use, new laws regulating secure communications may be adopted. These laws and regulations may cover, among other things, issues relating to privacy, data protection, cybersecurity, pricing, taxation, telecommunications over the Internet, content, copyrights, distribution and quality of products and services. We intend to work to comply with all new applicable laws and regulations as they are adopted and put in force. New and evolving laws and regulations, and changes in their enforcement and interpretation, may have material impacts upon our development and commercialization plans or business practices, and may significantly increase our compliance costs and otherwise adversely affect our business, financial condition, and results of operations.

The U.S. government has controlled the authoritative domain name system, or DNS, root server since the inception of the Internet. On July 1, 1997, the President of the United States directed the U.S. Secretary of Commerce to privatize the management of the domain name system in a manner that increases competition and facilitates international participation in its management.

On September 29, 2006, the U.S. Department of Commerce extended its delegation of authority by entering into a new agreement with the Internet Corporation for Assigned Names and Numbers, or ICANN, a California non-profit corporation headquartered in Marina Del Rey, California. ICANN is responsible for managing the accreditation of registry providers and registrars that manage the assignment of top- level domain names associated with the authoritative DNS root directory. Although it is possible to create and manage other DNS root directories privately without accreditation from ICANN, the possibility of conflicting name and number assignments makes it less likely that users would widely adopt a top-level domain name associated with an alternative DNS root directory provided by a non-ICANN- accredited registry service.

Employees and Human Capital

As of December 31, 2023, we had 27 full and part time employees, most of whom work remotely from our corporate offices. We have had a work-from-home workforce since our inception. The emphasis of our employees is on our technology research and product development with 14 employees focused on this effort. Our team has been working on enhancing our products and adding new functionality along with successfully filing several new patent applications in 2022. We also continue building our sales and marketing teams to expand our product-lines and customer base. In 2024, the Chief Operating Officer to our team in Japan was promoted to Chief Operating Officer of the Company, who will be focused on growing our operations, expanding the Company's line of security products into Japan as well as the broader Pacific Rim, and transacting with military-affiliated partners within the United States to facilitate the collaborative development of next-generation cybersecurity and protective artificial intelligence solutions.

In addition to our regular employees, we also engage with consultants on a regular basis. These consultants can be involved in our product development, customer relations, legal, and/or regulatory compliance and reporting. We have experienced low employee turnover rates over the years with both employees and consultants participating in our equity incentive plan.

Available Information

We file or furnish various reports, such as registration statements, periodic and current reports, proxy statements and other materials with the SEC. Our website address is http://www.virnetx.com. You may obtain, free of charge on our website, copies of our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information we post is intended for reference purposes only; none of the information posted on our website is part of this report or incorporated by reference herein.

The SEC also maintains website at http://www.sec.gov that contains reports, proxy and other information statements, and other information regarding issuers, including us, that file electronically with the SEC.

Item 1A. Risk Factors

Our operations and financial results are subject to various risks and uncertainties, including those described below, which could adversely affect our business, financial condition, results of operations, cash flows, and the trading price of our common and capital stock. You should carefully consider the risks and uncertainties described below in addition to the other information set forth in this Report, including in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes, before making any investment in our common stock. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. If any of these risk factors occur, you could lose substantial value or your entire investment in our shares.

Summary Risk Factors

An investment in our common stock involves a high degree of risk, and the following is a summary of key risk factors when considering an investment.
 
You should read this summary together with the more detailed description of each risk factor contained in the subheadings further below.
 

Long and unpredictable sales cycles.
 

We have limited technical resources and are at an early stage in commercialization of our products.
 

Intensely competitive market with established brand names.
 

Our business has been, and may continue to be, negatively affected by shareholders intent upon alternate business strategies.
 

Our products are subject to governmental export and import controls that could subject us to liability or impair our ability to compete in international markets.
 

If we are not able to adequately protect our patent rights and trade secrets, our business would be negatively impacted.
 
Risks Related to Our Business and Our Financial Reporting
 
Our operating results may not be consistent and may be difficult to predict and we may not be able to achieve or sustain profitability in the future.
 
Our operating results have fluctuated in the past due to several factors. We expect that our future operating results may also fluctuate due to the same or similar factors. We had a net loss of $27.9 million for the year ended December 31, 2023. We had a net loss of $36.3 million for the year ended December 31, 2022. As of December 31, 2023, we had an accumulated deficit of $186 million. The following include some of the factors that may cause our operating results to fluctuate:
 

Time and resources required to accelerate transition to new product development and sales strategies targeting large enterprises and government customers;
 

Customer adoption of our VirnetX OneTM platform and software products and services;
 

The number of product license sales of VirnetX Warroom, VirnetX Matrix and associated services;
 

Adoption of VirnetX OneTM platform by third party application providers of secure communications;
 

Intensely competitive market with established brands that have larger customer bases, and greater resources than we do;
 

Prolonged economic uncertainties or downturns, globally or in certain regions or industries, could materially adversely affect our business;
 

Government export and import control regulations on selling products with encryption technology in certain international markets;
 
These fluctuations may make our business particularly difficult to manage, adversely affect our business and operating results, make our operating results difficult for investors to predict and, further, cause our results to fall below investor’s expectations and adversely affect the market price of our common stock. If we fail to increase our revenue to offset any increases in our operating expenses, we may not achieve or sustain profitability in the future.

We expect that we will experience long and unpredictable sales cycles, which may impact our operating results.
 
The sales cycle between initial customer contact and execution of a contract or license agreement with a customer or purchaser of our products can vary widely. We expect that our sales cycles will be long and unpredictable due to several factors, including but not limited to:
 

The need to educate potential customers about our patent rights and our product and service capabilities;
 

Our customers’ willingness to invest potentially substantial resources and modify their network infrastructures to take advantage of our products;
 

Our customers’ budgetary constraints and timing of their budget cycles;
 

Delays caused by customers’ internal review processes; and
 

Long sales cycles may increase the risk that our financial resources are exhausted before we are able to generate significant revenue.
 
In addition, potential customers of our products include local, state, federal and foreign government authorities. Sales to government authorities can be extensive and unpredictable. Government authorities generally have complex budgeting, purchasing, and regulatory processes that govern their capital spending, and their spending is likely to be adversely impacted by economic conditions. In addition, in many instances, sales to government authorities may require field trials and may be delayed by the time it takes for government officials to evaluate multiple competing bids, negotiate terms, and award contracts.
 
For these reasons, the sales cycle associated with our products is subject to a number of significant risks that are beyond our control. Consequently, if customer orders are not realized or delayed, our revenues and results of operations could be materially and adversely affected.
 
We have limited technical resources and are at an early stage in commercialization of our VirnetX One™ platform and software products.
 
Part of our business includes the internal development of commercial products we seek to monetize. This aspect of our business may require significant capital, time and resources and we cannot guarantee that it will be successful or meet our expectations. Based on the scale of our technical resources, our limited historical financial data upon which to base our projected revenue or planned operating expenses related to our software products and services, we may not be able to effectively:
 
Implement an effective marketing strategy to promote awareness of our products;
 
Attract and retain customers for our products;
 
Generate revenues or profit from product sales;
 
Provide appropriate levels of customer training and technical support for our products;
 
Rapidly anticipate and adapt to changes in the market and evolving customer requirements;
 
Protect our products from any system failures or other breaches.
 
In addition, a high percentage of our expenses are and will continue to be fixed. Accordingly, if we do not generate revenue as and when anticipated, our losses may be greater than expected and our operating results will suffer.

10

The market in which we participate is intensely competitive, and if we do not compete effectively, our operating results could be harmed.
 
The market for Zero Trust Network Access (“ZTNA”) security solutions is rapidly evolving and highly competitive as new entrants and traditional network solutions companies offer cloud-based cybersecurity solutions. Many of our competitors and potential competitors have established brand recognition, larger customer bases, and greater resources than we do. Our primary competitors in the zero-trust network access market include Appgate, Cloudflare, and Illumio. In the enterprise market, our primary competitors include Zscaler (ZPA), Palo Alto Networks (Prisma Access), Cisco (Umbrella), Citrix (Secure Private Access), Netskope (Private Access for ZTNA) and Cato Networks. As we expand our product offerings and use cases, we will begin to compete with companies that offer bundled security-as-a-service solutions that include Secure Access Service Edge (SASE) and Security Service Edge (SSE). With the introduction of new technologies and market entrants, we expect competition to intensify in the future. For example, disruptive technologies such as generative AI may fundamentally alter the market for our services in unpredictable ways and reduce customer demand. If we fail to compete effectively, our business will be harmed. Some of our competitors offer their products or services at lower prices or for free as part of a broader bundled product sale or enterprise license arrangement, which has placed pricing pressure on our business. If we are unable to achieve our target pricing levels, our operating results will be negatively impacted. For us to compete effectively, we need to introduce new products and services in a timely and cost-effective manner, meet customer expectations and needs at prices that customers are willing to pay, and continue to enhance the features and functionalities of our cloud content management platform. In addition, pricing pressures and increased competition could result in reduced sales, lower margins, losses or the failure of our services to achieve or maintain widespread market acceptance, any of which could harm our business.
 
Many of our competitors are able to devote greater resources to the development, promotion and sale of their products or services. In addition, many of our competitors have established marketing relationships and major distribution agreements with channel partners, consultants, system integrators and resellers. Competitors may offer products or services at lower prices or with greater depth than our services. Our competitors may be able to respond more quickly and effectively to new or changing opportunities, technologies, standards or customer requirements. Furthermore, some potential customers, particularly large enterprises, may elect to develop their own internal solutions. For any of these reasons, we may not be able to compete successfully against our competitors.
 
Our success depends in part on establishing and maintaining relationships with other companies to distribute our technology and products or to incorporate our products and services, into their technology or vice versa.
 
Part of our business strategy is to enter into partnerships, strategic investments, and other cooperative arrangements with third parties. We have invested in and we continue to seek to invest in or acquire businesses, technologies, or other assets that we believe could complement or expand our business. In addition, we are regularly involved in cooperative efforts with respect to the incorporation of our products into products of others and vice versa, research and development efforts, and marketing, distributor and reseller arrangements. These relationships are generally non-exclusive, and some of our partners also have cooperative relationships with certain of our competitors or offer some products and services that are competitive with ours. If we lose third-party relationships, if these relationships are not commercially successful, or if we are unable to enter into third-party relationships on commercially reasonable terms in the future, our business could be negatively impacted.

11

Our products are highly technical and may contain undetected errors, which could cause harm to our reputation and adversely affect our business.
 
Our products are highly technical and complex and, when deployed, may contain errors or defects. Despite testing, some errors in our products may only be discovered after a product has been installed and used by customers. Any errors or defects discovered in our products after commercial release could result in failure to achieve market acceptance, loss of revenue or delay in revenue recognition, loss of customers and increased service and warranty cost, any of which could adversely affect our business, operating results, and financial condition. In addition, we could face claims for product liability, tort, or breach of warranty, including claims relating to changes to our products made by our channel partners. The performance of our products could have unforeseen or unknown adverse effects on the networks over which they are delivered as well as on third-party applications and services that utilize our services, which could result in legal claims against us, harming our business. Furthermore, we expect to provide implementation, consulting, and other technical services in connection with the implementation and ongoing maintenance of our products, which typically involves working with sophisticated software, computing, and communications systems. We expect that our contracts with customers will contain provisions relating to warranty disclaimers and liability limitations, which may not be upheld. Defending a lawsuit, regardless of its merit, is costly and may divert management’s attention and adversely affect the market’s perception of us and our products. In addition, if our business liability insurance coverage proves inadequate or future coverage is unavailable on acceptable terms or at all, our business, operating results, and financial condition could be adversely impacted.
 
Malfunctions of third-party communications infrastructure, hardware and software expose us to a variety of risks that we cannot control.
 
Our business will depend upon, among other things, the capacity, reliability, security, and unimpeded access of the infrastructure owned by third parties that we will use to deploy our offerings. We have no control over the operation, quality, or maintenance of a significant portion of that infrastructure or whether those third parties will upgrade or improve their equipment. We depend on these companies to maintain the operational integrity of our connections. If one or more of these companies is unable or unwilling to supply or expand its levels of service to us in the future, our operations could be severely interrupted. Also, to the extent that the number of users of networks utilizing our current or future products suddenly increases, the technology platform and secure hosting services which will be required to accommodate a higher volume of traffic may result in slower response times or service interruptions. System interruptions or increases in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users. In addition, users depend on real-time communications; outages caused by increased traffic could result in delays and system failures. These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners, and customers.
 
System failure or interruption or our failure to meet increasing demands on our systems could harm our business.
 
The success of our license and service offerings will depend on the uninterrupted operation of various systems, secure data centers and other computer and communication networks that we establish. To the extent, the number of users of networks utilizing our future products suddenly increases, the technology platform and hosting services which will be required to accommodate a higher volume of traffic may result in slower response times, service interruptions or delays or system failures. Our systems and operations will also be vulnerable to damage or interruption from, among other things:
 
12

Power loss, transmission cable cuts and other telecommunications failures;
 
Damage or interruption caused by fire, earthquake, and other natural disasters;
 
Computer viruses, electronic break-ins, sabotage, vandalism or software defects; and
 
Physical or electronic break-ins, sabotage, intentional acts of vandalism, terrorist attacks and other events beyond our control.
 
System interruptions or failures and increases or delays in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users. These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners, and customers, and result in lost revenue, customer dissatisfaction, or lawsuits against us.
 
Our business has been, and may continue to be, negatively affected by shareholders intent upon alternate business strategies.
 
Responding to actions by activist shareholders is costly and time-consuming, has diverted the attention of management, our board of directors and our employees, and may be disruptive to our operations. Additionally, perceived uncertainties as to our future direction as a result of shareholder activism may lead to the perception of a change in the direction of our business or other instability, which may be exploited by our competitors, cause concern to our current or potential customers, and make it more difficult to attract and retain qualified personnel. Furthermore, if customers choose to delay, defer or reduce transactions with us or do business with our competitors instead of us, then our business, financial condition and operating results would be adversely affected. In addition, our share price could experience periods of increased volatility as a result of shareholder activism.
 
If we are not able to adequately protect our patent rights and trade secrets, our business would be negatively impacted.
 
We believe our patents are valid, enforceable, and valuable. Notwithstanding this belief, third parties may make claims of infringement with respect to our products or services or invalidity claims with respect to our patents or become aware of our trade secrets by way of leaks from bad actors within or outside of our employee base or otherwise, and such claims could give rise to material cost for defense or settlement or both, and such claims or leaks could jeopardize or substantially delay a successful outcome of litigation we are or may become involved in, divert resources away from our other activities, limit or cease our related revenues, or otherwise materially and adversely affect our business. Additionally, several of our patents are currently, and other patents may in the future be, subject to USPTO post-grant inter partes review proceedings (“IPR”) which may result in all, or part of these patents being invalidated, or the claims of our patents being limited. Unfavorable or adverse outcomes in our litigation or IPRs or material leaks of trade secrets may result in losses, exhaustion of financial resources, reduction in our ability to protect our intellectual property rights, or other adverse effects, which could encumber our ability to develop and commercialize our products. Even if we are successful in protecting our intellectual property rights, they may not ultimately provide us with any competitive advantages and may be less valuable than we currently expect. These risks may be heightened in countries other than the United States where laws regarding patent protection are less developed and may be negatively affected by the fact that legal standards in the United States and elsewhere for protection of intellectual property rights in Internet-related businesses are uncertain and still evolving. In addition, there are a significant number of United States and foreign patents and patent applications in our areas of interest, and we expect that significant litigation in these areas will continue and will add uncertainty to the value of certain patents and other intellectual property rights in our areas of interest. If we are unable to protect our intellectual property rights or otherwise realize value from them, our business would be negatively affected.

13

If we experience security breaches or incidents, we could be exposed to liability and our reputation and business could suffer.
 
We expect to retain certain confidential and proprietary customer information in our secure data centers and secure domain name registry, as well as personal data and other confidential and proprietary information relating to our business. It will be critical to our business strategy that our facilities and infrastructure remain secure and are perceived by the marketplace to be secure. Our secure domain name registry operations will also depend on our ability to maintain our computer and telecommunications equipment in effective working order and to reasonably protect our systems against interruption, and potentially depend on protection by other registrars in the shared registration system. The secure domain name servers that we will operate will be critical hardware to our registry services operations. Additionally, we maintain confidential and proprietary business information, including trade secrets. We expect to have to expend significant time and money to maintain or increase the security of our products, facilities, and infrastructure. Security technologies are constantly being tested by computer professionals, academics and “hackers.” Advances in computer capabilities and the techniques for attacking security solutions, new discoveries in the field of cryptography or other events or developments could result in compromises or breaches of our security measures and could make some or all our products obsolete or unmarketable. Likewise, we may need to dedicate engineering and other resources to eliminate security vulnerabilities and may find it necessary or appropriate to repair or replace products already sold or licensed to our customers. Despite the security measures that we and our service providers utilize, our infrastructure and that of our service providers may be vulnerable to physical break-ins, ransomware, computer viruses, other malicious code attacks by hackers, phishing attacks, social engineering, or similar disruptive problems. Any disruption or security breach or incident that we or our service providers suffer or are perceived to suffer, including any such disruption, breach or incident resulting in a loss of, or damage to, data or systems, or inappropriate disclosure, access, loss, or other processing of confidential, financial, proprietary or personal information, including data related to our personnel, could result in loss, disclosure or other unauthorized processing of such data, could delay our research and development or commercialization efforts, could compel us to comply with breach notification laws and regulations, subject us to mandatory corrective action, and otherwise subject us to liability under laws and regulations that protect the privacy and security of personal information. It is possible that we may have to expend additional financial and other resources to address such problems. The increase in remote work by our personnel and those of third parties in recent years has resulted in increased vulnerability to cyber-attacks. As a provider of Internet security software and technology, we may be the target of dedicated efforts by hackers and other third parties to overcome or defeat our security measures. Any physical or electronic break-in or other security breach or incident or compromise impacting our products, or any information stored at our secure data centers and domain name registration systems, including any compromise due to human error or employee or contractor malfeasance, may jeopardize the security of information stored on our premises or in the computer systems and networks of our customers. Additionally, any such data security incident, or the perception that one has occurred could also result in adverse publicity, harm to our reputation and competitive position, and therefore adversely affect the market’s perception of the security of electronic commerce and communications over IP networks as well as the security or reliability of our services, which could have a material adverse impact on our business, financial condition, and results of operation.

14

A security breach or other security incident, or the perception any such event has occurred, could require a substantial level of financial resources to address and otherwise respond to, may be difficult to identify or address in a timely manner, and could result in claims, investigations, inquiries, and other proceedings or actions by private parties or governmental entities that may divert management’s attention and require the expenditure of significant time and resources, and which may cause us to incur substantial fines, penalties, or other liability and related legal and other costs. Any actual or perceived security breach or other security incident may also harm our reputation, result in a loss of customers, and make it more difficult or impossible for us to successfully market to others. Any of the foregoing matters could harm our business, operating results and financial condition.
 
Our products are subject to governmental export and import controls that could subject us to liability or impair our ability to compete in international markets.
 
Because we incorporate encryption technology into our products, certain of our products are subject to U.S. export controls and may be exported outside the U.S. only with the required export license or through an export license exception. If we were to fail to comply with U.S. export licensing requirements, U.S. customs regulations, U.S. economic sanctions, or other laws, we could be subject to substantial civil and criminal penalties, including fines, incarceration for responsible employees and managers, and the possible loss of export or import privileges. Obtaining the necessary export license for a particular sale may be time-consuming and may result in the delay or loss of sales opportunities. Furthermore, U.S. export control laws and economic sanctions prohibit the shipment of certain products to U.S. embargoed or sanctioned countries, governments, and persons. Even though we take precautions to ensure that we comply with all relevant regulations, any failure by us or any partners to comply with such regulations could have negative consequences for us, including reputational harm, government investigations, and penalties.
 
In addition, various countries regulate the import of certain encryption technology, including through import permit and license requirements, and have enacted laws that could limit our ability to distribute our products or could limit our end-customers’ ability to implement our products in those countries. Changes in our products or changes in export and import regulations may create delays in the introduction of our products into international markets, prevent our end-customers with international operations from deploying our products globally or, in some cases, prevent or delay the export or import of our products to certain countries, governments, or persons altogether. Any change in export or import regulations, economic sanctions, or related legislation, shift in the enforcement, or scope of existing regulations, or change in the countries, governments, persons, or technologies targeted by such regulations, could result in decreased use of our products by, or in our decreased ability to export or sell our products to, existing or potential end-customers with international operations. Any decreased use of our products or limitation on our ability to export to or sell our products in international markets would likely adversely affect our business, financial condition, and results of operations.

15

Privacy and data security concerns, data collection and transfer restrictions and related domestic or foreign regulations may limit the use and adoption of our solutions and adversely affect our business.
 
Personal privacy, information security, and data protection are significant issues in the United States, Europe, and many other jurisdictions where we have operations or offer our products. The regulatory framework governing the collection, processing, storage and use of confidential and proprietary business information and personal data is rapidly evolving. The United States federal and various state and foreign governments have adopted or proposed requirements regarding the collection, distribution, use, security and storage of personally identifiable information and other data relating to individuals, and federal and state consumer protection laws are being applied to enforce regulations related to the online collection, use and dissemination of data.
 
Further, many foreign countries and governmental bodies, including the European Union (“EU”), where we conduct business, have laws and regulations concerning the collection and use of personal data obtained from their residents or by businesses operating within their jurisdiction. These laws and regulations often are more restrictive than those in the United States. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage, disclosure, and security of data that identifies or may be used to identify or locate an individual, such as names, email addresses and, in some jurisdictions, IP addresses.
 
We also expect that there will continue to be new proposed laws, regulations and industry standards concerning privacy, data protection and information security in the United States, the EU, and other jurisdictions. For example, the European Commission adopted a General Data Protection Regulation (the “GDPR”) that became fully effective on May 25, 2018, superseding prior EU data protection legislation, imposing more stringent EU data protection requirements, and providing for greater penalties for noncompliance. The United Kingdom has enacted a Data Protection Act and legislation referred to as the UK GDPR that substantially implements the GDPR and provides for a penalty regime similar to the GDPR. We may be required to incur substantial expense in order to make significant changes to our product and business operations in connection with obtaining and maintaining compliance with the GDPR and similar legislation, such as the UK GDPR and UK Data Protection Act, all of which may adversely affect our revenue and product sales. California has enacted legislation, the California Consumer Privacy Act (the “CCPA”) that, among other things, requires covered companies to provide disclosures to California consumers, and afford such consumers abilities to opt-out of certain sales of personal information. The CCPA was modified and expanded by the California Privacy Rights Act (the “CPRA”), which was approved by California voters in the November 2020 election. Additionally, other U.S. states continue to propose, and in certain cases adopt, privacy-focused legislation. For example, Connecticut, Virginia, and Colorado have enacted legislation similar to the CCPA and CPRA that has taken effect in 2023; Utah has enacted such legislation that is effective as of December 31, 2023; Florida, Montana, Oregon, and Texas have enacted similar legislation that becomes effective in 2024; Delaware, Tennessee, and Iowa have enacted similar legislation that will take effect in 2025; and Indiana has enacted similar legislation that will become effective in 2026. We cannot yet fully determine the impact these or future laws, regulations and standards may have on our business, but they may require us to modify our data processing practices and policies and to incur substantial costs and expenses in efforts to comply. Privacy, data protection and information security laws and regulations are often subject to differing interpretations, may be inconsistent among jurisdictions, and may be alleged to be inconsistent with our current or future practices. Additionally, we may be bound by contractual requirements applicable to our collection, use, processing, and disclosure of various types of data, including personal data, and may be bound by, or voluntarily comply with, self-regulatory or other industry standards relating to these matters. These and other requirements could reduce demand for our products, increase our costs, impair our ability to grow our business, or restrict our ability to store and process data or, in some cases, impact our ability to offer our service in some locations and may subject us to liability. Any failure or perceived failure to comply with applicable laws, regulations, industry standards, and contractual obligations may adversely affect our business. Further, in view of new or modified federal, state, or foreign laws and regulations, industry standards, contractual obligations and other legal obligations, or any changes in their interpretation, we may find it necessary or desirable to fundamentally change our business activities and practices or to expend significant resources to modify our product and otherwise adapt to these changes. We may be unable to make such changes and modifications in a commercially reasonable manner or at all, and our ability to develop new products and features could be limited.

16

The costs of compliance with and other burdens imposed by laws, regulations and standards may limit the use and adoption of our service and reduce overall demand for it, or lead to significant fines, penalties, or liabilities for any noncompliance. Privacy, information security, and data protection concerns, whether valid or not valid, may inhibit market adoption of our platform, particularly in certain industries and foreign countries.
 
Risks Related to Ownership of Our Common Stock
 
We do not regularly pay dividends on our common stock and thus stockholders must look to appreciation of our common stock to realize a gain on their investments.
 
Our dividend policy is within the discretion of our Board of Directors and will depend upon various factors, including our business, financial condition, results of operations, capital requirements, and investment opportunities. We therefore cannot make assurances that our Board of Directors will determine to pay regular or special dividends in the future. Accordingly, unless our Board of Directors determines to pay dividends, stockholders will be required to look to appreciation of our common stock to realize a gain on their investment, which may not occur.
 
The exercise of our outstanding stock options, warrants, and RSUs would result in a dilution of our current stockholders’ voting power and an increase in the number of shares eligible for future resale in the public market which may negatively impact the market price of our stock.
 
The exercise of our outstanding vested stock options, warrants, and RSUs would dilute the ownership interests of our existing stockholders. As of December 31, 2023, we had outstanding options, warrants and RSUs to purchase an aggregate of 348,717 shares of common stock representing approximately 10% of our total shares outstanding of which 287,503 were vested and therefore exercisable. To the extent outstanding stock options or warrants are exercised, additional shares of common stock will be issued, existing stockholders’ percentage voting interests will decline and the number of shares eligible for resale in the public market will increase. Such increase may have a negative effect on the value or market trading price of our common stock.
 
Investors may have limited influence because ownership of our common stock is limited.
 
As of December 31, 2023, our executive officers and directors beneficially owned approximately 14% of our outstanding common stock. Because of their beneficial ownership interest, our officers and directors could significantly influence stockholder actions of which you disapprove or that are contrary to your interests. This ability to exercise significant influence could prevent or significantly delay another company from acquiring or merging with us.

17

Our protective provisions in our Amended and Restated Certificate of Incorporation and bylaws could make it difficult for a third party to successfully acquire us even if you would like to sell your stock to them.
 
We have protective provisions in our Amended and Restated Certificate of Incorporation and bylaws that could delay, discourage, or prevent a third party from acquiring control of us without the approval of our Board of Directors. These protective provisions include:
 
A staggered Board of Directors: Only one or two directors (of our five-person Board of Directors) will be up for election at any given annual meeting. This delays the ability of stockholders to affect a change in control of us because it would take two annual meetings to effectively replace a majority of the Board of Directors.
 
Blank check preferred stock: Our Board of Directors has the authority to establish the rights, preferences, and privileges of our 10,000,000 authorized, but unissued, shares of preferred stock. Therefore, this stock may be issued at the discretion of our Board of Directors with preferences over your shares of our common stock in a manner that is materially dilutive to you. In addition, blank check preferred stock can be used to create a “poison pill” which is designed to deter a hostile bidder from buying a controlling interest in our stock without the approval of our Board of Directors. We have not adopted such a “poison pill;” but our Board of Directors can do so in the future, very rapidly and without stockholder approval.
 
Advance notice requirements for director nominations and for business to be brought before stockholder meetings: Stockholders wishing to submit director nominations or raise matters to a vote of the stockholders must provide notice to us within very specific date windows and in very specific form to have the matter voted on at a stockholder meeting. This gives our Board of Directors and management more time to react to stockholder proposals generally and could also permit us to disregard a stockholder proposal to the extent such proposal is not submitted in accordance with the bylaws.
 
No stockholder actions by written consent: No stockholder or group of stockholders may take action by written consent. Along with the advance notice requirements described above, this provision also gives our Board of Directors and management more time to react to proposed stockholder actions.
 
Super majority requirement for stockholder amendments to the bylaws: Stockholder proposals to alter or amend our bylaws or to adopt new bylaws can only be approved by the affirmative vote of at least 66 2/3% of the outstanding shares of our common stock.
 
No ability of stockholders to call a special meeting of the stockholders: A special meeting of the stockholders, other than as required by statute, may be called at any time by the Board of Directors, or by the chairman of the board, or by the president, and any power of stockholders to call a special meeting of stockholders is specifically denied. Accordingly, stockholders, even those who represent a significant percentage of our shares of common stock, may need to wait for the annual meeting before nominating directors or raising other business proposals to be voted on by the stockholders.
 
In addition, the provisions of Section 203 of the Delaware General Corporation Law govern us. These provisions may prohibit large stockholders, particularly those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time.

18

These and other provisions in our Amended and Restated Certificate of Incorporation, our bylaws and under Delaware law could discourage potential takeover attempts, reduce the price that investors might be willing to pay for shares of our common stock in the future and result in the market price being lower than it would be without these provisions.
 
Our amended and restated bylaws designate a state or federal court located within the State of Delaware as the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to choose the judicial forum for disputes with us or our directors, officers, or employees.
 
Our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (1) any derivative action or proceeding brought on our behalf, (2) any action asserting a claim of breach of a fiduciary duty owed by any of our directors, stockholders, officers, or other employees to us or our stockholders, (3) any action arising pursuant to any provision of the Delaware General Corporation Law, or our amended and restated certificate of incorporation or amended and restated bylaws or (4) any other action asserting a claim that is governed by the internal affairs doctrine shall be the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware), in all cases subject to the court having jurisdiction over indispensable parties named as defendants.
 
However, notwithstanding the exclusive forum provisions, our amended and restated bylaws explicitly state that they would not preclude the filing of claims brought to enforce any liability or duty created under federal securities laws, including the Securities Act or the Exchange Act.
 
Any person or entity purchasing or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to this provision. This exclusive-forum provision may limit a stockholder’s ability to bring a claim in a judicial forum of its choosing for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers, and other employees. If a court were to find this exclusive-forum provision in our amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could harm our results of operations.
 
General Risk Factors
 
We may need to raise additional capital to support our business growth, and this capital may be dilutive, may cause our stock price to drop or may not be available on acceptable terms, if at all.
 
We may need to raise additional capital, which may not be available to us when needed or may not be available on terms acceptable to us, to support our business growth or to respond to business opportunities, challenges, or unforeseen circumstances, including sales under our past and any future shelf registration statements. Our ability to obtain additional capital, if and when required, will depend on our business plans, investor demand, our operating performance, the condition of the capital markets, the terms of our current contractual obligations and other factors.

19

If we raise additional funds through the issuance of equity, equity-linked or debt securities, including those under our past and any future shelf registration statements, those securities may have rights, preferences, or privileges senior to the rights of our common stock, and our existing stockholders may experience dilution. Additionally, we are unable to predict the future success of any future offerings. Sales of a substantial number of shares of our common stock in the public market, or the perception that these sales or other financings might occur, could depress the market price of our common stock, and could also impair our ability to raise capital through the sale of additional equity securities. If we issue debt securities or incur indebtedness, we could experience increased future payment obligations and a need to comply with restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. If we are unable to obtain additional capital or are unable to obtain additional capital on satisfactory terms, our ability to continue to support our business growth or to respond to business opportunities, challenges, or other circumstances could be adversely affected, and our business may be harmed.
 
The departure of Kendall Larsen, our Chief Executive Officer and President, and/or other key personnel could compromise our ability to execute our strategic plan and materially harm our business.
 
Our success depends on the skills, experience, and performance of our key personnel. Due to the specialized nature of our business and limited staff, we are particularly dependent on Kendall Larsen, our Chief Executive Officer and President. We have no employment agreements with any of our key executives that prevent them from leaving us at any time. In addition, we do not maintain key person life insurance for any of our officers or key employees. The loss of Mr. Larsen, or our failure to retain other key personnel or plan for the succession of key personnel, would jeopardize our ability to execute our strategic plan and materially harm our business.
 
We will need to recruit and retain additional qualified personnel to successfully grow our business.
 
Our future success will depend, in part, on our ability to attract and retain qualified engineering, operations, marketing, sales and executive personnel. Inability to attract and retain such personnel could adversely affect our business. Competition for engineering, operations, marketing, sales, and executive personnel is intense, particularly in the technology and Internet sectors and in the regions where we conduct our business. We may need to invest significant amounts of cash and equity to attract and retain employees and expend significant time and resources to identify, recruit, train and integrate such employees, and we may never realize returns on these investments. Additionally, we can provide no assurance that we will attract or retain such personnel.
 
War, terrorism, other acts of violence, or natural or manmade disasters as well as macroeconomic conditions may affect the markets in which we operate, our clients and our service delivery.
 
Our business may be adversely affected by instability, disruption, or destruction in a geographic region in which we operate, regardless of cause, including war, terrorism, riot, civil insurrection, or social unrest, and natural or manmade disasters, including famine, flood, fire, earthquake, storm, or pandemic events and spread of disease, such as the COVID-19 pandemic. Our business may also be adversely affected by further downturn in macroeconomic conditions, including inflation and rising interest rates, global political and economic uncertainty and tensions, such as the ongoing Russia-Ukraine and Israel-Hamas conflicts as well as any related political or economic response, counter responses or otherwise, financial services sector instability, a reduction in business confidence and activity, financial market volatility, and other factors. Such events can adversely affect our operations or the economy as a whole and may cause our customers to delay their decisions on spending for the services we provide and perpetuate significant changes in regional and global economic conditions and cycles. These events may also pose risks to our personnel and to physical facilities and operations, which could adversely affect our financial results.

20

Trading in our common stock is limited and the price of our common shares may be subject to volatility.
 
Our common stock is currently listed on the NYSE and was previously listed on the NYSE American LLC (formerly the NYSE MKT LLC). Over the past years, the market price of our common stock has experienced significant fluctuations. Between January 1, 2023, and December 31, 2023, the adjusted closing price on the NYSE for our common stock ranged between $3.53 and $12.60, adjusted for a 1-for-20 reverse stock split effective October 26, 2023. The price of our common stock may continue to be volatile as a result of several factors, some of which are beyond our control. These factors include, but not limited to, the following:
 
Annual variations, actual or anticipated, in our operating results;
 
Significant changes in our management;
 
Large purchases or sales of common stock or derivative transactions related to our stock;
 
Actual or anticipated announcements of new products or services by us or competitors;
 
General conditions in the markets in which we compete; and
 
General social, political, economic, and financial conditions, including the significant volatility in the global financial markets.
 
In addition, we believe there has been and may continue to be substantial trading in derivatives of our stock, including short selling activity or related similar activities, which are beyond our control, and which may be beyond the full control of the SEC and Financial Institutions Regulatory Authority or “FINRA.” While the SEC and FINRA rules prohibit some forms of short selling and other activities that may result in stock price manipulation, such activity may nonetheless occur without detection or enforcement. We have held conversations with regulators concerning trading activity in our stock; however, there can be no assurance that should there be any illegal manipulation in the trading of our stock, it will be detected, prosecuted, or successfully eradicated. Significant short selling market manipulation could cause our stock trading price to decline, to become more volatile, or both. For more information regarding trading in our common stock and listing on the NYSE, see additional risk factors included elsewhere in this Annual Report on Form 10-K.
 
We have broad discretion in how we apply our funds, and we may not use these funds effectively, which could affect our results of operations and cause our stock price to decline.
 
Our management has broad discretion in the application of our existing cash, cash equivalents and investments and could spend these funds in ways that do not improve our results of operations or enhance the value of our common stock. Pending their use, we may invest our available funds in a manner that does not produce income or that loses value. The failure by our management to apply our available funds effectively could result in financial losses that could cause the price of our common stock to decline and delay the development of our products.
 
In addition, an entity that, among other things, is or holds itself out as being engaged primarily, or proposes to engage primarily, in the business of investing, reinvesting, owning, trading, or holding certain types of securities would be deemed an Investment Company under the Investment Company Act of 1940 (the “1940 Act”). If we do not manage our investments and business in a manner that meets the requirements for an exemption under the 1940 Act, we may be deemed to be an investment company under the 1940 Act and subject to additional limitations on operating our business including limitations on the issuance of securities, which may make it difficult for us to raise capital.

21

Item 1B.
Unresolved Staff Comments

None.

22

Item 1C.
Cybersecurity

Cybercriminals, hackers, and threat-actors are becoming more sophisticated and effective every day. To mitigate threats to our business, we take a comprehensive approach to cybersecurity risk management and make securing the data that our customers and other stakeholders entrust to us a top priority. We are committeed to safeguarding the confidentiality, integrity, and availability of all physical and electronic information assets to ensure that regulatory, operational, and contractual requirements are fulfilled. Our board of directors (the “Board”) and our management are actively involved in the oversight of our risk management program, of which cybersecurity represents an important component. As described in more detail below, we have established policies, processes and practices for assessing, identifying, and managing material risks from cybersecurity threats. We have devoted significant resources to implement and maintain security measures to meet regulatory requirements and customer expectations, and we intend to continue to make significant investments to maintain the security of our data and cybersecurity infrastructure. Notwithstanding the extensive approach we take to cybersecurity, we may not be successful in preventing or mitigating a cybersecurity incident that could have a material adverse effect on us.  While we have technology and processes in place to detect and respond to cybersecurity threats, we are continually at risk from the evolving cybersecurity threat landscape. We have not previously experienced a cybersecurity event that was determined to be material, and our business strategy, results of operations and financial condition have not been materially affected by risks from cybersecurity threats. For additional information regarding risks from cybersecurity threats, please refer to Item 1A, “Risk Factors,” in this Annual Report on Form 10-K.
 
Risk Management and Strategy

We have developed detailed policies, processes and practices for assessing, identifying, and managing material risks from cybersecurity threats as a part of our overall risk management program and are based on frameworks established by the National Institute of Standards and Technology (“NIST”), and other applicable industry standards. This does not imply that we meet any particular technical standards, specifications or requirements, however, we do use these frameworks as a guide to help us identify, assess, and manage cybersecurity risks relevant to our business. Our cybersecurity program in particular focuses on the following key areas:

Collaboration

Our cybersecurity risks are identified and addressed through a comprehensive, cross-functional approach. Key security, risk, and compliance stakeholders meet regularly to develop strategies for preserving the confidentiality, integrity and availability of our own and our customer’s information, identifying, preventing and mitigating cybersecurity threats, and effectively responding to cybersecurity incidents. We maintain controls and procedures that are designed to ensure prompt escalation of certain cybersecurity incidents so that decisions regarding such incidents can be made by management, the Board, and legal counsel in a timely manner.

Risk Assessment

We conduct cybersecurity risk assessments annually, quarterly and upon certain triggering events. Such risk assessments take into account information from internal stakeholders, known information security vulnerabilities, and information from external sources (e.g., reported security incidents that have impacted other companies, industry trends, and recommendations from our IT vendors). The results of the assessment are used to drive alignment on, and prioritization of, initiatives to enhance our security controls, make recommendations to improve processes, and inform a broader enterprise-level risk assessment that is presented to our Board and members of senior management.

Technical Safeguards

We regularly assess and deploy technical safeguards designed to protect our information systems and infrastructure from cybersecurity threats. Such safeguards are regularly evaluated and improved based on vulnerability assessments, cybersecurity threat intelligence and incident response experience.

Incident Response and Recovery Planning

We have established comprehensive incident response and management plans and continue to regularly test and evaluate the effectiveness of those plans. Our incident response and management plans address — and guide our employees, management, and Board on — our response to a cybersecurity incident. In the event of an incident, we intend to follow our incident response playbook, which outlines the steps to be followed from incident detection to mitigation, recovery and notification, including notifying functional areas (e.g., legal), as well as the Board and senior management, as appropriate.

Third-Party Risk Management

We have implemented controls designed to identify and mitigate cybersecurity threats associated with our use of third-party service providers. Such providers are subject to security risk assessments at the time of onboarding, contract renewal, and upon detection of an increase in risk profile. We use a variety of inputs in such risk assessments, including information supplied by providers and third parties. In addition, we encourage our providers to meet appropriate security procedures, controls and responsibilities and investigate security incidents that have impacted our third-party providers, as appropriate.

Education and Awareness

Our policies require each of our employees to contribute to our cybersecurity efforts. We regularly remind employees of the importance of handling and protecting customer and employee data, including through privacy and security trainings to enhance employee awareness of how to detect and report cybersecurity threats and cybersecurity incidents.

Governance

Board Oversight

The Nominating and Corporate Governance Committee (the “Committee”) and senior management oversee our cybersecurity risk processes and policies. The Committee receives regular reports from senior management about the prevention, detection, mitigation, and remediation of cybersecurity incidents, including security risks and information security vulnerabilities. The Committee also ensures that procedures for safeguarding the Company’s information technology (“IT”) systems are documented and implemented, monitors the effectiveness of the Company’s cybersecurity program for protecting against internal and external threats as well as disaster recovery and disruption mitigation, and addresses deficiencies as the threat and business landscape continues to evolve. The Board receives regular updates from the Committee based on such oversight and communications with senior management regarding cybersecurity risk resulting from risk and control maturity assessments, progress of risk reduction initiatives, external auditor feedback and relevant internal and industry cybersecurity incidents.

Our Board has technical and industry expertise in risk management, computer security and information technology matters. Specifically, the chairperson of the Committee has 39 years of experience in the cybersecurity field, is a former sub-chairman of the NIST Board of Assessment for Programs/National Research Council and holds CISSP and CRISC certifications.

Management’s Role

Our chief technology officer (“CTO”), Director of IT (Information Technology), Director of SecDevOps (Security, Development Operations) (collectively, the “Security Team”) have primary responsibility for assessing and managing cybersecurity risks. The Security Team reviews security performance metrics, identifies security risks, and assesses the status of approved security enhancements. The Security Team also considers and makes recommendations on security policies and procedures, security service requirements, and risk mitigation strategies.

Our CTO has served in various roles in information technology and information security for over 30 years, He holds a PhD in Information Technology and has been with VirnetX since 2007. Our Director of IT has served in various roles in information technology for 29 years. He holds degree in Computer Technology. Our SecDevOps Director has served in various roles in information technology and information security for over 33 years.
 
23

Item 2.
Properties

Our principal executive offices are located at 308 Dorla Court, Suite 206, Zephyr Cove, Nevada, 89448. We lease this property, which comprises approximately 2,090 square feet of office space, from a third party for a term that ends in October 2025. Additionally, we lease a facility in Farmington, Utah. The space includes 28,970 square feet to be used for technical integration and training. The lease continues through April 2029. We believe that our office and facility leases are suitable and appropriately support our current business needs.

Item 3.
Legal Proceedings

See Note 12 in the notes to our consolidated financial statements.

Item 4.
Mine Safety Disclosure

Not applicable.

24

PART II

Item 5.
Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common stock currently trades under the symbol “VHC” on the NYSE.

Holders of Record

As of December 31, 2023, we had 41 stockholders of record. Because many of our shares of common stock are held of record by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of beneficial stockholders represented by such record holders.

Dividend Policy

See Note 8 in the notes to our consolidated financial statements.

Since our founding as a public company in 2007, each time we have been successful in generating cash relating to the successful outcome of litigation, we have made a special distribution to common shareholders. In 2010, a distribution of $10 per common share closely followed a litigation outcome that resulted in our receipt of $200 million. In 2020, a distribution of $20.00 per share closely followed a litigation outcome that resulted in our receipt of $454 million. In 2023, we paid a one-time capital dividend of $20 share of common stock, to shareholders. Over the course of VirnetX’s history as a public company VirnetX has distributed over $165.9 million in cash to shareholders.

Securities Authorized for Issuance under Equity Compensation Plan

See Item 12, Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters for information regarding securities authorized for issuance.

Stock Performance Graph

This performance graph shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or incorporated by reference into any filing of VirnetX Holding Corporation under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The stock price performance reflected on this graph is not necessarily indicative of future stock price performance. See the disclosure in part I, Item 1A. “Risk Factors” for more information regarding the risks in investing in our common stock.

The graph below matches VirnetX Holding Corp’s cumulative 5-Year total shareholder return on common stock with the cumulative total returns of the S&P 500 index and the RDG Technology Composite index. The graph tracks the performance of a $100 investment in our common stock and in each index (with the reinvestment of all dividends) from 12/31/2018 to 12/31/2023.

25

graphic

  *$100 invested on 12/31/18 in stock or index, including reinvestment of dividends.
Fiscal year ending December 31.
 
 
 
 
  Copyright© 2024 Standard & Poor’s, a division of S&P Global. All rights reserved.  

     
12/18
     
12/19
     
12/20
     
12/21
     
12/22
     
12/23
 
                                                 
VirnetX Holding Corp
   
100.00
     
158.33
     
246.02
     
126.92
     
63.46
     
44.33
 
S&P 500
   
100.00
     
131.49
     
155.68
     
200.37
     
164.08
     
207.21
 
RDG Technology Composite
   
100.00
     
142.93
     
222.56
     
266.61
     
181.18
     
261.37
 

Recent Sales of Unregistered Securities

None.

Item 6.
[Reserved]

Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations

26

The Company

We are an Internet security software and technology company with patented technology for Zero Trust Network Access (“ZTNA”) based secure network communications. VirnetX’s software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One™, War Room™, VirnetX Matrix™, and GABRIEL Connection Technology™, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services, and critical infrastructures. Our technology generates secure connections on a “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.

Our product portfolio includes sophisticated technologies, products and services that are available for sale worldwide. Our next-generation, VirnetX One™ platform builds upon our patented Secure Domain Name Registry and Technology and GABRIEL Connection Technology™ to further enhance the security and efficiency of our patented secure communication links. VirnetX One™ is a security-as-a-service platform that protects enterprise applications, services, and infrastructure from cyber-attacks. Our platform allows businesses and other enterprises of all sizes to add a “security umbrella” as an added layer on top of their existing infrastructure to further reduce risk and bolster security against ever-growing cyberthreats to data, operating systems, other infrastructure products and gateway security controllers.

Our War Room™ software product provides safe and secure video conferencing meeting environment where sensitive communications and data is invisible to those not authorized to view it. War Room™ validates permissions of all the users, and devices requesting access to any secure meeting room prior to granting access. We believe our War Room™ will be an attractive solution for government and law enforcement agencies as well as all professional sectors such as legal, financial, and medical where limiting access to confidential data is a critical requirement.

Our VirnetX Matrix™ product provides superior security for internet-enabled enterprise applications and their connected devices, and for control systems currently deployed by those enterprises (e.g., file servers, data back-up systems, VPN/firewalls). VirnetX Matrix™ provides a true “zero-trust” access protection, “single-click” ease of use, and is a highly-effective added layer of protection that is deployed simply, without the need for changes to an enterprise’s existing, in-place infrastructure. We believe VirnetX Matrix™ is an attractive solution for all businesses, cloud and on-premise application service providers, and original equipment manufacturers (“OEMs”), looking to improve visibility and management of their networks to mitigate morphing attacks on their networks and for real time access and control of their users.

Our GABRIEL Collaboration Suite™ is a set of communication applications and tools that use our GABRIEL Secure Communication Platform™. It enables seamless and secure cross platform communications between devices that are enrolled in our “VIRNETX SECURED” network and have our software installed. Effective May 31, 2023 we have ended the support for our GABRIEL Collaboration Suite™. All the existing customers and partners have been notified of this announcement.

We have undertaken activities to commercialize our products and intellectual property in and outside the United States including VirnetX One™, War Room™, VirnetX Matrix™, GABRIEL Connection Technology™ and our Secured Domain Name Registry and Technology. We believe our product portfolio to secure devices and systems are suitable in areas such as City, County and State Governments, Healthcare, Finance, Legal, Oil and Gas, Medical, Law Enforcement, National Defense and related support industries. We continue to actively pursue new sales opportunities in and outside of United States.

During 2023, we actively engaged in discussions with certain third-parties to pitch the capabilities of VirnetX One™. As a result of our efforts, we made a series of announcements with Solution Synergy, WeSecure, Samsung, Envoy Data Corporation, and Object Security. We also announced new deployments of our VirnetX Matrix™ product at City of Bridgeport, International Association of Certified ISAOs (IACI) and SkinWalker Ranch. Although there can be no assurance in this regard, the Company believes that there are opportunities for Company products’ sales directly to, resale arrangements with and/or adoption as vendor standards by, one or more of these third parties.

27

We invested in two companies in the artificial intelligence (“AI”) sector partnering with them to augment the Company’s strategy to provide secure AI to the marketplace. The first investment was with L2 Holdings, LLC (“OmniTeq”), an AI, machine learning (“ML”) and predictive analytics-based solutions provider with a primary focus on selling into the space and defense sectors. Under the terms of our agreement, OmniTeq will deploy and integrate our VirnetX One™ family of products at SkinWalker Ranch to secure their data and protect against cyber hackers. Our second investment was with OP Media, Inc, a dynamic software platform provider, addressing a critical market requirement for transforming static infrastructure processes and knowledgebases into digital processes that can be continuously optimized using AI, ML, and blockchain technologies for making informed decisions and creating streamlined workflows in real-time, without requiring coding or programming skills. Further, under the terms of our respective agreements, both OmniTeq and OP Media have agreed to integrate our VirnetX One™ family of products and services into their solutions and to resell them to their current and future customers. Both companies have committed to using VirnetX as their exclusive global cybersecurity solution provider and go-to-market partner.

We have an ongoing licensing program under which we offer licenses to our technology, software, and some of our patented inventions, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. Our GABRIEL Connection Technology™ License is offered to OEM customers who want to adopt the GABRIEL Connection Technology™ as their solution for establishing secure connections using secure domain names within their products. We have developed GABRIEL Connection Technology™ Software Development Kit  to assist with rapid integration of these techniques into existing software implementations.

Our employees include the core development team behind our inventions, technology, and software. Some members of this team have worked together for over twenty years and were on the same team that invented and developed this technology while working at Leidos. The team has continued its research and development work to refine our unique network security technology and make it more secure and easy to deploy.

Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 205 total patents and pending applications, including 72 U.S. patents/patent applications and 133 foreign patents/validations/pending applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, and related services, and is used in all our technology and products, some of which were acquired by our principal operating subsidiary; VirnetX, Inc., from Leidos, Inc., or Leidos, (f/k/a Science Applications International Corporation, or SAIC) in 2006.

We expect to continue to launch new and enhanced security platforms, software products, and services based on our GABRIEL Connection Technology™. We will provide updates to new and existing customers as they are released to the public. Many small and medium businesses have installed our software products in their corporate networks. We intend to continue to expand our customer base with targeted promotions and direct sales initiatives to large enterprise and governmental organizations.

Litigation

We are subject to various legal proceedings, the outcomes of which are inherently uncertain. We record any potential gains related to legal proceedings only after cash is collected. We record a liability when it is probable that a loss has been incurred and the amount is reasonably estimable, the determination of which requires significant judgment. Resolution of legal matters in a manner inconsistent with management’s expectations could have a material impact on our financial condition and operating results. See Note 12 in the notes to our consolidated financial statements for more information.

Commitments and Related Party Transactions

We lease our offices in Nevada under an operating lease with a third party expiring in October 2025. We recognize rent expense on a straight-line basis over the term of the lease.

We have a facility lease in Utah to be used for technical integration and as a training facility. This lease requires monthly payments and expires in April 2029.

We have a 12-month non-exclusive service agreement, for the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for our employees. Our Chief Executive Officer and Chief Administrative Officer are the managing partners of the LLC and control the equity interests of the LLC. We pay for the Company’s business usage of the aircraft at a rate of $8 per flight hour.

In March 2024, we renewed our facility lease, used for corporate, promotional and marketing purposes. The renewal period begins in 2025, continues for 10 years through 2035, requires either a single payment of $6,000, or annual payments each March, beginning in 2025 starting at $600 and increasing annually for a total commitment of approximately $7,500.

28

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. The critical accounting policies we employ in the preparation of our consolidated financial statements are those which involve income taxes, fair value of financial instruments and stock-based compensation.

Use of Estimates

We prepare our consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the Audit Committee of our Board of Directors.


Investments


Investments classified as available-for-sale are recorded at fair market value. Unrealized gains and losses are reported as other comprehensive income. Realized gains and losses are recorded in income in the period they are realized using specific identification of each security's cost basis. We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less than two years. By policy, we limit the amount of credit exposure to any one issuer.


We have elected the investment measurement alternative for other investments without readily determinable fair values. During 2023, we invested $2,000 in L2 Holdings LLC and $500 in OP Media Inc. These investments are carried at our initial cost less any impairment, because we do not have the ability to exercise significant influence over operating and financial matters. For these investments, we adjust the carrying value for any purchases or sales of our ownership interests. Periodically, we evaluate these investments for impairment. If we identify an impairment, we reduce the carrying value for the impairment loss with a charge to earnings. We have not identified any impairment as of December 31, 2023.


Income Taxes

We account for income taxes using the asset and liability method. The asset and liability method require the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing our deferred tax assets, we consider whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance if any, as an income tax benefit in our statements of operations.

We account for our uncertain tax positions in accordance with U.S. GAAP. The U.S. GAAP method of accounting for uncertain tax positions utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates.

29

Fair Value

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value. When we estimate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. We use valuation techniques, primarily the income and market approach, which maximizes the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

Stock-based Compensation

We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs on a straight-line basis over the requisite service period of the award, which is generally a vesting term of 4 years. We recognize forfeitures, if any, when they occur. In addition, we record stock-based compensation expense for awards granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued, as they vest, over the performance period. See Note 6 in the notes to our consolidated financial statements for more information.

Results of Operations (all amounts in this section are expressed in thousands)

Revenue
   
2023
   
2022
 
Revenue
 
$
7
   
$
48
 

Revenue generated in 2023 was $7, compared to $48 in 2022. The change in revenue from 2022 to 2023 was the expiration of contracts with NEC and Mitel.

Licensing Costs
   
2023
   
2022
 
Licensing costs
 
$
   
$
(4
)

Research and Development Expenses
   
2023
   
2022
 
Research and Development
 
$
9,713
   
$
6,406
 

Research and development costs include expenses paid to outside development consultants and compensation-related expenses for our engineering staff. Research and development costs are expensed as incurred. Our research and development expenses in 2023 were $9,713 compared to $6,406 in 2022. The fluctuation in 2023 compared to 2022 was primarily due to changes in engineering compensation costs, including bonuses.

Selling, General and Administrative Expenses
   
2023
   
2022
 
Selling, General and Administrative
 
$
21,739
   
$
15,722
 

Selling, general and administrative expenses include compensation costs for management and administrative personnel, as well as expenses for outside legal, accounting, and consulting services. Our selling, general and administrative expenses in 2023 were $21,739 compared to $15,722 in 2022. The increase in selling, general and administrative expenses was primarily due to outside services and additional compensation costs, including bonuses.

30

Interest and Other Income, net
   
2023
   
2022
 
Interest and Other Income
 
$
3,495
   
$
1,848
 

Interest and other income in 2023 was $3,495 compared to $1,848 in 2022, due to higher interest rates.

Effective Income Tax Rate

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

   
Year
Ended
December
31,
2023
   
Year
Ended
December
31,
2022
 
United States federal statutory rate
   
21.00
%
   
21.00
%
State taxes, net of federal benefit
   
(0.01
)%
   
(0.55
)%
Valuation allowance
   
(20.31
)%
   
(91.21
)%
Stock based compensation
   
(0.58
)%
   
(9.44
)%
R&D Credit
   
2.20
%
   
1.22
%
Other
   
(2.03
)%
   
(0.29
)%
Effective income tax rate
   
0.28
%
   
(79.27
)%

The Company’s effective tax rate for 2023 and 2022 was substantially lower than the statutory Federal income tax rate primarily due to our valuation allowance, additionally in 2022 our effective tax rate was further reduced by stock based compensation, including expiring options.

Liquidity and Capital Resources

As of December 31, 2023, our cash and cash equivalents totaled $26,289 and our short-term investments totaled $27,258 compared to $86,561 and $65,462, respectively, as of December 31, 2022. We expect that our cash and cash equivalents and short-term investments as of December 31, 2023, will be sufficient to fund our current level of selling, general and administration costs and provide related working capital for the foreseeable future. Over the longer term, we expect to derive the majority of our future revenue from license fees and royalties associated with our patent portfolio, technology, software and secure domain name registry and product sales.

Item 7A.
Quantitative and Qualitative Disclosures about Market Risk

Consistent with the rules applicable to “smaller reporting companies,” we have omitted the information required by Item 7A.

Item 8.
Financial Statements and Supplementary Data

Set forth below, are the audited consolidated financial statements for our company accompanied by all reports thereon of Farber Hass Hurley LLP (PCAOB No. 223)
 
31

FINANCIAL STATEMENTS
 
Financial Statements Index
 
 
Page
   
33
35
36
37
38
39
40

32

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
To the Board of Directors and
Stockholders of VirnetX Holding Corporation
 
Opinion on the Financial Statements
 
We have audited the accompanying consolidated balance sheets of VirnetX Holding Corporation (the “Company”) as of December 31, 2023 and 2022, and the related consolidated statements of operations, comprehensive loss, stockholders’ equity, and cash flows for each of the years in the two-year period ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.
 
Basis for Opinion
 
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
 
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
 
Critical Audit Matter
 
The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
 
33

Description of the Matter
Other Investments

As discussed in Note 2 to the financial statements, the Company purchased equity interests in two private entities. Given that the entities do not have a readily determinable fair market value, management must consider various factors, including the Company’s ability to apply significant influence to the overall operations of the entities, in determining the classification and the initial value of the Other Investments. In addition, management must also evaluate the investments as of each reporting period to determine if there are any factors that would impact the recognized value of Other Investments.

Our determination that the classification and the valuation of Other Investments is a critical audit matter results from the significant judgment by management when assessing the recognition method of the initial purchase as well as the ongoing analysis of the valuation of the investments. This in turn led to a high degree of auditor judgment, subjectivity, and effort in performing procedures relating to management’s assessment of the initial recognition and valuation of Other Investments.


Audit Procedures
Our principal audit procedures related to the Company’s Other Investments included the following:

-     We evaluated management’s analysis regarding their ability to apply significant influence in the operations of the entities by obtaining information of the ownership percentage of the entities, composition of the respective boards, and any other relevant factors in determining their recognition method being recognized as cost in accordance with Accounting Standards Codification 321.

-     We also evaluated management’s assessment of impairment factors or any observable transactions from inception of the investments through year-end to determine whether an adjustment in the recognized value was necessary. This includes reviewing management’s internal analysis as well as any publicly available data regarding any factors or events that could impact the entities’ values.

/s/ Farber Hass Hurley LLP
We have served as the Company’s auditor since 2008.
Chatsworth, California
March 15, 2024

34

VIRNETX HOLDING CORPORATION
CONSOLIDATED BALANCE SHEETS
(in thousands, except share amounts)

 
As of
December 31, 2023
   
As of
December 31, 2022
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
 
$
26,289
   
$
86,561
 
Investments available for sale
   
27,258
     
65,462
 
Accounts receivables
   
2
     
14
 
Prepaid expenses and other current assets
   
282
     
224
 
Total current assets
   
53,831
     
152,261
 
Prepaid expenses and other assets
   
4,014
     
703
 
Property and equipment, net
   
67
     
11
 
Other investments
   
2,500
     
 
Total assets
 
$
60,412
   
$
152,975
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts payable and accrued liabilities
 
$
440
   
$
373
 
Accrued payroll and related expenses
   
316
     
311
 
Other liabilities, current
   
498
     
47
 
Total current liabilities
   
1,254
     
731
 
                 
Other liabilities
   
3,145
     
 
Total liabilities
   
4,399
     
731
 
Commitments and contingencies (Note 4)
           
                 
Stockholders’ equity:
               
Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at December 31, 2023 and December 31, 2022, Issued and outstanding: 0 shares at December 31, 2023 and December 31, 2022
   
     
 
Common stock, par value $0.0001 per share
               
Authorized: 100,000,000 shares at December 31, 2023 and December 31, 2022, Issued and outstanding: 3,618,431 and 3,571,232 shares, at December 31, 2023 and December 31, 2022, respectively
           
Additional paid-in capital
   
242,520
     
239,753
 
Accumulated deficit
   
(186,495
)
   
(87,195
)
Accumulated other comprehensive loss
   
(12
)
   
(314
)
Total stockholders’ equity
   
56,013
     
152,244
 
Total liabilities and stockholders’ equity
 
$
60,412
   
$
152,975
 

See accompanying notes to consolidated financial statements.

35

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)

 
 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Revenue
 
$
7
   
$
48
 
Operating expense:
               
Licensing costs
   
     
(4
)
Research and development
   
9,713
     
6,406
 
Selling, general and administrative expenses
   
21,739
     
15,722
 
Total operating expense
   
31,452
     
22,124
 
(Loss) from operations
   
(31,445
)
   
(22,076
)
Interest and other income, net
   
3,495
     
1,848
 
(Loss) before taxes
   
(27,950
)
   
(20,228
)
Income tax (provision) benefit
   
79
     
(16,032
)
Net (loss)
 
$
(27,871
)
 
$
(36,260
)
Basic (loss) per share
 
$
(7.79
)
 
$
(10.17
)
Diluted (loss) per share
 
$
(7.79
)
 
$
(10.17
)
Weighted average shares outstanding basic
   
3,579
     
3,565
 
Weighted average shares outstanding diluted
   
3,579
     
3,565
 

See accompanying notes to consolidated financial statements.

36

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS)
(in thousands)

 
 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Net (loss)
 
$
(27,871
)
 
$
(36,260
)
Other comprehensive (loss) income, net of tax:
               
Change in unrealized (loss) gain on investments, net
   
306
     
(246
)
Change in foreign currency translation, net
   
(4
)
   
 
Total other comprehensive (loss) gain, net of tax
   
302
     
(246
)
Comprehensive (loss)
 
$
(27,569
)
 
$
(36,506
)

See accompanying notes to consolidated financial statements.

37

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands, except share amounts)

    Year Ended
 
    December 31,
 
   
2023
   
2022
 
Total shareholders’ equity, beginning balances
 
$
152,244
   
$
185,449
 
                 
Common stock and additional paid-in capital:
               
Beginning balances
   
239,753
     
236,452
 
Common stock issued for options/RSUs/RS, net
   
(11
)
   
(29
)
Stock-based compensation
   
2,778
     
3,330
 
Ending balances
   
242,520
     
239,753
 
                 
Accumulated deficit
               
Beginning balances
   
(87,195
)
   
(50,935
)
Net (loss)
   
(27,871
)
   
(36,260
)
Dividends
   
(71,429
)
   
 
Ending balances
   
(186,495
)
   
(87,195
)
                 
Accumulated other comprehensive loss:
               
Beginning balances
   
(314
)
   
(68
)
Change in unrealized investment (loss) gain, net
   
306
   
(246
)
Change in foreign currency translation, net
   
(4
)
   
 
Ending balances
   
(12
)
   
(314
)
                 
Total shareholders’ equity, ending balances
 
$
56,013
   
$
152,244
 
                 
Dividends per share
  $ 20     $  

See accompanying notes to consolidated financial statements.

38

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

 
 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Cash flows from operating activities:
 
           
Net (loss)
 
$
(27,871
)
 
$
(36,260
)
Adjustments to reconcile net (loss) to net cash from operating activities:
               
Depreciation
   
9
     
7
 
Stock-based compensation
   
2,778
     
3,330
 
Bad debt
    15        
Deferred income taxes
   
     
16,032
 
Changes in assets and liabilities:
               
Prepaid expenses and other current assets
   
(3,369
)
   
331
 
Accounts payable and accrued liabilities
   
67
     
35
 
Other liabilities
   
3,596
     
(54
)
Accrued payroll and related expenses
   
5
     
41
 
Accrued licensing costs
   
     
(355
)
Accounts receivable
   
(3
)
   
3
 
Prepaid income taxes
   
     
(3
)
Net cash used in operating activities
   
(24,773
)
   
(16,893
)
Cash flows from investing activities:
               
Purchase of property and equipment
   
(65
)
   
 
Purchase of investments at cost
    (2,500 )      
Purchase of investments
   
(47,215
)
   
(67,070
)
Proceeds from sale or maturity of investments
   
85,721
     
28,535
 
Net cash provided by (used in) investing activities
   
35,941
     
(38,535
)
Cash flows from financing activities:
               
Dividend
    (71,429 )      
Withholding taxes paid on cashless exercise of restricted stock and restricted stock units
   
(11
)
   
(29
)
Net cash used in financing activities
   
(71,440
)
   
(29
)
Net (decrease) in cash and cash equivalents
   
(60,272
)
   
(55,457
)
Cash and cash equivalents, beginning of period
   
86,561
     
142,018
 
Cash and cash equivalents, end of period
 
$
26,289
   
$
86,561
 
Cash paid for income taxes
 
$
   
$
2
 

See accompanying notes to consolidated financial statements.

39

VIRNETX HOLDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands except share, per share and per device amounts)

Note 1 − Formation and Business of the Company

VirnetX Holding Corporation, which we refer to as “we”, “us”, “our”, “the Company” or “VirnetX”, is engaged in the business of commercializing a portfolio of patents. We seek to derive revenue from selling our software products including VirnetX War Room™ and VirnetX Matrix™ and licensing our technology, including VirnetX One™, and our secure domain name technology GABRIEL Connection Technology™, to various original equipment manufacturers (“OEMs”) and others, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence, and unified communications markets or who seek to secure their systems and applications.

Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 205 total patents and pending applications, including 72 U.S. patents/patent applications and 133 foreign patents/validations/pending applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security. The subject matter of all our U.S and foreign patents and pending applications relates generally to securing communications over the Internet and such covers all our technology and other products. Some of our issued U.S. and foreign patents expire at various times during the period from 2023 to 2034.

Note 2 − Summary of Significant Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. The critical accounting policies we employ in the preparation of our consolidated financial statements are those which involve impairment of long-lived assets, income taxes, fair value of financial instruments and stock-based compensation.

Use of Estimates

We prepare our consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the Audit Committee of our Board of Directors.

Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.

Revenue Recognition

The Company derives revenue from licensing and royalty fees from contracts with customers which often span several years. We account for this revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements, with revenue for each unit of accounting recognized as the product or service is delivered to the customer.

40

With the licensing of our patents, performance obligations are generally satisfied at a point in time as work is complete when our patent rights are transferred to our customers. We generally have no further obligation to our customers regarding our technology.

Certain contracts may require our customers to enter into a hosting arrangement with us and for these arrangements, revenue is recognized over time, generally over the life of the servicing contract.

The Company actively monitors and enforces its intellectual property (“IP”) rights, including seeking appropriate compensation from third parties that utilize the Company’s IP without a license. As a result, the Company may, from time to time, receive payments as part of a settlement or compensation for a patent infringement dispute. Proceeds received are allocated to each element identified in the settlement or compensation, based on the fair value of each element. Generally, settlements and compensation may include the following elements: the value of a license or royalty agreement, cost reimbursement, damages, and interest. Elements identified related to licensing and royalty are recognized as revenue. Elements identified as reimbursed costs are generally recorded as a reduction to the reported expenses. Elements identified as damages or interest are generally recorded in other income in the condensed consolidated statement of operations.

Licensing Costs

Included in operating expenses are licensing costs we incurred in conjunction with a patent infringement case.

Contingent Gains

ASC Topic 450-30-25, Contingent Gains, prohibits recognition of contingent gains until realized. Accordingly, we do not record contingent gains ahead of such realization. Management generally considers any such gains as realized only upon the collection of cash.

Cash and Cash Equivalents

We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.

Investments

Investments classified as available-for-sale are recorded at fair market value. Unrealized gains and losses are reported as other comprehensive income. Realized gains and losses are recorded in income in the period they are realized using specific identification of each security’s cost basis. We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less than two years. By policy, we limit the amount of credit exposure to any one issuer.

We have elected the investment measurement alternative for other investments without readily determinable fair values. During 2023, we invested $2,000 in L2 Holdings LLC and $500 in OP Media Inc. These investments are carried at our initial cost less any impairment, because we do not have the ability to exercise significant influence over operating and financial matters. For these investments, we adjust the carrying value for any purchases or sales of our ownership interests. Periodically, we evaluate these investments for impairment. If we identify an impairment, we reduce the carrying value for the impairment loss with a charge to earnings. We have not identified any impairment as of December 31, 2023.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. A portion of those balances are insured by the Federal Deposit Insurance Corporation, or FDIC. In 2023, we had, at times, funds that were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.

41

Fair Value

The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.

Property and Equipment

Property and equipment are stated at historical cost, less accumulated depreciation, and amortization. Depreciation and amortization are computed using the accelerated and straight-line methods over the estimated useful lives of the assets, which range from five to seven years. Repair and maintenance costs are charged to expense as incurred.

Leases

The Company determines if an arrangement is a lease at inception in accordance with ASC Topic 842. Operating lease right-of-use (“ROU”) assets are included in Prepaid expenses, and other assets on the Condensed Consolidated Balance Sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term, using the risk-free rate, U.S. prime rate, of 8.5% in 2023.

Intangible Assets

We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.

Impairment of Long-Lived Assets

We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are deemed impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Research and Development

Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff. Research and development costs are expensed as incurred.

Income Taxes

We account for income taxes using the asset and liability method. The asset and liability method requires the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing our deferred tax assets, we consider whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.

42

The 2017 U.S. Tax Cuts and Jobs Act changes IRC Section 174, regarding capitalization of book research and development (“R&D”) expenses for income tax purposes.  Effective for tax years beginning in 2022 IRC Section 174 requires the capitalization of book R&D expenses which are capitalized and amortized over 5 years for domestic R&D expenses and over 15 years for foreign R&D expenses.  To date there has been limited guidance from the IRS on how to quantify the amount of book R&D expenses subject to capitalization, including the indirect expenses supporting the R&D function.  Due to the limited guidance, some assumptions were made in our estimates.

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.

We account for our uncertain tax positions in accordance with U.S. GAAP, which utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates.

Stock-Based Compensation

We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs on a straight-line basis over the requisite service period of the award, which is generally a vesting term of 4 years. We recognize forfeitures, if any, when they occur. In addition, we record stock-based compensation expense for awards granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued, as they vest, over the performance period (See Note 6 - Stock-Based Compensation).


Earnings per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.

New Accounting Pronouncements

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregated information about an entity’s effective tax rate reconciliation as well as information on income tax paid. The guidance in this ASU is effective for public companies with annual periods beginning after December 15, 2024. We plan to adopt the guidance for the fiscal year ending December 31, 2025. We are currently evaluating the effect adoption of this ASU will have on our consolidated financial statements.
43

Note 3 − Property and Equipment
 
Our major classes of property and equipment were as follows:

 
December 31
 
   
2023
   
2022
 
Office furniture
 
$
143
   
$
79
 
Computer equipment
   
92
     
92
 
Total
   
235
     
171
 
Less accumulated depreciation
   
(168
)
   
(160
)
Total property and equipment, net
 
$
67
   
$
11
 

Depreciation expense for 2023 and 2022 was $9 and $7, respectively.

Note 4 − Commitments, Contingencies and Related Party Transactions

We have a service agreement for the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for our employees. We incurred approximately $1,097 and $1,123 in rental fees and reimbursements to the LLC in 2023 and 2022, respectively. We pay for the Company’s business usage of the aircraft and have no right to purchase. Our Chief Executive Officer and Chief Administrative Officer are the managing partners of the LLC and control the equity interests of the LLC. We entered into a 12-month non-exclusive agreement with the LLC for use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be cancelled by either us or the LLC with 30 days’ notice. The agreement renews on an annual basis unless terminated by either party. Neither party has exercised their termination rights.

See Note 13 for further discussion of our lease commitments.

Note 5 − Stock Plan

Our stockholders approved the Amended and Restated Equity Incentive Plan (the “A&R Plan”) at our annual shareholders’ meeting in June 2023, which added 175,000 shares to the plan. Our prior plan expired March 29, 2023; no further awards will be made under the prior plan, and the A&R Plan will govern awards granted under the prior plan. The A&R Plan provides for the granting of stock options, restricted stock units (“RSUs”) and restricted stock. Options granted under the A&R Plan are granted with an exercise price equal to the fair value of the of our stock on the date of grant. RSUs and restricted stock are granted at the fair value of our stock on the date of grant because they have no exercise price. The fair value of options, RSUs and restricted stock are expensed over the vesting periods. All options, RSUs and restricted stock are subject to forfeiture if service terminates prior to the shares vesting. At December 31, 2023, there were 225,778 shares available for grant under the A&R Plan.

Note 6 − Stock-Based Compensation

The following tables summarize information and activity under the plan for the indicated periods.

Options Outstanding
   
Options Vested and Exercisable
 
Range of
Exercise Prices
 
Number
Outstanding
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Weighted
Average
Exercise
Price
   
Number
Exercisable
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Weighted
Average
Exercise
Price
 
$ 10.00 - 31.60     41,925       8.45     $
28.67       17,519       8.45     $
28.16  
$ 34.80 -  139.00
   
275,217
     
4.66
   
$
90.31
     
252,243
     
4.42
   
$
90.00
 
$ 290.40 - 308.00
   
12,875
     
0.49
   
$
304.24
     
12,875
     
0.49
   
$
304.24
 
     
330,017
     
4.98
   
$
90.63
     
282,637
     
4.49
   
$
95.70
 

44

 
Options
 
   
Number of
Shares
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2021
   
319,868
   
$
139.80
     
   
$
 
Options granted
   
40,050
     
29.60
     
     
 
Options exercised
   
   
     
     
 
Options cancelled
   
(19,120
)
   
501.20
     
     
 
Outstanding, December 31, 2022
   
340,798
   
$
106.60
     
   
$
 
Options granted
   
1,875
     
10.00
     
     
 
Options exercised
   
     
     
     
 
Options cancelled
   
(12,656
)
   
510.21
     
     
 
Outstanding, December 31, 2023
   
330,017
   
$
90.63
     
4.98
   
$
 
Options exercisable, December 31, 2023
   
282,637
   
$
95.70
     
4.49
   
$
 

 
RSUs
 
   
Number of
RSUs
   
Weighted
Average
Grant Date
Fair Value
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2021
   
25,457
   
$
107.80
   
$
 
RSUs granted
   
12,918
     
29.20
     
 
RSUs vested
   
(10,770
)
   
103.00
     
 
RSUs cancelled
   
     
     
 
Outstanding, December 31, 2022
   
27,605
   
$
73.00
   
$
 
RSUs granted
   
1,250
     
10.00
     
 
RSUs vested
   
(11,405
)
   
83.81
     
 
RSUs cancelled
                 
Outstanding, December 31, 2023
   
17,450
   
$
60.81
   
$
 

   
Restricted Stock
 
 
 
Number of
Restricted Stock
   
Weighted
Average
Grant Date
Fair Value
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2022
   
   
$
   
$
 
Restricted stock granted
   
36,927
     
9.12
     
 
Restricted stock vested
   
(3,617
)
   
9.19
     
 
Restricted stock cancelled
   
(604
)
   
9.60
     
 
Outstanding, December 31, 2023
   
32,706
   
$
9.11
   
$
 

Intrinsic value is calculated as the difference between the per-share market price of our common stock on the last trading day of 2023, which was $7 and the exercise price of the awards. For awards exercised, the intrinsic value is the difference between market price and the exercise price on the date of exercise.

45

Stock-based compensation expense is included in operating expense for each period as follows:

Stock-Based Compensation by Type of Award
 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Stock options
 
$
1,960
   
$
2,303
 
RSUs
   
778
     
1,027
 
Restricted stock
    40      
 
Total stock-based compensation expense
 
$
2,778
   
$
3,330
 

As of December 31, 2023, there was $3,006 of unrecognized stock-based compensation expense; $2,025 related to unvested stock options, $683 related to unvested RSUs, and $298 related to unvested restricted stock. These costs are expected to be recognized over a weighted-average period of 1.8 years for options, 1.74 years for RSUs, and 3.54 years for restricted stock.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions:

 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Expected stock price volatility
   
81.39
%
   
85.39
%
Risk-free interest rate
   
3.9
%
   
3.09
%
Expected life term
 
5.5 years
   
6.2 years
 
Expected dividends
   
0
%
   
0
%

Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $6.96 and $21.77 per share during 2023 and 2022, respectively. The expected life was determined using the simplified method outlined in ASC 718, “Compensation - Stock Compensation”. Expected volatility of the stock options was based upon historical data and other relevant factors.

Note 7 − Earnings Per Share

Basic earnings per share are based on the weighted average number of shares outstanding for a period. Diluted earnings per share are based upon the weighted average number of shares and potentially dilutive common shares outstanding. Potential common shares outstanding principally include stock options, RSUs and unvested restricted stock under our stock plan and warrants. During 2023 and 2022 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive.
The table below sets forth the basic and diluted loss per share calculations:

    Year Ended December 31,  
 
2023
   
2022
 
Net (loss) income
 
$
(27,871
)
 
$
(36,260
)
                 
Basic weighted average number of shares outstanding
    3,579       3,565  
Effect of dilutive securities
   
     
 
Diluted weighted average number of shares outstanding
   
3,579
     
3,565
 
                 
Basic (loss) earnings per share
 
$
(7.79
)
 
$
(10.17
)
Diluted (loss) earnings per share
 
$
(7.79
)
 
$
(10.17
)

46

Note 8 − Common Stock

Each share of common stock has the right to one vote. The holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by our Board of Directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. Our restated articles of incorporation authorize us to issue up to 100,000,000 shares of $0.0001 par value common stock.

Effective October 25, 2023, every 20 shares of our common stock outstanding was combined into one share of common stock. Proportional adjustments were also made to the number of restricted stock, common stock issuable upon the exercise of options, warrants as well as common stock issuable upon the vesting of RSUs. The exercise price of all equity awards were also proportionally adjusted. The accompanying financial statements include the effect of this adjustment on all periods presented.

Dividends

In 2023, we paid a one-time capital dividend of $20 per share of common stock to shareholders. The timing and amount of future dividends, if any, will depend on market conditions, corporate business and financial considerations and regulatory requirements.

Warrants

In 2020, we issued warrants for the purchase of 1,250 shares of common stock at an exercise price of $115 per share, exercisable on the date of grant, expiring in April 2025. The weighted average fair value at the grant date was $83.20 per warrant. The fair value at the grant date was estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions (i) dividend yield on our common stock of 0 percent (ii) expected stock price volatility of 97 percent (iii) a risk-free interest rate of 0.27 percent and (iv) and expected option term of 5 years.

Warrants
Issued
   
Exercise
Price
   
Outstanding and
Exercisable
December 31, 2022
   
Issued
   
Exercised
   
Terminated /
Cancelled
   
Outstanding and
Exercisable
December 31, 2023
 
Expiration Date
 
 
1,250
   
$
115
     
1,250
     
     
     
     
1,250
 
April 30, 2025
 

Note 9 − Employee Benefit Plan

We sponsor a defined contribution 401k plan covering substantially all our employees. Our matching contribution to the plan was approximately $229 and $179 in 2023 and 2022, respectively.

Note 10 − Income Taxes

The income tax provision (benefit) is comprised of the following:

 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Current:
           
Federal
 
$
   
$
 
State
   
2
     
3
 
Foreign
           
 
   
2
     
3
 
Deferred:
               
Federal
   
(79
)
   
15,920
 
State
   
(2
)
   
109
 

    (81 )     16,029  
Total income tax (benefit) provision
  $ (79 )  
$
16,032
 
 
47

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
United States federal statutory rate
   
21.00
%
   
21.00
%
State taxes, net of federal benefit
   
(0.01
)%
   
(0.55
)%
Valuation allowance
   
(20.31
)%
   
(91.21
)%
Stock based compensation
   
(0.58
)%
   
(9.44
)%
R&D Credit
   
2.20
%
   
1.22
%
Other
   
(2.03
)%
   
(0.29
)%
Effective income tax rate
    0.28 %    
(79.27
)%

Deferred tax assets (liabilities) consist of the following:

 
As of
December 31, 2023
   
As of
December 31, 2022
 
Deferred tax assets:
           
Reserves and accruals
 
$
65
   
$
147
 
Research and development credits and other credits
   
1,110
     
430
 
Net operating loss carry forward
   
15,262
     
11,988
 
Stock based compensation
   
4,360
     
5,018
 
Other
   
2,382
     
970
 
Total deferred tax assets
 
$
23,179
   
$
18,553
 
                 
Valuation allowance
   
(23,179
)
   
(18,553
)
Deferred tax assets after valuation allowance
   
     
 
                 
Total deferred tax liability – depreciation and amortization
   
     
 
                 
Net deferred tax assets
 
$
   
$
 

Pursuant to IRC Section 174, we capitalized direct and indirect research and development costs for our tax return totaling $8,599 in 2023 and $5,140 in 2022, of which $1,888 will be amortized in our 2023 tax return and $514 in our 2022 tax return. At December 31, 2023, unamortized capitalized direct and indirect research and development costs for our tax return totaled $11,337, resulting in a deferred tax asset of $2,381.

At December 31, 2023, we had federal and state net operating loss carryforwards of approximately $72,645 and $109,435, respectively. Federal net operating loss carryforwards do not expire. None of the state net operating loss carryforward is apportioned to a deferred tax asset, because currently we do not have operations in states where losses accumulated. The state net operating loss carryforward begins expiring in 2029. We provide full valuation allowances for our net deferred tax assets, including NOL carryforwards generated during the years, based on our evaluation of positive and negative evidence, including our history of operating losses and the uncertainty of generating future taxable income that would enable us to realize our deferred tax assets.

We are required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. At December 31, 2023, we have no uncertain tax positions.

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to NOLs and tax credits generated in these years were utilized in 2020. The statute of limitation for these years shall expire three years after the date of filing 2020 income tax returns, which is October 2024.

Our policy is to recognize interest and penalties, if any, accrued on any unrecognized tax benefits, as a component of income tax expense. We had no interest or penalties accrued in 2023.

48

Note 11 − Fair Value Measurement

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value. When we estimate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. We use valuation techniques, primarily the income and market approach, which maximizes the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

Mutual funds: Valued at the quoted net asset value (NAV) of shares held.
U.S. agency and treasury securities: Fair value measured at the closing price reported on the active market on which the individual securities are traded.

The following table shows the adjusted cost, gross unrealized gains, gross unrealized losses, and fair value of our financial assets as of December 31, 2023 and 2022 (in thousands):

 
December 31, 2023
 
   
Adjusted
Cost
   
Unrealized
Gains
   
Unrealized
Losses
   
Fair
Value
   
Cash
and Cash
Equivalents
   
Investments
Available
for Sale
 
Cash
 
$
1,452
   
$
   
$
   
$
1,452
   
$
1,452
   
$
 
Level 1:
                                               
Mutual funds
   
20,040
     
     
     
20,040
     
20,040
     
 
U.S. agency and treasury securities
   
32,046
     
27
     
(18
)
   
32,055
     
4,797
     
27,258
 
     
52,086
     
27
     
(18
)
   
52,095
     
24,837
     
27,258
 
Total
 
$
53,538
   
$
27
   
$
(18
)
 
$
53,547
   
$
26,289
   
$
27,258
 

 
December 31, 2022
 
   
Adjusted
Cost
   
Unrealized
Gains
   
Unrealized
Losses
   
Fair
Value
   
Cash
and Cash
Equivalents
   
Investments
Available
for Sale
 
Cash
 
$
16,949
   
$
   
$
   
$
16,949
   
$
16,949
   
$
 
Level 1:
                                               
Mutual funds
   
66,493
     
     
     
66,493
     
66,493
     
 
U.S. agency and treasury securities
    68,958       9       (386 )     68,581       3,119       65,462  
     
135,451
     
9
     
(386
)
   
135,074
     
69,612
     
65,462
 
Total
 
$
152,400
   
$
9
   
$
(386
)
 
$
152,023
   
$
86,561
   
$
65,462
 

The maturities of our investments generally range from within one to two years. Actual maturities could differ from contractual maturities due to call or prepayment provisions.

Note 12 − Litigation (all dollar amounts in this section are expressed in thousands except for rates per device)

We have several intellectual property infringement lawsuits pending in the United States Court of Appeals for the Federal Circuit (“USCAFC”).

49

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

This case began on November 6, 2012, when we filed a complaint against Apple Inc. (“Apple”) in United States District Court (“USDC”) in which we alleged that Apple infringed on certain of our patents, (U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151). We sought damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. The USDC entered a Final Judgment and issued its Memorandum Opinion and Order regarding post-trial motions, affirming the jury’s verdict of $502,600 and granting VirnetX motions for supplemental damages, a sunset royalty, and the royalty rate of $1.20 per infringing iPhone, iPad and Mac products, pre-judgment and post-judgment interest and costs. Apple filed a notice of appeal with the United States Court of Appeals for the Federal Circuit (“USCAFC”) in the Apple II case.

On October 9, 2018, USCAFC docketed the appeal as Case No. 19-1050 - VirnetX Inc. v. Apple Inc. On November 22, 2019, the USCAFC issued an opinion affirming the district court’s findings that Apple is precluded from making certain invalidity arguments and that Apple infringed the ‘135 and ‘151 patents; reversing the USDC’s finding that Apple infringed the ‘504 and ‘211 patents; and remanding the case for proceedings on damages. Apple sought panel and en banc rehearing, which the USCAFC denied on February 10, 2020.

On February 22, 2021, the USCAFC docketed the appeal as Case No. 19-1672. Apple’s opening brief was filed on June 2, 2021. VirnetX filed its responsive brief on July 26, 2021. Apple filed its reply brief on September 13, 2021. Oral arguments were held on September 8, 2022. On March 31, 2023, the USCAFC issued its decision vacating the USDC’s judgement in this matter and remanding it back to the USDC with instructions to dismiss the case as moot. On July 14, 2023 the District Court vacated its prior Final Judgment against Apple dated January 6, 2021 and dismissed the case as moot. On May 1, 2023, VirnetX filed a petition for panel rehearing. On June 27, 2023, the petition for panel rehearing was denied, and the mandate issued on June 30, 2023. VirnetX filed a petition for a writ of certiorari with the United States Supreme Court, on September 20, 2023. On February 20, 2024, the Supreme Court denied our petition. We are evaluating all our options in this matter.

VirnetX Inc. v. Mangrove Partners Master Fund, Ltd., Apple Inc. (USCAFC Case 20-2271) and VirnetX Inc. v. Mangrove Partners Master Fund, Ltd., Apple Inc., and Black Swamp, LLC (USCAFC Case 20-2272)

On September 15, 2020, we filed with the USCAFC an appeal of the invalidity findings by the Patent Trial and Appeal Board (“PTAB”) in inter-partes review proceedings IPR2015-01046 and IPR2016-00062 involving our U.S. Patent No. 6,502,135, and an appeal of the invalidity findings by the PTAB in inter-partes review proceedings IPR2015-1047, IPR2016-00063, and IPR2016-00167 involving our U.S. Patent No. 7,490,151. On September 25, 2020, the USCAFC issued an order consolidating the two appeals. On December 15, 2020, we filed a motion to vacate the PTAB decisions below and to remand these appeals to the PTAB. On March 16, 2021, the USCAFC denied the motion without prejudice to us raising the challenges made in the motion in our opening brief. Our opening brief was filed on June 7, 2021.

On June 23, 2021, the USCAFC entered an order directing us (and parties in other appeals that raised Appointments Clause challenges) to file a brief explaining how they believe their cases should proceed in light of the Supreme Court’s decision in United States v. Arthrex, Inc., 141 S. Ct. 1970 (2021). On July 7, 2021, we filed a brief in response to the court’s order. Other parties, including the U.S. Patent and Trademark Office (“USPTO”) filed their responses on July 21, 2021. On August 19, 2021, USCAFC issued an order remanding these appeals for the limited purpose of allowing VirnetX the opportunity to request rehearing of the PTAB’s final written decisions by the Director of the USPTO. The USCAFC retained jurisdiction over the appeals in the meantime. On September 20, 2021, we filed our requests for Director rehearing with the USPTO. On October 29, 2021, our requests for Director rehearing were denied. We subsequently filed an amended opening brief to the USCAFC on December 10, 2021, the other parties filed response briefs on February 2, 2022, and we filed a reply brief on February 22, 2022. All the briefings have been completed. The oral arguments in this matter were held on September 8, 2022. On March 30, 2023, the USCAFC issued its decision affirming PTAB’s decisions finding certain claims of the ‘135 patent and the ‘151 patent to be unpatentable. On June 5, 2023, VirnetX filed a petition for panel rehearing. On June 22, 2023, the petition for panel rehearing was denied, and the mandate issued on June 29, 2023. VirnetX filed a petition for a writ of certiorari with the United States Supreme Court, on September 20, 2023. On February 20, 2024, the Supreme Court denied our petition. We are evaluating all our options in this matter.

50

VirnetX Inc. v. Hirshfeld (USCAFC Case 17-2593, -2594)

On September 22, 2017, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes review proceeding IPR2016-00693 involving our U.S. Patent No. 7,418,504, and an appeal of the invalidity findings by the PTAB in inter-partes review proceeding IPR2016-00957 involving our U.S. Patent No. 7,921,211. On September 16, 2021, USCAFC issued an order remanding these appeals for the limited purpose of allowing VirnetX the opportunity to request rehearing of the PTAB’s final written decisions by the Director of the USPTO. The USCAFC retained jurisdiction over the appeals in the meantime. On October 18, 2021, we filed our requests for Director rehearing with the USPTO. On January 7, 2022, our requests for Director rehearing were denied. On January 21, 2022, we informed the USCAFC about the denial of Director rehearing and requested that the court dismiss the appeal involving IPR2016-00957 as moot and vacate the PTAB’s underlying decision. On April 4, 2022, the USCAFC vacated the PTAB’s decision in IPR2016-00957 and remanded Appeal No. 17-2594 with instructions to dismiss. In the April 4, 2022 order, the USCAFC further set a briefing schedule, in Appeal No. 17-2593. VirnetX filed its opening brief on September 12, 2022. The USPTO filed its response brief on December 20, 2022. VirnetX filed its reply brief on February 14, 2023. On April 18, 2023, VirnetX filed a motion to hold this appeal in abeyance pending the disposition of any petition for rehearing in the No. 20-2271, -2272 appeal, and pending the United States Supreme Court’s disposition of a pending petition for a writ of certiorari in Arthrex, Inc. v. Smith & Nephew, Inc., No. 22-639. That motion was denied on June 1, 2023. On October 20, 2023, the USCAFC issued a decision finding the appeal moot in view of its concurrent decision in USCAFC No. 22-2234.  VirnetX sought rehearing, which was denied, and the mandate to close the case was issued on January 12, 2024.

VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 19-1671)

On March 18, 2019, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,679 involving our U.S. Patent No. 6,502,135. On October 5, 2021, USCAFC issued an order remanding these appeals for the limited purpose of allowing VirnetX the opportunity to request rehearing of the PTAB’s final written decisions by the Director of the PTO. The USCAFC retained jurisdiction over the appeals in the meantime. Our request for Director rehearing with the PTO was filed on November 5, 2021. On January 10, 2022, our request for Director rehearing was denied. We informed the USCAFC about the denial of Director rehearing. VirnetX’s opening brief was filed on June 23, 2022. The USPTO’s response brief was filed on August 2, 2022, and Cisco’s response brief was filed on September 2, 2022. VirnetX filed its reply brief on October 7, 2022. On April 18, 2023, VirnetX filed a motion to hold this appeal in abeyance pending the disposition of any petition for rehearing in the No. 20-2271, -2272 appeal, and pending the Supreme Court’s disposition of a pending petition for a writ of certiorari in Arthrex, Inc. v. Smith & Nephew, Inc., No. 22-639. The motion, filed on April 18, 2023, was denied on June 1, 2023.  On October 20, 2023, the USCAFC issued a decision finding the appeal moot in view of its concurrent decision in USCAFC No. 22-1523 and its prior decision in USCAFC No. 20-2271.  VirnetX sought rehearing, which was denied, and the mandate to close the case was issued on January 12, 2024.

VirnetX Inc. v. Apple Inc. (USCAFC Case 22-1523) (“Apple Reexam I”)

On March 10, 2022, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,682 involving our U.S. Patent No. 6,502,135. Our opening brief was filed on August 22, 2022. Apple and USPTO each filed a response brief on December 28, 2022. VirnetX filed its reply brief on February 8, 2023. On April 18, 2023, VirnetX filed a motion to hold this appeal in abeyance pending the disposition of any petition for rehearing in the No. 20-2271, -2272 appeal, and pending the Supreme Court’s disposition of a pending petition for a writ of certiorari in Arthrex, Inc. v. Smith & Nephew, Inc., No. 22-639, which was denied on June 1, 2023.  On October 20, 2023, the USCAFC issued a decision affirming the PTAB’s invalidity findings.  VirnetX sought rehearing, which was denied, and the mandate to close the case was issued on January 12, 2024.

VirnetX Inc. v. Apple Inc. (USCAFC Case 22-1997) (“Apple Reexam II”)

On July 6, 2022, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,697 involving our U.S. Patent No. 7,490,151. On October 17, 2022, we filed a motion to remand the appeal in light of the PTAB’s refusal to permit Director rehearing. On January 23, 2023, the USCAFC denied that motion without prejudice to the parties raising their arguments in the merits briefs. VirnetX opening brief was filed on May 8, 2023, and Apple and the USPTO each filed a response brief on July 24, 2023. VirnetX filed its reply brief on September 1, 2023. We currently await scheduling of oral arguments.

51

VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 22-2234)

On September 16, 2022, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,851 involving our U.S. Patent No. 7,418,504. We filed our opening brief on February 28, 2023. Cisco’s response brief was filed on May 10, 2023, and VirnetX reply brief was filed on June 21, 2023. On October 20, 2023, the USCAFC issued a decision affirming the PTAB’s invalidity findings.  The mandate to close the case was issued on December 26, 2023.

VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 23-1765)

On April 7, 2023, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,714 involving our U.S. Patent No. 7,490,151. The certified list is due to be filed by the USPTO by May 30, 2023, and our opening brief will be due 60 days thereafter.  In addition, on April 21, 2023, Cisco filed a cross-appeal.  On September 29, 2023, VirnetX filed a motion to remand.  That motion was denied without prejudice to VirnetX raising the same arguments in its opening appeal brief in an order dated December 27, 2023, which also set the deadline for VirnetX to file an opening brief for February 5, 2024. VirnetX filed its opening brief on February 5, 2024, and Cisco’s opening/response brief’s is currently due March 18, 2024

Other Legal Matters

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are likely valid, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we could prevail on such potential claims if we made them. In addition, bringing a lawsuit may lead to potential counterclaims which may distract our management and our other resources, including capital resources, from efforts to successfully commercialize our products.

Currently, we are not a party to any other pending legal proceedings and are not aware of any proceeding threatened or contemplated against us.

Note 13 − Leases

In October 2023, we renewed our lease for office space in Nevada with a third party recording an ROU asset and lease liability of $102. The lease requires monthly payments of $4.6 and expires in October 2025. At December 31, 2023, our ROU asset and lease liability totaled $93. Lease expense totaled $55 in 2023 and $54 in 2022.

In October 2023, we executed a facility lease in Utah to be used for technical integration and as a training facility recording an ROU asset and a lease liability of $3,587. This operating lease requires monthly payments starting at $72, includes periodic increases, provides six months of free rent, and expires in April 2029.  At December 31, 2023, our ROU asset and lease liability totaled $3,479 and $3,546, respectively. Lease expense totaled $140 in 2023.

The weighted average remaining life of the office and facility leases discussed above is approximately 5 years, and the related lease liability is as follows:

Due in 2024
 
$
494
 
Due in 2025
 
$
946
 
Due in 2026
 
$
927
 
Due in 2027
 
$
954
 
Due in 2028
 
$
983
 
Thereafter
 
$
336
 
Total undiscounted lease liability
 
$
4,640
 
Less: imputed interest
  $ (1,001 )
Total lease liability
  $ 3,639  

We also lease a facility for corporate promotional and marketing purposes which was prepaid at inception and expires in 2025. At December 31, 2023 and 2022, the ROU asset totaled $349 and $648, respectively; lease expense totaled $300 per year in 2023 and 2022. In March 2024, we renewed our facility lease, used for corporate, promotional and marketing purposes. The renewal period begins in 2025, continues for 10 years through 2035, requires either a single payment of $6,000, or annual payments each March, beginning in 2025 starting at $600 and increasing annually for a total commitment of approximately $7,500.

52

We have a service agreement for the use of an aircraft from a related party discussed in more detail in Note 4. We incurred approximately $1,097 and $1,123 in rental fees and reimbursements to the entity in 2023 and 2022, respectively.

Note 14 − Subsequent Event
In January 2024, we issued 71,000 shares of restricted stock from our Amended and Restated Equity Incentive Plan.

53

Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A.
Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, December 31, 2023.

The purpose of this evaluation was to determine whether as of December 31, 2023 our disclosure controls and procedures were effective to provide reasonable assurance that the information we are required to disclose in our filings with the SEC, (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of December 31, 2023, our disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal controls over financial reporting (as such term is defined in rules 13a-15(f) under the Securities Exchange Act of 1934, as amended) during the fiscal year ended December 31, 2023, that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is a process to provide reasonable assurance regarding the reliability of our financial reporting for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes maintaining records that in reasonable detail accurately and fairly reflect our transactions; providing reasonable assurance that transactions are recorded as necessary for preparation of our financial statements; providing reasonable assurance that receipts and expenditures of Company assets are made in accordance with management authorization; and providing reasonable assurance that unauthorized acquisition, use or disposition of Company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of our financial statements would be prevented or detected.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2023. There were no changes in our internal control over financial reporting during the period ended December 31, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 9B.
Other Information

Securities Trading Plans of Directors and Executive Officers.

During the three months ended December 31, 2023, the Company did not adopt, modify or terminate and no directors or officers, as defined in Rule 16a-1(f), adopted, modified or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement," each as defined in Regulation SK Item 408.


54

Item 9C.
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

None.

PART III

Item 10.
Directors, Executive Officers and Corporate Governance

The information required by this item will be contained in our definitive proxy statement to be filed with the SEC in connection with our 2024 Annual Meeting of Stockholders (the “Proxy Statement”), which is expected to be filed not later than 120 days after the end of our fiscal year ended December 31, 2023 and is incorporated in this report by reference.

Item 11.
Executive Compensation

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

Securities Authorized for Issuance Under the Equity Compensation Plans

Our Amended and Restated Equity Incentive Plan (the “A&R Plan”) was approved by our shareholders in June 2023. Our prior plan expired March 29, 2023; no further awards will be made under the prior plan, and the A&R Plan will govern awards granted under the prior plan. The A&R Plan allows us to grant stock options, restricted stock units (“RSUs”) and restricted stock. Options granted under the A&R Plan are granted with an exercise price equal to the fair value of the of our stock on the date of grant. RSUs and restricted stock are granted at the fair value of our stock on the date of grant. The fair value of options, RSUs and restricted stock are expensed over the vesting periods. All awards are subject to forfeiture if service terminates prior to the shares vesting. At December 31, 2023, there were 225,778 shares available for grant under the A&R Plan.
Plan Category
 
Number of
Securities to be
Issued Upon
Exercise of
Outstanding
Options and
RSUs
   
Weighted-Average
Exercise Price of
Outstanding
Options and RSUs
   
Number of
Securities
Remaining
Available for
Future Issuance
Under Equity
Compensation
Plans
 
Equity compensation plans approved by security holders
   
347,467
   
$
89.32
     
225,778
 
Equity compensation plans not approved by security holders
   
     
         
Total
   
347,467
   
$
89.32
     
225,778
 

During 2023, we granted 1,875 stock options and 1,251 RSUs to members of our Board of Directors and 36,927 restricted stock awards to our employees respectively.

55

Item 13.
Certain Relationships and Related Transactions, and Director Independence

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

Item 14.
Principal Accounting Fees and Services

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

PART IV

Item 15.
Exhibits and Financial Statement Schedules


(a)
The following documents are filed as part of this Annual Report on Form 10-K


(1)
Financial Statements: See the Index to Consolidated Financial Statements under Item 8 of this Annual Report on Form 10-K.


(2)
Financial Statement Schedule: Financial statement schedules are omitted because they are not applicable, or the required information is shown in the financial statements or notes thereto. All other schedules are omitted because of the absence of conditions under which they are required or because the required information is given in the financial statements or the notes thereto.


(3)
Exhibits: The documents listed in the Exhibit Index of this Annual Report on Form 10-K are incorporated by reference or are filed with this Annual Report on Form 10-K, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

56

EXHIBIT INDEX

Exhibit
Number
 
Description
Incorporated by reference herein
 
Form
Exhibit No.
Filing Date
File No.
Filed Herewith
3.1
8-K
3.1
11/01/2007
000-26895
 
 
3.2
8-K
3.1
10/25/2023
001-33852
 
3.3
8-K
3.1
1/27/2023
001-33852
 
4.2
S-3
4.1
07/30/2018
333-226413
 
4.3
S-3
4.2
07/30/2018
333-226413
 
4.4
S-3
4.4
07/30/2018
333-226413
 
4.5
10-K
4.6
03/16/2020
001-33852
 
10.1
10-K
10.1
03/18/2019
001-33852
 
10.2*
10-Q
10.2
05/10/2012
001-33852
 
10.3*
10-Q
4.5
05/10/2011
001-33852
 
10.4*
10-Q
10.3
05/10/2012
001-33852
 
10.5*
DEF 14A
Appendix A
04/13/2021
001-33852
 
10.6*
S-8
10.1
06/15/2023
333-272677
 
10.7*
10-K
10.6
03/02/2015
001-33852
 
10.8*
10-K
10.7
03/02/2015
001-33852
 
10.9*
10-Q
10.2
08/11/2023
001-33852
 
10.10
8-K
10.4
07/12/2007
000-26895
 
10.11**
8-K
10.6
07/12/2007
000-26895
 
10.12
8-K
10.1
03/18/2008
001-33852
 
10.13
8-K
10.5
07/12/2007
000-26895
 
10.14
8-K
10.7
07/12/2007
000-26895
 
10.15
8-K
10.8
07/12/2007
000-26895
 
10.16**
10-Q/A
10.1
01/31/2011
001-33852
 
10.17**
10-K
10.23
03/02/2015
001-33852
 
10.18*
10-Q
10.1
11/08/2021
001-33852
 
10.19*
Offer Letter by and between Darl C. McBride and the Company, dated as of December 22, 2023.
       
X
10.20
8-K
10.1
03/30/2023
001-33852
 

57

10.21
10-Q
10.2
05/15/2023
001-33852
 
10.22*
Outside Director Compensation Policy, as amended.
       
X
21.1
10-K
21.1
03/16/2021
001-33852
 
Consent of Farber Hass Hurley LLP, Independent Registered Public Accounting Firm.
 
 
 
 
X
24.1
Power of Attorney (contained on signature page hereto)
 
 
 
 
X
Chief Executive Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act.
 
 
 
 
X
Chief Financial Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act.
 
 
 
 
X
Chief Executive Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
 
 
X
Chief Financial Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
 
X
97.1*
Compensation Recovery Policy of the Company as adopted November 8, 2023.
       
X
101.INS
XBRL Instance Document
 
 
 
 
X
101.SCH
XBRL Taxonomy Extension Schema Document
 
 
 
 
X
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
 
X
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
 
X
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
 
X
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
 
 
104
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
 
 
 
 
X




*
Indicates management contract or compensatory plan.


**
Confidential treatment has been granted by the SEC as to certain portions of this exhibit.


***
Portions of this exhibit have been omitted pending a determination by the SEC as to whether these portions should be granted confidential treatment.


The certifications attached as Exhibit 32.1 and 32.2 that accompany this Report are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of VirnetX Holding Corporation under the Securities Act or the Exchange Act, whether before or after the date of this Report, irrespective of any general incorporation language contained in such filing.

58

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

 
VirnetX Holding Corporation
     
 
By:
/s/ Kendall Larsen
   
Name: Kendall Larsen
   
Title: Chief Executive Officer and President
     
Dated: March 15, 2024
   

59

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kendall Larsen as his attorney-in-fact, with full power of substitution, for him in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact, or his substitute or substitutes may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities indicated.

Name
 
Capacity
 
Date
         
/s/Kendall Larsen
 
Director, Chief Executive Officer and President
 
March 15, 2024
Kendall Larsen
 
(Principal Executive Officer)
   
         
/s/Katherine Allanson
 
Chief Financial Officer
 
March 15, 2024
Katherine Allanson
 
(Principal Financial Officer and
Principal Accounting Officer)
   
         
/s/Robert D. Short III
 
Director
 
March 15, 2024
Robert D. Short III
       
         
/s/Gary Feiner
 
Director
 
March 15, 2024
Gary Feiner
       
         
/s/Michael F. Angelo
 
Director
 
March 15, 2024
Michael F. Angelo
       
         
/s/Thomas M. O’Brien
 
Director
 
March 15, 2024
Thomas M. O’Brien
       


EX-23.1 2 ef20015315_ex23-1.htm EXHIBIT 23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-149883, 333-196064, 333-218467, and 333-258131) of our reports dated March 15, 2024, relating to the consolidated financial statements of VirnetX Holding Corporation (the “Company”), appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2023.

/s/ Farber Hass Hurley LLP

Chatsworth, California
March 15, 2024



EX-31.1 3 ef20015315_ex31-1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kendall Larsen, certify that:

1.
I have reviewed this Annual Report on Form 10-K of VirnetX Holding Corporation for the fiscal year ended December 31, 2023;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

  (a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

  (b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

  (c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

  (d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

  (a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

  (b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
/s/ Kendall Larsen
 
Kendall Larsen
 
President and Chief Executive Officer
 
(Principal Executive Officer)
Date: March 15, 2024
 



EX-31.2 4 ef20015315_ex31-2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Katherine Allanson, certify that:

1.
I have reviewed this Annual Report on Form 10-K of VirnetX Holding Corporation for the fiscal year ended December 31, 2023;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
/s/ Katherine Allanson
 
Katherine Allanson
 
Chief Financial Officer
 
(Principal Financial Officer and Principal Accounting Officer)
Date: March 15, 2024
 



EX-35.1 5 ef20015315_ex32-1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION  OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of VirnetX Holding Corporation (the “Company”) on Form 10-K for the fiscal year ended December 31, 2023 as filed with the Securities and Exchange Commission on March 15, 2024 (the “Report”), I, Kendall Larsen, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:


(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
/s/ Kendall Larsen
 
Kendall Larsen
 
President and Chief Executive Officer
 
(Principal Executive Officer)
Date: March 15, 2024
 



EX-32.2 6 ef20015315_ex32-2.htm EXHIBIT 32.2
EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of VirnetX Holding Corporation (the “Company”) on Form 10-K for the fiscal year ended December 31, 2023 as filed with the Securities and Exchange Commission on March 15, 2024 (the “Report”), I, Katherine Allanson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:


(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
/s/ Katherine Allanson
 
Katherine Allanson
 
Chief Financial Officer
 
(Principal Financial Officer and Principal Accounting Officer)
Date: March 15, 2024
 



EX-101.SCH 7 vhc-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 040100 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 050000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - Formation and Business of the Company link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - Commitments, Contingencies and Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - Stock Plan link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - Employee Benefit Plan link:presentationLink link:calculationLink link:definitionLink 061000 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 061100 - Disclosure - Fair Value Measurement link:presentationLink link:calculationLink link:definitionLink 061200 - Disclosure - Litigation link:presentationLink link:calculationLink link:definitionLink 061300 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 061400 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 061500 - Disclosure - Insider Trading Arrangements link:presentationLink link:calculationLink link:definitionLink 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 080300 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 080600 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 080700 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - Common Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 081000 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 081100 - Disclosure - Fair Value Measurement (Tables) link:presentationLink link:calculationLink link:definitionLink 081300 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - Formation and Business of the Company (Details) link:presentationLink link:calculationLink link:definitionLink 090200 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - Commitments, Contingencies and Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - Stock Plan (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - Stock-Based Compensation, Information about Stock Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 090602 - Disclosure - Stock-Based Compensation, Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 090604 - Disclosure - Stock-Based Compensation, Summary of Restricted Stock Units and Restricted Stock Awards Activity (Details) link:presentationLink link:calculationLink link:definitionLink 090606 - Disclosure - Stock-Based Compensation, Stock-Based Compensation by Type of Award (Details) link:presentationLink link:calculationLink link:definitionLink 090608 - Disclosure - Stock-Based Compensation, Fair Value Assumptions Used (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - Common Stock, Summary (Details) link:presentationLink link:calculationLink link:definitionLink 090802 - Disclosure - Common Stock, Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 090900 - Disclosure - Employee Benefit Plan (Details) link:presentationLink link:calculationLink link:definitionLink 091000 - Disclosure - Income Taxes, Components of Provision (Benefit) for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 091002 - Disclosure - Income Taxes, Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 091004 - Disclosure - Income Taxes, Components of Deferred Tax Assets (Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 091006 - Disclosure - Income Taxes, Pre-tax Income (Losses) and Operating Loss Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 091008 - Disclosure - Income Taxes, Income Tax Uncertainties (Details) link:presentationLink link:calculationLink link:definitionLink 091100 - Disclosure - Fair Value Measurement (Details) link:presentationLink link:calculationLink link:definitionLink 091200 - Disclosure - Litigation (Details) link:presentationLink link:calculationLink link:definitionLink 091300 - Disclosure - Leases, Summary (Details) link:presentationLink link:calculationLink link:definitionLink 091302 - Disclosure - Leases, Lease Liability (Details) link:presentationLink link:calculationLink link:definitionLink 091304 - Disclosure - Leases, Lease Liability (Details) Calc 2 link:presentationLink link:calculationLink link:definitionLink 091400 - Disclosure - Subsequent Event (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 vhc-20231231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 vhc-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 vhc-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Insider Trading Arrangements [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Accounts receivables Accounts Receivable, after Allowance for Credit Loss, Current Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Additional paid-in capital Additional Paid in Capital Depreciation Depreciation expense Aircraft [Member] Air Transportation Equipment [Member] Restricted Stock [Member] CONSOLIDATED BALANCE SHEETS [Abstract] Basic (loss) per share (in dollars per share) Earnings Per Share, Basic Building [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Cash and Cash Equivalents Cash [Member] Accounts payable and accrued liabilities Accounts receivables Increase (Decrease) in Accounts Receivable Accrued payroll and related expenses Increase (Decrease) in Employee Related Liabilities Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Changes in assets and liabilities: Common stock, shares authorized (in shares) Common stock, shares authorized (in shares) Common stock, shares issued (in shares) Common stock, shares outstanding (in shares) Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at December 31, 2023 and December 31, 2022, Issued and outstanding: 3,618,431 and 3,578,983 shares, at December 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Current [Abstract] Deferred [Abstract] Components of Deferred Tax Assets and Liabilities [Abstract] Comprehensive (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Computer Equipment [Member] Rental fees incurred for use of aircraft Federal Foreign Current Foreign Tax Expense (Benefit) Current income tax provision (benefit) Current Income Tax Expense (Benefit) Total current liabilities Liabilities, Current Current liabilities: State Highly Liquid Debt Investments [Member] Debt Securities [Member] Federal Deferred Federal Income Tax Expense (Benefit) Deferred income tax provision (benefit) Deferred Income Tax Expense (Benefit) Total deferred tax liability - depreciation and amortization Deferred Tax Liabilities, Gross State Deferred State and Local Income Tax Expense (Benefit) Total deferred tax assets Deferred Tax Assets, Gross Net deferred tax assets Deferred Tax Assets, Net Deferred tax assets after valuation allowance Deferred Tax Assets, Net of Valuation Allowance Net operating loss carry forward Income Taxes [Abstract] Deferred Tax Assets, Operating Loss Carryforwards, Components [Abstract] Other Deferred Tax Assets, Other Research and development credits and other credits Stock based compensation Reserves and accruals Valuation allowance Deferred Tax Assets, Valuation Allowance Diluted (loss) per share (in dollars per share) Earnings Per Share, Diluted Basis of Consolidation Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Effective Tax Rate Reconciliation [Abstract] Valuation allowance United States federal statutory rate Other State taxes, net of federal benefit R&D Credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Stock-based compensation Stock-based compensation expense Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-based Compensation [Abstract] Stock-Based Compensation [Abstract] Share-Based Payment Arrangement, Noncash Expense [Abstract] Fair Value Federal [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets [Line Items] Gain Contingencies, Nature [Axis] Gain Contingencies [Line Items] Gain Contingencies [Table] Gain Contingency, Nature [Domain] Intangible Assets Impairment of Long-Lived Assets CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] Income Taxes Income Tax Disclosure [Text Block] Accrued interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Income Taxes Cash paid for income taxes Intangible Assets [Abstract] Finite-Lived Intangible Assets, Net [Abstract] Investments Investment, Policy [Policy Text Block] Investments [Abstract] Total liabilities Liabilities Total liabilities and stockholders' equity Liabilities and Equity LIABILITIES AND STOCKHOLDERS' EQUITY Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Cash flows from financing activities: Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from investing activities: Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from operating activities: Net (loss) Net (loss) Office Furniture [Member] Net operating loss carryforwards (Loss) from operations Operating Income (Loss) Formation and Business of the Company Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Change in unrealized investment (loss) gain, net Change in unrealized (loss) gain on investments, net Other investments Patents [Member] Dividend Payments of Dividends Dividend [Abstract] Subsequent Events [Abstract] Employee Benefit Plan Retirement Benefits [Text Block] Positive Outcome of Litigation [Member] Preferred stock, shares authorized (in shares) Preferred stock, shares issued (in shares) Preferred stock, shares outstanding (in shares) Preferred stock, par value (in dollars per share) Proceeds from sale or maturity of investments Property and equipment, gross Property, Plant and Equipment, Gross Property and equipment, net Property and equipment, net Property and Equipment [Abstract] Property and Equipment Bad debt Purchase of investments at cost Payments to Acquire Other Investments Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Research and Development Accumulated deficit Property and Equipment Property, Plant and Equipment [Table Text Block] Investments available for sale Debt Securities, Available-for-Sale, Current Selling, general and administrative expenses Information about Stock Options Outstanding [Abstract] Share-Based Payment Arrangement, Disclosure [Abstract] Cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Granted (in shares) Number of restricted stock issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Outstanding, end of period (in shares) Outstanding, beginning of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Outstanding, beginning of period (in dollars per share) Outstanding, end of period (in dollars per share) Weighted average fair value of warrants at grant date (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Unrecognized stock-based compensation expense expected to be recognized related to stock awards Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested (in dollars per share) Options vested and exercisable, number exercisable (in shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Exercise Price Range [Axis] Options outstanding, number outstanding (in shares) Exercise price range, upper range limit (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Shares available for grant (in shares) Options granted, weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Options outstanding, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Outstanding, beginning of period (in shares) Outstanding, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Outstanding, beginning of period (in dollars per share) Outstanding, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Options exercisable, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Options exercisable, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Expected dividends Dividend yield Expected stock price volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Risk-free interest rate Equity Award [Domain] Award Type [Domain] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Information about Stock Options Outstanding Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] State [Member] CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) [Abstract] CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY [Abstract] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Stockholders' equity: Warrants issued (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Subsequent Event Type [Axis] Subsequent Event [Line Items] Subsequent Event [Table] Subsequent Event Type [Domain] Subsidiary, Sale of Stock [Line Items] Total current assets Assets, Current Current assets: U.S. Agency and Treasury Securities [Member] US Treasury and Government [Member] Uncertain tax positions Warrants [Member] Diluted weighted average number of shares outstanding (in shares) Weighted average shares outstanding diluted (in shares) Effect of dilutive securities (in shares) Basic weighted average number of shares outstanding (in shares) Weighted average shares outstanding basic (in shares) Common Stock [Member] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Long-Lived Tangible Asset [Domain] Research and development Research and Development Expense Total assets Assets Other liabilities, current Other liabilities Income Tax Authority [Domain] Financial Instruments [Domain] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Fair Value Disclosure Statement [Table] ASSETS Assets [Abstract] Statement [Line Items] Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets Information about Warrants Outstanding Class of Warrant or Right [Table] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Level 1 [Member] Commitments, Contingencies and Related Party Transactions [Abstract] Leases, Operating [Abstract] Concentration of Credit Risk and Other Risks and Uncertainties [Abstract] Fair Value Measurement Fair Value Disclosures [Text Block] Class of Warrant or Right [Line Items] Purchase of investments Payments to Acquire Debt Securities, Available-for-Sale Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Property and Equipment [Abstract] Property, Plant and Equipment, Net, by Type [Abstract] Deferred income taxes Increase (Decrease) in Deferred Income Taxes Operating expense: Total operating expense Operating Expenses Calculation of basic and diluted loss per share [Abstract] Earnings Per Share [Abstract] Earnings per Share Commitments, Contingencies and Related Party Transactions Other liabilities Increase (Decrease) in Other Operating Liabilities Schedule of Available-for-sale Securities [Line Items] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule of Property, Plant and Equipment [Table] Common stock, par value (in dollars per share) Common stock, par value (in dollars per share) Change in foreign currency translation, net Change in foreign currency translation, net Long-Lived Tangible Asset [Axis] Property, Plant and Equipment [Line Items] Property and Equipment [Line Items] Balance Balance Total stockholders' equity Equity, Attributable to Parent Deferred tax assets [Abstract] Total income tax (benefit) provision Income tax (provision) benefit Income Tax Expense (Benefit) Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at December 31, 2023 and December 31, 2022, Issued and outstanding: 0 shares at December 31, 2023 and December 31, 2022 Preferred Stock, Value, Issued Dividends per share (in dollars per share) Dividends per share (in dollars per share) Equity Components [Axis] Accumulated Deficit [Member] Accumulated Other Comprehensive Loss [Member] AOCI Attributable to Parent [Member] Equity Component [Domain] Exercise price range, lower range limit (in dollars per share) Stock Options [Member] Options cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Options cancelled (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Common stock issued for options/RSUs/RS, net Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Options exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Options, number of shares [Roll Forward] Options, additional disclosures [Abstract] Number of Shares [Roll Forward] Fair value assumptions used in estimating fair value of each option grant [Abstract] Stock Plan [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract] Earnings Per Share Earnings Per Share [Text Block] Common Stock [Abstract] Class of Stock Disclosures [Abstract] Schedule of Stock by Class [Table] Leases [Abstract] Commitments and contingencies (Note 4) Dividends Dividends, Cash Adjustments to reconcile net (loss) to net cash from operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Total Investment Securities [Member] Available-for-Sale Securities [Member] Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Accrued payroll and related expenses Other comprehensive (loss) income, net of tax: Total other comprehensive (loss) gain, net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition (Loss) before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Prepaid expenses and other assets Prepaid Expense and Other Assets, Noncurrent Fair Value, Measurement Frequency [Domain] Fair Value Hierarchy and NAV [Domain] Recurring [Member] Withholding taxes paid on cashless exercise of restricted stock and restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Asset Class [Domain] Interest and other income, net Interest and Other Income Business Description and Basis of Presentation [Abstract] Asset Class [Axis] Fair Value Hierarchy and NAV [Axis] Measurement Frequency [Axis] Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Income Tax Provision (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Commitments, Contingencies and Related Party Transactions [Abstract] Litigation Legal Matters and Contingencies [Text Block] Income Taxes [Abstract] Fair Value Measurement [Abstract] Subsequent Event Employee Benefit Plan [Abstract] Restricted Stock Units Activity Stock-Based Compensation by Type of Award Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Fair Value Assumptions Stock-Based Compensation [Abstract] Use of Estimates Use of Estimates, Policy [Policy Text Block] Restricted Stock Units (RSUs) [Member] RSUs [Member] Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract] Assets, Fair Value Disclosure [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Prepaid income taxes Increase (Decrease) in Prepaid Taxes Summary of Significant Accounting Policies [Abstract] Subsequent Event [Abstract] Income Tax Authority [Axis] Options granted (in shares) Basic and Diluted Loss Per Share Calculations Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Operating Leased Assets [Table] Operating Leased Assets [Line Items] Options vested and exercisable, weighted average exercise price (in dollars per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Options outstanding, weighted average exercise price (in dollars per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Options exercisable, aggregate intrinsic value Matching contribution to defined contribution plan Schedule of Finite-Lived Intangible Assets [Table] Outstanding and Exercisable (in shares) Outstanding and Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Terminated/ cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations Weighted Average Grant Date Fair Value [Abstract] Cancelled (in dollars per share) Unrecognized stock-based compensation expense expected to be recognized related to unvested stock options Unrecognized stock-based compensation expense expected to be recognized related to unvested stock awards Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Per share market price of common stock on last trading day of year (in dollars per share) Share Price Financial Instrument [Axis] Options, weighted average exercise price [Roll Forward] Options granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Options exercised (in dollars per share) Compensation cost not yet recognized [Abstract] Plan Name [Axis] Plan Name [Domain] Award Type [Axis] Amount of damages awarded in patent infringement case Loss Contingency, Damages Awarded, Value Subsequent Event [Member] Income Statement Location [Axis] Income Statement Location [Domain] Additional shares authorized (in shares) Estimated useful lives New Accounting Pronouncements Concentration of Credit Risk and Other Risks and Uncertainties Useful lives Options outstanding, weighted average remaining contractual life Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Options exercisable, weighted average remaining contractual life Expected life term Expected option term Option vesting term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Weighted-average period for recognition of unrecognized stock-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Options vested and exercisable, weighted average remaining contractual life Options outstanding, weighted average remaining contractual life Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Reverse stock split ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Operating Expense [Member] Intellectual Property [Member] Litigation [Abstract] Gain Contingency, Quantities, Patents [Abstract] Operating loss carryforwards, expiration date Restricted Stock Activity Aggregate Intrinsic Value [Abstract] Outstanding, end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Award Date [Axis] Award Date [Domain] Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Unrealized Gains Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Geographic Distribution [Axis] Geographic Distribution [Domain] Foreign [Member] Non-US [Member] Mutual Funds [Member] Mutual Fund [Member] Operating lease ROU assets Future Minimum Rents Due [Abstract] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Operating lease discount rate using risk-free rate Lessee, Operating Lease, Discount Rate Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Leases [Abstract] Leases [Abstract] Lessee, Operating Lease, Description [Abstract] Net (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Total undiscounted lease liability Lessee, Operating Lease, Liability, to be Paid Thereafter Due in 2024 Due in 2028 Due in 2027 Due in 2026 Due in 2025 Lease Liability Lease expense Total lease liability Operating lease liability Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Leases Lessee, Leases [Policy Text Block] Leases Operating lease weighted average remaining life Operating Lease, Weighted Average Remaining Lease Term Term of lease Lessee, Operating Lease, Term of Contract Lease renewal period Lessee, Operating Lease, Renewal Term Stock based compensation Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent Equity Securities without Readily Determinable Fair Value [Table] Equity Securities without Readily Determinable Fair Value [Line Items] Investment in equity security without readily determinable fair value Equity Securities without Readily Determinable Fair Value, Amount Revenue Recognition Schedule of Available-for-sale Securities [Table] Investment in Equity Securities without Readily Determinable Fair Value [Abstract] Equity Securities without Readily Determinable Fair Value, Annual Amount [Abstract] Impairment on investment in equity security without readily determinable fair value Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount Investment, Name [Domain] Investment, Name [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Minimum [Member] Litigation Case [Domain] Counterparty Name [Axis] Counterparty Name [Domain] Litigation Case [Axis] U.S. [Member] UNITED STATES Cover [Abstract] Document Type Document Annual Report Document Transition Report Document Financial Statement Error Correction [Flag] Entity Interactive Data Current Amendment Flag ICFR Auditor Attestation Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Shell Company Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Public Float Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Common Stock, Shares Outstanding Auditor Name Auditor Location Auditor Firm ID Amount of total commitment payable for single payment. Operating Lease, Single Payment Operating lease, single payment Amount of cash commitment for lease extension. Operating Lease, Cash Commitment, Amount Operating lease, commitment Amount of annual obligation for lease extension. Operating Lease, Annual Obligation for Extension, Operating lease, annual payments for lease extension Period of free rent for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Operating Lease, Period of Free Rent Period of free rent Amount of monthly payment for lessee's operating lease. Operating Lease, Monthly Rent Payment Operating lease monthly payment Operating lease for office space. Office [Member] Office [Member] Operating lease for a facility used for corporate promotional and marketing purposes. Promotional and Marketing [Member] Corporate Promotional and Marketing Facility [Member] Operating lease for facility. Facility [Member] Facility [Member] Disclosure of accounting policy for the licensing costs. Licensing Costs [Policy Text Block] Licensing Costs Disclosure of accounting policy for an existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization, and describes and quantifies a gain recognized in the period resulting from resolution of a previously disclosed gain contingency. Gain Contingencies [Policy Text Block] Contingent Gains Issuance date of warrant that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Warrant Issuance Date 2 [Member] Warrants Issued in 2020 [Member] Date the warrants or rights are to expire, in CCYY-MM-DD format. Class of Warrant or Right, Expiration Date Expiration date Information About Warrants [Abstract] Warrants [Abstract] Refers to number of votes entitled to each share of common stock. Number of votes entitled to each share of common stock Represents number of patents and pending applications owned by the entity. Number of patents and pending applications owned Number of patents and pending applications Formation and Business of the Company Disclosure [Abstract] Formation and Business of the Company Disclosure [Abstract] Represents options within the stated exercise price range. Exercise Price Range 3 [Member] $290.40 - 308.00 [Member] Represents Options within the stated exercise price range. Exercise Price Range 1 [Member] $10.00 - 31.60 [Member] Represents Options within the stated exercise price range. Exercise Price Range 2 [Member] $34.80 - 139.00 [Member] Refers to the term of notice for cancellation of lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Term of Notice for Cancellation of Lease Term of notice for cancellation of lease Refers to the rate of aircraft lease in dollars per flight hour. Rate of Aircraft Lease Rate of aircraft lease (in dollars per flight hour) The counterparty from which the Company leased the use of an aircraft for business travel for employees of the Company K2 Investment Fund LLC [Member] K2 Investment Fund LLC [Member] Operating lease for office space and facility. Office and Facility [Member] Office and Facility [Member] Investment in a nonconsolidated investee. L2 Holdings LLC [Member] L2 Holdings LLC [Member] Investment in a nonconsolidated investee. OP Media [Member] OP Media Inc. [Member] Period of time between issuance and maturity of investment securities, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Contractual Maturities of Investment Securities Contractual maturities of investment securities Number of financial institutions holding the company's cash and cash equivalents. Concentration Risk, Number of Financial Institutions Number of financial institutions holding company's cash The equity incentive plan has been amended and restated by the entity. Amended and Restated Equity Incentive Plan [Member] Amended and Restated Equity Incentive Plan [Member] The entire disclosure of the description of the plan, the basis for determining contributions, including the employee groups covered, and the nature and effect of significant matters affecting comparability of information for all periods presented. For leveraged ESOPs and pension reversion ESOPs, the disclosure may include the basis for releasing shares and how dividends on allocated and unallocated shares are used. Stock Plan [Text Block] Stock Plan Stock Plan [Abstract] The aggregate licensing costs related to revenues. Licensing Costs Licensing costs The entire disclosure for common stock. Common Stock Disclosure [Text Block] Common Stock Common Stock [Abstract] Opening brief due period after the certified list is filled, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Opening Brief Due Period Opening brief due period Information about litigation regarding VirnetX Inc. v. The Mangrove Partners (Case 20-2271 and Case 20-2272) ("Consolidated Appeal"). VirnetX Inc. v. The Mangrove Partners (Case 20-2271 and Case 20-2272) ("Consolidated Appeal") [Member] VirnetX Inc. v. The Mangrove Partners (Case 20-2271 and Case 20-2272) ("Consolidated Appeal") [Member] Information about litigation regarding VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 23-1765). VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 23-1765) [Member] Information about litigation regarding VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) ("Apple II"). VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) ("Apple II") [Member] Royalty rate per device used in calculating infringement damages by the court. Royalty Rate per Device Used in Infringement Damages Royalty rate per device used in calculating infringement damages Number of appeals consolidated in a court order. Loss Contingency, Number of Appeals Consolidated Number of appeals consolidated Litigation [Abstract] The increase (decrease) in accrued licensing costs during the reporting period. Increase (Decrease) in Accrued Licensing Costs Accrued licensing costs The amount of capitalized direct and indirect research and development costs. Capitalized Direct and Indirect Research and Development Costs Capitalized direct and indirect research and development costs The unamortized capitalized direct and indirect research and development costs. Unamortized Capitalized Direct and Indirect Research and Development Costs Unamortized capitalized direct and indirect research and development costs Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalized direct and indirect research and development costs. Deferred Tax Assets, Capitalized Direct and Indirect Research and Development Costs Deferred tax assets relating to capitalized direct and indirect research and development costs The amortization of capitalized direct and indirect research and development costs during the period. Amortization of Capitalized Direct and Indirect Research and Development Costs Amortization of capitalized direct and indirect research and development costs Period of maturity of a debt security categorized as neither trading nor held-to-maturity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Available-for-sale Securities, Debt Maturity Period Maturities of investments Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading, excluding cash and cash equivalents. Available-for-sale Securities, Excluding Cash and Cash Equivalents Investments Available for Sale Fair value portion of cash and investment in debt and equity securities categorized neither as held-to-maturity nor trading. Cash and Available-for-sale Securities, Fair Value Disclosure Fair Value This item represents the cost of cash and debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Cash and Available-for-sale Securities, Amortized Cost Basis Adjusted Cost Common stock that is subordinate to all other stock of the issuer and excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders related to additional paid-in capital. Common Stock and Additional Paid-in Capital [Member] Common Stock and Additional Paid-in Capital [Member] EX-101.PRE 11 vhc-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 12 image01.jpg begin 644 image01.jpg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end GRAPHIC 13 image02.jpg begin 644 image02.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# 8$!08%! 8&!08'!P8("A *"@D) M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_ MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P 1" '* F # 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#ZIHHHH ** M** ,WQ'KNF>&M&N=6UV\BLM/MUW2329P/0 #DDG@ DGI7D_A[]I3P'K.MPZ M6.I-DQ6^H1K&TX R=A5F4D>F0>I (!KC;HZ4?VMK8^(#;& Z'$=% M,^W9YN\;/+[9_P!=M]^G.*?^TL^FCQ9\.Q8_9SXN&L6YAV8,XM]Y^\!SLWXQ MGC(;'>@#MD^,?AUOBC_P@;6VIIJWG&#SVCC^SEO+WCYM^[GH/EZG\:7QC\8O M#OA3QW8>$[ZWU*?4[PPA7MHD:*,ROM4,6<$'H3@'@CZ5\]^-[66+XL?$KQ%: M(7O/#MS8ZE$%.#\LD8;\-I;/M5;Q%.OB;Q=HOCE.8=6\9+;VKE<%K:'R4B)S MR,C/'KF@#W+QO^T+X4\'>*;_ $#4]/UR6\LF5)'MX(FC)*AN"90>C#L*['X9 M_$?0/B+H\]_H$DZ?9GV7%O=($EA)SM+ $C! )!!(_$$#PF74O'NF_M ?$1OA MQHFG:M.YMA=+>.%$:^6NTC,L?4Y]:=?6OB+X,?&(M+#Q+XME6UAL; M1AM@9C("3 ME?-'@7Q_X7\.^-_AW>>'HM0M?LEK_9FMO=1HDH;/,BBOHD3SP,EMA5V!( R0<''(S@XU]#^*/AW5--\3ZA(UU86/AV MY>VO9KN, ;E)!*!&8L"1P,9)(&,UY'\*9-=^(_QFB\1>,Y=(TS5O"T$EJVCV MT,D=QEMRAW#YRG[QN5<@$+P-V3B^&8M"NO /QDL_%>I2:7I=SX@:-KQ('F\J M3S=T9*("2-ZKD<9Z9&: /2?"O[1_@?Q#K]MI2KJNGR7+^7%/>PQK$7)P%)5V M(R>Y 'J17:_$OXD>'?AUIL5UXAN)/-G.+>TMT#S38(SM!( SDDD#MG) /@O MC!O%'AWP'X=/Q#TKPQXQ\"VIC>&]TVZDM;E$(VP%&4QY^5A@(IRJ_,1]ZNGU M"YTJ\_:LT:Y\0>4;6;0XI-'^U@!?.+Y3;GC?DR8[[L8YQ0!V?PY^.?@[QYJW M]EZ?)>6&HM_J8-0B6,S\9.PJS*2/0D'T!P<:]I\4= N/BA=^ V6\@UF!-PDE M11#,=BOL1@Q8MM8GE1]T\],^>?M/OIHUKP"+'[.?%XUJV-MLP9Q!N/4#G;YF MS';(;'>O/O'/A74/$7QP^(U]X>EDB\0:%'::G8F/J[)'%E,=R1T]2 .A- 'T MMIOC?3=0^(.K>#X8+Q=3TRW2YFE=%$+*X4@*=VXGYQU4=ZUO$FO:9X9T6YU; M7;R.ST^W&9)GR<9. !DDD\ $FOGWX!>+(O''QT\3>((8_*-WHEMYL?.$D4 M0JZC/4!@<'TK?_:O\K^R_!?]J;O[!_MV'^T,YV;,'.['^SOH GT/]IKP'JFK M0V4RZMIJ2MM%U>6Z"%3VW%'8@'UQ@=\#FNN^*?Q8T'X;1Z2^M6^HW::F)6@: MP2.0839DGF-O\ M.>V:\.\8PZ_=>&OV?H=)N8[377BD6RGG7*1G_1_*8@JW&W;V/TH ]K^&OQR\ M-?$+Q)_8NBV.L077DM/ONX8E3:N,\K(QSSZ5VGC_ ,7:=X&\*W>OZRMP]I;% M%,=NH:1RS!0%!('?/4< US/PKTGXEZ;?7S?$;Q#I>K6KQJ+9+.-5*/GDG$,? M&/+-0EM5\*^+-&$@-.\>?$/2O ^H:+;Z[;7Z M6VJ3_9X[Z-$-O"^1Q*Q8%>#GH> ?0UP7@>?5_"'QTNO!$GB#5_$&C7>E#48W MU2?SY[:0-MP9,?=.T\8 ^9>^2?2_B)X1L?''@_4-!U(8CN4_=R@9,,@Y1Q]# M^8R.A- %/Q?\0-+\,>(]"T&>WOK[5M9D*6]M9(CLJ@@%WW,NU.O/^RWH:X;Q M;^T;X1\+^)-1T34-.UZ2[L9C#(\$$)0L/[I,H./J!7.?LI:5<:__ &CXW\1W MCZCJ]OMT2T>4Y\B&)$R1[G(YZ_>)Y8USVC:7\0]2^,7Q/_X5MKNFZ1Y=_%]M M^VQAO-SYGE[[?"SXE:/\2M.O;S0K;4+>*TE$,@O(T0DD9X MVNW%4]'^+OAK5OB9=^![7[8-6MVDC,KH@@D>,9=%(;<6&&ZJ/NM572=3\6> MOA?K^L?$S5K#5M3LC)<0R6JA$,>Q!'$<1Q\F3(Z?Q#GT^1=-\<:+I&B>&+^P MBU)O&FG:S)J=Y=2(@AN%D(WIN#ECD(@Y4#YG]>0#[(^*_P 5=#^&7]E_V]:Z MES=NW.O\ ?&,9[USO@?\ :%\&>+_$EMHEK'JMA=71V0/? M0QK'(_9 4=L,>V0 <8SD@'DOVB-6U"[\5?"'5O!D$&H7\\ES #ZF8A5)8@ N?M+> M*UJ73XSJFH)&^QKRS@1H,YP<%G M4L!Z@$'MFO0?BQ]J_P"%8>*_[/\ ,^U?V7<[/+^]_JVZ>^,].?2N,^ X\+GX M!6 _XEW]EFUD_M;S-NSS,'SO.S[8^]_#M[8H Z3Q%\4?#FC>$]%\21R7&I:3 MJ]W'9VLMDBL2[AR"P=EP!L8$=0>".M:/Q&\;Z;X T&/5]8@O)[:2X2V"VJ*S M[FS@X9E&.#WKQ+XV2>%4^"G@ZX\#FU'AJWU^VD5K<'"*(Y=Q?/S;LGG=\V3S M70_M;7EM-\,M)CAN(7>[U2W:W"N#YJ[6.Y?4(?CEJ]K$I:>'PQ)=0A3@F2-7=,>^0*X MOXG:TWQ&\.ZWXR89BL(M+TR(E>=[(\DXYZ8D.,]QB@#ZY7QYI9\?V?A 07O] MI76GC4DEV+Y(CR1@G=G=\IXQCWJ2^\;Z;9?$33?!LL%X=4O[1KR*547R0B[\ MACNW9^0]%/;FO*YYXK/]J;PN;J1(1<^&5BA+G =]TGRCWX/%7/$$T4_[7/AB M.&1))+?0I1,JL"8R?.(!]#A@<>A![T >C>!?'6F>-)]0:?87-[>2".VMHFFE<]%1023^ %>*?LR_P#(3^)7 M_8PS?^A-5K]K'Q2/#_PKGL(GQ>:S*+- #R(_O2'Z8 4_[XH ZWX5_%'0?B9; MZA)H,=[ ]BZ++%>(B/A@=K *S#!P1U[5P^L_M->#=(UB^TVYTSQ"T]G/);R- M';PE2R,5)&90<9'I7EGPI\?^%].^.&A_\(I%?V>C:EIT.CW:7T:1EIU4+'( MKL"24C!Y'WF/>O5/VJO^09X(_P"QAM__ $%J -#0_P!H3PIK*Z:UKI^N(+_4 M4TR+S(8AB5MN"V)3\OS#D9/M79^"_'^E^+-=\0Z/96]]:ZAH<_V>ZBNT52QR MP#)M9MRY4\\=1ZBO._VD_P#D9OA7_P!C#%_Z''67\0=1B^%GQ_MO%MSN30_$ M&F2PWFWIYT* CCU.V(#O\S?B >BW_P 6="M-7\66 M-3G/AFU^U7\\,<9B[? MNT)<$OR>" /E;GUX+_AJOP1_T"O$G_@/!_\ 'JP_"6D7,7[,_CKQ+JJYU;Q- M'8>SU%\/?#OQQN/ VA3>'O&6@6FCR6<36D$T*EXXMHVJQ^ MS-R![GZT ?2NCW\6JZ39:C;JZPW<"7$:R !@KJ& ."1G!]:\5U;]IWP9IFJ7 MEA<:9XA::UF>!REO"5+*Q4XS*.,BOXQ@DX )JAX. M_:+\#^)];ATL'4M+FFPL4FHPHD;N2 $W([8)S_%@<=E0?#KX[^&/'WB>+0M'L=9ANY(WD#W4,2IA1D\K(Q_2M7QT;D_ ' M63?Y^V'P[)Y^1@[_ +/\WZYK@M/\4CPA^R-8:BC[;J33S:VN#@^;([*"/]T$ MM_P$T =]\/\ XN^&O'?B;5-#T3[8MW8!G+SHBQSHK["T9#$D9(/('#"MC4?' M6F6'Q%TKP7-!>-JFHVK7<4J(IA5%#DACNW _NVZ*>HKXZ\&^/O#'AKQ#\.+[ M0H=0MKK38S9ZW)<1HL,9_B% '4> _V@O!OC+Q);Z) M:1ZI87=R"(&OH45)7[("CMACSC. <8SD@&'QI^T/X3\(^*-0T+4M/UV6[LG$ MG M7O0!ZKX<^./AK7_!_B'Q'9V.L)8Z&$-RDL,0D??G&P"0@].Y%F?"W3_&VG:/=Q_$76+#5M1:?=!+9H%5(MH^4XC3G.X]#UZU MY_I'_)X&M_\ 8O+_ .A0T =QX(^)^B^,?$$FCZ9:ZC%#5+2Q%^\K(ODF,E!@'=NW?./X<=>: M\V\+SQ6W[6GC&&XD2.6[TB P*QP9=J0YV^I&"<>@)[&CPS/%<_M<>*&MY4E6 M'P^L,A1@=K^9!E3[T 4O^&J_!'_0*\2?^ \'_P >KO)/B[X9_P"%8R>.K8WE MUI$3)'+##&OGQ2,RKL968 ,"XS\V,<@D$9^:_A5XY^)/@OX6/>^'O#^E77A6 M&Z4DICA13,I9PA0J6"[ ME8X/S8X.":@UGXM^$M%&DC4]0%O-J,,%RL,A56AAF5V61\G&!Y9!VEB"5X^8 M9^8O?PW\$:YX1N3)+X>\4:?;:GI4AR?)G#Q-+%^0/X!#U8U] S?#FW\<^ M$/!UQ>:M?VOV#1XC9QP,%6"Z*1E+D8P69=I&&)&#QM.20#U'3+ZVU33;2_L) M1-9W4*3PR@$!T8!E;GGD$&K-,A1HX8T>1Y650ID< ,Y''/B+ M81P>(;:03P_ZB\MWV3P\@D D$$''1@1SG&>:POAQ\#?!_@+5_P"U-.CO;[45 MXAGOY5,]2 MT&ZUBXO=FCW/VN&VB=1%-(""/,!4D@;>Q'4^M=;10!SGQ!\':9X[\+W&A:T9 MUM9F1_,MV"R1LK @J2" >W0\$UGVWP\TV'QGH_BA[W4I]4TS3%TJ,RR(5EC& M[YW 0$N=Y)(('M79T4 <9J_P[TG4/B#IWC**XO[#6K-!$[6DB(EU'_=F4J=P MP2,@@XQSPN*^B_"SPYIFF^)]/E2YU"Q\17+W5[!>.I&YCG"%54J >0':3^S'X#T_5X+V236+Z.)]_V2ZN(S"_H&"QJQ ZXW!-8_M M73TOK_4$_P!3-J$JN8.""4"JHR<]2"1CC'.>HT;P+IFD>/=<\6VT]XVI:O&D M4\LOPQXWO-5\;7.GW5M!'HEV)QH]R@8/.ULXCG#Y. M#ECE, ?*I//6EG^)]A%=2(-$UZ6W34I-(%U'#$8WNT+ 1*/,WG<5 #[=@+#< MRX;: 2>#_A?H'A+QIK7B71FO([K5@PFMV=3!'N<.=BA01\PZ9(&< 8KI_$N M@:7XGT:XTK7K**]T^<8DBDR,^A!&"".Q!!%8*>/[%M.:5M-U--2&H?V6-**1 M&Y:YV"38"',>/+._=OVA>I'2HI_B-I\.GPROIFK&_?4AI#Z:L<9N(KDHSJK? M/LPR@$.'*X8$D#) !PNC_LR> M.U>*]E;5[^.-BWV2[N$,+>@(5%8@=<;N<< MY&17H?BKP%I7B77_ OJ]Y+=P3^'9FFLX[=D6-BQ3AP5)(_=KC!'>HU\?V3: M:)1IFJ'4VU!M,720D1NC<*N\KGS/*P(_WA;?MV]\\5I^$/$UOXGMK^2WL[ZS MDL;MK*XAO(U1TE559A\K,"!O R#@X)&1@D WJYGX@>"='\>:%_9>NQS>6D@F MAF@?9+!( 0'1N><$]01[5F6/C66V\*>);W78HAJGA^:>"Y@MU8"4@;X2BDD_ MO(WB(Y/+$=JKGQW/H=K>#Q1"TU]90:<+F#3K7 $]T[1X0M*=X##T! '5LX ! M<\!?#C2?!M_?ZE!=ZKJVLWP"3ZEJUS]HN&C $>[ &T;0>F>F20 !VM<)J/Q M'@T^;4(;CP[K_FZ;9QWU^J+;M]EA;?\ ,Q$V&($;':A8^@/.-'5_&UK8W$\= MIIFJ:I':VZW5Y-91QE+6-@64MO=2Y*@MLC#M@#CYER )\-O NF?#[0I]*T:> M\GMYKI[MFNW5G#L%! *JHQ\H[5P/BW]G+PCXH\2:CK>H:CKT=W?3&:1()X0@ M8_W08B%E#E&" +A M01MH^'H-4\0#3]0N8;FX/GP[W,0;:F?*QMRV3QG*CD=_3M:\/Z? MK'A>[\/W46W3;FV-HR1\%$*[1M]".,?05D^,/%UOX8U[P_!J=YI]CIE^;A9[ MF\E$00H@90&+!1DGOFLR#XE:1/K^NBVU/3;[0-+TNWO'NK&3[0PE>696CRA( M)PD>% SEN^10!#9_"31;9/!:G4-7F_X1-Y7L&EEC)<.5.V3$8R!M &-O'K6E MXZ^'>D^,-7T75KFXO]/U;2)/,MKW3Y$CEQG.QBRL&7(S@CN>Q.:&O_$.2S\. MZ_+'I-YIFN:=8_;HK/540^;&3@.#%(P(SP1N# XR!D99XZ^([Z-8:F^BZ5>7 M?V&YBM);]XE-I%,SH#&W[Q9"0' W*I4,0">" >BL RD, 0>"#WKQ+7/V9_ M6J:Q+?1?VKIR2-O:TLIT6$'.3@,C%0?0$ =@*[6\\?6^G7%Y#/:WU],-<&BV M\%G;*KF4VJS@$M+@@C/SG8!D @!2YG7Q_9-ID4R:9JK:E+?OIJZ2J1&Y\] 6 M9<^9Y6 @W[M^W;CG) H GOOA]X9O/ H\'OI<:: B!([>-F!C(;< W;MV3D MG))."\(_LX^"/#>O6NK(^K:C-;,)(HKZ=&C5P05;"(I)!'0DCU!KTKPC MXEM_$]G=SVUI>V;6ET]G/#>1JDB2J%+#"L0<;L9!P<$C(P3AVVL>)_$4>H7_ M (9?1[73K:XGM;>*_MY)7O7A=D=O,211"I=64?+(<#=WV@ N2^ M*F^(3^,9 M9;MM1>Q.GM 77R#&>OR[=V?^!8]JY>W^!?A:W^'EYX.BN=5&FW=X+Z2;SH_/ M\P!0 &V8VX4<;?6NIO?&4EG]DM6\/ZM=:U)9"^N--LC#(]JF<'<[2*A^;*@* MQ+;20, X;!X]T^^U/2++1K+4-4.IV:W\G) ]2* /$-9_9E\&ZOK%]J5SJ?B%9[R>2XD6.XA"AG8L0,Q$XR?6M_P , M_ [PUX?U#P[=07VL72Z"\LMI! MDM9K*[\.W-RT^+SPRA,6I647F>7(7=Y<%X\[F4Q*#@J#R"0#J?&_@73/&-]H M%UJ<]Y%)HMXM];BW=5#N"I ?Q23,DSK* MK!(5B52Q+J<].,BMG7-3\03>-X]#T*[TJSB&G?;7EO+&2Y9F\W9M 6:/ []Z M -+5_"FG:EX(F\*MYMOI4EF+$" @/'$%"@*2",@ =C7C_P#PRIX(_P"@KXD_ M\"(/_C->M>!M* MYG0_'5QJGBJ6V;5M/MM/&I36$,,FBW7[YHV9=BWID$)D;8Q"A2<<8)!H [OP M]I4&@Z!IFD6;2O;:?:Q6D32D%V2- H+$ #.!S@"L3QYX&TSQM_8_]JSWD/\ M9=ZE]#]F=5W.O0-N4Y7Z8/O6);^,]9=;'6Y$T\>'+W5_[*CMA$_VE%,[6Z3& M7?M;=(%.P(,*_P!XE>2W\9ZRZV.MR)IX\.7NK_V5';")_M**9VMTF,N_:VZ0 M*=@085_O$KR =-XX\'Z)XWT-]*\1V2W5J3O0@E7B?LZ,.01^1Z'()%>=>#_V M<_ _AK7(=4']IZI+!AHHM0F1XD<$$/M1%R1CHV1STS@CT3Q5K5SI&H>&8+9( M634]4^Q3&0$E4^SSR97!&#F)>N1@GCN,K2_B)8ZC>VL:Z5J\%G=7\VF17TT< M0A-Q&9 4P)"^#Y38;;MY )!R =)XET>W\0^'M2T>]>5+:_MY+:5HB ZJZE2 M5)!&<'N#7%WGP@T"\\.>%="N;O5)-,\.SBX@A,D>+A@<@3?)R.6'R[>&-+J? MQ'-I^H:LNG#4KB)?L\P^8/Y>)-X.5.&9 IVG&>,[%OXZLIKZ%/ M[/U*/3+B[^PP:JZ1BVFFR5"@;_, + J&*!20,$Y4D O>//">G>-_"UYH.L^< M+.ZVEGA8+(A5@P9200#D>G3(K@_&OP&\-^,6T=M8U37C)IEA'I\4D<\0:2-" M2&?,1RWS')&/I75Z3X_TS5-2MM,MK6^&KO<307%@RQ^=9"(@/)-AR GS1X92 MV[S$QG)QV% 'F7PN^"_AWX;ZW)>:$\DELD+J(W+[<[P5)/W1T(KJ:* .,\;?#K2?%FO M:+K=Q<7^GZQI#[[>\L)$20C.=C[E8,N<\8[MV)SQOC3]GCPGXN\4:AKNI:AK ML5W>N))$MYXEC! X!B)[>IKV6B@#@/A1\*M#^&7]J?V#=:E_;MVHO]\YSGM6I;^!=,M_B1=>-4GO#JMQ9BQ>(NODA 5.0-N[=\@_BQUX MKJZ* /./B?\ !SPM\1KRWO=:6\M;^%1']ILI51W09PK!E92 2><9]\<5>^%_ MPN\.?#>VNDT".XDN+K'G7=W('E=03A> % &3T SWS@5W-% ')?#_ , Z1X'\ M)OX=TYKF\TZ1Y'<7Q20OO&&4X4 KCMBN;M_@GX?M_ NL>$(M2US^P]1N$N/) M:XC8VS*X?$1,? )5'SK3='XH?6R=[8 M\@SO)M^[]_##CIGO7H=% 'G5QX+U:+5KS6+"6Q>_C\0'6+.&:1UCEC:R2U>. M1@I*,1O((#8PO!R0"'P7JT^I6VKZA-8KJ,NNQZK=0PNS1111VSP)'&Q4%VP5 M)8ARMC=W,]G%$(XT 8\&61/,;"DE8]Q'&<9 M&<_5?B/I]EQ+:0.0_[R122!&3M +'(P#S@ YGQ M'I4GA*_F\07FI:5:SR>)7U"S^VR216KQR6:V[1S3!"(6PKLK$%*K_2OA-=>*+6 MS2YU"+2Q>B$ >6',88D@NIV#.2 V[ .,G H K^)/!%QJGCK3]4@N8(]&D,4F MK6C [KE[=F>V*]N'8%L]1&@J'Q-X*U'5-;U>\MYK18KNXTB6,.[ @6ER99,X M4\E3A?4]<=:KR_$BZL=6UF/4/#^HO9Z?IUMJ$PMDB:2U1Q*9#*3+M8#RQA8] MS<-P:W]7\;6MC<3QVFF:IJD=K;K=7DUE'&4M8V!92V]U+DJ"VR,.V ./F7(! M2USPG?7]QXZ>&6V4:[I,=A;;F8;)%CG4E_EX7,J],G@\>O.WGPTECU66]30? M"6O/>6EO%*VLQY:UFBB6/=&?*N:=?>&;E)(IT\G7([R1@U\V2WVO(4YGW%LYP MRNU:;I>J^--9BUB]TNZ\/^59:C=6D-C-83!YEAE9 #.)\*6"_>\L@$]#TJ:U M\97GB8:'!X32VMI]0TU=5GN-0C:5;2)L!4,:,I=V;,=1SDBL/Q7X*NM>UK7KE;J"WAOM*M+.!R M"[1SP7$TP9EX!3+IT;)PW3@UO^'9?$"W5[:>(8;*58MCV^H62F*.X# [E,+. M[(RD?WF!# @@Y487C;4?%>E:EIG]EZEH:V>HZA'8QQW.ERR20[D8EBZW"A^4 M/&U>OMR 97B+P=XC\4VNM7.KG2;+4;C26TNSM[:XDFA7>ZN\CR-&K2((L9# LI(?<,!L;3C) MZ:[\1W>D/!IEQ97/B#7! ;F=-(MT@5(MQ"N1--ANRW5G_: AL(T#QP9P&;S70 EL@)G>2K?+\IP 9W_"%:C_ ,)#]O\ M.M/)_P"$G_MK&]MWD_V?]FV_=^_OYQTV]\\5@^(=,D\'W_\ ;UWJ6DVUQ)XB MFO;7[=+)%:R12VHB:.68(1"^$+*Q!!*A>2W&U>_$A[#7-;CDT?4+S2K#3K74 MFDM8 DEO%(LK.TPE=3P$&$4%^&X..-#6_B)8Z7>ZE!'I6KWZ:;9QZA=SVD<1 MCAMW#D.=\BD\1L=J@MQP#S0!6^#C7=SHVMZA>FW8ZAJ]QV.FSW2P:=JFI064"7-]#M7TJZ\+&^ M:P\K1(+ZU)AF=VF65HC&^"@VGY&RN3CC!;/&(OPNN8K71I[G3_#NN75C+J"R MV.I@FWDBN;IYT=',3E)%^4'Y"""PST-=EJ'C-K%K>U_X1_5[S6&LA?W.G67D MR26L9R/F9I%1B6#* K,6VM@8%4]0^)6F0F#^RM/U76TFTT:NKZ?''M^RY(WD MR.G(Q]W[W/ .#@ W?">D/I'AV.R:TTK39/G8P:1;^5!"6).%!'S$9Y8J-Q&= MJYP./U?PEXC\0V^F6/B&V\.W$]A-&\7B)'87J;)%?S(X/) BD?8H.V7:"2<$ M#96M9_$;3;A)97T_5+>W_LV75[66:)%%[;1[=SQ@.6!^=/ED"'YAQUP_2_B' MIMTIDU"QU/1K9K&34X)]0C14N+9,%Y%V.Q&T,K%7"MA@<<' !R_BOX;ZQJTF MK6MC)I<'V[41J4.NF21;ZR;:%*B-5Q( H*#,BC:V"IQ\VGIGPZ@N[[19?%6D M:#>V^GZ)'IHMFC-TD>W/4ZD/Q$TZ..XDUG3]4T5(]/DU2( MW\2#[3;QC,C((W<[E!0E&"O\X^7KA+[QO)%X)]6NK33]7N=-ETBTU6/45OE=A[9HHF6, 2GYR7+;CM0(RDD$/CIO#OB"+6I+VW M:SN]/U"R95N;.[">9'N7'.50?*"W!:^#-;06>B2OIQ\-V6L?VK%_V;/XC.J6DLT%AK-OI-K'91[I9#-# R MY#-@G?,1QCC'%7%\?62V-X]SINJ6VHVMY'8'3'2-KAYY$5XU78[1GV>%4TS5/MLPD)!9/L\\>%P#DYE7K@8!Y['G;7P3J M46@:!8M-9F73_$,VK2D.VUHGN)Y J_+][$J\' R#SW)I/Q$DEO?$JZGI5W;? MV?>6UE:V B4W0K(5,7(RR,V.<@;6V@&#;^#?$UM'X?T:)](.A:/JBWJ7+32? M:9H0S%8S'Y>U67?C=O.[:#A<\1>&?ALVA:C:PIX=\&3V]K>&XBUF:UW7YCW; MU!3RP!*#A1+YI^Z&VY^6N^\.:_;>((KN?3XYS9P7#VZ7+!?+N"APS1D$DJ&! M7) R5.,CFM>@#SOP[X0UW3?%[^*+FYL9=2U5VBU6W5V\J.W 'D"%M@+-'MP2 MP7?YCDXPH'HE%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YA\ M0O >J>)M6U-FATG4K&[LQ!:?VGDQA9&(6:*.=6).T?)F9<'&>#P._HM% 'E]QX-\3:?IVI M6N@OI$W]K:7!97+7DTB?9IHX?),D86-O,4KCY3LP5SDYP.EUGPU?3^$M8OK7QBUR=/@N=N/>?#26/59;U-!\):\]Y:6\4K:S'EK6:*)8]T M9\IS(A"@[#LY7[WS<>LT4 >&O[&N?"4EK//8:PP. M&'>44 <'X#\&2:)XDU/6I--T'1OM=O':KIVC1YC 1F;S'DV1[W8N1_JQ@*.3 M6[XLT:XUB;06MGB46&IQWLOF$C=^-/ O]J>,%U^+ M0_#FO>99)92V>MC:(]CNRR12>5+@GS&#+MYPIR,8,EMX8US0;^VU+P_:^'I; MEM,CTZXLUWZ?:QF.1Y$>(*DI S+("A'.0=PQ@^@44 <%?>$=7O(O&9N;FP>Y MUS1H;"-XU>-!,L=9[]6T*WTN [VPLL< M,R$M\O"YD7!&3@'BO0Z* /-I/"/B33XM4M]$DTEXM9M((+F:YED5K.1(1"TD M:A")@44$*3'RO)PW#;CX>WT$US+I5S:AK;^S9-.%PS$.UHK*5EP/E#!L;ER1 MG.#C!]+HH \C\5:1>:>EYXN\17NE:;J;7U@T$?F2R64"PF1426?RP5#F>7,I M0*FY>#CYLJ*[_MCPQ\2-8U2^TV""^EA%A=V4QFMVGBA3RO)D(4S$2JH^4#+@ MJ!D5[C10!C>#=,ET?PS86=T5:\"&6Z9>CW$C&25OQD9SWZ]37.VFC^*_#L-] MIOAI-#N=-FGFN+6>^N)8I+-II&D93&L;"959B1\\9(.WC&X]W10!P M17$*^'AI(EDRCO-O=F]>B44 >4:]X2O]-\*6,\\MJR:-X/O= M+N C,2TK10X*97E?W+B68\42:=9VBZ'-86[6$CRO,UQ& MJM,X95$>U5&(P7R6.6PHSZM10!Y^OAWQ-JE];7FMG0H9M.T^>TM(XC)&]$^T,F+;18N,*#S)+LCWG).!L7;SR MS%RVJ6>IV$.4A3M# N R[L9!P<8KT6B@#R;4_A[K> MO_VU>Z[#H$EY<:E:ZC:V+E[BU80P^48IBT8)# M\P4X)!V\;:O?\(5J3>'=3 MTO3](\*>'(M7=+>[728CN2UVD2'?Y2"61@65040(&)RQ&#Z710!SG@/1;SPW MHO\ 8T[P26%E(8M.D1B9/LW5$D! &Y0=N03N"@G!)%='110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% '.>-O&>C^#;.WGUJ6;?=2>5;V]O"TTTS 9 M.U%!. 23T''.2 :-W\3/"-K;V$\FKJ\5[:?;XG@MY9@MON"F638I\I S %G MV@'(/(..*_:6L=(FTG1;V]UN71-9M9I!IMT8BT)+;?-CD)&P91<@,RYVG&<$ M5FZUXWCUSX(0V_C.]&E>(]2TF6[2U\IHX]25694C5B,-YO[LF.-A)B0$;00: M /5=3\;^'M,U:'3KS456YE\HY2*22./S3MB\R15*1[R,+O(SVIP\:: ?$?\ M80O\ZCYIM]ODR>5YH3>8O-V^7YFWG9NW8[5\^^*_M[:;XYTN_M?[-\0^(K?0 M#ING@_,[!8ED2($Y81NK[L= ,GK6ILF;7XO#X8KKH^([:LUJ3^]^Q8,GGXZ^ M7LPN[IGCM0!]'T4R<2M"PMW1)&Z@:&ZACFA;&Z.10RG!R,@^]2T44 %% M%% !69I'_(0UO_K\7_TGAK3K,TC_ )"&M_\ 7XO_ *3PT :=%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !69I'_(0UO\ Z_%_])X:TZS-(_Y"&M_]?B_^D\- &G1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 44C,%4LQ"J.22< 5S^I>+M.M&,<#-=SYP%A&1GZ]/RS7/B,51 MPT>:M)(UI4*E9VIQN=#02 ,D@ =S7(?:O$^J_P#'M;Q:; ?XI/O?KS^@IR^# MWNCNU?5+JY/7:IP!^>?Z5Q?VC5J_[M1E)=W[J_'7\#I^J0I_QJB7DM7^&GXF M_/K&FP'$U];*?3S!G\JJGQ/HP.#?Q_@"?Z5#;^$M&A'-J9#ZN['^N*MKX?TD M# T^V_%,T[YE+6T%_P"!/_(+8-=9/[E_F-B\0Z1*?EU" ?[S;?YUHP3Q7";X M)4E3^\C!A^E9DOAK1Y?O6$0_W-7@^VV8./M$74#W_\ MKX^M=-IFI6NIV_G6SUC-?9>C_X/JC*MA)TES[Q[ MK5?\#YENBBBNXY@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **9-*D,323.J1J,LS' K$TWQ"NJ:LUM8VSR6J [[DG ![8'^3^5 M85<52HSC3F]9;+K_ ,-Y[&L*,ZD7**T6YO4445N9!1110!X_^T9XGUOPUIFB M/IUS>Z=HT\[C4M2LX@\D "CRER58*K,>3C/R@#J+Q6OQ!A-G M!I9$$EEIT*C4KT_ZMFW^9A3@ QH%(^<[@!A>R^)'A[6_$6DQ6^@:S#ISJW[Z M&YMA-#$TLO$%J^G>'86\C3[_36G@DN7 M=G>,3X6&F>1'Y?EX*"7?M\SS/, M&?O;<<;>]=9XL\$:WXJM;K3=7\3Q/H5_';K>64>FJK!HR#)Y$F_,:R$#(<2E M><,*KI\,$3Q$EPNIC^PTUL^(5T_[/^\%X4*_ZW?CR]Q+[=F<_P 6* /1)YHK M>%I;B1(HD&6=V"JH]R:RO#UQ#=7.LS6LT?AM\6H/WEK\3/,FZA9HVV_J#_*M_J<%I*K&_ MS?Y(7,^Q[Q17S_-XH^,O@3$OB?1;+Q3I:@?#OXM M^%?'3+;Z;>-:ZF1DV%V-DOOM[-^!)]0*BI@JD(\\;2CW6O\ PWS!26QZ!117 M.ZMXJM;63[/8*U]>$[0D7(!^O?Z"O,Q&*HX6//6E9?GZ+J;T:%2M+EIJYT$C MK&A>1E1%&2S' %]58]"U/6Y%F\07)B@SE M;6(XQ]>P_4UT^GZ?:Z=#Y=E D2]\#D_4]37![3&8S^&O90[O63]%LOGKY'5R M8?#_ !OGEV6WW]?D!]>W\_K71:;I-CIJXL[9(S MC!?&6/XGFKU%=.'RZAAYAB)T'>#]5T?J8'A_Q$FH2&TO4^RZBG#1-QN^F?Y5OUB>( MO#\.K*)4/D7L?,*I^']=F6Z.E:V/*OTX1STE]/Q_G7'1Q57"U%A M\6[W^&71^3[2_!G14HPK1=7#]-X]O-=U^1T]%%%>L< 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !5'5]4MM)M3/=O@=%4?><^@%5?$&NV^CPX/ M[VZ?_5PKU/N?05EZ/H5S?W8U/Q$?,FZQVY^Z@]Q_3\Z\S$XV;G]6PJO/J^D? M-^?9;G;1PT5'VU=VC^+]/\RM#9ZAXKF6XU O::4#F. 'E_?_ .O^5=?9VL%E M;K!:Q+%$O15%345MA,###MS;YIO>3W?^2\D9U\3*M:*5HK9+;_@OS"BBBNTY M@HHHH **** "BBB@ K,TC_D(:W_U^+_Z3PUIUF:1_P A#6_^OQ?_ $GAH TZ M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O+_ (H_ M%[3?!]RNCZ1;OK?B>8[(M/MLMY;'IYF,G_@(Y/MUKF?B#\3]8\2>('\%_"91 M=:B:JI_=6R]#M;H,=W_! H#=L3J/B&<$W.HS#+$GE@F?N MCU[GN>P[XT(4(JIB-WM'K\^R_%DW;T1PFA_"/7_'E_'K_P 8=2FDSAH-&MI- MD<2^C8^[]%Y]6S7N6B:/IVA:='8:-96]E9Q_=B@0(H]^.I]SR:O45A7Q52MI M+9;);+Y#44@HHK/U;6++2H]UY,%8C*QKRS?05QU:L*,7.H[)=67"$JDN6"NS M0KQ[XS> /"'B%6N6/]F^)E.Z&[L% D+YR#(H(#<]R0WH:Z\WFN>(^+",Z=8- M_P MF^\P]O\ ZWYUKZ+X;L=+(D"F>ZZF:7DY]AV_G7!2S+%UI+WGC&X\*#0?#WCS5]8^SW2X.I36N%8?[;#&> MW]XC()]:]PT+3=-LK2.33%C=)5#"=6#F13R#N[@^W%1^*O#FE>*M$GTK7;1+ MJSF'*MU5NS*>JL.Q%>!:5JFN? 'Q#'H_B!Y]3\ 7DI%I>A=S6A/.".Q'=>_W MEYR*]+!Y30J?O4W*OU_S/I2BH+"\MM0LH+RQG MCN+6=!)%+&VY74C((/I4]-JVC.<**** "BBB@ HHHH **** "BBB@ K)\0Z) M!K-KM?\ =W")Q'(QXE';GU]^_UKS*%:>!J+#8AWB_AE_[;+S[/KZG;4IQQ,76HJS7Q+]5 MY?D=31117L'GA1110 4444 %%%% !1110 4444 %%%% !7/^(O$ L7%EIZ_: M-2D^5449V9[GW]J@U[7Y7N?[+T,>=?/\K2+R(O7\?Y5<\.Z!#I*&61O/OI.9 M)FYZ]0/\\UY-;%5,5-X?".R7Q3[>2[R_!'?3HPH157$+?:/?S?9?F5_#WAW[ M++]OU-_M&I/\Q9CD(?;W]_RKHZ**[L-A:>%A[.DM/Q;[ONSEK5YUY<\V%%%% M=!D%%%% !1110 45SGC;QGH_@VSMY]:EFWW4GE6]O;PM--,P&3M103@ $D]! MQSD@&C=?$OPE;V]I,=5::*ZLCJ2-:VLUQLM@<&:3RT;RT!R"7V@$$'H< '8T M5S6H>.?#FGZG;V%SJ:>?,(F#1Q/)$@E.(B\BJ4CWG[NXC=VS4@\:: ?$?]A" M_P ZCYIM]ODR>5YH3>8O-V^7YFWG9NW8[4 =#69I'_(0UO\ Z_%_])X:TZS- M(_Y"&M_]?B_^D\- &G1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%([*B,SD*JC)). !0 .RHC.[!549))P *^>/&OC?6OBOX@F\%?#.1HM(7Y M=3UH9";.A"G^Z>1QR_;"Y)C\;>*]7^,7B27P3\/Y6A\.PG&JZN =LBYY53W3 MK@?QG_9!)]L\#^$M)\%>'X-(T. 1P1\O(>7F?N[GN3^G0<5Z481P<5.HKU'L MNWF_/LB/BT6Q7^'?@?1_ >@)IFB0XSAI[AQ^\N'_ +S'^0Z#M74445Y\YRJ2 MP5#=W4%G TUU*D42]68XK&USQ+;Z?)]FME-W?$[1#'S@^_^'6L^S\/ MWFK3K>>))20.4M4.%4>_I^'/O7E5LP;FZ&%CSSZ_RQ]7^BU.VGA$H^TKOEC^ M+]%^NPDVOZCK4C6_AVW*1=&NI1@#Z>GZGVJ[I/A6VMI?M.H.;Z\8[B\O*@_0 M]?J:Z"&*.")8H46.-1A548 I]*EEJE)5<7+VDO\ R5>B_5W83QC4>2@N6/XO MU84445ZAQ!6=XBT33_$6C76E:Q;)G^T/^!#N*^CHI$EC22)U>-P&5 ME.0P/0@^E8WC+PSIOB_P[=Z-K,(EM;A< C[T;?PNI[,#_AT)KQCX5^)M2^&G MBD?#CQW*3:.W_$EU%ON.A/RID] >@_NGY>F,>A-+&0=2/\1;KNNZ\^_WD?#I MT/H*BBBO.+"BBB@ HHHH **** "BBB@ HHHH *R?$.B0:S:[7_=W">!FL/B7>+^&7Z2\^SZ^IVU*4<3%U:*M);Q_5>7ET.LHHHKV#SPHHHH * M*** "BBB@ HHJ*ZN8;2!IKF18HE&2S&E*2BN:3LAI-NR)20 22 !R2:X_5-9 MN=;NFTSP^3LZ3770*/8_U[]JAFN+_P 6S-;V8:VTA6P\K#F3'^>GYUU>F:?; M:9:K;VD81!U/=CZD]S7C.K4S)\E%\M+K+K+RCV7G]QZ"A#!KFJ:U.BZ+U\_+ M[ROH.BVNC6WEVXW2-_K)6'S-_@/:M.BBO6HT84(*G35DCAJ5)5).+/ MBEJVN> O#7A2^N-.T;Q%XELF?4K^\E6"WMK,LZ>8"Q W2HNX &@#3HHHH **** "BBB@ HHHH **** " MBBB@ HHHH ***1F"*6RF+08CC5=7 M&=CIGE5/=>H '+G_ &02?:O OA#2?!/AZ#2-$@\N%/FDD;EYG[NY[D_IT'%> ME&,<%%5*BO4>R[>;\^R(^+1;"^!?".E>"O#\&D:'!Y<$?S/(W+S/W=SW)_3H M.*Z"BLO7-(YDN]=+ M060^:*U0X)^OI]>OTKK[>"*VA6*WC6.-1A548 KR?]HS'O3I?=*7_P BOQ?D M=W[K"=I3_!?YO\#-T+0;31X\Q#S+AOO3./F/T]!6M117J4:%.A!4Z2LD<-2K M.K)SF[L****U("BBB@ HHHH *XCXN?#^R^(?A=]/N&6"_A)ELKK',,GO_LGH M1^/4"NWHJZ=25*2G!V:!J^AXY\"_B!?:A-=>"O&8,'BS2/W>9#S=1K_%[L!@ MD_Q AO6O8Z\?^/?@"YU:VM_%WA5OLOBO1?WR2(=IGC7DJ?4CG&>O*GKQ7T?X MZVE[X9T^0:/>S>(YDVR6$:$*)!W!Y.#U )YP:VQLZ*@L1%I7W79^2[,PG7A M17[QV/:*P?$?B_0/#@/]L:G;V\F,B+.^0_\ %R?TKSW^S_B7XSYU"\A\,:8 M_P#RR@SYQ'X'=^!9?I6_X;^$GAG1V$UU;OJMYG+2WIW@GO\ )]W\\GWKS/:U M:G\.-O-_Y;F7MZU3^%"R[RT_#?\ (QYOC"VI3-!X0\-:EJS@X\PJ54>^%#'' MUQ31/\7-9^:*WTK1(V^[OVLP'OG>?TKU>WABMX5BMXTBB485$4*!] *DI^PG M+XYOY:!]6J2_B5'\M/\ @_B>2_\ "#?$"[YOO';PD]?LZ-@?3&VC_A6_C!/] M7\1-2;_?63_XX:]:HH^J4^M_O?\ F'U&EUO][_S/)#X?^*FF?-8^)K#4$7_E MG.@W-^)3_P!F%-/C[QOH'_(U>#VF@7AKBQ)( ]3@N/S(KUVBCZNX_!-K\?S# MZHX_PYM?._YG">&_BMX4UQEC%]]AN&X\J]'E\_[V2OZUW2,KH&0AE89!!R"* MYSQ+X'\.^(U8ZII<#S-_RWC'ER_]]+@G\W!W?V?> MD%3[#^$G\%^M+GK4_B7,O+?[@]IB*7QQYEW6_P!W^3/7Z*\GTKXLOIMXNG>/ MM(N-&O.GGHA:)O?')Q[@L*].TS4;+5;1;K3;J"ZMVZ20N&'TX[^U:TZT*GPO M_,VI8BG6^!Z]NOW%JL[6](MM8M3#0_Y[5HT4ZM*%:#IU%=,Z83E M3DIP=FCC;#5[S0+A-/UX%[;I#=CD8]_;]1781NLB*\;*R,,AE.0145]9P7]L M]O=QB2)NH/\ ,>AKDVL=5\,2&33"U]II)+6[4? M7NO/='_=Z+;- M:6I.#=2\''M_];)K@Q&8T:,O9I\T_P"5:O\ X'SL=5+!U*BYGI'N]%_P?D;6 MNZ_9Z0NV0^; ])N-:O>GG,A6) M??'4CZ[1[U7M_AQX@\5S)=_$/7)6B!W+IUHP"+[$CY1^ )_VJYWB>9VI+F_+ M[SC>+4WRT%S/\/O_ ,C2\0?%[3(;K[!X7M+C7M2;Y56W4^7GZX);\!CWK*_X M13QUXX._Q=J@T;2WY^P6GWF'HV#C_OHM]*]-\/>'=)\.VOV?1K""U3&&*+EG M_P!YCR?Q-:M+V$ZG\:7R6B_S8OJTZNM>5_):+_-G)^%_AYX:\-;7L-.22Y7_ M )>;C][)GU!/"_@!76445T0A&"M%6.J%.--&M.LS2/^0AK?_7XO_I/#0!IT444 %%%% !1110 M4444 %%%% !1110 4453U?4[+1]-GO\ 5;J*TLH%WR32MM51_GMWII-NR M2 MR)#$\DKJD: LS,R-;^&XCMU/6""%D7NJ_[ M)YP.K^RYS%J>M^(_CUJ\NC>&O/TCP%!)MO+]UP]UC^$#OGLG;JW85[QX0\,Z M5X1T*WTC0K5;>TA'U:1N[N>['U_H *]%1C@5S3UJ=%_+YOS[(CXO0K^ _!^D M^"/#T&D:)#LA3YI)6Y>9^[N>Y/Z=!Q70U7O[VWT^V:>[E6.->Y[^P' M_O\ E6IH^E6NDVPAM(\?WG/+.?VNGVKW-_<0VUNG+22 MN$4?B:\SUKXMQW-X=-\#:9<:YJ!X$@1A"OOZD?\ ?(]ZRJ5H4_B9C5Q%.C\; M_P _N/4+B>*VA>:XE2*%!EGD8*JCU)/2O,_$'Q;LA>?V;X/LIM>U-N%\E3Y0 M/KD M*_&&;[X2>(-.\<^"HYY=&@46 M^J6#2%QY9(!?GH#QSV8 ]"0/HJHKNWAO+6:VNHDFMYD,O,M4^$\NEW;ZCX UBXT>[Z_9WG6UDM>_7[SR&V^)6O>%YTM/B)H4T2$[5U"T7* M/[XSM/X$'VKTGP_XATGQ#:_:-&OX+N/&6"-\R_[RGD?B*T;B"&Z@>&YBCFA< M8:.10RL/0@]:\VU[X0:5/=?;O#5WU98>C^_9GIM%>/C6/B3X.^76--B\2:*J.*IWM+W7YZ%1QE*_+/W7YZ?\ Z_ M5_#FG:HQ>>'9,?\ EK$=K'Z]C^-9(T'7-/XTK6-T0Z).,X]NA'\JZ/3M3L-3 MB\S3KVVNX^NZ"57'Z&K=<]7+,-6E[5+EEWBVG^&YZM+'58QY4^:/9ZK\3DO( M\7MD?:K-?? _^)H_L#7;S_D(ZVR*>JP @'\MM=;2,0H)8@ =2:S_ +)I2TJ3 MG)=G)V_"QI]?FM81BO2*,'3?">EV1#O$;F7KOF.[GZ=*WP !P *YW5O& MWAG2-WV_6[%&7JBRB1Q_P%KUA^)/%>B>&X=^LZC!;MC*Q9W2- M]$')_*O//[.^)_BW_C_OK;PU8/\ \L[?_6X_ EL_\"7Z5M>'/A%X=TN;[5J( MFUF])W-)>GM4_A0MYRT_#?\C%F^)/B' MQ1(UO\/_ ],\6=IO[P (OOC.T?B3]*FTWX47&KW2:A\0=9N-6N>HMHW*Q)[ M9X./90M>KPQI#&L<*+'&HPJJ, #V%.IK#S6UTNS@M+=>B0H%!]SZGW-7:**Z$DE9'6DDK(****8PHHHH **** "BB MB@ HKQ_]HSQ/K?AK3-$?3KF]T[1IYW&I:E9Q!Y( %'E+DJP568\G&?E '4YK M?$#QAXLTKP#H6I>'-2TS4+)_LHNM>6-5:YWS*FV*#YE4D'+$G R0 #T /::* M\A\<^*]:TKQQJ,E]-XCTGP9IUO:)+?V%G:M#YTKG<[M.C,R % ?*#;<'.*I? M\)YKBZ^FIM?G^RV\8GPL-,\B/R_+P4$N_;YGF>8,_>VXXV]Z /:ZS-(_Y"&M M_P#7XO\ Z3PUH3S16\+2W$B11(,L[L%51[DUE>'KB&[N=9FM9HYH6O%VR1L& M4X@B!P1[T ;%%%% !1110 4444 %%%% !1110 45C^*?$^C>%-,;4/$.H06- MJ#@-(?$?QM\4+J33?A9IDFF:0&V3:Y>#:0.^WJ%^@W-_N MUTT,+4K+F6D>[V$Y)'I?Q*^)_AWP!:$ZI<>?J+C]SI]N0TSGL2/X5]S^&>E> M7Z;X-\6_&34[?6?B-YNC>&(B)+31H6*M*.Q;N,CJQ^;T"@YKMOAO\%]#\*72 MZMJLDFN^(F;S'OKSY@C]RBDGG_:.6]Q7I.HZA:Z= 9KR98D[9ZM[ =ZUGBZ. M#BW1>O63TMZ=O5ZA&$JCLE\A-*TZSTC3K>PTRVBM;.W79%#$NU5'L*R]<\2V MVGO]GME-W?$[1%'S@^_^'6LN34=5\2NT6DHUGI^2&N7X+?3_ 'YUNZ'H-EI M"9@3?.1\TS\L?IZ"OFGC*^.=L)I'K-_^VKKZO3U/15"EAM<1K+^5?J^GIN8] MAX>NM3N%OO$DA=NJ6RG"H/?_ _.NM1%C0(BA548"@8 I:*[,+@J6%3Y-6]V M]6_5G-7Q$Z[][9;);+T"BBBNLP"BBB@ HK$U;Q9X?TD'^T=9L(&'5#,I?_OD M<_I7&:G\:O#%O)Y6G)?ZG,3A1!!M!/\ P+!_(&LIUZ1?\)G\0?$''ASPD-/@;I/?DYQZC=M'Z&C_A7_C37^?%?C&2*%OO6UB"%(]# MC:/T-9_6>;^'%O\ !?B9?6W+^%!R_!?B=SXC\<>'/#JL-4U6W29?^6$;>9+_ M -\KDC\<5PDOQ)\1>*7-OX \/3&,G:;^\ "+[]=H/U)^E=)X=^%/A/1"CC3_ M +=.O/FWC>9_X[POZ5W4:+&BI&H5%& JC I')B*OQRY5Y;_ M 'O_ "/)K'X47>LW*7WQ UVYU2<BZ-IVB68M=)LH+2 M ?PQ+C/N3U)]S5^BM:="%/6*U[]36EAJ=+6*U[]?O"BBBM3<**** ,+QMX7T M[QCX:O-%U>/=;W"\.!\T3C[KKZ$'_#H37C_P=\4:EX&\3GX8>-W_ 'D9_P") M/?$_)-&?NID]C_#Z'*]@*]]K@?C#\.K3X@^'Q$&%MK5IF2PO!P8W_NDCG:<# M/IP1TKLPU:-G0K?"_P 'W_S):ZH[ZBO(/@;\1KO6C<^$_&(-MXOTHF.19>&N M47^,>K#C..HPPX)QZ_6%>C*A-PG_ %YC3NKA11160PHHHH **** "BBB@ HH MHH *Q]<\,Z)KRXU?2[2Z;IO>,;Q]&'(_.MBBDXJ2LT3**DK25SR_4/@GX:EE M\W39M1TV0=/(GW ?]] G]:J_\*KU^V^73OB#J\,79"'./RD _2O6J*YWA*.Z MC;TT_(YG@:%[J-O2Z_(\E_X5GXKEXN/B+J@3T02<_P#D44#X*VEVP.N>(]9U M ]3\X7/_ 'UNKUJBCZI2ZJ_S8OJ%#JK^K;_4X72?A1X/TW!&E+=2#^.ZD:3/ M_ <[?TKL[.SMK&$0V5O#;PCHD*!%'X"IZ*VA3A#X58Z*=&G3^"*044459H%% M%% !1110 4444 %%%% !1110 4444 CT4 <+XW\%:IXL.H:?=^(]OAC4! )].-BIEC$;;F$4X92H?"Y MWJY'.TC.!23X8(GB)+A=3']AIK9\0KI_V?\ >"\*%?\ 6[\>7N)?;LSG^+%> MCT4 %9FD?\A#6_\ K\7_ -)X:TZS-(_Y"&M_]?B_^D\- &G1110 4444 %%% M% !161XF\2Z+X7L#>>(-2MK"W[&9\%_95ZL?8 FO&=0^-&O^,;R33/A)X)MBC]\$X'J-QS_LFNFCA:M97BM.[T7WB*:M\:-;\77\FC_"'0I[^4':^J74>V*+_:"G 'UHM$D*P1_[.>#CV4*/K7K*3:#X4T^.RM4M;"WB' MR6UN@7'_ %?YU=2M@\%'GFU)KJ](K]7^ X4ZE5\L%_F>5>%_@7]NU%=<^*. MKS^)-7;G[.786\?MV+ >@VK[&O9,Z?HMA'&HM[*SB7:D:*$11Z*H_D*YUO$& MJZLQ30=/9(CQ]HG''^'\Z%\-P1?Z=XGU$3L.IDDV1K[9/_UJ\2OG5?'.V&CS M+N_=@O3O\E\SM6"A05\1+E\EJ_\ @?,6X\3W.HRFV\.6CS-T,\BX5??'^/Y5 M+I_A7S9Q=Z]<->W/]PGY%_Q_05G:A\2_!>AQ^3'J=O)LX$5DAD'YJ-OZUSS? M&)]18IX6\*ZMJ;9P&9=H'O\ *&_I7$L-2G)3QM3VDNWV5_VZM_5W.>IG%"BO M9T&H^FLG\U^AZTBJBA44*H& , 4M>2?VE\6=9_X]M+TS1HF^Z\I!8?4$L?_ M !VC_A7OC75N?$'CF>-3]Z.R5@I]N"@_2O3]NWI"#_+\SSOKED"#]:YC4OB3X0T_/GZ[:.1VMR9L_]\ US=G\$?#B2>;J M-UJ>H2G[QEF"@_D,_K73Z;\.?".G8^SZ#9,1T,ZF8_\ CY-'-B);)+YW#FQ4 MMHI>K;_*QR]W\;M \SRM+L-4U"8_=$<04'\SG]*@_P"$_P#'.J?\@+P+-"#] MU[UF /OSL'ZUZK:6EO9Q^7:6\,$?]V) H_(5-1[*K+XI_7Q5/N27 MYW/)/L'Q;U?_ %^I:5H\9^\L85F'T(5O_0J/^%1ZAJ?/B?QCJM\&^]%&2%'L M-Q8?I7K=%'U6#^-M^K#ZE3?QMR]6SS_2OA!X/T\AFT^2\0C'U]"?H> M#Q:^"WQ.B\5ZL@//U7JOTYKT^N6M1G1FX3 M5F-.^J"BBBLAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 5F:1_R$-;_ .OQ?_2>&M.L MS2/^0AK?_7XO_I/#0!IT444 %%>:^//C3X/\(,]O)>G4]3'RBSL,2L&]&;.U M?H3GV->;ZAXE^)WC_(B:#P)H,G_+25C]J=?88\STY 0>]=/U9PA[6O)0AWD[ M+_@A%.;Y8*[\CV;QM\0_#'@J$MX@U6&&?&5M4/F3/Z80<_B<#WKRF3XE?$+X MBL8/AGX<;2],<[?[7U$ <>JY^4?0;S5#1/"/@#P<_P!NOX9-?U7.]KS5W C+ M>JQ\@_\ LGWK=N/B5J>KN;7P]:WMX5^41Z=;D*O_ L9 _2O,J<09=0?+A8N MM+O;W?\ +\?D;3PSI?[S-4_)O7[E=_@)HOP2T6TO!K/Q-UV;Q%JS?,1%<(D48AAC'L .!^ KSRW\)_$#7)/,DB MLM&C8Y+W,GFRD?0;OU KIY$NE_% M77@!>:GI^@6Q',5N 7'T*[C_ ./BIK7X+V-S,)_$VN:IK%QW+R; ?SW-^M>K MT5Z2PE/[=WZLY/J5-ZU+R]7?_@',Z/X"\+:.!]BT2R#KT>5/-7_%OX3VOC%X]8T2?^R/%EJ0] MO?Q93S".@DQS]&'(]QQ7.>!?C!>Z1JZ>$_BQ:G2=:C^2/47 6"Y'0%CT&?[P M^4_[->YUSOCCP;HGC;1SIWB&S6>(9,1+75'0HRNH9"&5AD$'((I:^;X[GQK\!YUAO5G\3> +]$\9Z2-0\/7T=U#P)%'#Q,1]UU/*G^?;-17PLJ2YXOF@^J_ M7LP4KZ&]1117*4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% '.>-O&>C^#;.WGUJ6;?=2>5;V]O"TTTS 9.U% M!. 23T''.2 6WWCOPQ8^'=/UVZUBV32]0,:VDW),Y<@*%0#<3SR,97!SC!K MS[]I:QTB;2=%O;W6Y=$UFUFD&FW1B+0DMM\V.0D;!E%R S+G:<9P17-^.!)X MF^!NA>+_ !-I=O'XGDDLXO/VTZMXTT#2-9CTK M4+_RKUC&& AD=(C(VV/S)%4I'N((7>1GM0/&F@'Q'_80O\ZCYIM]ODR>5YH3 M>8O-V^7YFWG9NW8[5XC\5$F75/BCHY8QZMX@DT;^QX2?GN@I16\H?Q!&5RV. MG4]:-DS:_%X?#%=='Q';5FM2?WOV+!D\_'7R]F%W=,\=J /H^LG39$AN]>DF M=8XTNPS.QP% MX?7WA6]U_6M2^U7EOY M$WT-:4(S=IRY4-\2?%* MTMMT'A?3Y]>N^@EC816JGWF;AO\ @ :O)?%-UXI\62&#Q9XI%A9R\?V3HJE= MX]"W+O\ 0@CV%>XVO@#2DP;V2ZNSUVM(8T_),$CV)-=%IFDZ=I4933+&VM%/ M40Q!,_7'6N>,\QGM*-)>2YI?>]%\D:.="&D(\WG+1?\^;6_$"VZ'[T.FQ8/_?Q^?TKU M>BL_[)HU)^UQ#=27>3;,YXBM-(^,O@O<:;JQ\2 M_"B^.A:TAW-9!MMO/ZJ!T7/]T@K].M>X45O0Q%2@[P?JNC]4)I,\5\#?&Z$Z MBOA[XD63>'/$49"%YE*P3'UR?N9]R5/9NU>THZR(KHP9&&58'((]:YWQMX*T M#QKIOV/Q%I\=RH'[N4?++$?5''(^G0]P:\8?0?B)\&6:;PO-)XK\(*=SV$V3 M- O?:!DCZID=RM=/LZ.)UI>Y+L]GZ/IZ/[R;N.Y]%45Y_P##KXM>%_'2I#87 M?V35,?/I]WA)0>^WLX^G/J!7H%<=2E.E+EFK,I.^P4445F,**** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*ZMX;J!H;J&.:% ML;HY%#*<'(R#[U+110 4444 %9FD?\A#6_\ K\7_ -)X:TZS-(_Y"&M_]?B_ M^D\- &G1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110!YO\ $;X.^&/&SM>20-IFLYW+J%F CEO5QT?ZGGT(K@$U[XF_"/\ =>)K M1O%_A>/@7\!)GA4?WCR1_P #!'8-7T/1793QDHQ]G47-'L^GH]T2X]4<9X"^ M)GA;QS$O]AZDGVO&6LI_WS_ +M;GT)17G'@3XS>#O&!C@M]0_L_46X^QW^(G)]%.=K?0'/ ML*]'KDJT9T9(D\0Z5'R--U'[P']U=QQC_=9?I7T#1772QM6G'D?O1[/5?\ ^1+ MBCP[1/V@+.SO%TSXB:%J/AK41PSO$SQ'WQC>!] P]Z]=\/\ B'1_$5I]IT+4 M[2_@[M;RA]OL0.0?8U+K6C:9KEF;36=/M;^V/_+.YB611[C(X/O7D?B#]GK0 MFN_[0\&:GJ/AC4ER4>VE9XP?H2&'X-CVK2^$K;W@_O7^?YA[R/:Z*\"%Q\;_ M 1\LUOI_C'3H^-Z?Z_;^&UB?P>KVD?M$Z&ET++QCHVK>&[X??6>%I$7Z\!_ M_'*3P%5J]*TUY._X;_@',NI[?17-:!X\\*>(-HT?Q#IES(W2(7"K)_WP<-^E M=+7'*$H.TE8H****D HHHH **** "BBB@ HHHH **** "BBB@ KP[X_>+M;\ M/>)_#]JFL7?AWP[<("VK6]L)E%UY@PDF5/RJ@9MHQNY!X''N-7=6EU9B:-OF'[U"I5PX&X;2Q5@1PI&2 $&M+:R>PEL MDDG1(B-WE3@KM+A5!WJ^#DKC( !\+HEU]9HM3V:$-:7Q =/^SYD^UJFT8EWX M$>X!]NS.1][% 'HL\T5O"TL\B11(,L[L%"CW)K*\/7$-U+M>- M@RG$$0X(]ZV*S-(_Y"&M_P#7XO\ Z3PT :=%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 52U?2-. MUFU-MJ]A:7UN?^6=S"LB_D0:NT4TVG= >5:]\ OA_J^YDTJ73I6ZO8SLGY*< MJ/RKFA\#?$6A?\B5\1=7L8E^[;7&YD_':P7_ ,5 M'@OV#X]Z%_J=3T'Q!&OW5<(K$>Y*QG_QZE_X6;\5M*_Y#?PQ>[*_>.GNY!^F MWS*]YHJOKD9?'2B_E;\F'+V9X-_PT7;V'_(R>"_$.F8^]\@;'_?>RM2Q_:/\ M W./.GU*TS_SVM"FUZ2_ MS06EW..L?C7\/+W'E>)[5,_\]HI(O_0E%=!8^//"5_C['XGT28G^%;Z+=^6[ M-9]]\+/ M[GSO"FD+GKY-LL7_H&*Y^^^ /PZNLE=$DMV/>&\F'Z%B/THM@WU MDON?^0>\>G6MU;W2;[6>*9/[T;AA^E35X;=?LS^$"_F:?J6NV4H^Z8[A& _- M,_K4'_"B=?L>=!^)VOV8'1&WD'Z[91_*CV&&>U6WK%_I<+R['O-%>#?\(;\; M=(_Y!7CK3M0C7^"\C^9O^^HV_P#0A72?#^]^+0\306GC72]&;1"CF6]MY%$B ML%.W #\Y.!]WIWJ9X1*+E&I%_/7\4'-Y'JM%%%<904444 %%%% !1110 5F: M1_R$-;_Z_%_])X:TZS-(_P"0AK?_ %^+_P"D\- &G1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17'^*/B M/X9\,Z]::1J]\\=W.5WE(6>.W#;MK2N!A 2I S]3A02+TWC30(?$::')?XU% MI5MP/)D,0F*%UB,NWRQ(5!(0L&([2!_^L4M !1110 4444 %%%% !1110 4444 %%%(S!1EB ,@9)QR>!0 M%%% M !1110 4444 %%%% !1110 4444 %%%(K!U#(0RD9!!R"* %HHHH **** "B MBB@ HHHH **** "BBB@ HI P8L 02IP<'H>M+0 4444 %%%% !1110 4444 M%%%% !112;@&"DC<02!GD@?_ *Q0 M%%% !1110 4444 ?-_QRND\,_$^PU_ MPEJSP^+3Y0GTFXMRT=\-CK%Y>0-Q(,D9V%CE@/E/5MZ)SK%]X?E!B\17GC^V MU2&UW!I?LH2-_. ZF-5C?+#@%<=>*^C9;>"::&66&-Y86+1.R@F,D$$J>Q() M''8FN7^(WQ!T#X?:2M[XAN6#2$B"U@ >>WT_5K>:ZD34+ M<2"5\V3X!"*G'[WIA!^M9?BCQW; M^'7F>ZT76Y]/MK=+JZU"&W3[/;QL<9+.ZER!R5C#D#MVJ>^\=Z#I]QJBW]V+ M>TTRR@OKF]D($ 68N(U!SEG.S(4#GH\G6O^?_ $[_ , 7_P#CU:=% &9Y.M?\_P#IW_@"_P#\>H\G M6O\ G_T[_P 7_\ CU:=% &9Y.M?\_\ IW_@"_\ \>H\G6O^?_3O_ %__CU: M=% &9Y.M?\_^G?\ @"__ ,>H\G6O^?\ T[_P!?\ ^/5IT4 9GDZU_P _^G?^ M +__ !ZCR=:_Y_\ 3O\ P!?_ ./4_7]9T[P]I%SJFM7D-E86R[Y9I6P%'8>I M)/ Y)( !)KF-)^(MGK?A;3=)1]B?&&*D_\M>OR#]:L>3K7_/\ Z=_X O\ M_'JP],^(&CZE:Z)+:I=%]5NY;%82BA[>6)':42_-@!/+()4MR5QD'-9UC\7? M"5^OB>:SO))['P]$DMW>1INAD#%AB(@Y?E",@8.1@F@#K?)UK_G_ -._\ 7_ M /CU'DZU_P _^G?^ +__ !ZJ'A;Q9;>(+J]LC97VF:E9K')-97RH)!'(,I(# M&[J5.&'#9!4@@<5T5 &9Y.M?\_\ IW_@"_\ \>H\G6O^?_3O_ %__CU:=% & M9Y.M?\_^G?\ @"__ ,>H\G6O^?\ T[_P!?\ ^/5IT4 9GDZU_P _^G?^ +__ M !ZCR=:_Y_\ 3O\ P!?_ ./5IT4 9GDZU_S_ .G?^ +_ /QZCR=:_P"?_3O_ M !?_P"/5IT,0JDL0 .23VH S/)UK_G_ -._\ 7_ /CU5[W3]6O(5CEU&P"K M)'*-MD^F5%8&B_%'P]KUQXCCT'[;JBZ'&LDTEE;F9;@MO 6#:^ 31IOQ$TF_P#$D>DQ6U^DK3HH S/)UK_G_P!._P# %_\ X]1Y.M?\_P#IW_@"_P#\>K3H MH S/)UK_ )_]._\ %__ (]1Y.M?\_\ IW_@"_\ \>K3HH S/)UK_G_T[_P! M?_X]1Y.M?\_^G?\ @"__ ,>K3HH S/)UK_G_ -._\ 7_ /CU'DZU_P _^G?^ M +__ !ZM.N0U#XB>'[+QYIW@\7+W&N7A;,5N ZV^$9QYIS\I(4X')Z' !!H MV_(UK_G_ -._\ 7_ /CU06&GZO96-O:Q:C8&."-8E+63Y(48&?WO7BLJW\>V MC:]::;>Z1K.FI>W$MI9W=] D45S*@)(5=_F#(!*ED4$#@\C,#_$."2S6ZTSP M_P"(-3A+W2F2UMXPBK;R&-G+O(J88J=HW;B!G:* .D\G6O\ G_T[_P 7_\ MCU'DZU_S_P"G?^ +_P#QZN4U/XM>$K%?#86^:ZGU]H196]NFZ39*P59'4D;% MR<<\Y! !(('?4 9GDZU_S_Z=_P" +_\ QZCR=:_Y_P#3O_ %_P#X]6G10!F> M3K7_ #_Z=_X O_\ 'J/)UK_G_P!._P# %_\ X]6G10!F>3K7_/\ Z=_X O\ M_'J/)UK_ )_]._\ %__ (]6G10!F>3K7_/_ *=_X O_ /'J/)UK_G_T[_P! M?_X]6G10!F>3K7_/_IW_ ( O_P#'J/)UK_G_ -._\ 7_ /CU8OQ&^(.@?#[2 M5O?$-RP:0D06L #SSD3K7_ #_Z=_X O_\ 'JQ]2\<65K>7UK9:?JNJSVMO;7!73K<2[_M#,L:K M\PP<(6);"A2"6JI;_$*WNH94L]!UZYU2"]-A3K7_/_IW_ ( O_P#'JB\)>(K+Q3HL>I:; MYJQEWADBF4"2&1&*NC $C(((X)!Z@D$&MB@#,\G6O^?_ $[_ , 7_P#CU'DZ MU_S_ .G?^ +_ /QZM.B@#,\G6O\ G_T[_P 7_\ CU'DZU_S_P"G?^ +_P#Q MZM.B@#,\G6O^?_3O_ %__CU'DZU_S_Z=_P" +_\ QZM.B@#,\G6O^?\ T[_P M!?\ ^/4>3K7_ #_Z=_X O_\ 'JTZS]?UG3O#VD7.J:U>0V5A;+OEFE; 4=AZ MDD\ #DD@ $F@!GDZU_S_ .G?^ +_ /QZBUL;S^TH[N^NK>4QPO$BPVYC^^4) M)R[9^X/3J:YO2?B+9ZWX6TW7-"T77=2AU"XDMX8+>V02#8S*SN6<)&N4."S# MJ!C/%3Z?\0M'O[+1KBVCO7?4[J:S6W6(-+!)$DC2B103]WRR#MW9)7&0=?'[1Y=6^%?B%-.TY[W56MA# L$!DF*F6-F5< M@[ 2!_=![5Z+10!X1\ M8[G6?$>OZ7X,:RURP\("*.?6-2M-+N;DW(&"+>,Q1MCMDGC/7[NUN\^'^DI/ M<^);^_T^2.*YU1!9PW=N4V0VR1I"RHXR/F1G4X[@CUKNZ* /G;0="U:W^%_@ MJVU32-5CL;77;FXU)+>UD%]!&9IC&\80>Q -?/6GZEXO\'_ ?3-,T M'0=67Q#?WUW#YG]GS2?8(VN)"9W14+?=8%?E. #P<"O9J* /)OA3H]X?'&O:](^O2: M=)86EA!-K=O]GN9G3"#WHHH \?M5O?"/COXE:Q8^'KZXLXM-TY-/MK2U;;<-'$ZB*+:N M" 2H.T':.U<;X1T;5]8T^>]\0Q:U-XJ\3:K9#4U?2;JWAL;*.3S/)5I$"XVQ ME202,LHY^\WTE10!X/XPGU/QE\7+33-=T_7+#P3H5PDR"/2;J4:I=*?E)=(V M58E/&/#VKIKGA;09M-OXI-$\0:AJ5S=M;NML8&\PQ,DI&QR_FJ M-JDL,-N P:]]HH **** "BBB@ HHHH **** "O-?'.C3/\4OAY>Z?ILC01WE M[->W$$!*JS6H17E8# )VJH+=< =J]*HH ^>8]2UCQ+\2;_Q+XCTGQ#:6/A]) MQX>TD:-=M]HE"']_(XCV9(&%7.@")6/F,Q?CL.XSN7Z HH \;\:^%[6'P7X$M_">DWLD-KK.EAF- ME(MP+>%V^:8%0X"[F)W ;B>,U[)110 4444 %%%% !1110 4444 >=?'[1Y M=6^%?B%-.TY[W56MA# L$!DF*F6-F5< M@[ 2!_=![5QOQCN=9\1Z_I?@QK+ M7+#P@(HY]8U*TTNYN3<@8(MXS%&V.V2>,]?N[6]WHH \:B+32[);*4E88HDAC6"LCYP,Y'3.:Y*VN/$/@SX7S1^&K37 M]6\;>(+TOJ>J2Z->(MK(X&Z0(T08JBX"X4Y.3CC97TA10!QGPAT2P\/> [#3 MM->_F6,LT\]]:2VTL\S',CF.558 L3C(Z8Y/6NSHHH **** "BBB@ HHHH * MBN;:"Z14N88ID5UD59$# .I#*PSW! (/8@&I:* /G73]2\7^#_@/IFF:#H.K M+XAO[Z[A\S^SYI/L$;7$A,[HJ%ONL"ORG.<@'&#T/P[T&'0;[0TL;?7+K3-! MT>[NI;BYTZ>"2[O9Y%WD)*JL6Q')A>3AUY.KZIXMUKQUXRT MCQ -;6WD@TS1$TNXC%K:J">>Y"KV/PVCNI?'7BS4K*PU"T\ M/WRV\@?5+62&YENMI\S'F@2F-5V* ?D4C"< UZ710 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9%UXDTFT\36/A^ MYNO+U>^A>>V@,;XE1/O8;&W(ZXSG'.* ->BN?;QAHOV_6K*&>XN;S1O*^W0V MMG-.\7F#* !$.\D<&*X+*I 7"?5-.1'NXDC< MK"&^Z&?&WF+$UW#Y;#RA(NY/F(V MG('8G'>CPSX@TSQ/I*:EH=S]JLF=XQ)Y;)ED8JPPP!X((Z4 :M%97B#Q#IGA MZ.Q?6+G[.M[=QV-N?+9]\TF=B_*#C.#R<#U-'B;Q!IGAC27U+7+G[+9*Z1F3 MRV?#.P51A03R2!TH U:*JP7\,^H75FB7(FM@I=GMI$C.X9&R0J$?WVDXZ'%6 MJ "BBL7Q=XJT3P?I#:GXDU&&PL@P0.^6+L>BJJ@LQZG !. 3T!H VJ*Y[P7X MT\/>-K"6\\+ZG%?P1/LDVJR,A[;D8!AGL2.<'%=#0 4444 %%%% !1110 44 M44 %%%% !1110 45QDOQ1\&1>,E\*R:];C76F%N+?8^WS".$\S;LW=L;LY^7 MKQ5WQ%XZ\.^'=0^PZM?M% M-_B'X6\#K8-XHU062WP,-!\::6^H>&-1C MO[5)#$[*C(R,.Q5@&'XCF@#?HKB?%_Q4\&>#]:32?$6L_8]0:-91%]EFD^5B M0#E$(['O5C7/B1X1T+Q1;>'=6UNWMM8N-FR!E<@;CA0S@%4)]&(Z@]Q0!UU% MXKKJ "BBB@ HHH MH **** "BBB@ HHKE?'7Q!\,>!/L7_"5ZG]@^V[_ +/_ */++OV;=WW%;&-Z M]<=: .JHKAK'XL^"+_PMJ7B.TUV.32--D2.[E$$H:(N55,QE-^"6 !"XZ\\' M$O@OXH^#?&NH26/AK7(KR\C3S#"T,D+%?51(J[L=\9QWH [2BN%\7?%OP/X0 MU=M+\0:_#;7ZJ'>%(99B@/0-Y:L%..<'!P0<8(KM+*[M[^SANK&XAN;690\4 MT+ATD4]"K#@CW% $U%>6S?'[X9PS/%+XEVNC%6'V"Y.".O\ RSKU%&#HK*(=+\0?VE_9%S]H_LZ]DT^Z_=LGESQXWI\P&<9'(R/0T :M%% M% !165_PD.E_\)5_PCGVG_B=?8O[0^S^6W^HW^7OW8V_>XQG/MBM6@ HHHH M**SO$.MZ;XYU77+R&RT^V7?)-*< >P'4D] HR2< FL7P1\0_"OCG[2/" MVKQ7SV^#+'Y;Q.H/?:ZJ2/<#% '5T444 %%%% !11575+^'3+"6[N4N7BCQN M6VMI+B0Y('$<:LS=>P.!DG@&@"U16?;:SIUUK5[I-O=Q2ZC91QRW,"')B63= MLW=@3M)QUQ@XP1G0H *\+N/#7Q[:XD,/C;PZ(BQ*#[.HP,\Z4 M5O1KNC>T4[]TF)JYX/\ \(S\?O\ H=_#O_?A/_D6C_A&?C]_T._AW_OPG_R+ M7O%%;_7I?R1_\!0N7S/!_P#A&?C]_P!#OX=_[\)_\BUM?&BQU'3/!_AGQ?,4 MN]>\)W$-W=/ F!/&P5+D*.P;[WL%KUZBL:V(=9).*7HDAI6/FCQ!I-S;?LM> M+-.,9(IOB+POI.N>/_BYJ.J6S3W.DZ'; M36?[QE6.0V+_ #E00&(V\9SC)KZ9HKG&?,/PVT&#PWXJ^&=YH'GQZAK_ (:N M'O6DG=Q,ZP1M&"&. %.T # 4<<5RWP+LKW4/B1:V]U>:>?[-BO//S = MOWR-N,'IUS[5R.FK,G[/7AI=1>^D\.C7YAK[V88,UIYTN\L$^81[MN[;SCI7 MU910!\A1BRW6I\'_ &W_ (0#_A,=&_LC[09-GFXE^T>5YGS[=VW.>_XUE_$' M^PO/\6_V]_:?_"QO^$AXW^=M_L_S8_*Z?N_*V[=N?FSMQQBOM&B@#Y;^+_\ MQ]_'C_KUT3^:UK6V@S>$?&GCW2/ OVV.YN_"0OT43O++)>;G42 L22YR2/<\ M5]'5S7Q. ;X;>+ P!!TF[!![_N7H ^>/A"/"C?$KX=/X)_M!HO[-NCJ!G,QC M^U^0GF$;_EW\C=L^7[F.U>G_ !DFCT'QUX%\6:U!-+X9TI[F.\E2%IA:22HH MBF90"<9&-V.#C') /@G[)>I7VI?%JSBU&]N;N*RTN>.U2>5I! F4&U 3\H]A MBOMB@#YW\3^)++Q;X1^(&L?#C1-3C:0VB7.N6D)CDU"(,!,L08!LH@(/'N>H MSA^&1X?SX[/PM^W?\(/_ ,(I=?;/,,WD?;]IV[?-^;?Y>\+Z!H'P'^'UXEM=QKJNJZ5=:G+;R2//+F)\[.200I(4+CMCFO0/V=/[+&M> M-?\ A"3=GP)YUK_9OG>9L\[RSY_E^9\V,[,Y]JV?V@O^0?X'_P"QLT[^;UZK M0 4444 %%%% !7*^/++Q;>PV8\&:I9:>ZLWV@W*!MXXVXRC8QSV[BNJHJ9QY MERD3ASQY6[>FAY+_ &'\7_\ H:M%_P"_2_\ QBC^P_B__P!#5HO_ 'Z7_P", M5ZU16'U9?S2^]G-]3C_/+_P)GDO]A_%__H:M%_[]+_\ &*Z7P+IWCBSU"X?Q MAK.GW]FT6(H[>,!E?(YR(TXQGUZUVM%5'#J+OS/[V7#"J$E+FD_5L^3]7UBW MT/XBW6G^%[R[GNY_$:W%UX-UG1A,7F8_-=0S88*,$.A!4X&[)& 9/C@TMY\0 M=>U+4KBRL?[)2UM(]#>62WF\0V3MN1S]645N=)\U:SK& MJ^/]<^"][HE_!X;UFY35T\V&W%RMF\<2AT\N0 9PI7!Z;N,X!/L/PW\$3>$O M[7O-3UB76M;U>=9[V]:W6W5RJ[4"QKD+@>_)KM** /EGXL7BZ/\ $KQ3=Z7X MB\5V'CFX>Q_LC2K6V*6U\H"J!P66=/OYW; &WC#'(J+XG7'V:\^)7A:_M)CX MI\37>G3:3'' [_:E&P91\8 0JXY/J!G!KZKHH ^5?BC,EI?_ !,\*7=O<2>) MO$MYITNCJMNS&[1=@W*P& $*N.2,<@=#7U2@(10QW,!@G&,TM% !1110 444 M4 %T4[]UU>W45TX;!K#MM3E*_\TF_S,*V(=5).*7HDCY!\3?:4^%_Q M:C\7W,TOC]9M/34BZHD4L"7$8@DA554%"IY.,],XS7I-YXNT+XE_%#P++X%E MEU)]'N)[F_O5M9(EMH&C*[&9U4_.> !GH:]UHKK,#YCF\66_PXT_QQX?UD:= M8>)-2U>>Z2?6[*YFM-2M)3][="K,<+N7'0$D==V/9O@M]N_X5?H*ZMHL.A7: M1.C:=%"\2PJ)&"?*Y+ E0K'<2222>M=M10!Y5<_\G06?_8IO_P"E=>&^'DUB M3X[9N;_3;3Q:NOLTXF343?36H;_585&M_),."IXPH4[@*^QZ* /ESPZ_AM/B M;,?$7_"3'XH_\)+)Y2V6_P QK7G8#O\ W7V;RNO\6W./EK(O]#LXM/\ &7BV M/[0NN:=\09H;29;B15A5IXM^$!VY;=@G&2 !VKZZHH ^0]0T&R2P\9>+D^T+ MKFF_$*6&UF6=PL2F>+=A =N3NY.,_*O/%:GQ8_L/_A./&O\ PG7]M?\ "1[( M?^$/\CS\9\OY?L_E_+N\[&[=WQCG-?5%% 'SAK \3CQY*(?/_P"$N'PQ&[RC MF7[5]H&_;C^+=G&.^,5F?"@:(?''A[_A5?\ :GV@:9/_ ,)3]H,VSS_)_=>; MYGR^;YV[[G'WL<9KZBH8!E(8 @\$'O0!\=>!QH+ZW\.VLO[7;Q?_ &\Q\1?: M3.0;G]X@)YQZT 'Q]MY$T[PQK$UG-?:-HNL17^IP1 M1^85@56!E*?Q!,Y/H,GH#7.WWC+2?&]SXLO_ (9Z1=WNN0Z#)#%XAAMWCQ)D MD6Z;P&W\[@0,GCT%>ZT4 ?+7PP'AX^,="_X5K_:O&E7'_"6^>9MOF>3^[\WS M/E\WSMWW./O8XS6!X$\$:-<0_",R"]!\2Q:C;ZL4O)4^U0QCF_^ MU*]5H ^7]&LM(O\ X=_$>#1M6U32/AF\UJ=+NWM[BX5,*_LI_P!G'XBV>DZ79V]E;7%B?MNFSWC6=S(T\18(EU\Z.HV!O7*]L9^R M** /E_Q%IEII/Q>^*']B0W$7B^YTI;O1/L_G&5F>%C)[Y]&O]&;2?[.5;RSTU-0QY^X;)7-PFP28WKA' (SA< FOI^B@#__V0$! end XML 14 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2023
Mar. 08, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Document Transition Report false    
Entity File Number 001-33852    
Entity Registrant Name VirnetX Holding Corp    
Entity Central Index Key 0001082324    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 77-0390628    
Entity Address, Address Line One 308 Dorla Court    
Entity Address, Address Line Two Suite 206    
Entity Address, City or Town Zephyr Cove    
Entity Address, State or Province NV    
Entity Address, Postal Zip Code 89448    
City Area Code 775    
Local Phone Number 548-1785    
Title of 12(b) Security Common Stock, par value $0.0001 per share    
Trading Symbol VHC    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 29,557,799
Entity Common Stock, Shares Outstanding   3,681,970  
Auditor Firm ID 223    
Auditor Name Farber Hass Hurley LLP    
Auditor Location Chatsworth, California    
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 26,289 $ 86,561
Investments available for sale 27,258 65,462
Accounts receivables 2 14
Prepaid expenses and other current assets 282 224
Total current assets 53,831 152,261
Prepaid expenses and other assets 4,014 703
Property and equipment, net 67 11
Other investments 2,500 0
Total assets 60,412 152,975
Current liabilities:    
Accounts payable and accrued liabilities 440 373
Accrued payroll and related expenses 316 311
Other liabilities, current 498 47
Total current liabilities 1,254 731
Other liabilities 3,145 0
Total liabilities 4,399 731
Commitments and contingencies (Note 4)
Stockholders' equity:    
Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at December 31, 2023 and December 31, 2022, Issued and outstanding: 0 shares at December 31, 2023 and December 31, 2022 0 0
Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at December 31, 2023 and December 31, 2022, Issued and outstanding: 3,618,431 and 3,578,983 shares, at December 31, 2023 and December 31, 2022, respectively 0 0
Additional paid-in capital 242,520 239,753
Accumulated deficit (186,495) (87,195)
Accumulated other comprehensive loss (12) (314)
Total stockholders' equity 56,013 152,244
Total liabilities and stockholders' equity $ 60,412 $ 152,975
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Stockholders' equity:    
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 100,000,000 100,000,000
Common stock, shares issued (in shares) 3,618,431 3,571,232
Common stock, shares outstanding (in shares) 3,618,431 3,571,232
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Revenue $ 7 $ 48
Operating expense:    
Licensing costs 0 (4)
Research and development 9,713 6,406
Selling, general and administrative expenses 21,739 15,722
Total operating expense 31,452 22,124
(Loss) from operations (31,445) (22,076)
Interest and other income, net 3,495 1,848
(Loss) before taxes (27,950) (20,228)
Income tax (provision) benefit 79 (16,032)
Net (loss) $ (27,871) $ (36,260)
Basic (loss) per share (in dollars per share) $ (7.79) $ (10.17)
Diluted (loss) per share (in dollars per share) $ (7.79) $ (10.17)
Weighted average shares outstanding basic (in shares) 3,579 3,565
Weighted average shares outstanding diluted (in shares) 3,579 3,565
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) [Abstract]    
Net (loss) $ (27,871) $ (36,260)
Other comprehensive (loss) income, net of tax:    
Change in unrealized (loss) gain on investments, net 306 (246)
Change in foreign currency translation, net (4) 0
Total other comprehensive (loss) gain, net of tax 302 (246)
Comprehensive (loss) $ (27,569) $ (36,506)
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock and Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Total
Balance at Dec. 31, 2021 $ 236,452 $ (50,935) $ (68) $ 185,449
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued for options/RSUs/RS, net (29)      
Stock-based compensation 3,330      
Net (loss)   (36,260)   (36,260)
Dividends   0    
Change in unrealized investment (loss) gain, net     (246) (246)
Change in foreign currency translation, net     0 0
Balance at Dec. 31, 2022 239,753 (87,195) (314) 152,244
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued for options/RSUs/RS, net (11)      
Stock-based compensation 2,778      
Net (loss)   (27,871)   (27,871)
Dividends   (71,429)    
Change in unrealized investment (loss) gain, net     306 306
Change in foreign currency translation, net     (4) (4)
Balance at Dec. 31, 2023 $ 242,520 $ (186,495) $ (12) $ 56,013
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY [Abstract]    
Dividends per share (in dollars per share) $ 20 $ 0
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net (loss) $ (27,871) $ (36,260)
Adjustments to reconcile net (loss) to net cash from operating activities:    
Depreciation 9 7
Stock-based compensation 2,778 3,330
Bad debt 15 0
Deferred income taxes 0 16,032
Changes in assets and liabilities:    
Prepaid expenses and other current assets (3,369) 331
Accounts payable and accrued liabilities 67 35
Other liabilities 3,596 (54)
Accrued payroll and related expenses 5 41
Accrued licensing costs 0 (355)
Accounts receivables (3) 3
Prepaid income taxes 0 (3)
Net cash used in operating activities (24,773) (16,893)
Cash flows from investing activities:    
Purchase of property and equipment (65) 0
Purchase of investments at cost (2,500) 0
Purchase of investments (47,215) (67,070)
Proceeds from sale or maturity of investments 85,721 28,535
Net cash provided by (used in) investing activities 35,941 (38,535)
Cash flows from financing activities:    
Dividend (71,429) 0
Withholding taxes paid on cashless exercise of restricted stock and restricted stock units (11) (29)
Net cash used in financing activities (71,440) (29)
Net (decrease) in cash and cash equivalents (60,272) (55,457)
Cash and cash equivalents, beginning of period 86,561 142,018
Cash and cash equivalents, end of period 26,289 86,561
Cash paid for income taxes $ 0 $ 2
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
Formation and Business of the Company
12 Months Ended
Dec. 31, 2023
Business Description and Basis of Presentation [Abstract]  
Formation and Business of the Company
Note 1 − Formation and Business of the Company

VirnetX Holding Corporation, which we refer to as “we”, “us”, “our”, “the Company” or “VirnetX”, is engaged in the business of commercializing a portfolio of patents. We seek to derive revenue from selling our software products including VirnetX War Room™ and VirnetX Matrix™ and licensing our technology, including VirnetX One™, and our secure domain name technology GABRIEL Connection Technology™, to various original equipment manufacturers (“OEMs”) and others, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence, and unified communications markets or who seek to secure their systems and applications.

Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 205 total patents and pending applications, including 72 U.S. patents/patent applications and 133 foreign patents/validations/pending applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security. The subject matter of all our U.S and foreign patents and pending applications relates generally to securing communications over the Internet and such covers all our technology and other products. Some of our issued U.S. and foreign patents expire at various times during the period from 2023 to 2034.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 2 − Summary of Significant Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. The critical accounting policies we employ in the preparation of our consolidated financial statements are those which involve impairment of long-lived assets, income taxes, fair value of financial instruments and stock-based compensation.

Use of Estimates

We prepare our consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the Audit Committee of our Board of Directors.

Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.

Revenue Recognition

The Company derives revenue from licensing and royalty fees from contracts with customers which often span several years. We account for this revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements, with revenue for each unit of accounting recognized as the product or service is delivered to the customer.

With the licensing of our patents, performance obligations are generally satisfied at a point in time as work is complete when our patent rights are transferred to our customers. We generally have no further obligation to our customers regarding our technology.

Certain contracts may require our customers to enter into a hosting arrangement with us and for these arrangements, revenue is recognized over time, generally over the life of the servicing contract.

The Company actively monitors and enforces its intellectual property (“IP”) rights, including seeking appropriate compensation from third parties that utilize the Company’s IP without a license. As a result, the Company may, from time to time, receive payments as part of a settlement or compensation for a patent infringement dispute. Proceeds received are allocated to each element identified in the settlement or compensation, based on the fair value of each element. Generally, settlements and compensation may include the following elements: the value of a license or royalty agreement, cost reimbursement, damages, and interest. Elements identified related to licensing and royalty are recognized as revenue. Elements identified as reimbursed costs are generally recorded as a reduction to the reported expenses. Elements identified as damages or interest are generally recorded in other income in the condensed consolidated statement of operations.

Licensing Costs

Included in operating expenses are licensing costs we incurred in conjunction with a patent infringement case.

Contingent Gains

ASC Topic 450-30-25, Contingent Gains, prohibits recognition of contingent gains until realized. Accordingly, we do not record contingent gains ahead of such realization. Management generally considers any such gains as realized only upon the collection of cash.

Cash and Cash Equivalents

We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.

Investments

Investments classified as available-for-sale are recorded at fair market value. Unrealized gains and losses are reported as other comprehensive income. Realized gains and losses are recorded in income in the period they are realized using specific identification of each security’s cost basis. We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less than two years. By policy, we limit the amount of credit exposure to any one issuer.

We have elected the investment measurement alternative for other investments without readily determinable fair values. During 2023, we invested $2,000 in L2 Holdings LLC and $500 in OP Media Inc. These investments are carried at our initial cost less any impairment, because we do not have the ability to exercise significant influence over operating and financial matters. For these investments, we adjust the carrying value for any purchases or sales of our ownership interests. Periodically, we evaluate these investments for impairment. If we identify an impairment, we reduce the carrying value for the impairment loss with a charge to earnings. We have not identified any impairment as of December 31, 2023.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. A portion of those balances are insured by the Federal Deposit Insurance Corporation, or FDIC. In 2023, we had, at times, funds that were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.

Fair Value

The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.

Property and Equipment

Property and equipment are stated at historical cost, less accumulated depreciation, and amortization. Depreciation and amortization are computed using the accelerated and straight-line methods over the estimated useful lives of the assets, which range from five to seven years. Repair and maintenance costs are charged to expense as incurred.

Leases

The Company determines if an arrangement is a lease at inception in accordance with ASC Topic 842. Operating lease right-of-use (“ROU”) assets are included in Prepaid expenses, and other assets on the Condensed Consolidated Balance Sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term, using the risk-free rate, U.S. prime rate, of 8.5% in 2023.

Intangible Assets

We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.

Impairment of Long-Lived Assets

We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are deemed impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Research and Development

Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff. Research and development costs are expensed as incurred.

Income Taxes

We account for income taxes using the asset and liability method. The asset and liability method requires the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing our deferred tax assets, we consider whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.

The 2017 U.S. Tax Cuts and Jobs Act changes IRC Section 174, regarding capitalization of book research and development (“R&D”) expenses for income tax purposes.  Effective for tax years beginning in 2022 IRC Section 174 requires the capitalization of book R&D expenses which are capitalized and amortized over 5 years for domestic R&D expenses and over 15 years for foreign R&D expenses.  To date there has been limited guidance from the IRS on how to quantify the amount of book R&D expenses subject to capitalization, including the indirect expenses supporting the R&D function.  Due to the limited guidance, some assumptions were made in our estimates.

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.

We account for our uncertain tax positions in accordance with U.S. GAAP, which utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates.

Stock-Based Compensation

We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs on a straight-line basis over the requisite service period of the award, which is generally a vesting term of 4 years. We recognize forfeitures, if any, when they occur. In addition, we record stock-based compensation expense for awards granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued, as they vest, over the performance period (See Note 6 - Stock-Based Compensation).


Earnings per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.

New Accounting Pronouncements

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregated information about an entity’s effective tax rate reconciliation as well as information on income tax paid. The guidance in this ASU is effective for public companies with annual periods beginning after December 15, 2024. We plan to adopt the guidance for the fiscal year ending December 31, 2025. We are currently evaluating the effect adoption of this ASU will have on our consolidated financial statements.
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment
12 Months Ended
Dec. 31, 2023
Property and Equipment [Abstract]  
Property and Equipment
Note 3 − Property and Equipment
 
Our major classes of property and equipment were as follows:

 
December 31
 
   
2023
   
2022
 
Office furniture
 
$
143
   
$
79
 
Computer equipment
   
92
     
92
 
Total
   
235
     
171
 
Less accumulated depreciation
   
(168
)
   
(160
)
Total property and equipment, net
 
$
67
   
$
11
 

Depreciation expense for 2023 and 2022 was $9 and $7, respectively.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
Commitments, Contingencies and Related Party Transactions
12 Months Ended
Dec. 31, 2023
Commitments, Contingencies and Related Party Transactions [Abstract]  
Commitments, Contingencies and Related Party Transactions
Note 4 − Commitments, Contingencies and Related Party Transactions

We have a service agreement for the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for our employees. We incurred approximately $1,097 and $1,123 in rental fees and reimbursements to the LLC in 2023 and 2022, respectively. We pay for the Company’s business usage of the aircraft and have no right to purchase. Our Chief Executive Officer and Chief Administrative Officer are the managing partners of the LLC and control the equity interests of the LLC. We entered into a 12-month non-exclusive agreement with the LLC for use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be cancelled by either us or the LLC with 30 days’ notice. The agreement renews on an annual basis unless terminated by either party. Neither party has exercised their termination rights.

See Note 13 for further discussion of our lease commitments.
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock Plan
12 Months Ended
Dec. 31, 2023
Stock Plan [Abstract]  
Stock Plan
Note 5 − Stock Plan

Our stockholders approved the Amended and Restated Equity Incentive Plan (the “A&R Plan”) at our annual shareholders’ meeting in June 2023, which added 175,000 shares to the plan. Our prior plan expired March 29, 2023; no further awards will be made under the prior plan, and the A&R Plan will govern awards granted under the prior plan. The A&R Plan provides for the granting of stock options, restricted stock units (“RSUs”) and restricted stock. Options granted under the A&R Plan are granted with an exercise price equal to the fair value of the of our stock on the date of grant. RSUs and restricted stock are granted at the fair value of our stock on the date of grant because they have no exercise price. The fair value of options, RSUs and restricted stock are expensed over the vesting periods. All options, RSUs and restricted stock are subject to forfeiture if service terminates prior to the shares vesting. At December 31, 2023, there were 225,778 shares available for grant under the A&R Plan.
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2023
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
Note 6 − Stock-Based Compensation

The following tables summarize information and activity under the plan for the indicated periods.

Options Outstanding
   
Options Vested and Exercisable
 
Range of
Exercise Prices
 
Number
Outstanding
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Weighted
Average
Exercise
Price
   
Number
Exercisable
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Weighted
Average
Exercise
Price
 
$ 10.00 - 31.60     41,925       8.45     $
28.67       17,519       8.45     $
28.16  
$ 34.80 -  139.00
   
275,217
     
4.66
   
$
90.31
     
252,243
     
4.42
   
$
90.00
 
$ 290.40 - 308.00
   
12,875
     
0.49
   
$
304.24
     
12,875
     
0.49
   
$
304.24
 
     
330,017
     
4.98
   
$
90.63
     
282,637
     
4.49
   
$
95.70
 

 
Options
 
   
Number of
Shares
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2021
   
319,868
   
$
139.80
     
   
$
 
Options granted
   
40,050
     
29.60
     
     
 
Options exercised
   
   
     
     
 
Options cancelled
   
(19,120
)
   
501.20
     
     
 
Outstanding, December 31, 2022
   
340,798
   
$
106.60
     
   
$
 
Options granted
   
1,875
     
10.00
     
     
 
Options exercised
   
     
     
     
 
Options cancelled
   
(12,656
)
   
510.21
     
     
 
Outstanding, December 31, 2023
   
330,017
   
$
90.63
     
4.98
   
$
 
Options exercisable, December 31, 2023
   
282,637
   
$
95.70
     
4.49
   
$
 

 
RSUs
 
   
Number of
RSUs
   
Weighted
Average
Grant Date
Fair Value
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2021
   
25,457
   
$
107.80
   
$
 
RSUs granted
   
12,918
     
29.20
     
 
RSUs vested
   
(10,770
)
   
103.00
     
 
RSUs cancelled
   
     
     
 
Outstanding, December 31, 2022
   
27,605
   
$
73.00
   
$
 
RSUs granted
   
1,250
     
10.00
     
 
RSUs vested
   
(11,405
)
   
83.81
     
 
RSUs cancelled
                 
Outstanding, December 31, 2023
   
17,450
   
$
60.81
   
$
 

   
Restricted Stock
 
 
 
Number of
Restricted Stock
   
Weighted
Average
Grant Date
Fair Value
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2022
   
   
$
   
$
 
Restricted stock granted
   
36,927
     
9.12
     
 
Restricted stock vested
   
(3,617
)
   
9.19
     
 
Restricted stock cancelled
   
(604
)
   
9.60
     
 
Outstanding, December 31, 2023
   
32,706
   
$
9.11
   
$
 

Intrinsic value is calculated as the difference between the per-share market price of our common stock on the last trading day of 2023, which was $7 and the exercise price of the awards. For awards exercised, the intrinsic value is the difference between market price and the exercise price on the date of exercise.

Stock-based compensation expense is included in operating expense for each period as follows:

Stock-Based Compensation by Type of Award
 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Stock options
 
$
1,960
   
$
2,303
 
RSUs
   
778
     
1,027
 
Restricted stock
    40      
 
Total stock-based compensation expense
 
$
2,778
   
$
3,330
 

As of December 31, 2023, there was $3,006 of unrecognized stock-based compensation expense; $2,025 related to unvested stock options, $683 related to unvested RSUs, and $298 related to unvested restricted stock. These costs are expected to be recognized over a weighted-average period of 1.8 years for options, 1.74 years for RSUs, and 3.54 years for restricted stock.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions:

 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Expected stock price volatility
   
81.39
%
   
85.39
%
Risk-free interest rate
   
3.9
%
   
3.09
%
Expected life term
 
5.5 years
   
6.2 years
 
Expected dividends
   
0
%
   
0
%

Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $6.96 and $21.77 per share during 2023 and 2022, respectively. The expected life was determined using the simplified method outlined in ASC 718, “Compensation - Stock Compensation”. Expected volatility of the stock options was based upon historical data and other relevant factors.
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings Per Share
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Earnings Per Share
Note 7 − Earnings Per Share

Basic earnings per share are based on the weighted average number of shares outstanding for a period. Diluted earnings per share are based upon the weighted average number of shares and potentially dilutive common shares outstanding. Potential common shares outstanding principally include stock options, RSUs and unvested restricted stock under our stock plan and warrants. During 2023 and 2022 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive.
The table below sets forth the basic and diluted loss per share calculations:

    Year Ended December 31,  
 
2023
   
2022
 
Net (loss) income
 
$
(27,871
)
 
$
(36,260
)
                 
Basic weighted average number of shares outstanding
    3,579       3,565  
Effect of dilutive securities
   
     
 
Diluted weighted average number of shares outstanding
   
3,579
     
3,565
 
                 
Basic (loss) earnings per share
 
$
(7.79
)
 
$
(10.17
)
Diluted (loss) earnings per share
 
$
(7.79
)
 
$
(10.17
)
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock
12 Months Ended
Dec. 31, 2023
Common Stock [Abstract]  
Common Stock
Note 8 − Common Stock

Each share of common stock has the right to one vote. The holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by our Board of Directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. Our restated articles of incorporation authorize us to issue up to 100,000,000 shares of $0.0001 par value common stock.

Effective October 25, 2023, every 20 shares of our common stock outstanding was combined into one share of common stock. Proportional adjustments were also made to the number of restricted stock, common stock issuable upon the exercise of options, warrants as well as common stock issuable upon the vesting of RSUs. The exercise price of all equity awards were also proportionally adjusted. The accompanying financial statements include the effect of this adjustment on all periods presented.

Dividends

In 2023, we paid a one-time capital dividend of $20 per share of common stock to shareholders. The timing and amount of future dividends, if any, will depend on market conditions, corporate business and financial considerations and regulatory requirements.

Warrants

In 2020, we issued warrants for the purchase of 1,250 shares of common stock at an exercise price of $115 per share, exercisable on the date of grant, expiring in April 2025. The weighted average fair value at the grant date was $83.20 per warrant. The fair value at the grant date was estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions (i) dividend yield on our common stock of 0 percent (ii) expected stock price volatility of 97 percent (iii) a risk-free interest rate of 0.27 percent and (iv) and expected option term of 5 years.

Warrants
Issued
   
Exercise
Price
   
Outstanding and
Exercisable
December 31, 2022
   
Issued
   
Exercised
   
Terminated /
Cancelled
   
Outstanding and
Exercisable
December 31, 2023
 
Expiration Date
 
 
1,250
   
$
115
     
1,250
     
     
     
     
1,250
 
April 30, 2025
 
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Employee Benefit Plan
12 Months Ended
Dec. 31, 2023
Employee Benefit Plan [Abstract]  
Employee Benefit Plan
Note 9 − Employee Benefit Plan

We sponsor a defined contribution 401k plan covering substantially all our employees. Our matching contribution to the plan was approximately $229 and $179 in 2023 and 2022, respectively.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income Taxes [Abstract]  
Income Taxes
Note 10 − Income Taxes

The income tax provision (benefit) is comprised of the following:

 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Current:
           
Federal
 
$
   
$
 
State
   
2
     
3
 
Foreign
           
 
   
2
     
3
 
Deferred:
               
Federal
   
(79
)
   
15,920
 
State
   
(2
)
   
109
 

    (81 )     16,029  
Total income tax (benefit) provision
  $ (79 )  
$
16,032
 
 
A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
United States federal statutory rate
   
21.00
%
   
21.00
%
State taxes, net of federal benefit
   
(0.01
)%
   
(0.55
)%
Valuation allowance
   
(20.31
)%
   
(91.21
)%
Stock based compensation
   
(0.58
)%
   
(9.44
)%
R&D Credit
   
2.20
%
   
1.22
%
Other
   
(2.03
)%
   
(0.29
)%
Effective income tax rate
    0.28 %    
(79.27
)%

Deferred tax assets (liabilities) consist of the following:

 
As of
December 31, 2023
   
As of
December 31, 2022
 
Deferred tax assets:
           
Reserves and accruals
 
$
65
   
$
147
 
Research and development credits and other credits
   
1,110
     
430
 
Net operating loss carry forward
   
15,262
     
11,988
 
Stock based compensation
   
4,360
     
5,018
 
Other
   
2,382
     
970
 
Total deferred tax assets
 
$
23,179
   
$
18,553
 
                 
Valuation allowance
   
(23,179
)
   
(18,553
)
Deferred tax assets after valuation allowance
   
     
 
                 
Total deferred tax liability – depreciation and amortization
   
     
 
                 
Net deferred tax assets
 
$
   
$
 

Pursuant to IRC Section 174, we capitalized direct and indirect research and development costs for our tax return totaling $8,599 in 2023 and $5,140 in 2022, of which $1,888 will be amortized in our 2023 tax return and $514 in our 2022 tax return. At December 31, 2023, unamortized capitalized direct and indirect research and development costs for our tax return totaled $11,337, resulting in a deferred tax asset of $2,381.

At December 31, 2023, we had federal and state net operating loss carryforwards of approximately $72,645 and $109,435, respectively. Federal net operating loss carryforwards do not expire. None of the state net operating loss carryforward is apportioned to a deferred tax asset, because currently we do not have operations in states where losses accumulated. The state net operating loss carryforward begins expiring in 2029. We provide full valuation allowances for our net deferred tax assets, including NOL carryforwards generated during the years, based on our evaluation of positive and negative evidence, including our history of operating losses and the uncertainty of generating future taxable income that would enable us to realize our deferred tax assets.

We are required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. At December 31, 2023, we have no uncertain tax positions.

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to NOLs and tax credits generated in these years were utilized in 2020. The statute of limitation for these years shall expire three years after the date of filing 2020 income tax returns, which is October 2024.

Our policy is to recognize interest and penalties, if any, accrued on any unrecognized tax benefits, as a component of income tax expense. We had no interest or penalties accrued in 2023.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value Measurement
12 Months Ended
Dec. 31, 2023
Fair Value Measurement [Abstract]  
Fair Value Measurement
Note 11 − Fair Value Measurement

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value. When we estimate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. We use valuation techniques, primarily the income and market approach, which maximizes the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

Mutual funds: Valued at the quoted net asset value (NAV) of shares held.
U.S. agency and treasury securities: Fair value measured at the closing price reported on the active market on which the individual securities are traded.

The following table shows the adjusted cost, gross unrealized gains, gross unrealized losses, and fair value of our financial assets as of December 31, 2023 and 2022 (in thousands):

 
December 31, 2023
 
   
Adjusted
Cost
   
Unrealized
Gains
   
Unrealized
Losses
   
Fair
Value
   
Cash
and Cash
Equivalents
   
Investments
Available
for Sale
 
Cash
 
$
1,452
   
$
   
$
   
$
1,452
   
$
1,452
   
$
 
Level 1:
                                               
Mutual funds
   
20,040
     
     
     
20,040
     
20,040
     
 
U.S. agency and treasury securities
   
32,046
     
27
     
(18
)
   
32,055
     
4,797
     
27,258
 
     
52,086
     
27
     
(18
)
   
52,095
     
24,837
     
27,258
 
Total
 
$
53,538
   
$
27
   
$
(18
)
 
$
53,547
   
$
26,289
   
$
27,258
 

 
December 31, 2022
 
   
Adjusted
Cost
   
Unrealized
Gains
   
Unrealized
Losses
   
Fair
Value
   
Cash
and Cash
Equivalents
   
Investments
Available
for Sale
 
Cash
 
$
16,949
   
$
   
$
   
$
16,949
   
$
16,949
   
$
 
Level 1:
                                               
Mutual funds
   
66,493
     
     
     
66,493
     
66,493
     
 
U.S. agency and treasury securities
    68,958       9       (386 )     68,581       3,119       65,462  
     
135,451
     
9
     
(386
)
   
135,074
     
69,612
     
65,462
 
Total
 
$
152,400
   
$
9
   
$
(386
)
 
$
152,023
   
$
86,561
   
$
65,462
 

The maturities of our investments generally range from within one to two years. Actual maturities could differ from contractual maturities due to call or prepayment provisions.
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
Litigation
12 Months Ended
Dec. 31, 2023
Litigation [Abstract]  
Litigation
Note 12 − Litigation (all dollar amounts in this section are expressed in thousands except for rates per device)

We have several intellectual property infringement lawsuits pending in the United States Court of Appeals for the Federal Circuit (“USCAFC”).

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

This case began on November 6, 2012, when we filed a complaint against Apple Inc. (“Apple”) in United States District Court (“USDC”) in which we alleged that Apple infringed on certain of our patents, (U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151). We sought damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. The USDC entered a Final Judgment and issued its Memorandum Opinion and Order regarding post-trial motions, affirming the jury’s verdict of $502,600 and granting VirnetX motions for supplemental damages, a sunset royalty, and the royalty rate of $1.20 per infringing iPhone, iPad and Mac products, pre-judgment and post-judgment interest and costs. Apple filed a notice of appeal with the United States Court of Appeals for the Federal Circuit (“USCAFC”) in the Apple II case.

On October 9, 2018, USCAFC docketed the appeal as Case No. 19-1050 - VirnetX Inc. v. Apple Inc. On November 22, 2019, the USCAFC issued an opinion affirming the district court’s findings that Apple is precluded from making certain invalidity arguments and that Apple infringed the ‘135 and ‘151 patents; reversing the USDC’s finding that Apple infringed the ‘504 and ‘211 patents; and remanding the case for proceedings on damages. Apple sought panel and en banc rehearing, which the USCAFC denied on February 10, 2020.

On February 22, 2021, the USCAFC docketed the appeal as Case No. 19-1672. Apple’s opening brief was filed on June 2, 2021. VirnetX filed its responsive brief on July 26, 2021. Apple filed its reply brief on September 13, 2021. Oral arguments were held on September 8, 2022. On March 31, 2023, the USCAFC issued its decision vacating the USDC’s judgement in this matter and remanding it back to the USDC with instructions to dismiss the case as moot. On July 14, 2023 the District Court vacated its prior Final Judgment against Apple dated January 6, 2021 and dismissed the case as moot. On May 1, 2023, VirnetX filed a petition for panel rehearing. On June 27, 2023, the petition for panel rehearing was denied, and the mandate issued on June 30, 2023. VirnetX filed a petition for a writ of certiorari with the United States Supreme Court, on September 20, 2023. On February 20, 2024, the Supreme Court denied our petition. We are evaluating all our options in this matter.

VirnetX Inc. v. Mangrove Partners Master Fund, Ltd., Apple Inc. (USCAFC Case 20-2271) and VirnetX Inc. v. Mangrove Partners Master Fund, Ltd., Apple Inc., and Black Swamp, LLC (USCAFC Case 20-2272)

On September 15, 2020, we filed with the USCAFC an appeal of the invalidity findings by the Patent Trial and Appeal Board (“PTAB”) in inter-partes review proceedings IPR2015-01046 and IPR2016-00062 involving our U.S. Patent No. 6,502,135, and an appeal of the invalidity findings by the PTAB in inter-partes review proceedings IPR2015-1047, IPR2016-00063, and IPR2016-00167 involving our U.S. Patent No. 7,490,151. On September 25, 2020, the USCAFC issued an order consolidating the two appeals. On December 15, 2020, we filed a motion to vacate the PTAB decisions below and to remand these appeals to the PTAB. On March 16, 2021, the USCAFC denied the motion without prejudice to us raising the challenges made in the motion in our opening brief. Our opening brief was filed on June 7, 2021.

On June 23, 2021, the USCAFC entered an order directing us (and parties in other appeals that raised Appointments Clause challenges) to file a brief explaining how they believe their cases should proceed in light of the Supreme Court’s decision in United States v. Arthrex, Inc., 141 S. Ct. 1970 (2021). On July 7, 2021, we filed a brief in response to the court’s order. Other parties, including the U.S. Patent and Trademark Office (“USPTO”) filed their responses on July 21, 2021. On August 19, 2021, USCAFC issued an order remanding these appeals for the limited purpose of allowing VirnetX the opportunity to request rehearing of the PTAB’s final written decisions by the Director of the USPTO. The USCAFC retained jurisdiction over the appeals in the meantime. On September 20, 2021, we filed our requests for Director rehearing with the USPTO. On October 29, 2021, our requests for Director rehearing were denied. We subsequently filed an amended opening brief to the USCAFC on December 10, 2021, the other parties filed response briefs on February 2, 2022, and we filed a reply brief on February 22, 2022. All the briefings have been completed. The oral arguments in this matter were held on September 8, 2022. On March 30, 2023, the USCAFC issued its decision affirming PTAB’s decisions finding certain claims of the ‘135 patent and the ‘151 patent to be unpatentable. On June 5, 2023, VirnetX filed a petition for panel rehearing. On June 22, 2023, the petition for panel rehearing was denied, and the mandate issued on June 29, 2023. VirnetX filed a petition for a writ of certiorari with the United States Supreme Court, on September 20, 2023. On February 20, 2024, the Supreme Court denied our petition. We are evaluating all our options in this matter.

VirnetX Inc. v. Hirshfeld (USCAFC Case 17-2593, -2594)

On September 22, 2017, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes review proceeding IPR2016-00693 involving our U.S. Patent No. 7,418,504, and an appeal of the invalidity findings by the PTAB in inter-partes review proceeding IPR2016-00957 involving our U.S. Patent No. 7,921,211. On September 16, 2021, USCAFC issued an order remanding these appeals for the limited purpose of allowing VirnetX the opportunity to request rehearing of the PTAB’s final written decisions by the Director of the USPTO. The USCAFC retained jurisdiction over the appeals in the meantime. On October 18, 2021, we filed our requests for Director rehearing with the USPTO. On January 7, 2022, our requests for Director rehearing were denied. On January 21, 2022, we informed the USCAFC about the denial of Director rehearing and requested that the court dismiss the appeal involving IPR2016-00957 as moot and vacate the PTAB’s underlying decision. On April 4, 2022, the USCAFC vacated the PTAB’s decision in IPR2016-00957 and remanded Appeal No. 17-2594 with instructions to dismiss. In the April 4, 2022 order, the USCAFC further set a briefing schedule, in Appeal No. 17-2593. VirnetX filed its opening brief on September 12, 2022. The USPTO filed its response brief on December 20, 2022. VirnetX filed its reply brief on February 14, 2023. On April 18, 2023, VirnetX filed a motion to hold this appeal in abeyance pending the disposition of any petition for rehearing in the No. 20-2271, -2272 appeal, and pending the United States Supreme Court’s disposition of a pending petition for a writ of certiorari in Arthrex, Inc. v. Smith & Nephew, Inc., No. 22-639. That motion was denied on June 1, 2023. On October 20, 2023, the USCAFC issued a decision finding the appeal moot in view of its concurrent decision in USCAFC No. 22-2234.  VirnetX sought rehearing, which was denied, and the mandate to close the case was issued on January 12, 2024.

VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 19-1671)

On March 18, 2019, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,679 involving our U.S. Patent No. 6,502,135. On October 5, 2021, USCAFC issued an order remanding these appeals for the limited purpose of allowing VirnetX the opportunity to request rehearing of the PTAB’s final written decisions by the Director of the PTO. The USCAFC retained jurisdiction over the appeals in the meantime. Our request for Director rehearing with the PTO was filed on November 5, 2021. On January 10, 2022, our request for Director rehearing was denied. We informed the USCAFC about the denial of Director rehearing. VirnetX’s opening brief was filed on June 23, 2022. The USPTO’s response brief was filed on August 2, 2022, and Cisco’s response brief was filed on September 2, 2022. VirnetX filed its reply brief on October 7, 2022. On April 18, 2023, VirnetX filed a motion to hold this appeal in abeyance pending the disposition of any petition for rehearing in the No. 20-2271, -2272 appeal, and pending the Supreme Court’s disposition of a pending petition for a writ of certiorari in Arthrex, Inc. v. Smith & Nephew, Inc., No. 22-639. The motion, filed on April 18, 2023, was denied on June 1, 2023.  On October 20, 2023, the USCAFC issued a decision finding the appeal moot in view of its concurrent decision in USCAFC No. 22-1523 and its prior decision in USCAFC No. 20-2271.  VirnetX sought rehearing, which was denied, and the mandate to close the case was issued on January 12, 2024.

VirnetX Inc. v. Apple Inc. (USCAFC Case 22-1523) (“Apple Reexam I”)

On March 10, 2022, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,682 involving our U.S. Patent No. 6,502,135. Our opening brief was filed on August 22, 2022. Apple and USPTO each filed a response brief on December 28, 2022. VirnetX filed its reply brief on February 8, 2023. On April 18, 2023, VirnetX filed a motion to hold this appeal in abeyance pending the disposition of any petition for rehearing in the No. 20-2271, -2272 appeal, and pending the Supreme Court’s disposition of a pending petition for a writ of certiorari in Arthrex, Inc. v. Smith & Nephew, Inc., No. 22-639, which was denied on June 1, 2023.  On October 20, 2023, the USCAFC issued a decision affirming the PTAB’s invalidity findings.  VirnetX sought rehearing, which was denied, and the mandate to close the case was issued on January 12, 2024.

VirnetX Inc. v. Apple Inc. (USCAFC Case 22-1997) (“Apple Reexam II”)

On July 6, 2022, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,697 involving our U.S. Patent No. 7,490,151. On October 17, 2022, we filed a motion to remand the appeal in light of the PTAB’s refusal to permit Director rehearing. On January 23, 2023, the USCAFC denied that motion without prejudice to the parties raising their arguments in the merits briefs. VirnetX opening brief was filed on May 8, 2023, and Apple and the USPTO each filed a response brief on July 24, 2023. VirnetX filed its reply brief on September 1, 2023. We currently await scheduling of oral arguments.

VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 22-2234)

On September 16, 2022, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,851 involving our U.S. Patent No. 7,418,504. We filed our opening brief on February 28, 2023. Cisco’s response brief was filed on May 10, 2023, and VirnetX reply brief was filed on June 21, 2023. On October 20, 2023, the USCAFC issued a decision affirming the PTAB’s invalidity findings.  The mandate to close the case was issued on December 26, 2023.

VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 23-1765)

On April 7, 2023, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,714 involving our U.S. Patent No. 7,490,151. The certified list is due to be filed by the USPTO by May 30, 2023, and our opening brief will be due 60 days thereafter.  In addition, on April 21, 2023, Cisco filed a cross-appeal.  On September 29, 2023, VirnetX filed a motion to remand.  That motion was denied without prejudice to VirnetX raising the same arguments in its opening appeal brief in an order dated December 27, 2023, which also set the deadline for VirnetX to file an opening brief for February 5, 2024. VirnetX filed its opening brief on February 5, 2024, and Cisco’s opening/response brief’s is currently due March 18, 2024

Other Legal Matters

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are likely valid, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we could prevail on such potential claims if we made them. In addition, bringing a lawsuit may lead to potential counterclaims which may distract our management and our other resources, including capital resources, from efforts to successfully commercialize our products.

Currently, we are not a party to any other pending legal proceedings and are not aware of any proceeding threatened or contemplated against us.
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Leases
Note 13 − Leases

In October 2023, we renewed our lease for office space in Nevada with a third party recording an ROU asset and lease liability of $102. The lease requires monthly payments of $4.6 and expires in October 2025. At December 31, 2023, our ROU asset and lease liability totaled $93. Lease expense totaled $55 in 2023 and $54 in 2022.

In October 2023, we executed a facility lease in Utah to be used for technical integration and as a training facility recording an ROU asset and a lease liability of $3,587. This operating lease requires monthly payments starting at $72, includes periodic increases, provides six months of free rent, and expires in April 2029.  At December 31, 2023, our ROU asset and lease liability totaled $3,479 and $3,546, respectively. Lease expense totaled $140 in 2023.

The weighted average remaining life of the office and facility leases discussed above is approximately 5 years, and the related lease liability is as follows:

Due in 2024
 
$
494
 
Due in 2025
 
$
946
 
Due in 2026
 
$
927
 
Due in 2027
 
$
954
 
Due in 2028
 
$
983
 
Thereafter
 
$
336
 
Total undiscounted lease liability
 
$
4,640
 
Less: imputed interest
  $ (1,001 )
Total lease liability
  $ 3,639  

We also lease a facility for corporate promotional and marketing purposes which was prepaid at inception and expires in 2025. At December 31, 2023 and 2022, the ROU asset totaled $349 and $648, respectively; lease expense totaled $300 per year in 2023 and 2022. In March 2024, we renewed our facility lease, used for corporate, promotional and marketing purposes. The renewal period begins in 2025, continues for 10 years through 2035, requires either a single payment of $6,000, or annual payments each March, beginning in 2025 starting at $600 and increasing annually for a total commitment of approximately $7,500.

We have a service agreement for the use of an aircraft from a related party discussed in more detail in Note 4. We incurred approximately $1,097 and $1,123 in rental fees and reimbursements to the entity in 2023 and 2022, respectively.
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
Subsequent Event
12 Months Ended
Dec. 31, 2023
Subsequent Event [Abstract]  
Subsequent Event
Note 14 − Subsequent Event
In January 2024, we issued 71,000 shares of restricted stock from our Amended and Restated Equity Incentive Plan.
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2023
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
Use of Estimates
Use of Estimates

We prepare our consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the Audit Committee of our Board of Directors.
Basis of Consolidation
Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.
Revenue Recognition
Revenue Recognition

The Company derives revenue from licensing and royalty fees from contracts with customers which often span several years. We account for this revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements, with revenue for each unit of accounting recognized as the product or service is delivered to the customer.

With the licensing of our patents, performance obligations are generally satisfied at a point in time as work is complete when our patent rights are transferred to our customers. We generally have no further obligation to our customers regarding our technology.

Certain contracts may require our customers to enter into a hosting arrangement with us and for these arrangements, revenue is recognized over time, generally over the life of the servicing contract.

The Company actively monitors and enforces its intellectual property (“IP”) rights, including seeking appropriate compensation from third parties that utilize the Company’s IP without a license. As a result, the Company may, from time to time, receive payments as part of a settlement or compensation for a patent infringement dispute. Proceeds received are allocated to each element identified in the settlement or compensation, based on the fair value of each element. Generally, settlements and compensation may include the following elements: the value of a license or royalty agreement, cost reimbursement, damages, and interest. Elements identified related to licensing and royalty are recognized as revenue. Elements identified as reimbursed costs are generally recorded as a reduction to the reported expenses. Elements identified as damages or interest are generally recorded in other income in the condensed consolidated statement of operations.
Licensing Costs
Licensing Costs

Included in operating expenses are licensing costs we incurred in conjunction with a patent infringement case.
Contingent Gains
Contingent Gains

ASC Topic 450-30-25, Contingent Gains, prohibits recognition of contingent gains until realized. Accordingly, we do not record contingent gains ahead of such realization. Management generally considers any such gains as realized only upon the collection of cash.
Cash and Cash Equivalents
Cash and Cash Equivalents

We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.
Investments
Investments

Investments classified as available-for-sale are recorded at fair market value. Unrealized gains and losses are reported as other comprehensive income. Realized gains and losses are recorded in income in the period they are realized using specific identification of each security’s cost basis. We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less than two years. By policy, we limit the amount of credit exposure to any one issuer.

We have elected the investment measurement alternative for other investments without readily determinable fair values. During 2023, we invested $2,000 in L2 Holdings LLC and $500 in OP Media Inc. These investments are carried at our initial cost less any impairment, because we do not have the ability to exercise significant influence over operating and financial matters. For these investments, we adjust the carrying value for any purchases or sales of our ownership interests. Periodically, we evaluate these investments for impairment. If we identify an impairment, we reduce the carrying value for the impairment loss with a charge to earnings. We have not identified any impairment as of December 31, 2023.
Concentration of Credit Risk and Other Risks and Uncertainties
Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. A portion of those balances are insured by the Federal Deposit Insurance Corporation, or FDIC. In 2023, we had, at times, funds that were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.
Fair Value
Fair Value

The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.
Property and Equipment
Property and Equipment

Property and equipment are stated at historical cost, less accumulated depreciation, and amortization. Depreciation and amortization are computed using the accelerated and straight-line methods over the estimated useful lives of the assets, which range from five to seven years. Repair and maintenance costs are charged to expense as incurred.
Leases
Leases

The Company determines if an arrangement is a lease at inception in accordance with ASC Topic 842. Operating lease right-of-use (“ROU”) assets are included in Prepaid expenses, and other assets on the Condensed Consolidated Balance Sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term, using the risk-free rate, U.S. prime rate, of 8.5% in 2023.
Intangible Assets
Intangible Assets

We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets

We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are deemed impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.
Research and Development
Research and Development

Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff. Research and development costs are expensed as incurred.
Income Taxes
Income Taxes

We account for income taxes using the asset and liability method. The asset and liability method requires the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing our deferred tax assets, we consider whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.

The 2017 U.S. Tax Cuts and Jobs Act changes IRC Section 174, regarding capitalization of book research and development (“R&D”) expenses for income tax purposes.  Effective for tax years beginning in 2022 IRC Section 174 requires the capitalization of book R&D expenses which are capitalized and amortized over 5 years for domestic R&D expenses and over 15 years for foreign R&D expenses.  To date there has been limited guidance from the IRS on how to quantify the amount of book R&D expenses subject to capitalization, including the indirect expenses supporting the R&D function.  Due to the limited guidance, some assumptions were made in our estimates.

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.

We account for our uncertain tax positions in accordance with U.S. GAAP, which utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates.
Stock-Based Compensation
Stock-Based Compensation

We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs on a straight-line basis over the requisite service period of the award, which is generally a vesting term of 4 years. We recognize forfeitures, if any, when they occur. In addition, we record stock-based compensation expense for awards granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued, as they vest, over the performance period (See Note 6 - Stock-Based Compensation).

Earnings per Share
Earnings per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.
New Accounting Pronouncements
New Accounting Pronouncements

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregated information about an entity’s effective tax rate reconciliation as well as information on income tax paid. The guidance in this ASU is effective for public companies with annual periods beginning after December 15, 2024. We plan to adopt the guidance for the fiscal year ending December 31, 2025. We are currently evaluating the effect adoption of this ASU will have on our consolidated financial statements.
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment (Tables)
12 Months Ended
Dec. 31, 2023
Property and Equipment [Abstract]  
Property and Equipment
Our major classes of property and equipment were as follows:

 
December 31
 
   
2023
   
2022
 
Office furniture
 
$
143
   
$
79
 
Computer equipment
   
92
     
92
 
Total
   
235
     
171
 
Less accumulated depreciation
   
(168
)
   
(160
)
Total property and equipment, net
 
$
67
   
$
11
 
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Stock-Based Compensation [Abstract]  
Information about Stock Options Outstanding
The following tables summarize information and activity under the plan for the indicated periods.

Options Outstanding
   
Options Vested and Exercisable
 
Range of
Exercise Prices
 
Number
Outstanding
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Weighted
Average
Exercise
Price
   
Number
Exercisable
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Weighted
Average
Exercise
Price
 
$ 10.00 - 31.60     41,925       8.45     $
28.67       17,519       8.45     $
28.16  
$ 34.80 -  139.00
   
275,217
     
4.66
   
$
90.31
     
252,243
     
4.42
   
$
90.00
 
$ 290.40 - 308.00
   
12,875
     
0.49
   
$
304.24
     
12,875
     
0.49
   
$
304.24
 
     
330,017
     
4.98
   
$
90.63
     
282,637
     
4.49
   
$
95.70
 
Stock Option Activity
 
Options
 
   
Number of
Shares
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contractual
Life (Years)
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2021
   
319,868
   
$
139.80
     
   
$
 
Options granted
   
40,050
     
29.60
     
     
 
Options exercised
   
   
     
     
 
Options cancelled
   
(19,120
)
   
501.20
     
     
 
Outstanding, December 31, 2022
   
340,798
   
$
106.60
     
   
$
 
Options granted
   
1,875
     
10.00
     
     
 
Options exercised
   
     
     
     
 
Options cancelled
   
(12,656
)
   
510.21
     
     
 
Outstanding, December 31, 2023
   
330,017
   
$
90.63
     
4.98
   
$
 
Options exercisable, December 31, 2023
   
282,637
   
$
95.70
     
4.49
   
$
 
Restricted Stock Units Activity
 
RSUs
 
   
Number of
RSUs
   
Weighted
Average
Grant Date
Fair Value
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2021
   
25,457
   
$
107.80
   
$
 
RSUs granted
   
12,918
     
29.20
     
 
RSUs vested
   
(10,770
)
   
103.00
     
 
RSUs cancelled
   
     
     
 
Outstanding, December 31, 2022
   
27,605
   
$
73.00
   
$
 
RSUs granted
   
1,250
     
10.00
     
 
RSUs vested
   
(11,405
)
   
83.81
     
 
RSUs cancelled
                 
Outstanding, December 31, 2023
   
17,450
   
$
60.81
   
$
 
Restricted Stock Activity
   
Restricted Stock
 
 
 
Number of
Restricted Stock
   
Weighted
Average
Grant Date
Fair Value
   
Aggregate
Intrinsic
Value
 
Outstanding, December 31, 2022
   
   
$
   
$
 
Restricted stock granted
   
36,927
     
9.12
     
 
Restricted stock vested
   
(3,617
)
   
9.19
     
 
Restricted stock cancelled
   
(604
)
   
9.60
     
 
Outstanding, December 31, 2023
   
32,706
   
$
9.11
   
$
 
Stock-Based Compensation by Type of Award
Stock-based compensation expense is included in operating expense for each period as follows:

Stock-Based Compensation by Type of Award
 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Stock options
 
$
1,960
   
$
2,303
 
RSUs
   
778
     
1,027
 
Restricted stock
    40      
 
Total stock-based compensation expense
 
$
2,778
   
$
3,330
 
Fair Value Assumptions
The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions:

 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Expected stock price volatility
   
81.39
%
   
85.39
%
Risk-free interest rate
   
3.9
%
   
3.09
%
Expected life term
 
5.5 years
   
6.2 years
 
Expected dividends
   
0
%
   
0
%
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Basic and Diluted Loss Per Share Calculations
The table below sets forth the basic and diluted loss per share calculations:

    Year Ended December 31,  
 
2023
   
2022
 
Net (loss) income
 
$
(27,871
)
 
$
(36,260
)
                 
Basic weighted average number of shares outstanding
    3,579       3,565  
Effect of dilutive securities
   
     
 
Diluted weighted average number of shares outstanding
   
3,579
     
3,565
 
                 
Basic (loss) earnings per share
 
$
(7.79
)
 
$
(10.17
)
Diluted (loss) earnings per share
 
$
(7.79
)
 
$
(10.17
)
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock (Tables)
12 Months Ended
Dec. 31, 2023
Common Stock [Abstract]  
Information about Warrants Outstanding
Warrants
Issued
   
Exercise
Price
   
Outstanding and
Exercisable
December 31, 2022
   
Issued
   
Exercised
   
Terminated /
Cancelled
   
Outstanding and
Exercisable
December 31, 2023
 
Expiration Date
 
 
1,250
   
$
115
     
1,250
     
     
     
     
1,250
 
April 30, 2025
 
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Taxes [Abstract]  
Income Tax Provision (Benefit)
The income tax provision (benefit) is comprised of the following:

 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
Current:
           
Federal
 
$
   
$
 
State
   
2
     
3
 
Foreign
           
 
   
2
     
3
 
Deferred:
               
Federal
   
(79
)
   
15,920
 
State
   
(2
)
   
109
 

    (81 )     16,029  
Total income tax (benefit) provision
  $ (79 )  
$
16,032
 
Effective Income Tax Rate Reconciliation
A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

 
Year Ended
December 31, 2023
   
Year Ended
December 31, 2022
 
United States federal statutory rate
   
21.00
%
   
21.00
%
State taxes, net of federal benefit
   
(0.01
)%
   
(0.55
)%
Valuation allowance
   
(20.31
)%
   
(91.21
)%
Stock based compensation
   
(0.58
)%
   
(9.44
)%
R&D Credit
   
2.20
%
   
1.22
%
Other
   
(2.03
)%
   
(0.29
)%
Effective income tax rate
    0.28 %    
(79.27
)%
Deferred Tax Assets and Liabilities
Deferred tax assets (liabilities) consist of the following:

 
As of
December 31, 2023
   
As of
December 31, 2022
 
Deferred tax assets:
           
Reserves and accruals
 
$
65
   
$
147
 
Research and development credits and other credits
   
1,110
     
430
 
Net operating loss carry forward
   
15,262
     
11,988
 
Stock based compensation
   
4,360
     
5,018
 
Other
   
2,382
     
970
 
Total deferred tax assets
 
$
23,179
   
$
18,553
 
                 
Valuation allowance
   
(23,179
)
   
(18,553
)
Deferred tax assets after valuation allowance
   
     
 
                 
Total deferred tax liability – depreciation and amortization
   
     
 
                 
Net deferred tax assets
 
$
   
$
 
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value Measurement (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Measurement [Abstract]  
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets
The following table shows the adjusted cost, gross unrealized gains, gross unrealized losses, and fair value of our financial assets as of December 31, 2023 and 2022 (in thousands):

 
December 31, 2023
 
   
Adjusted
Cost
   
Unrealized
Gains
   
Unrealized
Losses
   
Fair
Value
   
Cash
and Cash
Equivalents
   
Investments
Available
for Sale
 
Cash
 
$
1,452
   
$
   
$
   
$
1,452
   
$
1,452
   
$
 
Level 1:
                                               
Mutual funds
   
20,040
     
     
     
20,040
     
20,040
     
 
U.S. agency and treasury securities
   
32,046
     
27
     
(18
)
   
32,055
     
4,797
     
27,258
 
     
52,086
     
27
     
(18
)
   
52,095
     
24,837
     
27,258
 
Total
 
$
53,538
   
$
27
   
$
(18
)
 
$
53,547
   
$
26,289
   
$
27,258
 

 
December 31, 2022
 
   
Adjusted
Cost
   
Unrealized
Gains
   
Unrealized
Losses
   
Fair
Value
   
Cash
and Cash
Equivalents
   
Investments
Available
for Sale
 
Cash
 
$
16,949
   
$
   
$
   
$
16,949
   
$
16,949
   
$
 
Level 1:
                                               
Mutual funds
   
66,493
     
     
     
66,493
     
66,493
     
 
U.S. agency and treasury securities
    68,958       9       (386 )     68,581       3,119       65,462  
     
135,451
     
9
     
(386
)
   
135,074
     
69,612
     
65,462
 
Total
 
$
152,400
   
$
9
   
$
(386
)
 
$
152,023
   
$
86,561
   
$
65,462
 
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases (Tables)
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Lease Liability
The weighted average remaining life of the office and facility leases discussed above is approximately 5 years, and the related lease liability is as follows:

Due in 2024
 
$
494
 
Due in 2025
 
$
946
 
Due in 2026
 
$
927
 
Due in 2027
 
$
954
 
Due in 2028
 
$
983
 
Thereafter
 
$
336
 
Total undiscounted lease liability
 
$
4,640
 
Less: imputed interest
  $ (1,001 )
Total lease liability
  $ 3,639  
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
Formation and Business of the Company (Details) - Patents [Member]
Dec. 31, 2023
Patent
Formation and Business of the Company Disclosure [Abstract]  
Number of patents and pending applications 205
U.S. [Member]  
Formation and Business of the Company Disclosure [Abstract]  
Number of patents and pending applications 72
Foreign [Member]  
Formation and Business of the Company Disclosure [Abstract]  
Number of patents and pending applications 133
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
Institution
Investment in Equity Securities without Readily Determinable Fair Value [Abstract]  
Impairment on investment in equity security without readily determinable fair value $ 0
Concentration of Credit Risk and Other Risks and Uncertainties [Abstract]  
Number of financial institutions holding company's cash | Institution 2
Stock-Based Compensation [Abstract]  
Option vesting term 4 years
Leases [Abstract]  
Operating lease discount rate using risk-free rate 8.50%
Minimum [Member]  
Property and Equipment [Abstract]  
Useful lives 5 years
Intangible Assets [Abstract]  
Estimated useful lives 3 years
Maximum [Member]  
Property and Equipment [Abstract]  
Useful lives 7 years
Intangible Assets [Abstract]  
Estimated useful lives 15 years
L2 Holdings LLC [Member]  
Investment in Equity Securities without Readily Determinable Fair Value [Abstract]  
Investment in equity security without readily determinable fair value $ 2,000
OP Media Inc. [Member]  
Investment in Equity Securities without Readily Determinable Fair Value [Abstract]  
Investment in equity security without readily determinable fair value $ 500
Highly Liquid Debt Investments [Member] | Maximum [Member]  
Investments [Abstract]  
Contractual maturities of investment securities 2 years
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Property and Equipment [Abstract]    
Property and equipment, gross $ 235 $ 171
Less accumulated depreciation (168) (160)
Property and equipment, net 67 11
Depreciation expense 9 7
Office Furniture [Member]    
Property and Equipment [Abstract]    
Property and equipment, gross 143 79
Computer Equipment [Member]    
Property and Equipment [Abstract]    
Property and equipment, gross $ 92 $ 92
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
Commitments, Contingencies and Related Party Transactions (Details) - K2 Investment Fund LLC [Member] - Aircraft [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Commitments, Contingencies and Related Party Transactions [Abstract]    
Rental fees incurred for use of aircraft $ 1,097 $ 1,123
Term of lease 12 months  
Rate of aircraft lease (in dollars per flight hour) $ 8  
Term of notice for cancellation of lease 30 days  
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock Plan (Details) - Amended and Restated Equity Incentive Plan [Member] - shares
1 Months Ended
Jun. 30, 2023
Dec. 31, 2023
Stock Plan [Abstract]    
Additional shares authorized (in shares) 175,000  
Shares available for grant (in shares)   225,778
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation, Information about Stock Options Outstanding (Details) - Stock Options [Member]
12 Months Ended
Dec. 31, 2023
$ / shares
shares
Information about Stock Options Outstanding [Abstract]  
Options outstanding, number outstanding (in shares) | shares 330,017
Options outstanding, weighted average remaining contractual life 4 years 11 months 23 days
Options outstanding, weighted average exercise price (in dollars per share) $ 90.63
Options vested and exercisable, number exercisable (in shares) | shares 282,637
Options vested and exercisable, weighted average remaining contractual life 4 years 5 months 26 days
Options vested and exercisable, weighted average exercise price (in dollars per share) $ 95.7
$10.00 - 31.60 [Member]  
Information about Stock Options Outstanding [Abstract]  
Exercise price range, lower range limit (in dollars per share) 10
Exercise price range, upper range limit (in dollars per share) $ 31.6
Options outstanding, number outstanding (in shares) | shares 41,925
Options outstanding, weighted average remaining contractual life 8 years 5 months 12 days
Options outstanding, weighted average exercise price (in dollars per share) $ 28.67
Options vested and exercisable, number exercisable (in shares) | shares 17,519
Options vested and exercisable, weighted average remaining contractual life 8 years 5 months 12 days
Options vested and exercisable, weighted average exercise price (in dollars per share) $ 28.16
$34.80 - 139.00 [Member]  
Information about Stock Options Outstanding [Abstract]  
Exercise price range, lower range limit (in dollars per share) 34.8
Exercise price range, upper range limit (in dollars per share) $ 139
Options outstanding, number outstanding (in shares) | shares 275,217
Options outstanding, weighted average remaining contractual life 4 years 7 months 28 days
Options outstanding, weighted average exercise price (in dollars per share) $ 90.31
Options vested and exercisable, number exercisable (in shares) | shares 252,243
Options vested and exercisable, weighted average remaining contractual life 4 years 5 months 1 day
Options vested and exercisable, weighted average exercise price (in dollars per share) $ 90
$290.40 - 308.00 [Member]  
Information about Stock Options Outstanding [Abstract]  
Exercise price range, lower range limit (in dollars per share) 290.4
Exercise price range, upper range limit (in dollars per share) $ 308
Options outstanding, number outstanding (in shares) | shares 12,875
Options outstanding, weighted average remaining contractual life 5 months 26 days
Options outstanding, weighted average exercise price (in dollars per share) $ 304.24
Options vested and exercisable, number exercisable (in shares) | shares 12,875
Options vested and exercisable, weighted average remaining contractual life 5 months 26 days
Options vested and exercisable, weighted average exercise price (in dollars per share) $ 304.24
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation, Summary of Stock Option Activity (Details) - Stock Options [Member] - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Options, number of shares [Roll Forward]    
Outstanding, beginning of period (in shares) 340,798 319,868
Options granted (in shares) 1,875 40,050
Options exercised (in shares) 0 0
Options cancelled (in shares) (12,656) (19,120)
Outstanding, end of period (in shares) 330,017 340,798
Options exercisable, end of period (in shares) 282,637  
Options, weighted average exercise price [Roll Forward]    
Outstanding, beginning of period (in dollars per share) $ 106.6 $ 139.8
Options granted (in dollars per share) 10 29.6
Options exercised (in dollars per share) 0 0
Options cancelled (in dollars per share) 510.21 501.2
Outstanding, end of period (in dollars per share) 90.63 $ 106.6
Options exercisable, end of period (in dollars per share) $ 95.7  
Options, additional disclosures [Abstract]    
Options outstanding, weighted average remaining contractual life 4 years 11 months 23 days  
Options exercisable, weighted average remaining contractual life 4 years 5 months 26 days  
Options outstanding, aggregate intrinsic value $ 0 $ 0
Options exercisable, aggregate intrinsic value $ 0  
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation, Summary of Restricted Stock Units and Restricted Stock Awards Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation [Abstract]      
Per share market price of common stock on last trading day of year (in dollars per share) $ 7    
Restricted Stock Units (RSUs) [Member]      
Number of Shares [Roll Forward]      
Outstanding, beginning of period (in shares) 27,605 25,457  
Granted (in shares) 1,250 12,918  
Vested (in shares) (11,405) (10,770)  
Cancelled (in shares) 0 0  
Outstanding, end of period (in shares) 17,450 27,605  
Weighted Average Grant Date Fair Value [Abstract]      
Outstanding, beginning of period (in dollars per share) $ 73 $ 107.8  
Granted (in dollars per share) 10 29.2  
Vested (in dollars per share) 83.81 103  
Cancelled (in dollars per share) 0 0  
Outstanding, end of period (in dollars per share) $ 60.81 $ 73  
Aggregate Intrinsic Value [Abstract]      
Outstanding, end of period $ 0 $ 0 $ 0
Restricted Stock [Member]      
Number of Shares [Roll Forward]      
Outstanding, beginning of period (in shares) 0    
Granted (in shares) 36,927    
Vested (in shares) (3,617)    
Cancelled (in shares) (604)    
Outstanding, end of period (in shares) 32,706 0  
Weighted Average Grant Date Fair Value [Abstract]      
Outstanding, beginning of period (in dollars per share) $ 0    
Granted (in dollars per share) 9.12    
Vested (in dollars per share) 9.19    
Cancelled (in dollars per share) 9.6    
Outstanding, end of period (in dollars per share) $ 9.11 $ 0  
Aggregate Intrinsic Value [Abstract]      
Outstanding, end of period $ 0 $ 0  
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation, Stock-Based Compensation by Type of Award (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation [Abstract]    
Stock-based compensation expense $ 2,778 $ 3,330
Compensation cost not yet recognized [Abstract]    
Unrecognized stock-based compensation expense expected to be recognized related to stock awards 3,006  
Operating Expense [Member]    
Share-based Compensation [Abstract]    
Stock-based compensation expense 2,778 3,330
Stock Options [Member]    
Compensation cost not yet recognized [Abstract]    
Unrecognized stock-based compensation expense expected to be recognized related to unvested stock options $ 2,025  
Weighted-average period for recognition of unrecognized stock-based compensation expense 1 year 9 months 18 days  
Stock Options [Member] | Operating Expense [Member]    
Share-based Compensation [Abstract]    
Stock-based compensation expense $ 1,960 2,303
RSUs [Member]    
Compensation cost not yet recognized [Abstract]    
Unrecognized stock-based compensation expense expected to be recognized related to unvested stock awards $ 683  
Weighted-average period for recognition of unrecognized stock-based compensation expense 1 year 8 months 26 days  
RSUs [Member] | Operating Expense [Member]    
Share-based Compensation [Abstract]    
Stock-based compensation expense $ 778 $ 1,027
Restricted Stock [Member]    
Compensation cost not yet recognized [Abstract]    
Unrecognized stock-based compensation expense expected to be recognized related to unvested stock awards $ 298  
Weighted-average period for recognition of unrecognized stock-based compensation expense 3 years 6 months 14 days  
Restricted Stock [Member] | Operating Expense [Member]    
Share-based Compensation [Abstract]    
Stock-based compensation expense $ 40  
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation, Fair Value Assumptions Used (Details) - Stock Options [Member] - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Fair value assumptions used in estimating fair value of each option grant [Abstract]    
Expected stock price volatility 81.39% 85.39%
Risk-free interest rate 3.90% 3.09%
Expected life term 5 years 6 months 6 years 2 months 12 days
Expected dividends 0.00% 0.00%
Options granted, weighted average grant date fair value (in dollars per share) $ 6.96 $ 21.77
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Calculation of basic and diluted loss per share [Abstract]    
Net (loss) $ (27,871) $ (36,260)
Basic weighted average number of shares outstanding (in shares) 3,579 3,565
Effect of dilutive securities (in shares) 0 0
Diluted weighted average number of shares outstanding (in shares) 3,579 3,565
Basic (loss) per share (in dollars per share) $ (7.79) $ (10.17)
Diluted (loss) per share (in dollars per share) $ (7.79) $ (10.17)
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock, Summary (Details)
12 Months Ended
Oct. 25, 2023
Dec. 31, 2023
Vote
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Common Stock [Abstract]      
Common stock, shares authorized (in shares) | shares   100,000,000 100,000,000
Common stock, par value (in dollars per share)   $ 0.0001 $ 0.0001
Reverse stock split ratio 0.05    
Dividend [Abstract]      
Dividends per share (in dollars per share)   $ 20 $ 0
Common Stock [Member]      
Common Stock [Abstract]      
Number of votes entitled to each share of common stock | Vote   1  
Common stock, shares authorized (in shares) | shares   100,000,000  
Common stock, par value (in dollars per share)   $ 0.0001  
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock, Warrants (Details) - Warrants [Member] - Warrants Issued in 2020 [Member] - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2020
Warrants [Abstract]      
Weighted average fair value of warrants at grant date (in dollars per share)     $ 83.2
Dividend yield     0.00%
Expected stock price volatility     97.00%
Risk-free interest rate     0.27%
Expected option term     5 years
Warrants issued (in shares)   1,250 1,250
Exercise price (in dollars per share)   $ 115 $ 115
Outstanding and Exercisable (in shares) 1,250    
Issued (in shares) 0    
Exercised (in shares) 0    
Terminated/ cancelled (in shares) 0    
Outstanding and Exercisable (in shares) 1,250 1,250  
Expiration date Apr. 30, 2025    
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Employee Benefit Plan (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Employee Benefit Plan [Abstract]    
Matching contribution to defined contribution plan $ 229 $ 179
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes, Components of Provision (Benefit) for Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Current [Abstract]    
Federal $ 0 $ 0
State 2 3
Foreign 0 0
Current income tax provision (benefit) 2 3
Deferred [Abstract]    
Federal (79) 15,920
State (2) 109
Deferred income tax provision (benefit) (81) 16,029
Total income tax (benefit) provision $ (79) $ 16,032
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes, Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Effective Tax Rate Reconciliation [Abstract]    
United States federal statutory rate 21.00% 21.00%
State taxes, net of federal benefit (0.01%) (0.55%)
Valuation allowance (20.31%) (91.21%)
Stock based compensation (0.58%) (9.44%)
R&D Credit 2.20% 1.22%
Other (2.03%) (0.29%)
Effective income tax rate 0.28% (79.27%)
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes, Components of Deferred Tax Assets (Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets [Abstract]    
Reserves and accruals $ 65 $ 147
Research and development credits and other credits 1,110 430
Net operating loss carry forward 15,262 11,988
Stock based compensation 4,360 5,018
Other 2,382 970
Total deferred tax assets 23,179 18,553
Valuation allowance (23,179) (18,553)
Deferred tax assets after valuation allowance 0 0
Total deferred tax liability - depreciation and amortization 0 0
Net deferred tax assets $ 0 $ 0
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes, Pre-tax Income (Losses) and Operating Loss Carryforwards (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Taxes [Abstract]    
Capitalized direct and indirect research and development costs $ 8,599 $ 5,140
Amortization of capitalized direct and indirect research and development costs 1,888 $ 514
Unamortized capitalized direct and indirect research and development costs 11,337  
Deferred tax assets relating to capitalized direct and indirect research and development costs 2,381  
Federal [Member]    
Income Taxes [Abstract]    
Net operating loss carryforwards 72,645  
State [Member]    
Income Taxes [Abstract]    
Net operating loss carryforwards $ 109,435  
Operating loss carryforwards, expiration date Dec. 31, 2029  
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes, Income Tax Uncertainties (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
Income Taxes [Abstract]  
Uncertain tax positions $ 0
Accrued interest and penalties $ 0
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value Measurement (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Adjusted Cost $ 53,538 $ 152,400
Fair Value $ 53,547 152,023
Minimum [Member]    
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Maturities of investments 1 year  
Maximum [Member]    
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Maturities of investments 2 years  
Cash [Member]    
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Adjusted Cost $ 1,452 16,949
Fair Value 1,452 16,949
Total Investment Securities [Member]    
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Adjusted Cost 52,086 135,451
Unrealized Gains 27 9
Unrealized Losses (18) (386)
Fair Value 52,095 135,074
Mutual Funds [Member]    
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Adjusted Cost 20,040 66,493
Unrealized Gains 0 0
Unrealized Losses 0 0
Fair Value 20,040 66,493
U.S. Agency and Treasury Securities [Member]    
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Adjusted Cost 32,046 68,958
Unrealized Gains 27 9
Unrealized Losses (18) (386)
Fair Value 32,055 68,581
Recurring [Member]    
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Cash and Cash Equivalents 26,289 86,561
Investments Available for Sale 27,258 65,462
Recurring [Member] | Cash [Member]    
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Cash and Cash Equivalents 1,452 16,949
Recurring [Member] | Level 1 [Member] | Total Investment Securities [Member]    
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Cash and Cash Equivalents 24,837 69,612
Investments Available for Sale 27,258 65,462
Recurring [Member] | Level 1 [Member] | Mutual Funds [Member]    
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Cash and Cash Equivalents 20,040 66,493
Investments Available for Sale 0 0
Recurring [Member] | Level 1 [Member] | U.S. Agency and Treasury Securities [Member]    
Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]    
Cash and Cash Equivalents 4,797 3,119
Investments Available for Sale $ 27,258 $ 65,462
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
Litigation (Details)
$ in Thousands
Apr. 07, 2023
Sep. 25, 2020
Appeal
Nov. 06, 2012
USD ($)
$ / Device
VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 23-1765) [Member]      
Litigation [Abstract]      
Opening brief due period 60 days    
Positive Outcome of Litigation [Member] | VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) ("Apple II") [Member]      
Litigation [Abstract]      
Amount of damages awarded in patent infringement case | $     $ 502,600
Royalty rate per device used in calculating infringement damages | $ / Device     1.2
Positive Outcome of Litigation [Member] | VirnetX Inc. v. The Mangrove Partners (Case 20-2271 and Case 20-2272) ("Consolidated Appeal") [Member]      
Litigation [Abstract]      
Number of appeals consolidated | Appeal   2  
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases, Summary (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Oct. 31, 2023
Leases [Abstract]      
Period of free rent 6 months    
Office [Member]      
Leases [Abstract]      
Operating lease monthly payment $ 4,600    
Operating lease ROU assets 93,000   $ 102,000
Operating lease liability 93,000   102,000
Lease expense $ 55,000 $ 54,000  
Operating lease weighted average remaining life 5 years    
Facility [Member]      
Leases [Abstract]      
Operating lease monthly payment $ 72,000    
Operating lease ROU assets 3,479,000   3,587,000
Operating lease liability 3,546,000   $ 3,587,000
Lease expense $ 140,000    
Operating lease weighted average remaining life 5 years    
Corporate Promotional and Marketing Facility [Member]      
Leases [Abstract]      
Operating lease ROU assets $ 349,000 648,000  
Lease expense $ 300,000 300,000  
Lease renewal period 10 years    
Operating lease, single payment $ 6,000,000    
Operating lease, annual payments for lease extension 600,000    
Operating lease, commitment 7,500,000    
Aircraft [Member] | K2 Investment Fund LLC [Member]      
Leases [Abstract]      
Rental fees incurred for use of aircraft $ 1,097,000 $ 1,123,000  
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases, Lease Liability (Details) - Office and Facility [Member]
$ in Thousands
Dec. 31, 2023
USD ($)
Future Minimum Rents Due [Abstract]  
Due in 2024 $ 494
Due in 2025 946
Due in 2026 927
Due in 2027 954
Due in 2028 983
Thereafter 336
Total undiscounted lease liability 4,640
Less: imputed interest (1,001)
Total lease liability $ 3,639
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Subsequent Event (Details) - Restricted Stock [Member] - shares
1 Months Ended 12 Months Ended
Jan. 31, 2024
Dec. 31, 2023
Subsequent Events [Abstract]    
Number of restricted stock issued (in shares)   36,927
Subsequent Event [Member] | Amended and Restated Equity Incentive Plan [Member]    
Subsequent Events [Abstract]    
Number of restricted stock issued (in shares) 71,000  
EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�V2G?-_H7YS%]J,(F]PD0]H/#8*KN%D4R5*;NMNT/ MUFR5IL+62E,YY X?27-;].'-I3D;M2)W0-AU1UG!1:ILB%(NJ3C%$U9 ZL Y MGIB0*'!G/ 2*S '>3*=,"QW\R%RT42,2$+ZY7^KU0$RR.J]YBIP(&08PS)R# MZ!\F;0:_TP?>"./>(IN,]7?#0>/4^& R*^N;,ZJ%#,**<6B/C78_0,>L1Z@N!Z.O5$>24 :_P_7PX, M7GC^=,G+9V,X!K@PD@%@ =%>D0E3^=MJ^@4"_EL*'!IP]'?K4Q0A.Y_&A#]_ M^U3I9_E,#-!F8%).*)OZ(&GE2!Q:EY,KH .+!N6BEB@J,V&8FL@J ]>#^-I M=31)1TF6A\ '(._JR17X7 (8DHY18M_F8O"_$XRL3[U=A;97ZIYE+ ECZ6D\ M!JC4)>IMX0U$9(6)%.\:P%S,0.';%-=3C?$PF.I_)FF<8?H-X@6V.:[YA[-* M)&K,$+G6\\H=64 "%)G%O+S1*YDU@\^ZQR< M6?\J%WD1+YAZRLF:GO)IY'8&8:7[IESC-^A%*YGIXH-H@ZITS)P!QA/_PIX=/V&!;9=^P:3F!H[C0V59I)6S[ MM)+3\H+,JNIY#IZW;Q?Z6K[FFB?9#>S5GN3R\,4*#_@FLYF>36B:5>"L]F\7 MYT#F3*"I6[+U)F,%@C5-QSV9BZ5I1_U]&8MESHI7FE=KC%-#^YK-6!NL\

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�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end XML 79 ef20015315_10k_htm.xml IDEA: XBRL DOCUMENT 0001082324 2023-01-01 2023-12-31 0001082324 2023-06-30 0001082324 2024-03-08 0001082324 2022-12-31 0001082324 2023-12-31 0001082324 2022-01-01 2022-12-31 0001082324 us-gaap:RetainedEarningsMember 2021-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001082324 vhc:CommonStockAndAdditionalPaidInCapitalMember 2021-12-31 0001082324 us-gaap:RetainedEarningsMember 2022-12-31 0001082324 vhc:CommonStockAndAdditionalPaidInCapitalMember 2022-12-31 0001082324 2021-12-31 0001082324 vhc:CommonStockAndAdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001082324 vhc:CommonStockAndAdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001082324 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001082324 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001082324 us-gaap:RetainedEarningsMember 2023-12-31 0001082324 vhc:CommonStockAndAdditionalPaidInCapitalMember 2023-12-31 0001082324 2023-10-01 2023-12-31 0001082324 us-gaap:PatentsMember us-gaap:NonUsMember 2023-12-31 0001082324 us-gaap:PatentsMember 2023-12-31 0001082324 us-gaap:PatentsMember country:US 2023-12-31 0001082324 srt:MaximumMember us-gaap:DebtSecuritiesMember 2023-01-01 2023-12-31 0001082324 vhc:L2HoldingsLLCMember 2023-12-31 0001082324 vhc:OPMediaMember 2023-12-31 0001082324 srt:MaximumMember 2023-12-31 0001082324 srt:MinimumMember 2023-12-31 0001082324 us-gaap:ComputerEquipmentMember 2023-12-31 0001082324 us-gaap:OfficeEquipmentMember 2023-12-31 0001082324 us-gaap:ComputerEquipmentMember 2022-12-31 0001082324 us-gaap:OfficeEquipmentMember 2022-12-31 0001082324 vhc:K2InvestmentFundLLCMember us-gaap:AirTransportationEquipmentMember 2022-01-01 2022-12-31 0001082324 vhc:K2InvestmentFundLLCMember us-gaap:AirTransportationEquipmentMember 2023-01-01 2023-12-31 0001082324 vhc:K2InvestmentFundLLCMember us-gaap:AirTransportationEquipmentMember 2023-12-31 0001082324 vhc:AmendedAndRestatedEquityIncentivePlanMember 2023-06-01 2023-06-30 0001082324 vhc:AmendedAndRestatedEquityIncentivePlanMember 2023-12-31 0001082324 us-gaap:EmployeeStockOptionMember vhc:ExercisePriceRange3Member 2023-01-01 2023-12-31 0001082324 us-gaap:EmployeeStockOptionMember vhc:ExercisePriceRange1Member 2023-01-01 2023-12-31 0001082324 us-gaap:EmployeeStockOptionMember vhc:ExercisePriceRange2Member 2023-01-01 2023-12-31 0001082324 us-gaap:EmployeeStockOptionMember vhc:ExercisePriceRange3Member 2023-12-31 0001082324 us-gaap:EmployeeStockOptionMember vhc:ExercisePriceRange2Member 2023-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2023-12-31 0001082324 us-gaap:EmployeeStockOptionMember vhc:ExercisePriceRange1Member 2023-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2021-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2022-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001082324 us-gaap:RestrictedStockMember 2022-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001082324 us-gaap:RestrictedStockMember 2023-01-01 2023-12-31 0001082324 us-gaap:RestrictedStockMember 2023-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember us-gaap:OperatingExpenseMember 2023-01-01 2023-12-31 0001082324 us-gaap:EmployeeStockOptionMember us-gaap:OperatingExpenseMember 2022-01-01 2022-12-31 0001082324 us-gaap:EmployeeStockOptionMember us-gaap:OperatingExpenseMember 2023-01-01 2023-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember us-gaap:OperatingExpenseMember 2022-01-01 2022-12-31 0001082324 us-gaap:RestrictedStockMember us-gaap:OperatingExpenseMember 2023-01-01 2023-12-31 0001082324 us-gaap:OperatingExpenseMember 2023-01-01 2023-12-31 0001082324 us-gaap:OperatingExpenseMember 2022-01-01 2022-12-31 0001082324 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001082324 us-gaap:CommonStockMember 2023-12-31 0001082324 2023-10-25 2023-10-25 0001082324 vhc:WarrantIssuanceDate2Member us-gaap:WarrantMember 2020-12-31 0001082324 vhc:WarrantIssuanceDate2Member us-gaap:WarrantMember 2020-01-01 2020-12-31 0001082324 vhc:WarrantIssuanceDate2Member us-gaap:WarrantMember 2022-12-31 0001082324 vhc:WarrantIssuanceDate2Member us-gaap:WarrantMember 2023-01-01 2023-12-31 0001082324 vhc:WarrantIssuanceDate2Member us-gaap:WarrantMember 2023-12-31 0001082324 us-gaap:DomesticCountryMember 2023-12-31 0001082324 us-gaap:StateAndLocalJurisdictionMember 2023-12-31 0001082324 us-gaap:StateAndLocalJurisdictionMember 2023-01-01 2023-12-31 0001082324 us-gaap:MutualFundMember 2022-12-31 0001082324 us-gaap:AvailableforsaleSecuritiesMember 2022-12-31 0001082324 us-gaap:MutualFundMember 2023-12-31 0001082324 us-gaap:CashMember 2022-12-31 0001082324 us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001082324 us-gaap:AvailableforsaleSecuritiesMember 2023-12-31 0001082324 us-gaap:CashMember 2023-12-31 0001082324 us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001082324 us-gaap:CashMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001082324 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001082324 us-gaap:MutualFundMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001082324 us-gaap:AvailableforsaleSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001082324 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001082324 us-gaap:CashMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001082324 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001082324 us-gaap:MutualFundMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001082324 srt:MaximumMember 2023-01-01 2023-12-31 0001082324 srt:MinimumMember 2023-01-01 2023-12-31 0001082324 vhc:VirnetXIncVAppleIncCase612CV00855LEDAppleIIMember us-gaap:PositiveOutcomeOfLitigationMember 2012-11-06 2012-11-06 0001082324 vhc:VirnetXIncVTheMangrovePartnersCase202271AndCase202272ConsolidatedAppealMember us-gaap:PositiveOutcomeOfLitigationMember 2020-09-25 2020-09-25 0001082324 vhc:VirnetXIncVCiscoSystemsIncUSCAFCCase231765Member 2023-04-07 2023-04-07 0001082324 vhc:OfficeMember 2023-01-01 2023-12-31 0001082324 vhc:FacilityMember 2023-01-01 2023-12-31 0001082324 vhc:PromotionalAndMarketingMember 2023-12-31 0001082324 vhc:OfficeMember 2023-12-31 0001082324 vhc:FacilityMember 2023-12-31 0001082324 vhc:OfficeMember 2023-10-31 0001082324 vhc:PromotionalAndMarketingMember 2022-12-31 0001082324 vhc:FacilityMember 2023-10-31 0001082324 vhc:PromotionalAndMarketingMember 2022-01-01 2022-12-31 0001082324 vhc:PromotionalAndMarketingMember 2023-01-01 2023-12-31 0001082324 vhc:OfficeMember 2022-01-01 2022-12-31 0001082324 vhc:OfficeAndFacilityMember 2023-12-31 0001082324 us-gaap:RestrictedStockMember vhc:AmendedAndRestatedEquityIncentivePlanMember us-gaap:SubsequentEventMember 2024-01-01 2024-01-31 iso4217:USD shares iso4217:USD shares vhc:Patent vhc:Institution pure vhc:Vote iso4217:USD vhc:Device vhc:Appeal false --12-31 2023 FY 0001082324 P5Y 0.05 P1Y 223 2025-04-30 2029-12-31 10-K true 2023-12-31 false 001-33852 VirnetX Holding Corp DE 77-0390628 308 Dorla Court Suite 206 Zephyr Cove NV 89448 775 548-1785 Common Stock, par value $0.0001 per share VHC NYSE No No Yes Yes Non-accelerated Filer false true false false false 29557799 3681970 Farber Hass Hurley LLP Chatsworth, California 26289000 86561000 27258000 65462000 2000 14000 282000 224000 53831000 152261000 4014000 703000 67000 11000 2500000 0 60412000 152975000 440000 373000 316000 311000 498000 47000 1254000 731000 3145000 0 4399000 731000 0.0001 0.0001 10000000 10000000 0 0 0 0 0 0 0.0001 0.0001 100000000 100000000 3618431 3618431 3571232 3571232 0 0 242520000 239753000 -186495000 -87195000 -12000 -314000 56013000 152244000 60412000 152975000 7000 48000 0 -4000 9713000 6406000 21739000 15722000 31452000 22124000 -31445000 -22076000 3495000 1848000 -27950000 -20228000 -79000 16032000 -27871000 -36260000 -7.79 -10.17 -7.79 -10.17 3579 3565 3579 3565 -27871000 -36260000 306000 -246000 -4000 0 302000 -246000 -27569000 -36506000 152244000 185449000 239753000 236452000 11000 29000 2778000 3330000 242520000 239753000 -87195000 -50935000 -27871000 -36260000 71429000 0 -186495000 -87195000 -314000 -68000 306000 -246000 -4000 0 -12000 -314000 56013000 152244000 20 0 -27871000 -36260000 9000 7000 2778000 3330000 15000 0 0 -16032000 3369000 -331000 67000 35000 3596000 -54000 5000 41000 0 -355000 3000 -3000 0 3000 -24773000 -16893000 65000 0 2500000 0 47215000 67070000 85721000 28535000 35941000 -38535000 71429000 0 11000 29000 -71440000 -29000 -60272000 -55457000 86561000 142018000 26289000 86561000 0 2000 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 1 − Formation and Business of the Company</div> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">VirnetX Holding Corporation, which we refer to as “we”, “us”, “our”, “the Company” or “VirnetX”, is engaged in the business of commercializing a portfolio of patents. We seek to derive revenue from selling our software products including VirnetX War Room™ and VirnetX Matrix™ and licensing our technology, including VirnetX One™, and our secure domain name technology GABRIEL Connection Technology™, to various original equipment manufacturers (“OEMs”) and others, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence, and unified communications markets or who seek to secure their systems and applications.<br/> </div> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 205 total patents and pending applications, including 72 U.S. patents/patent applications and 133 foreign patents/validations/pending applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security. The subject matter of all our U.S and foreign patents and pending applications relates generally to securing communications over the Internet and such covers all our technology and other products. Some of our issued U.S. and foreign patents expire at various times during the period from 2023 to 2034.</div> 205 72 133 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 2 − Summary of Significant Accounting Policies</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. The critical accounting policies we employ in the preparation of our consolidated financial statements are those which involve impairment of long-lived assets, income taxes, fair value of financial instruments and stock-based compensation.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</div> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We prepare our consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the Audit Committee of our Board of Directors.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Basis of Consolidation</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Revenue Recognition</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company derives revenue from licensing and royalty fees from contracts with customers which often span several years. We account for this revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements, with revenue for each unit of accounting recognized as the product or service is delivered to the customer.</div> <div><br/></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">With the<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> </span>licensing of our patents, performance obligations are generally satisfied at a point in time as work is complete when our patent rights are transferred to our customers. We generally have no further obligation to our customers regarding our technology.</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Certain contracts may require our customers to enter into a hosting arrangement with us and for these arrangements, revenue is recognized over time, generally over the life of the servicing contract.</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company actively monitors and enforces its intellectual property (“IP”) rights, including seeking appropriate compensation from third parties that utilize the Company’s IP without a license. As a result, the Company may, from time to time, receive payments as part of a settlement or compensation for a patent infringement dispute. Proceeds received are allocated to each element identified in the settlement or compensation, based on the fair value of each element. Generally, settlements and compensation may include the following elements: the value of a license or royalty agreement, cost reimbursement, damages, and interest. Elements identified related to licensing and royalty are recognized as revenue. Elements identified as reimbursed costs are generally recorded as a reduction to the reported expenses. Elements identified as damages or interest are generally recorded in other income in the condensed consolidated statement of operations. <br/> </div> <div><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Licensing Costs</div> <div><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Included in operating expenses are licensing costs we incurred in conjunction with a patent infringement case.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Contingent Gains</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ASC Topic 450-30-25, Contingent Gains, prohibits recognition of contingent gains until realized. Accordingly, we do not record contingent gains ahead of such realization. Management generally considers any such gains as realized only upon the collection of cash.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Cash and Cash Equivalents</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Investments</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Investments classified as available-for-sale are recorded at fair market value. Unrealized gains and losses are reported as other comprehensive income. Realized gains and losses are recorded in income in the period they are realized using specific identification of each security’s cost basis. We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less than two years. By policy, we limit the amount of credit exposure to any one issuer.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">We have elected the investment measurement alternative for other investments without readily determinable fair values. During 2023, we invested $2,000 in L2 Holdings LLC and $500 in OP Media Inc. These investments are carried at our initial cost less any impairment, because we do not have the ability to exercise significant influence over operating and financial matters. For these investments, we adjust the carrying value for any purchases or sales of our ownership interests. Periodically, we evaluate these investments for impairment. If we identify an impairment, we reduce the carrying value for the impairment loss with a charge to earnings. We have not identified any impairment as of December 31, 2023.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentration of Credit Risk and Other Risks and Uncertainties</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. A portion of those balances are insured by the Federal Deposit Insurance Corporation, or FDIC. In 2023, we had, at times, funds that were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.</div> <div><br/></div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Fair Value</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Property and Equipment</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Property and equipment are stated at historical cost, less accumulated depreciation, and amortization. Depreciation and amortization are computed using the accelerated and straight-line methods over the estimated useful lives of the assets, which range from <span style="-sec-ix-hidden:Fact_73b8a865531b49549928b511fdbc21c9">five</span> to seven years. Repair and maintenance costs are charged to expense as incurred.</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Leases</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company determines if an arrangement is a lease at inception in accordance with ASC Topic 842. Operating lease right-of-use (“ROU”) assets are included in Prepaid expenses, and other assets on the Condensed Consolidated Balance Sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term, using the risk-free rate, U.S. prime rate, of 8.5% in 2023. </span> </div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Intangible Assets</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are deemed impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Research and Development</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff. Research and development costs are expensed as incurred.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Income Taxes</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We account for income taxes using the asset and liability method. The asset and liability method requires the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing our deferred tax assets, we consider whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The 2017 U.S. Tax Cuts and Jobs Act changes IRC Section 174, regarding capitalization of book research and development (“R&amp;D”) expenses for income tax purposes.  Effective for tax years beginning in 2022 IRC Section 174 requires the capitalization of book R&amp;D expenses which are capitalized and amortized over 5 years for domestic R&amp;D expenses and over 15 years for foreign R&amp;D expenses.  To date there has been limited guidance from the IRS on how to quantify the amount of book R&amp;D expenses subject to capitalization, including the indirect expenses supporting the R&amp;D function.  Due to the limited guidance, some assumptions were made in our estimates.</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We account for our uncertain tax positions in accordance with U.S. GAAP, which utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Stock-Based Compensation</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs on a straight-line basis over the requisite service period of the award, which is generally a vesting term of 4 years. We recognize forfeitures, if any, when they occur. In addition, we record stock-based compensation expense for awards granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued, as they vest, over the performance period (See Note 6 - Stock-Based Compensation).</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/></div> <div><span style="font-style: italic; font-weight: bold;"><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Earnings per Share </span> </span> </div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.</div> <div><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">New Accounting Pronouncements</div> <div><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregated information about an entity’s effective tax rate reconciliation as well as information on income tax paid. The guidance in this ASU is effective for public companies with annual periods beginning after December 15, 2024. We plan to adopt the guidance for the fiscal year ending December 31, 2025. We are currently evaluating the effect adoption of this ASU will have on our consolidated financial statements.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</div> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We prepare our consolidated financial statements in accordance with U.S. GAAP. In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the Audit Committee of our Board of Directors.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Basis of Consolidation</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Revenue Recognition</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company derives revenue from licensing and royalty fees from contracts with customers which often span several years. We account for this revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements, with revenue for each unit of accounting recognized as the product or service is delivered to the customer.</div> <div><br/></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">With the<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> </span>licensing of our patents, performance obligations are generally satisfied at a point in time as work is complete when our patent rights are transferred to our customers. We generally have no further obligation to our customers regarding our technology.</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Certain contracts may require our customers to enter into a hosting arrangement with us and for these arrangements, revenue is recognized over time, generally over the life of the servicing contract.</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company actively monitors and enforces its intellectual property (“IP”) rights, including seeking appropriate compensation from third parties that utilize the Company’s IP without a license. As a result, the Company may, from time to time, receive payments as part of a settlement or compensation for a patent infringement dispute. Proceeds received are allocated to each element identified in the settlement or compensation, based on the fair value of each element. Generally, settlements and compensation may include the following elements: the value of a license or royalty agreement, cost reimbursement, damages, and interest. Elements identified related to licensing and royalty are recognized as revenue. Elements identified as reimbursed costs are generally recorded as a reduction to the reported expenses. Elements identified as damages or interest are generally recorded in other income in the condensed consolidated statement of operations. <br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Licensing Costs</div> <div><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Included in operating expenses are licensing costs we incurred in conjunction with a patent infringement case.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Contingent Gains</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ASC Topic 450-30-25, Contingent Gains, prohibits recognition of contingent gains until realized. Accordingly, we do not record contingent gains ahead of such realization. Management generally considers any such gains as realized only upon the collection of cash.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Cash and Cash Equivalents</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Investments</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Investments classified as available-for-sale are recorded at fair market value. Unrealized gains and losses are reported as other comprehensive income. Realized gains and losses are recorded in income in the period they are realized using specific identification of each security’s cost basis. We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less than two years. By policy, we limit the amount of credit exposure to any one issuer.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">We have elected the investment measurement alternative for other investments without readily determinable fair values. During 2023, we invested $2,000 in L2 Holdings LLC and $500 in OP Media Inc. These investments are carried at our initial cost less any impairment, because we do not have the ability to exercise significant influence over operating and financial matters. For these investments, we adjust the carrying value for any purchases or sales of our ownership interests. Periodically, we evaluate these investments for impairment. If we identify an impairment, we reduce the carrying value for the impairment loss with a charge to earnings. We have not identified any impairment as of December 31, 2023.</div> P2Y 2000000 500000 0 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentration of Credit Risk and Other Risks and Uncertainties</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. A portion of those balances are insured by the Federal Deposit Insurance Corporation, or FDIC. In 2023, we had, at times, funds that were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.</div> 2 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Fair Value</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Property and Equipment</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Property and equipment are stated at historical cost, less accumulated depreciation, and amortization. Depreciation and amortization are computed using the accelerated and straight-line methods over the estimated useful lives of the assets, which range from <span style="-sec-ix-hidden:Fact_73b8a865531b49549928b511fdbc21c9">five</span> to seven years. Repair and maintenance costs are charged to expense as incurred.</div> P7Y <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Leases</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company determines if an arrangement is a lease at inception in accordance with ASC Topic 842. Operating lease right-of-use (“ROU”) assets are included in Prepaid expenses, and other assets on the Condensed Consolidated Balance Sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term, using the risk-free rate, U.S. prime rate, of 8.5% in 2023. </span> </div> 0.085 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Intangible Assets</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.</div> P3Y P15Y <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are deemed impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Research and Development</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff. Research and development costs are expensed as incurred.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Income Taxes</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We account for income taxes using the asset and liability method. The asset and liability method requires the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing our deferred tax assets, we consider whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.</div> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The 2017 U.S. Tax Cuts and Jobs Act changes IRC Section 174, regarding capitalization of book research and development (“R&amp;D”) expenses for income tax purposes.  Effective for tax years beginning in 2022 IRC Section 174 requires the capitalization of book R&amp;D expenses which are capitalized and amortized over 5 years for domestic R&amp;D expenses and over 15 years for foreign R&amp;D expenses.  To date there has been limited guidance from the IRS on how to quantify the amount of book R&amp;D expenses subject to capitalization, including the indirect expenses supporting the R&amp;D function.  Due to the limited guidance, some assumptions were made in our estimates.</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We account for our uncertain tax positions in accordance with U.S. GAAP, which utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Stock-Based Compensation</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs on a straight-line basis over the requisite service period of the award, which is generally a vesting term of 4 years. We recognize forfeitures, if any, when they occur. In addition, we record stock-based compensation expense for awards granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued, as they vest, over the performance period (See Note 6 - Stock-Based Compensation).</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> P4Y <div><span style="font-style: italic; font-weight: bold;"><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Earnings per Share </span> </span> </div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">New Accounting Pronouncements</div> <div><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregated information about an entity’s effective tax rate reconciliation as well as information on income tax paid. The guidance in this ASU is effective for public companies with annual periods beginning after December 15, 2024. We plan to adopt the guidance for the fiscal year ending December 31, 2025. We are currently evaluating the effect adoption of this ASU will have on our consolidated financial statements.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 3 − Property and Equipment</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Our major classes of property and equipment were as follows:</div> <div style="text-align: left;"><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Office furniture</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">143</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">79</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Computer equipment</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">92</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">92</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">235</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">171</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less accumulated depreciation</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(168</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(160</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total property and equipment, net</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">67</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Depreciation expense for 2023 and 2022 was $9 and $7, respectively.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Our major classes of property and equipment were as follows:</div> <div style="text-align: left;"><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Office furniture</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">143</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">79</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Computer equipment</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">92</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">92</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">235</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">171</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less accumulated depreciation</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(168</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(160</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total property and equipment, net</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">67</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 143000 79000 92000 92000 235000 171000 168000 160000 67000 11000 9000 7000 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 4 − Commitments, Contingencies and Related Party Transactions</div> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We have a service agreement for the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for our employees. We incurred approximately $1,097 and $1,123 in rental fees and reimbursements to the LLC in 2023 and 2022, respectively. We pay for the Company’s business usage of the aircraft and have no right to purchase. Our Chief Executive Officer and Chief Administrative Officer are the managing partners of the LLC and control the equity interests of the LLC. We entered into a 12-month non-exclusive agreement with the LLC for use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be cancelled by either us or the LLC with 30 days’ notice. The agreement renews on an annual basis unless terminated by either party. Neither party has exercised their termination rights. <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">See Note 13 for further discussion of our lease commitments. <br/> </div> 1097000 1123000 P12M 8000 P30D <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 5 − Stock Plan</div> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Our stockholders approved the Amended and Restated Equity Incentive Plan (the “A&amp;R Plan”) at our annual shareholders’ meeting in June 2023, which added 175,000 shares to the plan. Our prior plan expired March 29, 2023; no further awards will be made under the prior plan, and the A&amp;R Plan will govern awards granted under the prior plan. The A&amp;R Plan provides for the granting of stock options, restricted stock units (“RSUs”) and restricted stock. Options granted under the A&amp;R Plan are granted with an exercise price equal to the fair value of the of our stock on the date of grant. RSUs and restricted stock are granted at the fair value of our stock on the date of grant because they have no exercise price. The fair value of options, RSUs and restricted stock are expensed over the vesting periods. All options, RSUs and restricted stock are subject to forfeiture if service terminates prior to the shares vesting. At December 31, 2023, there were 225,778 shares available for grant under the A&amp;R Plan.</div> 175000 225778 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 6 − Stock-Based Compensation</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following tables summarize information and activity under the plan for the indicated periods.</div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td colspan="12" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Options Outstanding</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Options Vested and Exercisable </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Range of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Exercise Prices</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Remaining</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Contractual</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Life (Years)</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercise</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Price</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercisable</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Remaining</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Contractual</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Life (Years)</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercise</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Price</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF;" valign="bottom">$ 10.00 - 31.60</td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">41,925</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8.45</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$ <br/> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">28.67</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">17,519</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8.45</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$ <br/> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">28.16</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$ <span style="text-indent: 0pt;">34.80</span> -  <span style="text-indent: 0pt;">139.00</span> </div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">275,217</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.66</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">90.31</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">252,243</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.42</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">90.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$ <span style="text-indent: 0pt;">290.40</span> - <span style="text-indent: 0pt;">308.00</span> </div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,875</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.49</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">304.24</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,875</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.49</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">304.24</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">330,017</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.98</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">90.63</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">282,637</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.49</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">95.70</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><br/></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="14" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Options</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercise</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Price</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Remaining</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Contractual</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Life (Years)</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Aggregate</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Intrinsic</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2021</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">319,868</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">139.80</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options granted</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">40,050</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">29.60</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options exercised</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options cancelled</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(19,120</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">501.20</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2022</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">340,798</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">106.60</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options granted</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,875</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options exercised</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options cancelled</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(12,656</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">510.21</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2023</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">330,017</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">90.63</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.98</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; padding-bottom: 4px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options exercisable, December 31, <span style="text-indent: 0pt;">2023</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">282,637</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">95.70</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.49</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RSUs</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RSUs</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Grant Date</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fair Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Aggregate</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Intrinsic</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2021</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">25,457</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">107.80</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs granted</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,918</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">29.20</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs vested</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10,770</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">103.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs cancelled</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2022</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,605</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">73.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs granted</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,250</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs vested</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,405</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">83.81</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom">RSUs cancelled<br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">—</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">—</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">—</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2023</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">17,450</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">60.81</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><br/> </div> <div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted Stock</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> </div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted Stock</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Grant Date</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fair Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Aggregate</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Intrinsic</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Outstanding, December </span><span style="font-size: 10pt; font-family: 'Times New Roman';">31,</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span>2022</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock granted</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">36,927</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">9.12</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock vested</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">(3,617</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">9.19</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock cancelled</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">(604</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">9.60</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Outstanding, December </span><span style="font-size: 10pt; font-family: 'Times New Roman';">31,</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span>2023</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">32,706</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">9.11</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> </div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Intrinsic value is calculated as the difference between the per-share market price of our common stock on the last trading day of 2023, which was $7 and the exercise price of the awards. For awards exercised, the intrinsic value is the difference between market price and the exercise price on the date of exercise.<br/> </div> <div><br/></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Stock-based compensation expense is included in operating expense for each period as follows:</div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock-Based Compensation by Type of Award</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Stock options</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,960</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,303</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">778</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,027</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">Restricted stock<br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">40</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"><br/> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total stock-based compensation expense</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,778</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,330</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of December 31, 2023, there was $3,006 of unrecognized stock-based compensation expense; $2,025 related to unvested stock options, $683 related to unvested RSUs, and $298 related to unvested restricted stock. These costs are expected to be recognized over a weighted-average period of 1.8 years for options, 1.74 years for RSUs, and 3.54 years for restricted stock.</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions:</div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Expected stock price volatility</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">81.39</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">85.39</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Risk-free interest rate</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.9</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.09</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> </tr> <tr> <td style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Expected life term</div> </td> <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5.5 years</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.2 years</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Expected dividends</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> </tr> </table> <div><br/> </div> <div style="background-color: #FFFFFF; margin: 0px 0px 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $6.96 and $21.77 per share during 2023 and 2022, respectively.</span> The expected life was determined using the simplified method outlined in ASC 718, “<span style="font-style: italic;">Compensation - Stock Compensation</span>”. Expected volatility of the stock options was based upon historical data and other relevant factors.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following tables summarize information and activity under the plan for the indicated periods.</div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td colspan="12" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Options Outstanding</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Options Vested and Exercisable </div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Range of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Exercise Prices</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Remaining</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Contractual</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Life (Years)</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercise</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Price</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercisable</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Remaining</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Contractual</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Life (Years)</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercise</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Price</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF;" valign="bottom">$ 10.00 - 31.60</td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">41,925</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8.45</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$ <br/> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">28.67</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">17,519</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8.45</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$ <br/> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">28.16</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$ <span style="text-indent: 0pt;">34.80</span> -  <span style="text-indent: 0pt;">139.00</span> </div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">275,217</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.66</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">90.31</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">252,243</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.42</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">90.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$ <span style="text-indent: 0pt;">290.40</span> - <span style="text-indent: 0pt;">308.00</span> </div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,875</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.49</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">304.24</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,875</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.49</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">304.24</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">330,017</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.98</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">90.63</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">282,637</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.49</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">95.70</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 10 31.6 41925 P8Y5M12D 28.67 17519 P8Y5M12D 28.16 34.8 139 275217 P4Y7M28D 90.31 252243 P4Y5M1D 90 290.4 308 12875 P0Y5M26D 304.24 12875 P0Y5M26D 304.24 330017 P4Y11M23D 90.63 282637 P4Y5M26D 95.7 <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="14" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Options</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercise</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Price</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Remaining</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Contractual</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Life (Years)</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Aggregate</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Intrinsic</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2021</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">319,868</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">139.80</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options granted</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">40,050</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">29.60</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options exercised</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options cancelled</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(19,120</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">501.20</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2022</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">340,798</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">106.60</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options granted</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,875</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options exercised</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options cancelled</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(12,656</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">510.21</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2023</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">330,017</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">90.63</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.98</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 51.94%; padding-bottom: 4px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Options exercisable, December 31, <span style="text-indent: 0pt;">2023</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">282,637</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">95.70</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.49</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1.04%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.14%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 8.99%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1.04%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 319868 139.8 40050 29.6 0 0 19120 501.2 340798 106.6 0 1875 10 0 0 12656 510.21 330017 90.63 P4Y11M23D 0 282637 95.7 P4Y5M26D 0 <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RSUs</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RSUs</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Grant Date</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fair Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Aggregate</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Intrinsic</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2021</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">25,457</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">107.80</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs granted</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,918</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">29.20</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs vested</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10,770</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">103.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs cancelled</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2022</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,605</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">73.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs granted</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,250</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs vested</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,405</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">83.81</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom">RSUs cancelled<br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">—</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">—</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">—</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Outstanding, December 31, <span style="text-indent: 0pt;">2023</span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">17,450</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">60.81</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 25457 107.8 0 12918 29.2 10770 103 0 0 27605 73 0 1250 10 11405 83.81 0 0 17450 60.81 0 <div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted Stock</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> </div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted Stock</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Average</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Grant Date</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fair Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Aggregate</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Intrinsic</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Outstanding, December </span><span style="font-size: 10pt; font-family: 'Times New Roman';">31,</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span>2022</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock granted</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">36,927</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">9.12</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock vested</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">(3,617</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">9.19</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock cancelled</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">(604</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">9.60</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Outstanding, December </span><span style="font-size: 10pt; font-family: 'Times New Roman';">31,</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span>2023</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">32,706</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">9.11</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> </div> 0 0 0 36927 9.12 3617 9.19 604 9.6 32706 9.11 0 7 <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Stock-based compensation expense is included in operating expense for each period as follows:</div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock-Based Compensation by Type of Award</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Stock options</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,960</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,303</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">RSUs</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">778</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,027</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">Restricted stock<br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">40</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"><br/> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total stock-based compensation expense</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,778</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,330</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 1960000 2303000 778000 1027000 40000 2778000 3330000 3006000 2025000 683000 298000 P1Y9M18D P1Y8M26D P3Y6M14D <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions:</div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Expected stock price volatility</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">81.39</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">85.39</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Risk-free interest rate</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.9</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3.09</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> </tr> <tr> <td style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Expected life term</div> </td> <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5.5 years</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">6.2 years</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Expected dividends</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> </tr> </table> 0.8139 0.8539 0.039 0.0309 P5Y6M P6Y2M12D 0 0 6.96 21.77 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 7 − Earnings Per Share</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Basic earnings per share are based on the weighted average number of shares outstanding for a period. Diluted earnings per share are based upon the weighted average number of shares and potentially dilutive common shares outstanding. Potential common shares outstanding principally include stock options, RSUs and unvested restricted stock under our stock plan and warrants. During 2023 and 2022 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The table below sets forth the basic and diluted loss per share calculations:</div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;" valign="bottom"><span style="font-weight: bold;">Year Ended December 31,</span></td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net (loss) income<br/> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(27,871</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(36,260</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Basic weighted average number of shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">3,579</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">3,565</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Effect of dilutive securities</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Diluted weighted average number of shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,579</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,565</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Basic (loss) earnings per share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(7.79</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10.17</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Diluted (loss) earnings per share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(7.79</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10.17</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> </table> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The table below sets forth the basic and diluted loss per share calculations:</div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;" valign="bottom"><span style="font-weight: bold;">Year Ended December 31,</span></td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net (loss) income<br/> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(27,871</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(36,260</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Basic weighted average number of shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">3,579</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">3,565</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Effect of dilutive securities</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Diluted weighted average number of shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,579</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3,565</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Basic (loss) earnings per share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(7.79</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10.17</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Diluted (loss) earnings per share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(7.79</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10.17</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> </table> -27871000 -36260000 3579 3565 0 0 3579 3565 -7.79 -10.17 -7.79 -10.17 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 8 − Common Stock</div> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Each share of common stock has the right to one vote<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. The holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by our Board of Directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. Our restated articles of incorporation authorize us to issue up to </span>100,000,000<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> shares of $</span>0.0001<span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> par value common stock.</span></div> <div style="text-align: left;"><br/> </div> <div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Effective October 25, 2023, every <span style="-sec-ix-hidden:Fact_17be76c8fce14eefb3f1aab26291f6f8">20</span> shares of our common stock outstanding was combined into one share of common stock. Proportional adjustments were also made to the number of restricted stock, common stock issuable upon the exercise of options, warrants as well as common stock issuable upon the vesting of RSUs. The exercise price of all equity awards were also proportionally adjusted. The accompanying financial statements include the effect of this adjustment on all periods presented.</span><br/> </div> <div style="text-align: left;"><br/> </div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Dividends</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In 2023, we<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> paid a one-time capital dividend of $20 per share of common stock to shareholders. The timing and amount of future dividends, if any, will depend on market conditions, corporate business and financial considerations and regulatory requirements</span>.</div> <div><br/> </div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Warrants</div> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In 2020, we issued warrants for the purchase of 1,250 shares of common stock at an exercise price of $115 per share, exercisable on the date of grant, expiring in <span style="-sec-ix-hidden:Fact_f0b19eaa531d4e90a124ed20eff6f52b">April 2025</span>. The weighted average fair value at the grant date was $83.20 per warrant. The fair value at the grant date was estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions (i) dividend yield on our common stock of 0 percent (ii) expected stock price volatility of 97 percent (iii) a risk-free interest rate of 0.27 percent and (iv) and expected option term of 5 years.</div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Warrants</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Issued</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercise</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Price</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding and</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercisable</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Issued</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercised</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Terminated /</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cancelled</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding and </div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercisable</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2023</div> </td> <td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 16%; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Expiration Date<br/> </div> </td> <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,250</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">115</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,250</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,250</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; width: 16%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">April 30, 2025</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> </tr> </table> 1 100000000 0.0001 20 1250 115 83.2 0 0.97 0.0027 P5Y <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Warrants</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Issued</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercise</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Price</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding and</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercisable</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Issued</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercised</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Terminated /</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cancelled</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; white-space: nowrap; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding and </div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exercisable</div> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2023</div> </td> <td colspan="1" style="white-space: nowrap; text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"> </td> <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 16%; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Expiration Date<br/> </div> </td> <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,250</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">115</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,250</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,250</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td style="vertical-align: bottom; width: 16%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">April 30, 2025</div> </td> <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" valign="bottom"> </td> </tr> </table> 1250 115 1250 0 0 0 1250 2025-04-30 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 9 − Employee Benefit Plan</div> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We sponsor a defined contribution 401k plan covering substantially all our employees. Our matching contribution to the plan was approximately $229 and $179 in 2023 and 2022, respectively.</div> 229000 179000 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 10 − Income Taxes</div> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The income tax provision (benefit) is comprised of the following:</div> <div style="text-align: left;"><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Current:</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Federal</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">State</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt;">Foreign</div> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">—</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">—</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt;"> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Deferred:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Federal</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(79</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">15,920</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">State</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">109</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"><br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">(81</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">16,029</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Total income tax (benefit) provision</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">(79</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,032</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:</div> <div style="text-align: left;"><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">United States federal statutory rate</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State taxes, net of federal benefit</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.01</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.55</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Valuation allowance</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(20.31</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(91.21</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Stock based compensation</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.58</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(9.44</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">R&amp;D Credit</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.20</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.22</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2.03</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.29</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Effective income tax rate</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">0.28</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(79.27</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> </tr> </table> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets (liabilities) consist of the following:</div> <div style="text-align: left;"><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets:</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Reserves and accruals</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">147</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Research and development credits and other credits</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,110</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">430</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net operating loss carry forward</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">15,262</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,988</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Stock based compensation</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,360</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,018</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,382</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">970</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred tax assets</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,179</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">18,553</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Valuation allowance</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(23,179</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(18,553</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets after valuation allowance</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred tax liability <span style="color: rgb(0, 0, 0);">– depreciation</span> and amortization<br/> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax assets</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div style="text-align: left;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Pursuant to IRC Section 174, we capitalized direct and indirect research and development costs for our tax return totaling $8,599 in 2023 and $5,140 in 2022, of which $1,888 will be amortized in our 2023 tax return and $514 in our 2022 tax return. At December 31, 2023, unamortized capitalized direct and indirect research and development costs for our tax return totaled $11,337, resulting in a deferred tax asset of $2,381. </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">At December 31, 2023, we had federal and state net operating loss carryforwards of approximately $72,645 and $109,435, respectively. Federal net operating loss carryforwards do not expire. None of the state net operating loss carryforward is apportioned to a deferred tax asset, because currently we do not have operations in states where losses accumulated. The state net operating loss carryforward begins expiring in <span style="-sec-ix-hidden:Fact_519d5b9c52554809b21d804b961dcdb5">2029</span>. We provide full valuation allowances for our net deferred tax assets, including NOL carryforwards generated during the years, based on our evaluation of positive and negative evidence, including our history of operating losses and the uncertainty of generating future taxable income that would enable us to realize our deferred tax assets.<br/> </div> <div><br/></div> <div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="background-color: #FFFFFF; margin: 0px 0px 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none;">We are required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. At December 31, 2023, we have no uncertain tax positions.</div> <div style="background-color: #FFFFFF; margin: 0px 0px 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none;"> <br/> </div> <div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to NOLs and tax credits generated in these years were utilized in 2020. The statute of limitation for these years shall expire three years after the date of filing 2020 income tax returns, which is October 2024.</div> <div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </span></div> <div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Our policy is to recognize interest and penalties, if any, accrued on any unrecognized tax benefits, as a component of income tax expense. We had no interest or penalties accrued in 2023.</span><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The income tax provision (benefit) is comprised of the following:</div> <div style="text-align: left;"><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Current:</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Federal</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">State</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt;">Foreign</div> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">—</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">—</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-indent: -9pt; margin-left: 9pt;"> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Deferred:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Federal</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(79</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">15,920</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">State</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">109</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"><br/> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">(81</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">16,029</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Total income tax (benefit) provision</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">$</td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">(79</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,032</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 0 0 2000 3000 0 0 2000 3000 -79000 15920000 -2000 109000 -81000 16029000 -79000 16032000 <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:</div> <div style="text-align: left;"><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">United States federal statutory rate</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.00</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State taxes, net of federal benefit</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.01</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.55</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Valuation allowance</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(20.31</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(91.21</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Stock based compensation</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.58</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(9.44</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">R&amp;D Credit</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2.20</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1.22</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2.03</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.29</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Effective income tax rate</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">0.28</td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(79.27</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)%</div> </td> </tr> </table> 0.21 0.21 -0.0001 -0.0055 -0.2031 -0.9121 -0.0058 -0.0944 -0.022 -0.0122 -0.0203 -0.0029 0.0028 -0.7927 <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets (liabilities) consist of the following:</div> <div style="text-align: left;"><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets:</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Reserves and accruals</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">147</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Research and development credits and other credits</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,110</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">430</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net operating loss carry forward</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">15,262</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11,988</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Stock based compensation</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,360</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">5,018</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,382</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">970</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred tax assets</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">23,179</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">18,553</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Valuation allowance</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(23,179</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(18,553</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets after valuation allowance</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred tax liability <span style="color: rgb(0, 0, 0);">– depreciation</span> and amortization<br/> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax assets</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 65000 147000 1110000 430000 15262000 11988000 4360000 5018000 2382000 970000 23179000 18553000 23179000 18553000 0 0 0 0 0 0 8599000 5140000 1888000 514000 11337000 2381000 72645000 109435000 0 0 <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 11 − Fair Value Measurement</div> <div><br/> </div> <div style="text-align: justify; margin-top: 4.9pt; margin-right: 5.7pt;"><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.</span></div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="margin-top: 0.35pt; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; margin-right: 5.6pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Our financial instruments are stated at amounts that equal, or approximate, fair value. When we estimate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. We use valuation techniques, primarily the income and market approach, which maximizes the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.</div> <div style="text-align: justify; margin-right: 5.6pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div style="text-align: justify; margin-right: 5.6pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-style: italic;">Mutual funds:</span> Valued at the quoted net asset value (NAV) of shares held.<br/> <span style="font-style: italic;">U.S. agency and treasury securities:</span> Fair value measured at the closing price reported on the active market on which the individual securities are traded.<br/> </div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following table shows the adjusted cost, gross unrealized gains, gross unrealized losses, and fair value of our financial assets as of December 31, 2023 and 2022 (in thousands):</div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="22" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Adjusted<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Cost</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Unrealized<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Gains</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Unrealized<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Losses</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cash<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>and Cash<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Equivalents</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investments<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Available<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>for Sale</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Cash</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,452</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,452</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,452</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Level 1:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Mutual funds</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">20,040</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">20,040</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">20,040</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">U.S. agency and treasury securities</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,046</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(18</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,055</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,797</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,258</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">52,086</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(18</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">52,095</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">24,837</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,258</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">53,538</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(18</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">53,547</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">26,289</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,258</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="22" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Adjusted<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Cost</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Unrealized<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Gains</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Unrealized<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Losses</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cash<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>and Cash<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Equivalents</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investments<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Available<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>for Sale</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Cash</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,949</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,949</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,949</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Level 1:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Mutual funds</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">66,493</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">66,493</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">66,493</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 28%; padding-bottom: 2px;" valign="bottom"> <div style="margin-left: 9pt; text-indent: -9pt;">U.S. agency and treasury securities<br/> </div> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">68,958</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">9</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">(386</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">68,581</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">3,119</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">65,462</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">135,451</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(386</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">135,074</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">69,612</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65,462</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">152,400</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(386</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">152,023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">86,561</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65,462</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><span style="font-family: 'Times New Roman';"><br/> </span> </div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The maturities of our investments generally range from within <span style="-sec-ix-hidden:Fact_2971803a420d4c4a890df6dc5bc149ca">one</span> to two years. Actual maturities could differ from contractual maturities due to call or prepayment provisions.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following table shows the adjusted cost, gross unrealized gains, gross unrealized losses, and fair value of our financial assets as of December 31, 2023 and 2022 (in thousands):</div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="22" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Adjusted<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Cost</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Unrealized<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Gains</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Unrealized<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Losses</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cash<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>and Cash<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Equivalents</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investments<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Available<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>for Sale</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Cash</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,452</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,452</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,452</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Level 1:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Mutual funds</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">20,040</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">20,040</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">20,040</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">U.S. agency and treasury securities</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,046</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(18</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">32,055</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4,797</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,258</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">52,086</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(18</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">52,095</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">24,837</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,258</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">53,538</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(18</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">53,547</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">26,289</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,258</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"></td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="22" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Adjusted<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Cost</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Unrealized<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Gains</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Unrealized<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Losses</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Value</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cash<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>and Cash<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Equivalents</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investments<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>Available<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/> </span>for Sale</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Cash</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,949</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,949</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,949</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Level 1:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255);" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Mutual funds</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">66,493</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">66,493</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">66,493</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: bottom; width: 28%; padding-bottom: 2px;" valign="bottom"> <div style="margin-left: 9pt; text-indent: -9pt;">U.S. agency and treasury securities<br/> </div> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">68,958</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">9</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">(386</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">68,581</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">3,119</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">65,462</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">135,451</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(386</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">135,074</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">69,612</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65,462</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px;" valign="bottom"> <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">152,400</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(386</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">152,023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">86,561</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">65,462</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> 1452000 1452000 1452000 20040000 0 0 20040000 20040000 0 32046000 27000 18000 32055000 4797000 27258000 52086000 27000 18000 52095000 24837000 27258000 53538000 53547000 26289000 27258000 16949000 16949000 16949000 66493000 0 0 66493000 66493000 0 68958000 9000 386000 68581000 3119000 65462000 135451000 9000 386000 135074000 69612000 65462000 152400000 152023000 86561000 65462000 P2Y <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">Note 12 − Litigation (all dollar amounts in this section are expressed in thousands except for rates per device)</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">We have several intellectual property infringement lawsuits pending in the United States Court of Appeals for the Federal Circuit (“USCAFC”).</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">This case began on November 6, 2012, when we filed a complaint against Apple Inc. (“Apple”) in United States District Court (“USDC”) in which we alleged that Apple infringed on certain of our patents, (U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151). We sought damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. The USDC entered a Final Judgment and issued its Memorandum Opinion and Order regarding post-trial motions, affirming the jury’s verdict of $502,600 and granting VirnetX motions for supplemental damages, a sunset royalty, and the royalty rate of $1.20 per infringing iPhone, iPad and Mac products, pre-judgment and post-judgment interest and costs. Apple filed a notice of appeal with the United States Court of Appeals for the Federal Circuit (“USCAFC”) in the Apple II case.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On October 9, 2018, USCAFC docketed the appeal as Case No. 19-1050 - VirnetX Inc. v. Apple Inc. On November 22, 2019, the USCAFC issued an opinion affirming the district court’s findings that Apple is precluded from making certain invalidity arguments and that Apple infringed the ‘135 and ‘151 patents; reversing the USDC’s finding that Apple infringed the ‘504 and ‘211 patents; and remanding the case for proceedings on damages. Apple sought panel and en banc rehearing, which the USCAFC denied on February 10, 2020.</span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On February 22, 2021, the </span>USCAFC docketed the appeal as Case No. 19-1672. Apple’s opening brief was filed on June 2, 2021. VirnetX filed its responsive brief on July 26, 2021. Apple filed its reply brief on September 13, 2021. Oral arguments were held on September 8, 2022. On March 31, 2023, the USCAFC issued its decision vacating the USDC’s judgement in this matter and remanding it back to the USDC with instructions to dismiss the case as moot. On July 14, 2023 the District Court vacated its prior Final Judgment against Apple dated January 6, 2021 and dismissed the case as moot. On May 1, 2023, VirnetX filed a petition for panel rehearing. On June 27, 2023, the petition for panel rehearing was denied, and the mandate issued on June 30, 2023. VirnetX filed a petition for a writ of certiorari with the United States Supreme Court, on September 20, 2023. On February 20, 2024, the Supreme Court denied our petition. We are evaluating all our options in this matter.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; font-weight: bold; margin-right: 6.35pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">VirnetX Inc. v. Mangrove Partners Master Fund, Ltd., Apple Inc. (USCAFC Case 20-2271) and VirnetX Inc. v. Mangrove Partners Master Fund, Ltd., Apple Inc., and Black Swamp, LLC (USCAFC Case 20-2272)</div> <div style="text-align: justify; font-weight: bold; margin-right: 6.35pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); margin-right: 5.65pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On September 15, 2020, we filed with the USCAFC an appeal of the invalidity findings by the Patent Trial and Appeal Board (“PTAB”) in inter-partes review proceedings IPR2015-01046 and IPR2016-00062 involving our U.S. Patent No. 6,502,135, and an appeal of the invalidity findings by the PTAB in inter-partes review proceedings IPR2015-1047, IPR2016-00063, and IPR2016-00167 involving our U.S. Patent No. 7,490,151. On September 25, 2020, the USCAFC issued an order consolidating the two appeals. On December 15, 2020, we filed a motion to vacate the PTAB decisions below and to remand these appeals to the PTAB. On March 16, 2021, the USCAFC denied the motion without prejudice to us raising the challenges made in the motion in our opening brief. Our opening brief was filed on June 7, 2021.</div> <div style="text-align: justify; color: rgb(0, 0, 0); margin-right: 5.65pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div style="text-align: justify; margin-right: 5.65pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;">On June 23, 2021, the USCAFC entered an order directing us (and parties in other appeals that raised Appointments Clause challenges) to file a brief explaining how they believe their cases should proceed in light of the Supreme Court’s decision in United States v. Arthrex, Inc., 141 S. Ct. 1970 (2021). On July 7, 2021, we filed a brief in response to the court’s order. Other parties, including the U.S. Patent and Trademark Office (“USPTO”) filed their responses on July 21, 2021. On August 19, 2021, USCAFC issued an order remanding these appeals for the limited purpose of allowing VirnetX the opportunity to request rehearing of the PTAB’s final written decisions by the Director of the USPTO. The USCAFC retained jurisdiction over the appeals in the meantime. On September 20, 2021, we filed our requests for Director rehearing with the USPTO. On October 29, 2021, our requests for Director rehearing were denied. We subsequently filed an amended opening brief to the USCAFC on December 10, 2021, the other parties filed response briefs on February 2, 2022, and we filed a reply brief on February 22, 2022. All the briefings have been completed. The oral arguments in this matter were held on September 8, 2022. </span>On March 30, 2023, the USCAFC issued its decision affirming PTAB’s decisions finding certain claims of the ‘135 patent and the ‘151 patent to be unpatentable. On June 5, 2023, VirnetX filed a petition for panel rehearing. On June 22, 2023, the petition for panel rehearing was denied, and the mandate issued on June 29, 2023. VirnetX filed a petition for a writ of certiorari with the United States Supreme Court, on September 20, 2023. On February 20, 2024, the Supreme Court denied our petition. We are evaluating all our options in this matter.</div> <div> <br/> </div> <div><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">VirnetX Inc. v. Hirshfeld (USCAFC Case 17-2593, -2594) </span></div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); margin-right: 5.65pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On September 22, 2017, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes review proceeding IPR2016-00693 involving our U.S. Patent No. 7,418,504, and an appeal of the invalidity findings by the PTAB in inter-partes review proceeding IPR2016-00957 involving our U.S. Patent No. 7,921,211. On September 16, 2021, USCAFC issued an order remanding these appeals for the limited purpose of allowing VirnetX the opportunity to request rehearing of the PTAB’s final written decisions by the Director of the USPTO. The USCAFC retained jurisdiction over the appeals in the meantime. On October 18, 2021, we filed our requests for Director rehearing with the USPTO. On January 7, 2022, our requests for Director rehearing were denied. On January 21, 2022, we informed the USCAFC about the denial of Director rehearing and requested that the court dismiss the appeal involving IPR2016-00957 as moot and vacate the PTAB’s underlying decision. On April 4, 2022, the USCAFC vacated the PTAB’s decision in IPR2016-00957 and remanded Appeal No. 17-2594 with instructions to dismiss. In the April 4, 2022 order, the USCAFC further set a briefing schedule, in Appeal No. 17-2593. VirnetX filed its opening brief on September 12, 2022. The USPTO filed its response brief on December 20, 2022. VirnetX filed its reply brief on February 14, 2023. On April 18, 2023, VirnetX filed a motion to hold this appeal in abeyance pending the disposition of any petition for rehearing in the No. 20-2271, -2272 appeal, and pending the United States Supreme Court’s disposition of a pending petition for a writ of certiorari in <span style="font-style: italic;">Arthrex, Inc. v. Smith &amp; Nephew, Inc.<span style="font-style: normal;">,</span></span> No. 22-639. That motion was denied on June 1, 2023. On October 20, 2023, the USCAFC issued a decision finding the appeal moot in view of its concurrent decision in USCAFC No. 22-2234.  VirnetX sought rehearing, which was denied, and the mandate to close the case was issued on January 12, 2024.</div> <div style="font-weight: bold; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div style="font-weight: bold; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 19-1671)</div> <div style="font-weight: bold; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); margin-right: 5.65pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> On March 18, 2019, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,679 involving our U.S. Patent No. 6,502,135. On October 5, 2021, USCAFC issued an order remanding these appeals for the limited purpose of allowing VirnetX the opportunity to request rehearing of the PTAB’s final written decisions by the Director of the PTO. The USCAFC retained jurisdiction over the appeals in the meantime. Our request for Director rehearing with the PTO was filed on November 5, 2021. On January 10, 2022, our request for Director rehearing was denied. We informed the USCAFC about the denial of Director rehearing. VirnetX’s opening brief was filed on June 23, 2022. The USPTO’s response brief was filed on August 2, 2022, and Cisco’s response brief was filed on September 2, 2022. VirnetX filed its reply brief on October 7, 2022. On April 18, 2023, VirnetX filed a motion to hold this appeal in abeyance pending the disposition of any petition for rehearing in the No. 20-2271, -2272 appeal, and pending the Supreme Court’s disposition of a pending petition for a writ of certiorari in <span style="font-style: italic;">Arthrex, Inc. v. Smith &amp; Nephew, Inc.</span>, No. 22-639. The motion, filed on April 18, 2023, was denied on June 1, 2023.  On October 20, 2023, the USCAFC issued a decision finding the appeal moot in view of its concurrent decision in USCAFC No. 22-1523 and its prior decision in USCAFC No. 20-2271.  VirnetX sought rehearing, which was denied, and the mandate to close the case was issued on January 12, 2024. </span></div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/> </div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">VirnetX Inc. v. Apple Inc. (USCAFC Case 22-1523) (“Apple Reexam I”)</div> <div><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">On March 10, 2022, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,682 involving our U.S. Patent No. 6,502,135. Our opening brief was filed on August 22, 2022. Apple and USPTO each filed a response brief on December 28, 2022. VirnetX filed its reply brief on February 8, 2023. On April 18, 2023, VirnetX filed a motion to hold this appeal in abeyance pending the disposition of any petition for rehearing in the No. 20-2271, -2272 appeal, and pending the Supreme Court’s disposition of a pending petition for a writ of certiorari in <span style="font-style: italic;">Arthrex, Inc. v. Smith &amp; Nephew, Inc.</span>, No. 22-639, which was denied on June 1, 2023.  On October 20, 2023, the USCAFC issued a decision affirming the PTAB’s invalidity findings.  VirnetX sought rehearing, which was denied, and the mandate to close the case was issued on January 12, 2024.<br/> </div> <div><br/> </div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">VirnetX Inc. v. Apple Inc. (USCAFC Case 22-1997</span>)<span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> (“Apple Reexam II”)</span></div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> <br/> </span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">On July 6, 2022, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,697 involving our U.S. Patent No. 7,490,151. On October 17, 2022, we filed a motion to remand the appeal in light of the PTAB’s refusal to permit Director rehearing. On January 23, 2023, the USCAFC denied that motion without prejudice to the parties raising their arguments in the merits briefs. VirnetX opening brief was filed on May 8, 2023, and Apple and the USPTO each filed a response brief on July 24, 2023. VirnetX filed its reply brief on September 1, 2023. We currently await scheduling of oral arguments.</div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 22-2234)</div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">On September 16, 2022, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,851 involving our U.S. Patent No. 7,418,504. We filed our opening brief on February 28, 2023. Cisco’s response brief was filed on May 10, 2023, and VirnetX reply brief was filed on June 21, 2023. On October 20, 2023, the USCAFC issued a decision affirming the PTAB’s invalidity findings.  The mandate to close the case was issued on December 26, 2023. </div> <div style="text-align: justify; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">VirnetX Inc. v. Cisco Systems, Inc. </span>(USCAFC Case 23-1765)</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">On April 7, 2023, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes re-examination proceeding 95/001,714 involving our U.S. Patent No. 7,490,151. The certified list is due to be filed by the USPTO by May 30, 2023, and our opening brief will be due 60 days thereafter.  In addition, on April 21, 2023, Cisco filed a cross-appeal.  On September 29, 2023, VirnetX filed a motion to remand.  That motion was denied without prejudice to VirnetX raising the same arguments in its opening appeal brief in an order dated December 27, 2023, which also set the deadline for VirnetX to file an opening brief for February 5, 2024. VirnetX filed its opening brief on February 5, 2024, and Cisco’s opening/response brief’s is currently due March 18, 2024</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: bold;"> <br/> </span></div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">Other Legal Matters</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are likely valid, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we could prevail on such potential claims if we made them. In addition, bringing a lawsuit may lead to potential counterclaims which may distract our management and our other resources, including capital resources, from efforts to successfully commercialize our products.</div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-transform: none;">Currently, we are not a party to any other pending legal proceedings and are not aware of any proceeding threatened or contemplated against us.</div> 502600000 1.2 2 P60D <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 13 − Leases</div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"><br/> </span> </div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In October 2023, we renewed our lease for office space in Nevada with a third party recording an ROU asset and lease liability of $102. The lease requires monthly payments of $4.6 and expires in October 2025. At December 31, 2023, our ROU asset and lease liability totaled $93. Lease expense totaled $55 in 2023 and $54 in 2022.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-family: 'Times New Roman';"><br/> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In October 2023, we executed a facility lease in Utah to be used for technical integration and as a training facility recording an ROU asset and a lease liability of $3,587. This operating lease requires monthly payments starting at $72, includes periodic increases, provides six months of free rent, and expires in April 2029.  At December 31, 2023, our ROU asset and lease liability totaled $3,479 and <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$3,546, respectively</span>. Lease expense totaled $140 in 2023.<br/> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-family: 'Times New Roman';"><br/> </span></div> <div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The weighted average remaining life of the office and facility leases discussed above is approximately 5 years, and the related lease liability is as follows:</span> </div> <div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </span></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Due in 2024</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">494</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Due in 2025</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">946</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Due in 2026</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">927</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Due in 2027</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">954</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Due in 2028</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">983</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Thereafter</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">336</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Total undiscounted lease liability<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">4,640</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">Less: imputed interest<br/> </td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">$</td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">(1,001</td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Total lease liability<br/> </td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">$</td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">3,639</td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"> <span style="font-family: 'Times New Roman';"><br/> </span></div> <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"> We also lease a facility for corporate promotional and marketing purposes which was prepaid at inception and expires in 2025. At December 31, 2023 and 2022, the ROU asset totaled $349 and $648, respectively; lease expense totaled $300 per year in 2023 and 2022. In March 2024, we renewed our facility lease, used for corporate, promotional and marketing purposes. The renewal period begins in 2025, continues for 10 years through 2035, requires either a single payment of $6,000, or annual payments each March, beginning in 2025 starting at $600 and increasing annually for a total commitment of approximately $7,500.<br/> </div> <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"> <span style="font-family: 'Times New Roman';"><br/> </span></div> <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">We have a service agreement for the use of an aircraft from a related party discussed in more detail in Note 4. We incurred approximately $1,097 and $1,123 in rental fees and reimbursements to the entity in 2023 and 2022, respectively.</span><span style="font-family: 'Times New Roman';"><br/> </span></div> 102000 102000 4600 93000 93000 55000 54000 3587000 3587000 72000 P6M 3479000 3546000 140000 <div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The weighted average remaining life of the office and facility leases discussed above is approximately 5 years, and the related lease liability is as follows:</span> </div> <div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </span></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Due in 2024</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">494</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Due in 2025</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">946</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Due in 2026</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">927</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Due in 2027</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">954</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Due in 2028</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">983</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Thereafter</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">336</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="text-align: left; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Total undiscounted lease liability<br/> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">$</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt;">4,640</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">Less: imputed interest<br/> </td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">$</td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">(1,001</td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Total lease liability<br/> </td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">$</td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">3,639</td> <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> P5Y P5Y 494000 946000 927000 954000 983000 336000 4640000 1001000 3639000 349000 648000 300000 300000 P10Y 6000000 600000 7500000 1097000 1123000 <div style="text-align: left; margin-bottom: 8pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 14 − Subsequent Event</div> <div style="margin: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">In January 2024, we issued 71,000 shares of restricted stock from our Amended and Restated Equity Incentive Plan.</div> 71000 false false false false false false false false

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end XML 71 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 113 294 1 false 43 0 false 9 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://virnetx.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 010000 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://virnetx.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://virnetx.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 030000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) Sheet http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) Statements 5 false false R6.htm 040000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 040100 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquityParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Statements 7 false false R8.htm 050000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://virnetx.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 060100 - Disclosure - Formation and Business of the Company Sheet http://virnetx.com/role/FormationAndBusinessOfCompany Formation and Business of the Company Notes 9 false false R10.htm 060200 - Disclosure - Summary of Significant Accounting Policies Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 060300 - Disclosure - Property and Equipment Sheet http://virnetx.com/role/PropertyAndEquipment Property and Equipment Notes 11 false false R12.htm 060400 - Disclosure - Commitments, Contingencies and Related Party Transactions Sheet http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactions Commitments, Contingencies and Related Party Transactions Notes 12 false false R13.htm 060500 - Disclosure - Stock Plan Sheet http://virnetx.com/role/StockPlan Stock Plan Notes 13 false false R14.htm 060600 - Disclosure - Stock-Based Compensation Sheet http://virnetx.com/role/StockbasedCompensation Stock-Based Compensation Notes 14 false false R15.htm 060700 - Disclosure - Earnings Per Share Sheet http://virnetx.com/role/EarningsPerShare Earnings Per Share Notes 15 false false R16.htm 060800 - Disclosure - Common Stock Sheet http://virnetx.com/role/CommonStock Common Stock Notes 16 false false R17.htm 060900 - Disclosure - Employee Benefit Plan Sheet http://virnetx.com/role/EmployeeBenefitPlan Employee Benefit Plan Notes 17 false false R18.htm 061000 - Disclosure - Income Taxes Sheet http://virnetx.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 061100 - Disclosure - Fair Value Measurement Sheet http://virnetx.com/role/FairValueMeasurement Fair Value Measurement Notes 19 false false R20.htm 061200 - Disclosure - Litigation Sheet http://virnetx.com/role/Litigation Litigation Notes 20 false false R21.htm 061300 - Disclosure - Leases Sheet http://virnetx.com/role/Leases Leases Notes 21 false false R22.htm 061400 - Disclosure - Subsequent Event Sheet http://virnetx.com/role/SubsequentEvent Subsequent Event Notes 22 false false R23.htm 061500 - Disclosure - Insider Trading Arrangements Sheet http://virnetx.com/role/InsiderTradingArrangements Insider Trading Arrangements Notes 23 false false R24.htm 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://virnetx.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 080300 - Disclosure - Property and Equipment (Tables) Sheet http://virnetx.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://virnetx.com/role/PropertyAndEquipment 25 false false R26.htm 080600 - Disclosure - Stock-Based Compensation (Tables) Sheet http://virnetx.com/role/StockbasedCompensationTables Stock-Based Compensation (Tables) Tables http://virnetx.com/role/StockbasedCompensation 26 false false R27.htm 080700 - Disclosure - Earnings Per Share (Tables) Sheet http://virnetx.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://virnetx.com/role/EarningsPerShare 27 false false R28.htm 080800 - Disclosure - Common Stock (Tables) Sheet http://virnetx.com/role/CommonStockTables Common Stock (Tables) Tables http://virnetx.com/role/CommonStock 28 false false R29.htm 081000 - Disclosure - Income Taxes (Tables) Sheet http://virnetx.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://virnetx.com/role/IncomeTaxes 29 false false R30.htm 081100 - Disclosure - Fair Value Measurement (Tables) Sheet http://virnetx.com/role/FairValueMeasurementTables Fair Value Measurement (Tables) Tables http://virnetx.com/role/FairValueMeasurement 30 false false R31.htm 081300 - Disclosure - Leases (Tables) Sheet http://virnetx.com/role/LeasesTables Leases (Tables) Tables http://virnetx.com/role/Leases 31 false false R32.htm 090100 - Disclosure - Formation and Business of the Company (Details) Sheet http://virnetx.com/role/FormationAndBusinessOfCompanyDetails Formation and Business of the Company (Details) Details http://virnetx.com/role/FormationAndBusinessOfCompany 32 false false R33.htm 090200 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies 33 false false R34.htm 090300 - Disclosure - Property and Equipment (Details) Sheet http://virnetx.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) Details http://virnetx.com/role/PropertyAndEquipmentTables 34 false false R35.htm 090400 - Disclosure - Commitments, Contingencies and Related Party Transactions (Details) Sheet http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails Commitments, Contingencies and Related Party Transactions (Details) Details http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactions 35 false false R36.htm 090500 - Disclosure - Stock Plan (Details) Sheet http://virnetx.com/role/StockPlanDetails Stock Plan (Details) Details http://virnetx.com/role/StockPlan 36 false false R37.htm 090600 - Disclosure - Stock-Based Compensation, Information about Stock Options Outstanding (Details) Sheet http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails Stock-Based Compensation, Information about Stock Options Outstanding (Details) Details 37 false false R38.htm 090602 - Disclosure - Stock-Based Compensation, Summary of Stock Option Activity (Details) Sheet http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails Stock-Based Compensation, Summary of Stock Option Activity (Details) Details 38 false false R39.htm 090604 - Disclosure - Stock-Based Compensation, Summary of Restricted Stock Units and Restricted Stock Awards Activity (Details) Sheet http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails Stock-Based Compensation, Summary of Restricted Stock Units and Restricted Stock Awards Activity (Details) Details 39 false false R40.htm 090606 - Disclosure - Stock-Based Compensation, Stock-Based Compensation by Type of Award (Details) Sheet http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails Stock-Based Compensation, Stock-Based Compensation by Type of Award (Details) Details 40 false false R41.htm 090608 - Disclosure - Stock-Based Compensation, Fair Value Assumptions Used (Details) Sheet http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails Stock-Based Compensation, Fair Value Assumptions Used (Details) Details 41 false false R42.htm 090700 - Disclosure - Earnings Per Share (Details) Sheet http://virnetx.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://virnetx.com/role/EarningsPerShareTables 42 false false R43.htm 090800 - Disclosure - Common Stock, Summary (Details) Sheet http://virnetx.com/role/CommonStockSummaryDetails Common Stock, Summary (Details) Details 43 false false R44.htm 090802 - Disclosure - Common Stock, Warrants (Details) Sheet http://virnetx.com/role/CommonStockWarrantsDetails Common Stock, Warrants (Details) Details 44 false false R45.htm 090900 - Disclosure - Employee Benefit Plan (Details) Sheet http://virnetx.com/role/EmployeeBenefitPlanDetails Employee Benefit Plan (Details) Details http://virnetx.com/role/EmployeeBenefitPlan 45 false false R46.htm 091000 - Disclosure - Income Taxes, Components of Provision (Benefit) for Income Taxes (Details) Sheet http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails Income Taxes, Components of Provision (Benefit) for Income Taxes (Details) Details 46 false false R47.htm 091002 - Disclosure - Income Taxes, Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) Sheet http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails Income Taxes, Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) Details 47 false false R48.htm 091004 - Disclosure - Income Taxes, Components of Deferred Tax Assets (Liabilities) (Details) Sheet http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails Income Taxes, Components of Deferred Tax Assets (Liabilities) (Details) Details 48 false false R49.htm 091006 - Disclosure - Income Taxes, Pre-tax Income (Losses) and Operating Loss Carryforwards (Details) Sheet http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails Income Taxes, Pre-tax Income (Losses) and Operating Loss Carryforwards (Details) Details 49 false false R50.htm 091008 - Disclosure - Income Taxes, Income Tax Uncertainties (Details) Sheet http://virnetx.com/role/IncomeTaxesIncomeTaxUncertaintiesDetails Income Taxes, Income Tax Uncertainties (Details) Details 50 false false R51.htm 091100 - Disclosure - Fair Value Measurement (Details) Sheet http://virnetx.com/role/FairValueMeasurementDetails Fair Value Measurement (Details) Details http://virnetx.com/role/FairValueMeasurementTables 51 false false R52.htm 091200 - Disclosure - Litigation (Details) Sheet http://virnetx.com/role/LitigationDetails Litigation (Details) Details http://virnetx.com/role/Litigation 52 false false R53.htm 091300 - Disclosure - Leases, Summary (Details) Sheet http://virnetx.com/role/LeasesSummaryDetails Leases, Summary (Details) Details 53 false false R54.htm 091302 - Disclosure - Leases, Lease Liability (Details) Sheet http://virnetx.com/role/LeasesLeaseLiabilityDetails Leases, Lease Liability (Details) Details 54 false false R55.htm 091400 - Disclosure - Subsequent Event (Details) Sheet http://virnetx.com/role/SubsequentEventDetails Subsequent Event (Details) Details http://virnetx.com/role/SubsequentEvent 55 false false All Reports Book All Reports ef20015315_10k.htm vhc-20231231.xsd vhc-20231231_cal.xml vhc-20231231_def.xml vhc-20231231_lab.xml vhc-20231231_pre.xml image01.jpg image02.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 77 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ef20015315_10k.htm": { "nsprefix": "vhc", "nsuri": "http://virnetx.com/20231231", "dts": { "inline": { "local": [ "ef20015315_10k.htm" ] }, "schema": { "local": [ "vhc-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "vhc-20231231_cal.xml" ] }, "definitionLink": { "local": [ "vhc-20231231_def.xml" ] }, "labelLink": { "local": [ "vhc-20231231_lab.xml" ] }, "presentationLink": { "local": [ "vhc-20231231_pre.xml" ] } }, "keyStandard": 265, "keyCustom": 29, "axisStandard": 20, "axisCustom": 0, "memberStandard": 27, "memberCustom": 16, "hidden": { "total": 13, "http://xbrl.sec.gov/dei/2023": 6, "http://fasb.org/us-gaap/2023": 5, "http://virnetx.com/20231231": 2 }, "contextCount": 113, "entityCount": 1, "segmentCount": 43, "elementCount": 477, "unitCount": 9, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 497, "http://xbrl.sec.gov/dei/2023": 38, "http://xbrl.sec.gov/ecd/2023": 8 }, "report": { "R1": { "role": "http://virnetx.com/role/DocumentAndEntityInformation", "longName": "000100 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R2": { "role": "http://virnetx.com/role/ConsolidatedBalanceSheets", "longName": "010000 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c20231231", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231231", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R3": { "role": "http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c20231231", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231231", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R4": { "role": "http://virnetx.com/role/ConsolidatedStatementsOfOperations", "longName": "020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R5": { "role": "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss", "longName": "030000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS)", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:NetIncomeLoss", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "unique": true } }, "R6": { "role": "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity", "longName": "040000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c20211231_StatementEquityComponentsAxis_CommonStockAndAdditionalPaidInCapitalMember", "name": "us-gaap:StockholdersEquity", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20211231_StatementEquityComponentsAxis_CommonStockAndAdditionalPaidInCapitalMember", "name": "us-gaap:StockholdersEquity", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R7": { "role": "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquityParenthetical", "longName": "040100 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:CommonStockDividendsPerShareCashPaid", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows", "longName": "050000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:NetIncomeLoss", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:ProvisionForDoubtfulAccounts", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "unique": true } }, "R9": { "role": "http://virnetx.com/role/FormationAndBusinessOfCompany", "longName": "060100 - Disclosure - Formation and Business of the Company", "shortName": "Formation and Business of the Company", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R10": { "role": "http://virnetx.com/role/SummaryOfSignificantAccountingPolicies", "longName": "060200 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R11": { "role": "http://virnetx.com/role/PropertyAndEquipment", "longName": "060300 - Disclosure - Property and Equipment", "shortName": "Property and Equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R12": { "role": "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactions", "longName": "060400 - Disclosure - Commitments, Contingencies and Related Party Transactions", "shortName": "Commitments, Contingencies and Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:CommitmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:CommitmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R13": { "role": "http://virnetx.com/role/StockPlan", "longName": "060500 - Disclosure - Stock Plan", "shortName": "Stock Plan", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "vhc:StockPlanTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "vhc:StockPlanTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R14": { "role": "http://virnetx.com/role/StockbasedCompensation", "longName": "060600 - Disclosure - Stock-Based Compensation", "shortName": "Stock-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R15": { "role": "http://virnetx.com/role/EarningsPerShare", "longName": "060700 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R16": { "role": "http://virnetx.com/role/CommonStock", "longName": "060800 - Disclosure - Common Stock", "shortName": "Common Stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "vhc:CommonStockDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "vhc:CommonStockDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R17": { "role": "http://virnetx.com/role/EmployeeBenefitPlan", "longName": "060900 - Disclosure - Employee Benefit Plan", "shortName": "Employee Benefit Plan", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R18": { "role": "http://virnetx.com/role/IncomeTaxes", "longName": "061000 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R19": { "role": "http://virnetx.com/role/FairValueMeasurement", "longName": "061100 - Disclosure - Fair Value Measurement", "shortName": "Fair Value Measurement", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R20": { "role": "http://virnetx.com/role/Litigation", "longName": "061200 - Disclosure - Litigation", "shortName": "Litigation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R21": { "role": "http://virnetx.com/role/Leases", "longName": "061300 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R22": { "role": "http://virnetx.com/role/SubsequentEvent", "longName": "061400 - Disclosure - Subsequent Event", "shortName": "Subsequent Event", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R23": { "role": "http://virnetx.com/role/InsiderTradingArrangements", "longName": "061500 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c20231001to20231231", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231001to20231231", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R24": { "role": "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "070200 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R25": { "role": "http://virnetx.com/role/PropertyAndEquipmentTables", "longName": "080300 - Disclosure - Property and Equipment (Tables)", "shortName": "Property and Equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R26": { "role": "http://virnetx.com/role/StockbasedCompensationTables", "longName": "080600 - Disclosure - Stock-Based Compensation (Tables)", "shortName": "Stock-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R27": { "role": "http://virnetx.com/role/EarningsPerShareTables", "longName": "080700 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R28": { "role": "http://virnetx.com/role/CommonStockTables", "longName": "080800 - Disclosure - Common Stock (Tables)", "shortName": "Common Stock (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R29": { "role": "http://virnetx.com/role/IncomeTaxesTables", "longName": "081000 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R30": { "role": "http://virnetx.com/role/FairValueMeasurementTables", "longName": "081100 - Disclosure - Fair Value Measurement (Tables)", "shortName": "Fair Value Measurement (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R31": { "role": "http://virnetx.com/role/LeasesTables", "longName": "081300 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R32": { "role": "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails", "longName": "090100 - Disclosure - Formation and Business of the Company (Details)", "shortName": "Formation and Business of the Company (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "c20231231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember", "name": "vhc:NumberOfPatentsAndPendingApplicationsOwned", "unitRef": "U004", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231231_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember", "name": "vhc:NumberOfPatentsAndPendingApplicationsOwned", "unitRef": "U004", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R33": { "role": "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails", "longName": "090200 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R34": { "role": "http://virnetx.com/role/PropertyAndEquipmentDetails", "longName": "090300 - Disclosure - Property and Equipment (Details)", "shortName": "Property and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c20231231", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231231", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R35": { "role": "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails", "longName": "090400 - Disclosure - Commitments, Contingencies and Related Party Transactions (Details)", "shortName": "Commitments, Contingencies and Related Party Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c20230101to20231231_CounterpartyNameAxis_K2InvestmentFundLLCMember_PropertyPlantAndEquipmentByTypeAxis_AirTransportationEquipmentMember", "name": "us-gaap:AircraftRentalAndLandingFees", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20231231_CounterpartyNameAxis_K2InvestmentFundLLCMember_PropertyPlantAndEquipmentByTypeAxis_AirTransportationEquipmentMember", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "unique": true } }, "R36": { "role": "http://virnetx.com/role/StockPlanDetails", "longName": "090500 - Disclosure - Stock Plan (Details)", "shortName": "Stock Plan (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c20230601to20230630_PlanNameAxis_AmendedAndRestatedEquityIncentivePlanMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230601to20230630_PlanNameAxis_AmendedAndRestatedEquityIncentivePlanMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R37": { "role": "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails", "longName": "090600 - Disclosure - Stock-Based Compensation, Information about Stock Options Outstanding (Details)", "shortName": "Stock-Based Compensation, Information about Stock Options Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c20231231_AwardTypeAxis_EmployeeStockOptionMember", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231231_AwardTypeAxis_EmployeeStockOptionMember", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R38": { "role": "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails", "longName": "090602 - Disclosure - Stock-Based Compensation, Summary of Stock Option Activity (Details)", "shortName": "Stock-Based Compensation, Summary of Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c20221231_AwardTypeAxis_EmployeeStockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20211231_AwardTypeAxis_EmployeeStockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "unique": true } }, "R39": { "role": "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails", "longName": "090604 - Disclosure - Stock-Based Compensation, Summary of Restricted Stock Units and Restricted Stock Awards Activity (Details)", "shortName": "Stock-Based Compensation, Summary of Restricted Stock Units and Restricted Stock Awards Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c20231231", "name": "us-gaap:SharePrice", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231231", "name": "us-gaap:SharePrice", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R40": { "role": "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails", "longName": "090606 - Disclosure - Stock-Based Compensation, Stock-Based Compensation by Type of Award (Details)", "shortName": "Stock-Based Compensation, Stock-Based Compensation by Type of Award (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20231231", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "unique": true } }, "R41": { "role": "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails", "longName": "090608 - Disclosure - Stock-Based Compensation, Fair Value Assumptions Used (Details)", "shortName": "Stock-Based Compensation, Fair Value Assumptions Used (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "U006", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "U006", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R42": { "role": "http://virnetx.com/role/EarningsPerShareDetails", "longName": "090700 - Disclosure - Earnings Per Share (Details)", "shortName": "Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:NetIncomeLoss", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "unique": true } }, "R43": { "role": "http://virnetx.com/role/CommonStockSummaryDetails", "longName": "090800 - Disclosure - Common Stock, Summary (Details)", "shortName": "Common Stock, Summary (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c20231231", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember", "name": "vhc:NumberOfVotesEntitledToEachShareOfCommonStock", "unitRef": "U007", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "unique": true } }, "R44": { "role": "http://virnetx.com/role/CommonStockWarrantsDetails", "longName": "090802 - Disclosure - Common Stock, Warrants (Details)", "shortName": "Common Stock, Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c20201231_AwardDateAxis_WarrantIssuanceDate2Member_AwardTypeAxis_WarrantMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20201231_AwardDateAxis_WarrantIssuanceDate2Member_AwardTypeAxis_WarrantMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "unitRef": "U003", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R45": { "role": "http://virnetx.com/role/EmployeeBenefitPlanDetails", "longName": "090900 - Disclosure - Employee Benefit Plan (Details)", "shortName": "Employee Benefit Plan (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R46": { "role": "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails", "longName": "091000 - Disclosure - Income Taxes, Components of Provision (Benefit) for Income Taxes (Details)", "shortName": "Income Taxes, Components of Provision (Benefit) for Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R47": { "role": "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails", "longName": "091002 - Disclosure - Income Taxes, Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)", "shortName": "Income Taxes, Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "U006", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "U006", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R48": { "role": "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails", "longName": "091004 - Disclosure - Income Taxes, Components of Deferred Tax Assets (Liabilities) (Details)", "shortName": "Income Taxes, Components of Deferred Tax Assets (Liabilities) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c20231231", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231231", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R49": { "role": "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails", "longName": "091006 - Disclosure - Income Taxes, Pre-tax Income (Losses) and Operating Loss Carryforwards (Details)", "shortName": "Income Taxes, Pre-tax Income (Losses) and Operating Loss Carryforwards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c20231231", "name": "vhc:CapitalizedDirectAndIndirectResearchAndDevelopmentCosts", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231231", "name": "vhc:CapitalizedDirectAndIndirectResearchAndDevelopmentCosts", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R50": { "role": "http://virnetx.com/role/IncomeTaxesIncomeTaxUncertaintiesDetails", "longName": "091008 - Disclosure - Income Taxes, Income Tax Uncertainties (Details)", "shortName": "Income Taxes, Income Tax Uncertainties (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c20231231", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231231", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R51": { "role": "http://virnetx.com/role/FairValueMeasurementDetails", "longName": "091100 - Disclosure - Fair Value Measurement (Details)", "shortName": "Fair Value Measurement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c20231231", "name": "vhc:CashAndAvailableForSaleSecuritiesAmortizedCostBasis", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231231", "name": "vhc:CashAndAvailableForSaleSecuritiesAmortizedCostBasis", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R52": { "role": "http://virnetx.com/role/LitigationDetails", "longName": "091200 - Disclosure - Litigation (Details)", "shortName": "Litigation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c20230407to20230407_LitigationCaseAxis_VirnetXIncVCiscoSystemsIncUSCAFCCase231765Member", "name": "vhc:OpeningBriefDuePeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230407to20230407_LitigationCaseAxis_VirnetXIncVCiscoSystemsIncUSCAFCCase231765Member", "name": "vhc:OpeningBriefDuePeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R53": { "role": "http://virnetx.com/role/LeasesSummaryDetails", "longName": "091300 - Disclosure - Leases, Summary (Details)", "shortName": "Leases, Summary (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c20230101to20231231", "name": "vhc:OperatingLeasePeriodOfFreeRent", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20230101to20231231", "name": "vhc:OperatingLeasePeriodOfFreeRent", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R54": { "role": "http://virnetx.com/role/LeasesLeaseLiabilityDetails", "longName": "091302 - Disclosure - Leases, Lease Liability (Details)", "shortName": "Leases, Lease Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c20231231_PropertyPlantAndEquipmentByTypeAxis_OfficeAndFacilityMember", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231231_PropertyPlantAndEquipmentByTypeAxis_OfficeAndFacilityMember", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "U001", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true, "unique": true } }, "R55": { "role": "http://virnetx.com/role/SubsequentEventDetails", "longName": "091400 - Disclosure - Subsequent Event (Details)", "shortName": "Subsequent Event (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c20230101to20231231_AwardTypeAxis_RestrictedStockMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "div", "ix:continuation", "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "c20240101to20240131_AwardTypeAxis_RestrictedStockMember_PlanNameAxis_AmendedAndRestatedEquityIncentivePlanMember_SubsequentEventTypeAxis_SubsequentEventMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "U002", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20015315_10k.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued liabilities", "label": "Accounts Payable and Accrued Liabilities, Current", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r31" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivables", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r242", "r243" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://virnetx.com/role/PropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r56", "r170", "r524" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r38", "r39", "r96", "r175", "r520", "r538", "r539" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss [Member]", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r5", "r16", "r39", "r436", "r439", "r470", "r534", "r535", "r674", "r675", "r676", "r680", "r681", "r682" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r91", "r637", "r747" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock-based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r75", "r76", "r357" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net (loss) to net cash from operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AirTransportationEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AirTransportationEquipmentMember", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails", "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aircraft [Member]", "label": "Air Transportation Equipment [Member]", "documentation": "Equipment used for the primary purpose of air transportation." } } }, "auth_ref": [] }, "us-gaap_AircraftRentalAndLandingFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AircraftRentalAndLandingFees", "crdr": "debit", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails", "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "label": "Rental fees incurred for use of aircraft", "documentation": "Expenses incurred related to the lease of aircraft from outside third parties that are used in the entity's business operations and direct costs incurred at airports primarily consisting of fees paid to the airport authority for takeoff and landing, gate and facility fees, and other related fees." } } }, "auth_ref": [ "r99" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows", "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation", "terseLabel": "Stock-based compensation expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r389", "r401" ] }, "vhc_AmendedAndRestatedEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "AmendedAndRestatedEquityIncentivePlanMember", "presentation": [ "http://virnetx.com/role/StockPlanDetails", "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "documentation": "The equity incentive plan has been amended and restated by the entity.", "label": "Amended and Restated Equity Incentive Plan [Member]", "terseLabel": "Amended and Restated Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "vhc_AmortizationOfCapitalizedDirectAndIndirectResearchAndDevelopmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "AmortizationOfCapitalizedDirectAndIndirectResearchAndDevelopmentCosts", "crdr": "debit", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amortization of capitalized direct and indirect research and development costs during the period.", "label": "Amortization of Capitalized Direct and Indirect Research and Development Costs", "terseLabel": "Amortization of capitalized direct and indirect research and development costs" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r128", "r171", "r196", "r227", "r233", "r237", "r282", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r431", "r433", "r452", "r516", "r577", "r637", "r648", "r694", "r695", "r736" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r166", "r176", "r196", "r282", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r431", "r433", "r452", "r637", "r694", "r695", "r736" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets [Abstract]", "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r652", "r653", "r654" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r652", "r653", "r654" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r652", "r653", "r654" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "crdr": "credit", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Unrealized Gains", "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r250" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized Losses", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r251" ] }, "vhc_AvailableForSaleSecuritiesDebtMaturityPeriod": { "xbrltype": "durationItemType", "nsuri": "http://virnetx.com/20231231", "localname": "AvailableForSaleSecuritiesDebtMaturityPeriod", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "documentation": "Period of maturity of a debt security categorized as neither trading nor held-to-maturity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Available-for-sale Securities, Debt Maturity Period", "terseLabel": "Maturities of investments" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Investments available for sale", "label": "Debt Securities, Available-for-Sale, Current", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current." } } }, "auth_ref": [ "r245", "r291" ] }, "vhc_AvailableForSaleSecuritiesExcludingCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "AvailableForSaleSecuritiesExcludingCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading, excluding cash and cash equivalents.", "label": "Available-for-sale Securities, Excluding Cash and Cash Equivalents", "terseLabel": "Investments Available for Sale" } } }, "auth_ref": [] }, "us-gaap_AvailableforsaleSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableforsaleSecuritiesMember", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total Investment Securities [Member]", "label": "Available-for-Sale Securities [Member]", "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r133" ] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateAxis", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Award Date [Axis]", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723" ] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateDomain", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Award Date [Domain]", "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails", "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails", "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails", "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails", "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r360", "r361", "r362", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r384", "r385", "r386", "r387", "r388" ] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingMember", "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails", "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "label": "Building [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r109" ] }, "vhc_CapitalizedDirectAndIndirectResearchAndDevelopmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "CapitalizedDirectAndIndirectResearchAndDevelopmentCosts", "crdr": "debit", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of capitalized direct and indirect research and development costs.", "label": "Capitalized Direct and Indirect Research and Development Costs", "terseLabel": "Capitalized direct and indirect research and development costs" } } }, "auth_ref": [] }, "vhc_CashAndAvailableForSaleSecuritiesAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "CashAndAvailableForSaleSecuritiesAmortizedCostBasis", "crdr": "debit", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "documentation": "This item represents the cost of cash and debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.", "label": "Cash and Available-for-sale Securities, Amortized Cost Basis", "terseLabel": "Adjusted Cost" } } }, "auth_ref": [] }, "vhc_CashAndAvailableForSaleSecuritiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "CashAndAvailableForSaleSecuritiesFairValueDisclosure", "crdr": "debit", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "documentation": "Fair value portion of cash and investment in debt and equity securities categorized neither as held-to-maturity nor trading.", "label": "Cash and Available-for-sale Securities, Fair Value Disclosure", "terseLabel": "Fair Value" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r43", "r168", "r616" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r44" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents, beginning of period", "periodEndLabel": "Cash and cash equivalents, end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r43", "r103", "r194" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net (decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r4", "r103" ] }, "us-gaap_CashMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashMember", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Cash [Member]", "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits." } } }, "auth_ref": [ "r168" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDisclosuresAbstract", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock [Abstract]", "label": "Class of Stock Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price (in dollars per share)", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r324" ] }, "vhc_ClassOfWarrantOrRightExpirationDate": { "xbrltype": "dateItemType", "nsuri": "http://virnetx.com/20231231", "localname": "ClassOfWarrantOrRightExpirationDate", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Date the warrants or rights are to expire, in CCYY-MM-DD format.", "label": "Class of Warrant or Right, Expiration Date", "terseLabel": "Expiration date" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants issued (in shares)", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r324" ] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Table]", "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r64" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies (Note 4)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r36", "r83", "r517", "r564" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments, Contingencies and Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsDisclosureTextBlock", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Commitments, Contingencies and Related Party Transactions", "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights." } } }, "auth_ref": [ "r111" ] }, "vhc_CommonStockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://virnetx.com/20231231", "localname": "CommonStockAbstract", "lang": { "en-us": { "role": { "label": "Common Stock [Abstract]" } } }, "auth_ref": [] }, "vhc_CommonStockAndAdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "CommonStockAndAdditionalPaidInCapitalMember", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Common stock that is subordinate to all other stock of the issuer and excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders related to additional paid-in capital.", "label": "Common Stock and Additional Paid-in Capital [Member]", "terseLabel": "Common Stock and Additional Paid-in Capital [Member]" } } }, "auth_ref": [] }, "vhc_CommonStockDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://virnetx.com/20231231", "localname": "CommonStockDisclosureTextBlock", "presentation": [ "http://virnetx.com/role/CommonStock" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for common stock.", "label": "Common Stock Disclosure [Text Block]", "verboseLabel": "Common Stock" } } }, "auth_ref": [] }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareCashPaid", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails", "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquityParenthetical" ], "lang": { "en-us": { "role": { "label": "Dividends per share (in dollars per share)", "verboseLabel": "Dividends per share (in dollars per share)", "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r115" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r639", "r640", "r641", "r643", "r644", "r645", "r646", "r680", "r681", "r731", "r746", "r748" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails", "http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock, par value (in dollars per share)", "label": "Common stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r90" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails", "http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common stock, shares authorized (in shares)", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r90", "r565" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued (in shares)", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r90" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding (in shares)", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r17", "r90", "r565", "r583", "r748", "r749" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at December 31, 2023 and December 31, 2022, Issued and outstanding: 3,618,431 and 3,578,983 shares, at December 31, 2023 and December 31, 2022, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r90", "r519", "r637" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Employee Benefit Plan [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfDeferredTaxAssetsAbstract", "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract", "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets and Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive (loss)", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r40", "r181", "r183", "r188", "r509", "r529" ] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://virnetx.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration of Credit Risk and Other Risks and Uncertainties", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r84", "r137" ] }, "vhc_ConcentrationRiskNumberOfFinancialInstitutions": { "xbrltype": "integerItemType", "nsuri": "http://virnetx.com/20231231", "localname": "ConcentrationRiskNumberOfFinancialInstitutions", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of financial institutions holding the company's cash and cash equivalents.", "label": "Concentration Risk, Number of Financial Institutions", "terseLabel": "Number of financial institutions holding company's cash" } } }, "auth_ref": [] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r80", "r620" ] }, "vhc_ContractualMaturitiesOfInvestmentSecurities": { "xbrltype": "durationItemType", "nsuri": "http://virnetx.com/20231231", "localname": "ContractualMaturitiesOfInvestmentSecurities", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of investment securities, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Contractual Maturities of Investment Securities", "terseLabel": "Contractual maturities of investment securities" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails", "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r198", "r199", "r314", "r319", "r471", "r617", "r619" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Federal", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r663", "r679", "r729" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Current Foreign Tax Expense (Benefit)", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r663", "r679" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Current income tax provision (benefit)", "label": "Current Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r122", "r420", "r426", "r679" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "State", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r663", "r679", "r729" ] }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleTable", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Available-for-sale Securities [Table]", "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257" ] }, "us-gaap_DebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesMember", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Highly Liquid Debt Investments [Member]", "label": "Debt Securities [Member]", "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions." } } }, "auth_ref": [ "r51", "r641", "r751" ] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Deferred Federal Income Tax Expense (Benefit)", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r679", "r728", "r729" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred income tax provision (benefit)", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r10", "r122", "r143", "r425", "r426", "r679" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Total deferred tax liability - depreciation and amortization", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r87", "r88", "r129", "r414" ] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "Deferred State and Local Income Tax Expense (Benefit)", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r679", "r728", "r729" ] }, "vhc_DeferredTaxAssetsCapitalizedDirectAndIndirectResearchAndDevelopmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "DeferredTaxAssetsCapitalizedDirectAndIndirectResearchAndDevelopmentCosts", "crdr": "debit", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalized direct and indirect research and development costs.", "label": "Deferred Tax Assets, Capitalized Direct and Indirect Research and Development Costs", "terseLabel": "Deferred tax assets relating to capitalized direct and indirect research and development costs" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax assets", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r415" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r726" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred tax assets after valuation allowance", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r726" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Net operating loss carry forward", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r79", "r727" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsComponentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsComponentsAbstract", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes [Abstract]", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Components [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Deferred Tax Assets, Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r79", "r727" ] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Research and development credits and other credits", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards." } } }, "auth_ref": [ "r78", "r79", "r727" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Stock based compensation", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs." } } }, "auth_ref": [ "r79", "r727" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "crdr": "debit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Reserves and accruals", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals." } } }, "auth_ref": [ "r79", "r727" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r416" ] }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "crdr": "debit", "presentation": [ "http://virnetx.com/role/EmployeeBenefitPlanDetails" ], "lang": { "en-us": { "role": { "label": "Matching contribution to defined contribution plan", "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows", "http://virnetx.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation", "terseLabel": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r10", "r55" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://virnetx.com/role/StockbasedCompensation" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r355", "r359", "r390", "r391", "r393", "r634" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Stock-Based Compensation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DividendsCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCash", "crdr": "debit", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends", "label": "Dividends, Cash", "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred." } } }, "auth_ref": [ "r7", "r115" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r652", "r653", "r654" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r652", "r653", "r654", "r656" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r655" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticCountryMember", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "label": "Federal [Member]", "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations", "http://virnetx.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (loss) per share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r189", "r205", "r206", "r207", "r208", "r209", "r214", "r216", "r218", "r219", "r220", "r224", "r443", "r444", "r510", "r530", "r621" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations", "http://virnetx.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (loss) per share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r189", "r205", "r206", "r207", "r208", "r209", "r216", "r218", "r219", "r220", "r224", "r443", "r444", "r510", "r530", "r621" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r46", "r47" ] }, "us-gaap_EarningsPerShareReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareReconciliationAbstract", "presentation": [ "http://virnetx.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Calculation of basic and diluted loss per share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://virnetx.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "verboseLabel": "Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r213", "r221", "r222", "r223" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Effective income tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r408" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract", "presentation": [ "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Effective Tax Rate Reconciliation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "United States federal statutory rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r197", "r408", "r427" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "calculation": { "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Valuation allowance", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r725", "r730" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "calculation": { "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Other", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r725", "r730" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "calculation": { "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock based compensation", "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r662", "r725" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "calculation": { "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "State taxes, net of federal benefit", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r725", "r730" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch", "calculation": { "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "R&D Credit", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit." } } }, "auth_ref": [ "r725", "r730" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued payroll and related expenses", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r33" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://virnetx.com/role/StockPlanDetails", "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]", "terseLabel": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized stock-based compensation expense expected to be recognized related to stock awards", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r392" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract", "presentation": [ "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails" ], "lang": { "en-us": { "role": { "label": "Compensation cost not yet recognized [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average period for recognition of unrecognized stock-based compensation expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r392" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized stock-based compensation expense expected to be recognized related to unvested stock awards", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r724" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized stock-based compensation expense expected to be recognized related to unvested stock options", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r724" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails", "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails", "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Stock Options [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r650" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r650" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r650" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r659" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r650" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r650" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r650" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r650" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r660" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails", "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r17", "r164", "r185", "r186", "r187", "r200", "r201", "r202", "r204", "r210", "r212", "r225", "r283", "r284", "r325", "r394", "r395", "r396", "r421", "r422", "r435", "r436", "r437", "r438", "r439", "r440", "r442", "r456", "r457", "r458", "r459", "r460", "r461", "r470", "r534", "r535", "r536", "r553", "r603" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "auth_ref": [ "r279", "r280", "r281" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "crdr": "debit", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment in equity security without readily determinable fair value", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "documentation": "Amount of investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r277" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAnnualAmountAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAnnualAmountAbstract", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment in Equity Securities without Readily Determinable Fair Value [Abstract]", "label": "Equity Securities without Readily Determinable Fair Value, Annual Amount [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "crdr": "debit", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment on investment in equity security without readily determinable fair value", "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount", "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r278" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Equity Securities without Readily Determinable Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r685", "r686", "r687" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueTable", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Equity Securities without Readily Determinable Fair Value [Table]", "documentation": "Disclosure of information about investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r685", "r686", "r687" ] }, "vhc_ExercisePriceRange1Member": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "ExercisePriceRange1Member", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents Options within the stated exercise price range.", "label": "Exercise Price Range 1 [Member]", "terseLabel": "$10.00 - 31.60 [Member]" } } }, "auth_ref": [] }, "vhc_ExercisePriceRange2Member": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "ExercisePriceRange2Member", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents Options within the stated exercise price range.", "label": "Exercise Price Range 2 [Member]", "terseLabel": "$34.80 - 139.00 [Member]" } } }, "auth_ref": [] }, "vhc_ExercisePriceRange3Member": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "ExercisePriceRange3Member", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents options within the stated exercise price range.", "label": "Exercise Price Range 3 [Member]", "terseLabel": "$290.40 - 308.00 [Member]" } } }, "auth_ref": [] }, "vhc_FacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "FacilityMember", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "documentation": "Operating lease for facility.", "label": "Facility [Member]", "terseLabel": "Facility [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r446", "r447", "r450" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r446", "r447", "r450" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://virnetx.com/role/FairValueMeasurementTables" ], "lang": { "en-us": { "role": { "label": "Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Financial Assets", "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r81", "r126" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r18" ] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r81", "r82" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r315", "r339", "r340", "r341", "r342", "r343", "r344", "r447", "r478", "r479", "r480", "r627", "r628", "r630", "r631", "r632" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r446", "r447", "r448", "r449", "r451" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Measurement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://virnetx.com/role/FairValueMeasurement" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair Value Measurement", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r445" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r315", "r339", "r344", "r447", "r478", "r630", "r631", "r632" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r315", "r339", "r340", "r341", "r342", "r343", "r344", "r478", "r479", "r480", "r627", "r628", "r630", "r631", "r632" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "label": "Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r445", "r451" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r12", "r29" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r285", "r286", "r288", "r289", "r290", "r292", "r293", "r294", "r316", "r322", "r441", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r528", "r626", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r684", "r685", "r686", "r687" ] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Estimated useful lives", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r295", "r296", "r297", "r298", "r507", "r508" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails", "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r507" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r53", "r54" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNetAbstract", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets [Abstract]", "label": "Finite-Lived Intangible Assets, Net [Abstract]" } } }, "auth_ref": [] }, "vhc_FormationAndBusinessOfTheCompanyDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://virnetx.com/20231231", "localname": "FormationAndBusinessOfTheCompanyDisclosureAbstract", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails" ], "lang": { "en-us": { "role": { "label": "Formation and Business of the Company Disclosure [Abstract]", "terseLabel": "Formation and Business of the Company Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GainContingenciesByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainContingenciesByNatureAxis", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "label": "Gain Contingencies, Nature [Axis]", "documentation": "Information by nature of gain contingency." } } }, "auth_ref": [ "r693" ] }, "us-gaap_GainContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainContingenciesLineItems", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "label": "Gain Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r693" ] }, "vhc_GainContingenciesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://virnetx.com/20231231", "localname": "GainContingenciesPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for an existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization, and describes and quantifies a gain recognized in the period resulting from resolution of a previously disclosed gain contingency.", "label": "Gain Contingencies [Policy Text Block]", "terseLabel": "Contingent Gains" } } }, "auth_ref": [] }, "us-gaap_GainContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainContingenciesTable", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "label": "Gain Contingencies [Table]", "documentation": "Sets forth the existing conditions, situations, or sets of circumstances involving uncertainties as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization, and previously disclosed contingent gains that were recognized as income in the period." } } }, "auth_ref": [ "r693" ] }, "us-gaap_GainContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainContingencyNatureDomain", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "label": "Gain Contingency, Nature [Domain]", "documentation": "Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization." } } }, "auth_ref": [ "r693" ] }, "us-gaap_GainContingencyQuantitiesPatentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainContingencyQuantitiesPatentsAbstract", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation [Abstract]", "label": "Gain Contingency, Quantities, Patents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GeographicDistributionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeographicDistributionAxis", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails" ], "lang": { "en-us": { "role": { "label": "Geographic Distribution [Axis]", "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities." } } }, "auth_ref": [ "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r511", "r512", "r625" ] }, "us-gaap_GeographicDistributionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeographicDistributionDomain", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails" ], "lang": { "en-us": { "role": { "label": "Geographic Distribution [Domain]", "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities." } } }, "auth_ref": [ "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r511", "r512" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible Assets", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r13", "r52" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r652", "r653", "r654" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of Long-Lived Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r110" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "(Loss) before taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r1", "r97", "r131", "r227", "r232", "r236", "r238", "r512", "r526", "r623" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r299", "r300", "r588" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r300", "r588" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Taxes [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://virnetx.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "verboseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r197", "r403", "r409", "r412", "r418", "r423", "r428", "r429", "r430", "r552" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 1.0 }, "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations", "http://virnetx.com/role/IncomeTaxesComponentsOfProvisionBenefitForIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total income tax (benefit) provision", "negatedLabel": "Income tax (provision) benefit", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r134", "r144", "r211", "r212", "r230", "r407", "r424", "r532" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r184", "r405", "r406", "r412", "r413", "r417", "r419", "r546" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for income taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r45" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivables", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r9" ] }, "vhc_IncreaseDecreaseInAccruedLicensingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "IncreaseDecreaseInAccruedLicensingCosts", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in accrued licensing costs during the reporting period.", "label": "Increase (Decrease) in Accrued Licensing Costs", "terseLabel": "Accrued licensing costs" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred income taxes", "label": "Increase (Decrease) in Deferred Income Taxes", "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued payroll and related expenses", "label": "Increase (Decrease) in Employee Related Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Increase (Decrease) in Other Operating Liabilities", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInPrepaidTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidTaxes", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid income taxes", "label": "Increase (Decrease) in Prepaid Taxes", "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "vhc_InformationAboutWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://virnetx.com/20231231", "localname": "InformationAboutWarrantsAbstract", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Information About Warrants [Abstract]", "terseLabel": "Warrants [Abstract]" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r657" ] }, "us-gaap_IntellectualPropertyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntellectualPropertyMember", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails" ], "lang": { "en-us": { "role": { "label": "Intellectual Property [Member]", "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights." } } }, "auth_ref": [ "r28" ] }, "us-gaap_InterestAndOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndOtherIncome", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Interest and other income, net", "label": "Interest and Other Income", "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [] }, "us-gaap_InvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Investment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for investment in financial asset." } } }, "auth_ref": [ "r531", "r542", "r543", "r544", "r545", "r607", "r608" ] }, "us-gaap_InvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAbstract", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Investments [Abstract]" } } }, "auth_ref": [] }, "vhc_K2InvestmentFundLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "K2InvestmentFundLLCMember", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails", "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "documentation": "The counterparty from which the Company leased the use of an aircraft for business travel for employees of the Company", "label": "K2 Investment Fund LLC [Member]", "terseLabel": "K2 Investment Fund LLC [Member]" } } }, "auth_ref": [] }, "vhc_L2HoldingsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "L2HoldingsLLCMember", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Investment in a nonconsolidated investee.", "label": "L2 Holdings LLC [Member]", "terseLabel": "L2 Holdings LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeasesOperatingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesOperatingAbstract", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments, Contingencies and Related Party Transactions [Abstract]", "label": "Leases, Operating [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LegalMattersAndContingenciesTextBlock", "presentation": [ "http://virnetx.com/role/Litigation" ], "lang": { "en-us": { "role": { "verboseLabel": "Litigation", "label": "Legal Matters and Contingencies [Text Block]", "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies." } } }, "auth_ref": [ "r112" ] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails", "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r467" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails", "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r467" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r466" ] }, "us-gaap_LesseeOperatingLeaseDescriptionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseDescriptionAbstract", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails", "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "verboseLabel": "Leases [Abstract]", "label": "Lessee, Operating Lease, Description [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseDiscountRate", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease discount rate using risk-free rate", "label": "Lessee, Operating Lease, Discount Rate", "documentation": "Discount rate used by lessee to determine present value of operating lease payments." } } }, "auth_ref": [ "r635" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://virnetx.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Lease Liability", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r735" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://virnetx.com/role/LeasesLeaseLiabilityDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://virnetx.com/role/LeasesLeaseLiabilityDetailsCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total undiscounted lease liability", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r469" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://virnetx.com/role/LeasesLeaseLiabilityDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Thereafter", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r469" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://virnetx.com/role/LeasesLeaseLiabilityDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Due in 2024", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r469" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://virnetx.com/role/LeasesLeaseLiabilityDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Due in 2028", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r469" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://virnetx.com/role/LeasesLeaseLiabilityDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Due in 2027", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r469" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://virnetx.com/role/LeasesLeaseLiabilityDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Due in 2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r469" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://virnetx.com/role/LeasesLeaseLiabilityDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Due in 2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r469" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://virnetx.com/role/LeasesLeaseLiabilityDetailsCalc2": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r469" ] }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRenewalTerm", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease renewal period", "label": "Lessee, Operating Lease, Renewal Term", "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r734" ] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Term of lease", "label": "Lessee, Operating Lease, Term of Contract", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r734" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://virnetx.com/role/Leases" ], "lang": { "en-us": { "role": { "label": "Leases", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r463" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r32", "r196", "r282", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r432", "r433", "r434", "r452", "r563", "r622", "r648", "r694", "r736", "r737" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r95", "r130", "r522", "r637", "r678", "r688", "r732" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r34", "r167", "r196", "r282", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r432", "r433", "r434", "r452", "r637", "r694", "r736", "r737" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "auth_ref": [] }, "vhc_LicensingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "LicensingCosts", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "The aggregate licensing costs related to revenues.", "label": "Licensing Costs", "verboseLabel": "Licensing costs" } } }, "auth_ref": [] }, "vhc_LicensingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://virnetx.com/20231231", "localname": "LicensingCostsPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the licensing costs.", "label": "Licensing Costs [Policy Text Block]", "terseLabel": "Licensing Costs" } } }, "auth_ref": [] }, "vhc_LitigationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://virnetx.com/20231231", "localname": "LitigationAbstract", "lang": { "en-us": { "role": { "label": "Litigation [Abstract]" } } }, "auth_ref": [] }, "srt_LitigationCaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "LitigationCaseAxis", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]" } } }, "auth_ref": [] }, "srt_LitigationCaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "LitigationCaseTypeDomain", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LossContingencyDamagesAwardedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyDamagesAwardedValue", "crdr": "debit", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of damages awarded in patent infringement case", "label": "Loss Contingency, Damages Awarded, Value", "documentation": "Amount of damages awarded to the plaintiff in the legal matter." } } }, "auth_ref": [ "r690", "r691", "r692" ] }, "vhc_LossContingencyNumberOfAppealsConsolidated": { "xbrltype": "integerItemType", "nsuri": "http://virnetx.com/20231231", "localname": "LossContingencyNumberOfAppealsConsolidated", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of appeals consolidated in a court order.", "label": "Loss Contingency, Number of Appeals Consolidated", "terseLabel": "Number of appeals consolidated" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails", "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r301", "r302", "r303", "r304", "r354", "r505", "r533", "r555", "r556", "r606", "r609", "r610", "r611", "r612", "r613", "r614", "r624", "r629", "r633", "r638", "r696", "r738", "r739", "r740", "r741", "r742", "r743" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails", "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r301", "r302", "r303", "r304", "r354", "r505", "r533", "r555", "r556", "r606", "r609", "r610", "r611", "r612", "r613", "r614", "r624", "r629", "r633", "r638", "r696", "r738", "r739", "r740", "r741", "r742", "r743" ] }, "us-gaap_MutualFundMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MutualFundMember", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Mutual Funds [Member]", "label": "Mutual Fund [Member]", "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective." } } }, "auth_ref": [ "r697" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r193" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r193" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r103", "r104", "r105" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 0.0 }, "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://virnetx.com/role/ConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows", "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss", "http://virnetx.com/role/ConsolidatedStatementsOfOperations", "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://virnetx.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Net (loss)", "totalLabel": "Net (loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r98", "r105", "r132", "r165", "r179", "r182", "r187", "r196", "r203", "r205", "r206", "r207", "r208", "r211", "r212", "r217", "r227", "r232", "r236", "r238", "r282", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r444", "r452", "r527", "r585", "r601", "r602", "r623", "r647", "r694" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://virnetx.com/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r658" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://virnetx.com/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r658" ] }, "us-gaap_NonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonUsMember", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign [Member]", "label": "Non-US [Member]", "documentation": "Countries excluding the United States of America (US)." } } }, "auth_ref": [ "r750", "r752", "r753", "r754" ] }, "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock", "presentation": [ "http://virnetx.com/role/StockbasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Activity", "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares." } } }, "auth_ref": [ "r27" ] }, "vhc_NumberOfPatentsAndPendingApplicationsOwned": { "xbrltype": "integerItemType", "nsuri": "http://virnetx.com/20231231", "localname": "NumberOfPatentsAndPendingApplicationsOwned", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents number of patents and pending applications owned by the entity.", "label": "Number of patents and pending applications owned", "terseLabel": "Number of patents and pending applications" } } }, "auth_ref": [] }, "vhc_NumberOfVotesEntitledToEachShareOfCommonStock": { "xbrltype": "integerItemType", "nsuri": "http://virnetx.com/20231231", "localname": "NumberOfVotesEntitledToEachShareOfCommonStock", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails" ], "lang": { "en-us": { "role": { "documentation": "Refers to number of votes entitled to each share of common stock.", "label": "Number of votes entitled to each share of common stock" } } }, "auth_ref": [] }, "vhc_OPMediaMember": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "OPMediaMember", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Investment in a nonconsolidated investee.", "label": "OP Media [Member]", "verboseLabel": "OP Media Inc. [Member]" } } }, "auth_ref": [] }, "vhc_OfficeAndFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "OfficeAndFacilityMember", "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Operating lease for office space and facility.", "label": "Office and Facility [Member]", "terseLabel": "Office and Facility [Member]" } } }, "auth_ref": [] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OfficeEquipmentMember", "presentation": [ "http://virnetx.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Office Furniture [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "vhc_OfficeMember": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "OfficeMember", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "documentation": "Operating lease for office space.", "label": "Office [Member]", "terseLabel": "Office [Member]" } } }, "auth_ref": [] }, "vhc_OpeningBriefDuePeriod": { "xbrltype": "durationItemType", "nsuri": "http://virnetx.com/20231231", "localname": "OpeningBriefDuePeriod", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "documentation": "Opening brief due period after the certified list is filled, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Opening Brief Due Period", "terseLabel": "Opening brief due period" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenseMember", "presentation": [ "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails" ], "lang": { "en-us": { "role": { "label": "Operating Expense [Member]", "documentation": "Primary financial statement caption encompassing expenses associated with normal operations." } } }, "auth_ref": [ "r26" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expense", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating expense:" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "(Loss) from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r227", "r232", "r236", "r238", "r623" ] }, "vhc_OperatingLeaseAnnualObligationForExtension": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "OperatingLeaseAnnualObligationForExtension", "crdr": "credit", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of annual obligation for lease extension.", "label": "Operating Lease, Annual Obligation for Extension,", "terseLabel": "Operating lease, annual payments for lease extension" } } }, "auth_ref": [] }, "vhc_OperatingLeaseCashCommitmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "OperatingLeaseCashCommitmentAmount", "crdr": "credit", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of cash commitment for lease extension.", "label": "Operating Lease, Cash Commitment, Amount", "terseLabel": "Operating lease, commitment" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "label": "Lease expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r733" ] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Future Minimum Rents Due [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://virnetx.com/role/LeasesLeaseLiabilityDetailsCalc2": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/LeasesLeaseLiabilityDetails", "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total lease liability", "label": "Operating lease liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r465" ] }, "vhc_OperatingLeaseMonthlyRentPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "OperatingLeaseMonthlyRentPayment", "crdr": "debit", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of monthly payment for lessee's operating lease.", "label": "Operating Lease, Monthly Rent Payment", "terseLabel": "Operating lease monthly payment" } } }, "auth_ref": [] }, "vhc_OperatingLeasePeriodOfFreeRent": { "xbrltype": "durationItemType", "nsuri": "http://virnetx.com/20231231", "localname": "OperatingLeasePeriodOfFreeRent", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "documentation": "Period of free rent for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Period of Free Rent", "terseLabel": "Period of free rent" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease ROU assets", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r464" ] }, "vhc_OperatingLeaseSinglePayment": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "OperatingLeaseSinglePayment", "crdr": "credit", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of total commitment payable for single payment.", "label": "Operating Lease, Single Payment", "terseLabel": "Operating lease, single payment" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease weighted average remaining life", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r468", "r636" ] }, "us-gaap_OperatingLeasedAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasedAssetsLineItems", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Leased Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "label": "Net operating loss carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r78" ] }, "us-gaap_OperatingLossCarryforwardsExpirationDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsExpirationDate", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "label": "Operating loss carryforwards, expiration date", "documentation": "Expiration date of each operating loss carryforward included in operating loss carryforward, in YYYY-MM-DD format." } } }, "auth_ref": [ "r78" ] }, "us-gaap_OperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsLineItems", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsTable", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Table]", "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r77" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Business Description and Basis of Presentation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompany" ], "lang": { "en-us": { "role": { "verboseLabel": "Formation and Business of the Company", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r86", "r124", "r540", "r541" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss", "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Change in foreign currency translation, net", "label": "Change in foreign currency translation, net", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r6", "r96", "r453", "r454", "r455" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive (loss) gain, net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r8", "r15", "r125", "r180", "r183" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive (loss) income, net of tax:" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss", "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Change in unrealized investment (loss) gain, net", "label": "Change in unrealized (loss) gain on investments, net", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r177", "r178", "r276" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other liabilities, current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r33", "r637" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other liabilities", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r35" ] }, "us-gaap_OtherLongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLongTermInvestments", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other investments", "documentation": "Amount of long-term investments classified as other." } } }, "auth_ref": [ "r515", "r671" ] }, "us-gaap_PatentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PatentsMember", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails" ], "lang": { "en-us": { "role": { "label": "Patents [Member]", "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law." } } }, "auth_ref": [ "r123" ] }, "us-gaap_PaymentsOfDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividends", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividend", "label": "Payments of Dividends", "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests." } } }, "auth_ref": [ "r42" ] }, "us-gaap_PaymentsOfDividendsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsAbstract", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails", "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "label": "Dividend [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Withholding taxes paid on cashless exercise of restricted stock and restricted stock units", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r192" ] }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of investments", "label": "Payments to Acquire Debt Securities, Available-for-Sale", "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r41", "r191", "r244" ] }, "us-gaap_PaymentsToAcquireOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireOtherInvestments", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of investments at cost", "label": "Payments to Acquire Other Investments", "documentation": "Amount of cash outflow to acquire investments classified as other." } } }, "auth_ref": [ "r101" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r102" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://virnetx.com/role/EmployeeBenefitPlan" ], "lang": { "en-us": { "role": { "verboseLabel": "Employee Benefit Plan", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r336", "r337", "r338", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r632" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://virnetx.com/role/StockPlanDetails", "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://virnetx.com/role/StockPlanDetails", "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723" ] }, "us-gaap_PositiveOutcomeOfLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PositiveOutcomeOfLitigationMember", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "label": "Positive Outcome of Litigation [Member]", "documentation": "A potential favorable result upon resolution of a litigation matter, whether through trial, arbitration, mediation, or settlement of a legal threat made to another party, which results in collection of a damages award in cash or in other tangible or intangible assets." } } }, "auth_ref": [ "r693" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r89", "r317" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized (in shares)", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r89", "r565" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued (in shares)", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r89", "r317" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding (in shares)", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r89", "r565", "r583", "r748", "r749" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at December 31, 2023 and December 31, 2022, Issued and outstanding: 0 shares at December 31, 2023 and December 31, 2022", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r89", "r518", "r637" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r673" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other assets", "label": "Prepaid Expense and Other Assets, Noncurrent", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r127", "r672" ] }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale or maturity of investments", "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period." } } }, "auth_ref": [] }, "vhc_PromotionalAndMarketingMember": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "PromotionalAndMarketingMember", "presentation": [ "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "documentation": "Operating lease for a facility used for corporate promotional and marketing purposes.", "label": "Promotional and Marketing [Member]", "verboseLabel": "Corporate Promotional and Marketing Facility [Member]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Property and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails", "http://virnetx.com/role/LeasesLeaseLiabilityDetails", "http://virnetx.com/role/LeasesSummaryDetails", "http://virnetx.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r11" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://virnetx.com/role/PropertyAndEquipment" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r108", "r138", "r141", "r142" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://virnetx.com/role/PropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, gross", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r109", "r169", "r525" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://virnetx.com/role/PropertyAndEquipmentDetails", "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 }, "http://virnetx.com/role/PropertyAndEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets", "http://virnetx.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "totalLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r11", "r514", "r525", "r637" ] }, "us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNetByTypeAbstract", "presentation": [ "http://virnetx.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment [Abstract]", "label": "Property, Plant and Equipment, Net, by Type [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r11", "r138", "r141", "r523" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://virnetx.com/role/PropertyAndEquipmentTables" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r11" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails", "http://virnetx.com/role/LeasesLeaseLiabilityDetails", "http://virnetx.com/role/LeasesSummaryDetails", "http://virnetx.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r109" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Useful lives", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Bad debt", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r190", "r287" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails", "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r301", "r302", "r303", "r304", "r337", "r354", "r385", "r386", "r387", "r481", "r505", "r533", "r555", "r556", "r606", "r609", "r610", "r611", "r612", "r613", "r614", "r624", "r629", "r633", "r638", "r641", "r689", "r696", "r739", "r740", "r741", "r742", "r743" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails", "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r301", "r302", "r303", "r304", "r337", "r354", "r385", "r386", "r387", "r481", "r505", "r533", "r555", "r556", "r606", "r609", "r610", "r611", "r612", "r613", "r614", "r624", "r629", "r633", "r638", "r641", "r689", "r696", "r739", "r740", "r741", "r742", "r743" ] }, "vhc_RateOfAircraftLease": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "RateOfAircraftLease", "crdr": "debit", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Refers to the rate of aircraft lease in dollars per flight hour.", "label": "Rate of Aircraft Lease", "terseLabel": "Rate of aircraft lease (in dollars per flight hour)" } } }, "auth_ref": [] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails", "http://virnetx.com/role/LeasesSummaryDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "auth_ref": [ "r198", "r199", "r314", "r319", "r471", "r618", "r619" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "verboseLabel": "Research and development", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r85", "r402", "r744" ] }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Research and Development", "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination." } } }, "auth_ref": [ "r2", "r3", "r85" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails", "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r46" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "verboseLabel": "RSUs [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r92", "r115", "r521", "r537", "r539", "r551", "r566", "r637" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Accumulated Deficit [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r164", "r200", "r201", "r202", "r204", "r210", "r212", "r283", "r284", "r394", "r395", "r396", "r421", "r422", "r435", "r437", "r438", "r440", "r442", "r534", "r536", "r553", "r748" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r228", "r229", "r231", "r234", "r235", "r239", "r240", "r241", "r334", "r335", "r506" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r145", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r615" ] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RisksAndUncertaintiesAbstract", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration of Credit Risk and Other Risks and Uncertainties [Abstract]" } } }, "auth_ref": [] }, "vhc_RoyaltyRatePerDeviceUsedInInfringementDamages": { "xbrltype": "decimalItemType", "nsuri": "http://virnetx.com/20231231", "localname": "RoyaltyRatePerDeviceUsedInInfringementDamages", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "documentation": "Royalty rate per device used in calculating infringement damages by the court.", "label": "Royalty Rate per Device Used in Infringement Damages", "terseLabel": "Royalty rate per device used in calculating infringement damages" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://virnetx.com/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r658" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://virnetx.com/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r658" ] }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Available-for-sale Securities [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257" ] }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "presentation": [ "http://virnetx.com/role/StockbasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation by Type of Award", "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]", "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit." } } }, "auth_ref": [ "r74" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://virnetx.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Provision (Benefit)", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r121" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://virnetx.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Tax Assets and Liabilities", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r120" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://virnetx.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Basic and Diluted Loss Per Share Calculations", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r683" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://virnetx.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Effective Income Tax Rate Reconciliation", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r119" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://virnetx.com/role/StockPlanDetails", "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]", "terseLabel": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r74" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r279", "r280", "r281" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails", "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r53", "r54", "r507" ] }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://virnetx.com/role/StockbasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units Activity", "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units." } } }, "auth_ref": [ "r69" ] }, "us-gaap_ScheduleOfOperatingLeasedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOperatingLeasedAssetsTable", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Operating Leased Assets [Table]", "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://virnetx.com/role/PropertyAndEquipmentDetails", "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r11" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r356", "r358", "r360", "r361", "r362", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r384", "r385", "r386", "r387", "r388" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]", "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r65" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "presentation": [ "http://virnetx.com/role/StockbasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Information about Stock Options Outstanding", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms." } } }, "auth_ref": [ "r65" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://virnetx.com/role/StockbasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Option Activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r24", "r25", "r66" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://virnetx.com/role/StockbasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Fair Value Assumptions", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r118" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r57", "r58", "r59", "r60", "r61", "r62", "r63", "r113", "r114", "r115", "r172", "r173", "r174", "r226", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r547", "r548", "r549", "r550", "r629", "r661", "r677" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://virnetx.com/role/CommonStockTables" ], "lang": { "en-us": { "role": { "label": "Information about Warrants Outstanding", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r64" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r649" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r651" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://virnetx.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expenses", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r100" ] }, "us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedArrangementsToObtainGoodsAndServicesAbstract", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Information about Stock Options Outstanding [Abstract]", "label": "Share-Based Payment Arrangement, Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAbstract", "presentation": [ "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails", "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based Compensation [Abstract]", "terseLabel": "Stock-Based Compensation [Abstract]", "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract", "presentation": [ "http://virnetx.com/role/StockPlanDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Plan [Abstract]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Option vesting term", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r634" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cancelled (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r377" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Cancelled (in dollars per share)", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r377" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails", "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "verboseLabel": "Number of restricted stock issued (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r375" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r375" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Outstanding, end of period (in shares)", "periodStartLabel": "Outstanding, beginning of period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r372", "r373" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding, beginning of period (in dollars per share)", "periodEndLabel": "Outstanding, end of period (in dollars per share)", "terseLabel": "Weighted average fair value of warrants at grant date (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r372", "r373" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r376" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Vested (in dollars per share)", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r376" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "presentation": [ "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "label": "Fair value assumptions used in estimating fair value of each option grant [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails", "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividends", "label": "Dividend yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r386" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails", "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected stock price volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r385" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails", "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r387" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r356", "r358", "r360", "r361", "r362", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r384", "r385", "r386", "r387", "r388" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Terminated/ cancelled (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations", "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired." } } }, "auth_ref": [ "r23" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issued (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r21" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Outstanding and Exercisable (in shares)", "periodStartLabel": "Outstanding and Exercisable (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r19", "r20" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://virnetx.com/role/StockPlanDetails" ], "lang": { "en-us": { "role": { "label": "Additional shares authorized (in shares)", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://virnetx.com/role/StockPlanDetails" ], "lang": { "en-us": { "role": { "label": "Shares available for grant (in shares)", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r65" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Options, additional disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Options exercisable, end of period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r366" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Options exercisable, end of period (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r366" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Options cancelled (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r704" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options cancelled (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r704" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Options granted (in shares)", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r368" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options granted, weighted average grant date fair value (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r378" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options outstanding, aggregate intrinsic value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r65" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding, beginning of period (in shares)", "periodEndLabel": "Outstanding, end of period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r364", "r365" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Options, number of shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding, beginning of period (in dollars per share)", "periodEndLabel": "Outstanding, end of period (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r364", "r365" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Options, weighted average exercise price [Roll Forward]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails", "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails", "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails", "http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails", "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails", "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "label": "Equity Award [Domain]", "terseLabel": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r360", "r361", "r362", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r384", "r385", "r386", "r387", "r388" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Options exercised (in dollars per share)", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r369" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options granted (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r368" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r355", "r363", "r382", "r383", "r384", "r385", "r388", "r397", "r398", "r399", "r400" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Axis]", "documentation": "Information by range of option prices pertaining to options granted." } } }, "auth_ref": [ "r72" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]", "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r73" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price range, lower range limit (in dollars per share)", "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range." } } }, "auth_ref": [ "r73" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options vested and exercisable, number exercisable (in shares)", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied." } } }, "auth_ref": [ "r70" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options outstanding, number outstanding (in shares)", "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices." } } }, "auth_ref": [ "r67" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price range, upper range limit (in dollars per share)", "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range." } } }, "auth_ref": [ "r73" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Per share market price of common stock on last trading day of year (in dollars per share)", "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "crdr": "debit", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfRestrictedStockUnitsAndRestrictedStockAwardsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding, end of period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails", "http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails" ], "lang": { "en-us": { "role": { "label": "Expected life term", "terseLabel": "Expected option term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r384" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Options exercisable, aggregate intrinsic value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r65" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Options exercisable, weighted average remaining contractual life", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r65" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options outstanding, weighted average remaining contractual life", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r116" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options vested and exercisable, weighted average exercise price (in dollars per share)", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding." } } }, "auth_ref": [ "r68" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options vested and exercisable, weighted average remaining contractual life", "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r117" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Options outstanding, weighted average exercise price (in dollars per share)", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices." } } }, "auth_ref": [ "r67" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "presentation": [ "http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options outstanding, weighted average remaining contractual life", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r116" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r106", "r195" ] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "label": "State [Member]", "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails", "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r17", "r37", "r164", "r185", "r186", "r187", "r200", "r201", "r202", "r204", "r210", "r212", "r225", "r283", "r284", "r325", "r394", "r395", "r396", "r421", "r422", "r435", "r436", "r437", "r438", "r439", "r440", "r442", "r456", "r457", "r458", "r459", "r460", "r461", "r470", "r534", "r535", "r536", "r553", "r603" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r200", "r201", "r202", "r225", "r506", "r542", "r554", "r557", "r558", "r559", "r560", "r561", "r562", "r565", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r578", "r579", "r580", "r581", "r582", "r584", "r586", "r587", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r603", "r642" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED BALANCE SHEETS [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r200", "r201", "r202", "r225", "r506", "r542", "r554", "r557", "r558", "r559", "r560", "r561", "r562", "r565", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r578", "r579", "r580", "r581", "r582", "r584", "r586", "r587", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r603", "r642" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://virnetx.com/role/StockbasedCompensationSummaryOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Options exercised (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r17", "r89", "r90", "r115", "r369" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock issued for options/RSUs/RS, net", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r71", "r89", "r90", "r115" ] }, "vhc_StockPlanAbstract": { "xbrltype": "stringItemType", "nsuri": "http://virnetx.com/20231231", "localname": "StockPlanAbstract", "lang": { "en-us": { "role": { "label": "Stock Plan [Abstract]" } } }, "auth_ref": [] }, "vhc_StockPlanTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://virnetx.com/20231231", "localname": "StockPlanTextBlock", "presentation": [ "http://virnetx.com/role/StockPlan" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of the description of the plan, the basis for determining contributions, including the employee groups covered, and the nature and effect of significant matters affecting comparability of information for all periods presented. For leveraged ESOPs and pension reversion ESOPs, the disclosure may include the basis for releasing shares and how dividends on allocated and unallocated shares are used.", "label": "Stock Plan [Text Block]", "verboseLabel": "Stock Plan" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://virnetx.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets", "http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders' equity", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r90", "r93", "r94", "r107", "r567", "r583", "r604", "r605", "r637", "r648", "r678", "r688", "r732", "r748" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://virnetx.com/role/ConsolidatedBalanceSheets", "http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Stockholders' equity:" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse stock split ratio", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one." } } }, "auth_ref": [ "r30" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r462", "r473" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r462", "r473" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r462", "r473" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r462", "r473" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://virnetx.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r462", "r473" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Event [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://virnetx.com/role/SubsequentEvent" ], "lang": { "en-us": { "role": { "label": "Subsequent Event", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r472", "r474" ] }, "us-gaap_SubsidiarySaleOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockLineItems", "presentation": [ "http://virnetx.com/role/CommonStockSummaryDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiary, Sale of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "vhc_TermOfNoticeForCancellationOfLease": { "xbrltype": "durationItemType", "nsuri": "http://virnetx.com/20231231", "localname": "TermOfNoticeForCancellationOfLease", "presentation": [ "http://virnetx.com/role/CommitmentsContingenciesAndRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Refers to the term of notice for cancellation of lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Term of Notice for Cancellation of Lease", "terseLabel": "Term of notice for cancellation of lease" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://virnetx.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r316", "r322", "r441", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r528", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r684", "r685", "r686", "r687" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://virnetx.com/role/FormationAndBusinessOfCompanyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. [Member]", "label": "UNITED STATES" } } }, "auth_ref": [] }, "us-gaap_USTreasuryAndGovernmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USTreasuryAndGovernmentMember", "presentation": [ "http://virnetx.com/role/FairValueMeasurementDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Agency and Treasury Securities [Member]", "label": "US Treasury and Government [Member]", "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)." } } }, "auth_ref": [ "r513", "r630", "r745" ] }, "vhc_UnamortizedCapitalizedDirectAndIndirectResearchAndDevelopmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://virnetx.com/20231231", "localname": "UnamortizedCapitalizedDirectAndIndirectResearchAndDevelopmentCosts", "crdr": "debit", "presentation": [ "http://virnetx.com/role/IncomeTaxesPretaxIncomeLossesAndOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "The unamortized capitalized direct and indirect research and development costs.", "label": "Unamortized Capitalized Direct and Indirect Research and Development Costs", "terseLabel": "Unamortized capitalized direct and indirect research and development costs" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://virnetx.com/role/IncomeTaxesIncomeTaxUncertaintiesDetails" ], "lang": { "en-us": { "role": { "label": "Uncertain tax positions", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r404", "r411" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://virnetx.com/role/IncomeTaxesIncomeTaxUncertaintiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest and penalties", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r410" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r48", "r49", "r50", "r135", "r136", "r139", "r140" ] }, "vhc_VirnetXIncVAppleIncCase612CV00855LEDAppleIIMember": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "VirnetXIncVAppleIncCase612CV00855LEDAppleIIMember", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "documentation": "Information about litigation regarding VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (\"Apple II\").", "label": "VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (\"Apple II\") [Member]" } } }, "auth_ref": [] }, "vhc_VirnetXIncVCiscoSystemsIncUSCAFCCase231765Member": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "VirnetXIncVCiscoSystemsIncUSCAFCCase231765Member", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "documentation": "Information about litigation regarding VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 23-1765).", "label": "VirnetX Inc. v. Cisco Systems, Inc. (USCAFC Case 23-1765) [Member]" } } }, "auth_ref": [] }, "vhc_VirnetXIncVTheMangrovePartnersCase202271AndCase202272ConsolidatedAppealMember": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "VirnetXIncVTheMangrovePartnersCase202271AndCase202272ConsolidatedAppealMember", "presentation": [ "http://virnetx.com/role/LitigationDetails" ], "lang": { "en-us": { "role": { "documentation": "Information about litigation regarding VirnetX Inc. v. The Mangrove Partners (Case 20-2271 and Case 20-2272) (\"Consolidated Appeal\").", "label": "VirnetX Inc. v. The Mangrove Partners (Case 20-2271 and Case 20-2272) (\"Consolidated Appeal\") [Member]", "terseLabel": "VirnetX Inc. v. The Mangrove Partners (Case 20-2271 and Case 20-2272) (\"Consolidated Appeal\") [Member]" } } }, "auth_ref": [] }, "vhc_WarrantIssuanceDate2Member": { "xbrltype": "domainItemType", "nsuri": "http://virnetx.com/20231231", "localname": "WarrantIssuanceDate2Member", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Issuance date of warrant that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant Issuance Date 2 [Member]", "terseLabel": "Warrants Issued in 2020 [Member]" } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://virnetx.com/role/CommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r639", "r640", "r643", "r644", "r645", "r646" ] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "calculation": { "http://virnetx.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://virnetx.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Effect of dilutive securities (in shares)", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r683" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://virnetx.com/role/EarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations", "http://virnetx.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Diluted weighted average number of shares outstanding (in shares)", "label": "Weighted average shares outstanding diluted (in shares)", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r215", "r220" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://virnetx.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://virnetx.com/role/ConsolidatedStatementsOfOperations", "http://virnetx.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic weighted average number of shares outstanding (in shares)", "label": "Weighted average shares outstanding basic (in shares)", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r214", "r220" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "4", "SubTopic": "50", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482610/350-50-25-4" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "SubTopic": "40", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482633/350-40-30-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(1)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(2)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(3)-(4)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Subparagraph": "(c)", "Paragraph": "2", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "44", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-44" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB TOPIC 4.C)", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "320", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)-(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-8B" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(4)", "Publisher": "SEC" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(5)", "Publisher": "SEC" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(1)(i)", "Publisher": "SEC" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(1)(ii)", "Publisher": "SEC" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Subsection": "Instruction 5", "Publisher": "SEC" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1406", "Paragraph": "(a)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1406", "Paragraph": "(a)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1406", "Paragraph": "(a)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1406", "Paragraph": "(a)", "Subparagraph": "(4)", "Publisher": "SEC" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1406", "Paragraph": "(a)", "Subparagraph": "(5)", "Publisher": "SEC" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1406", "Paragraph": "(c)", "Publisher": "SEC" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "12", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r616": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r618": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r619": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r620": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r621": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r622": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r623": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r624": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r625": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12" }, "r626": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r627": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r628": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r629": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r630": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r633": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r634": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r635": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r636": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r637": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r638": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r639": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r641": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r645": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r646": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r647": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r648": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r649": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r650": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r651": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r653": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r654": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r655": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r657": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r658": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r659": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r660": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r661": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "SubTopic": "740", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480887/718-740-35-2" }, "r663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r667": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r668": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r669": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r670": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r671": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r672": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r673": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r674": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r675": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r676": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r677": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r678": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r679": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r680": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r681": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r682": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r683": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r684": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r685": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r686": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r687": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r688": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r689": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r690": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483049/450-30-50-1" }, "r694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r695": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r696": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r697": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r698": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r699": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r700": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r701": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r702": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r714": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r715": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r716": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r717": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r718": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r719": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r720": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r721": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r722": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r723": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r724": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r725": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 78 0001140361-24-013522-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-24-013522-xbrl.zip M4$L#!!0 ( ,R$;U@90' ?.@(" "M:% 2 968R,# Q-3,Q-5\Q,&LN M:'1M[+UI<]O(U2C\?7X%'B=Y8E>1,O?%,^-;M"S/*&-+NI(\D^2MMU)-H"$B M!@$& "4QO_Z>I;O1 $&)VBF94\F,2&+I/GWV]:?_?_#3Y,,+H-+H_3=Y3@)@Y]?3;)L]N[MVXN+ MBQW\9B=.SMZV&HWVVR!*,Q&Y\I6Z/@RB;U='P^%; M^M54?]:5!&G=:S?Y5F^4K M] UIDIF+?9&.Z4+X$BYNMBK=PH/@\\Y9?'[EF-0;S?U<^9I_4R(V?(F MU0^%C7JR!&;]1OBA<*$;SZ,L651?K'XLWC!/$D#357>H7XN+R9)ZMIC)M!J8 M\/-;_!GO:=4;;7O/6;(2 X9OX5=]820"-ZU>$OU46$\:N-67P@_%"[-9LN)* M^*5PJ;QT)]67XB]%"$I_!?"D7WRFZZUXI.L5+CR?Y!LZ#Y)(9I<[;CRE:YHM M \[5I(T\YM7['QSGIXD4'OX!?V9!%LKW/[WE__)W_U.O.Y\#5T:I])PL?N>< MS*?3(',^!1$0>B!"NHS^^1B[\ZF,,L=-I,C@\GD*G,WYD,3"2P+O3#I'QX=^ M$$JGU=EI[S1WNJU6)[]]-YXMDN!LDCFPQ*Y3=V S'?ON>EVM:2HSX>#.ZO(_ M\^#\YU>[<93!B^NG@%2O')<__?PJDY?96]KI6V"K;WFG/_PTCKV%DV:+4/[\ M:BS<;V<)8+U7=^,P3MXY?_+IGQ\=_;E!__P(T/K)"\Z= ([HX\G1IP")^-? M\V3T2C_-"])9*!;OG"B.)-SQ4W#Y#M\J$_Z3KJ8_X8(# %82N$XDIGBK#-Z- M 'H>0O!3*,Y>T9L^"3?[E^=W!_WQT&T/_'%G+!JBWQ_VW*[L=)M].9:NVO)E M=HR(YB(2-)J-9A;GZ,!\YN=7P)O>^<&E].J^"$$0O*?__/2VL*35*]PE:L\^ M!:DKPG](D>Q%WDO]SW^->4U>1XJ^UP41-1QT^F-O[#7Z?5BC:'EN MQVUUUUC3IW^LO:*]".A]L0MK2D2X'WGR\C>YL%8S$'"0[5;']V2_ \L8#WW@ M6V+8Z?=;0Z_?7F,U0#_-QJ %#UEK54J^O3M*XIE,LL51**)L%'E[0.TS!-[7 M5/KS\'/@VXC7;X\'8M#K=MO-<6?8[0R'K<&XVVSZWMAM-=UAQ3IQ=?\Z%M&9 M'%T&Z;^^!%$PG4^_R.E8)J_>'W57 ?%3 B\$H5U:[TD6N]\F<0CTGN):L\5! MG$GZ]F06!AFP*:7]':/,;UJ+;_;'LM]S!P#:9D=*?]SVFT*,6[W6L.GW_$'5 MXANMK@)R W%B'@7\ZU=0KEXYGG2#*1#WSZ]:< [C:[>BUY\->Q!LKP;G8L@ M%.-0?HJ3$Q'*$PE2/L@"F7Z4X^R+R/#3@G'7VD-KV&\.&FW1:36\CML1@V'# M\WN>VQV[S<[0%=^$&VOM0)SBT>.,C\-WD5!"((OF0-K7W7@=UJKVQ;- M<6_L Y/O=$ 8#=Q>P^\VNVV_#^?L]Y?7VKK+6I>1!]LTJD\%9>C>3:) MD=1I1R<9 B'R/L<@N/X&+"#U CHK:X_#>K5\?EO4?A+I2[0:9/K^)S0RWZ5D M/L**'#(ZWTT27!P<=UVO:NN[$!P&!'0J9 MT2.Z*?YRN_UU&NW&8+/VUT$+N#&XG_VU-@29K?VUBOAYM_UM"K$6\/,>]]E@(*D#(,UP7?_3@99>@[[N!$O^.%\"OY/6U;(4K]O+JO;ZL>E,_O:U\ MCX&F6<[-,+EYGYB\SI&-7#"&YR$ZBPZSB4SPYT1.$%;GDM60%W&*:^_S.1QL M:WNP&W.P]RI;UZ%8-!+CB%P:8 J,/#"U 6XB/!*!MQ_MBEF0B?!9'RW9F.OO M\J50[%9Z;A0MKG-D6UI\'%J\?R:[ 6K]@_&:H@&S1>&G0^&-L-S*SL4M/FP& M/CR5@_%F_&&KE7POE+\]Z>=+TS<[Z:UOX %] QN!#S?C\5M\>"Q\>#))L,6" MC?$8WFNT:BO8'\.Q].A'MK7"'L>Q=,\'V]CLA)9FXTET4\+W3T$49/(SL%@X M6@#R63 .Y2A-999^6'P1_XX32BLC[#\2F#VN2/I?O\CX+!&S2>!^#-(L"<9S MQ!*Z\"".OFXX.UN]^IR76=M8B>=KO_ &@,Y74(#X\Z"U.R'5IF++]O#NR!&^ MGGR'1WLOS$@5GKW[>O(L4*CD\##%4/OPV(3J.P@?,%T^3YY7^&,EN8M+.\E] MLS G3;)W9JFOWN/'PGKO159402W'ORKPO3AGB5+(X6R]>2@/?598O\AL$@.I MGLLTR]58^ULI#\24\>ASZ];#/!BD=CF ]Q>[_,!^,HRS \+4^Z$#I9Y)A/SVV8> MRK65I?F6U@$>^G[@RI=X?)4[>PZ'U]I2WZ-3WP,D<6ZI[[&H[WX/ MKQ3$WD4/A4QF8!8NC%K^6RO7<#_-(\^8)6N=^BA(3K$)T"Q.,BKEW7 $0!VF M"@RLOZ^$Q=T]!3?"N.N@^O+"ZR5OU!93'QEQ'IUPGK>O:XN?6T[Z>!90HZ>9 M([8V^!=NW" =-=R2'L#A&,"-.3GLIMJ/7%SKN<2K-Q.#S(%:^V'LN<&F'I+! M]-9F,(7V#O?!8+9G_$!G_%CQM&(KG;WI+(P7DAMI'<[REC/_.IF(1'X0J?30 M2@2P$9>B;U/5O.:_TOL*H$JLFQ$VZ8?%WJ5,W""51PD8*+E3";6["Y$' #NC]4K8OSQ-:*,QOKG%^"?#^.86XY\ XUN;C?&/B'^M^Z*9 M>Z/29XOQ&XCG6UWF1>DR#QLWW"S4W7 6_:)1]SJA\%Q1]\4CTW,]F*VALV%F MQ_>-NK>S7385K;Y[S;RY/<4-[5172KK8'M'S3DW8GN*&9C=5<4 ,)8$^D$F/ MMO0U"K+T^.3KLSR<*_?R+#CA]0?T$@[F^5#,U:)I2SO/541=K=MOS_6YZO@W M.M>7<)XO]1RWI[=9SI"M^-MP364KQS:<@NZ@DMOVPO"P8? AKL2P/?C';QM2MC+P;_' M3QK8\K][<>F\?!S\#N7P9O+!2D/QN\._EXQWF^(B>SDXM3WEU5)N>\K?@PQ9 MN\/W9A_QFOW8E_;SXJAX>ZK/Q;G7;+2ZBA#AKXWLP][JKHF_]J5WP]]&KMGB M4PA?_Q!) H#>3].YB%R)WZM$\Y(*K"[<;*1>H<<6UGY/3B,-04[F70W&!Z*7 MQGW22\,(KBV*/',4*3":QOJ"LO% *86!%YN- -5[L 8T5&WF MV1\16:>CR$-_4OBW>1*D7N!N?IG"=8=US;:>Q;%5.JRW!_@R!2QK\I]$D/PN MPKG\L*!Y1?E8IB_S;"Y";)"XV>>Z<@?YT9:W\ASTZ>N.9W0N@E",0^G'22I" M69[D\XR/Z[JM/8?C:V^I:Y-%W774M2O2R;,_F'P3+X%BOIZ<)E*D\V0!0OJ7 M^%PF$:[YV9_2E?MZ#K1TW<%M)=6S/KXM*]PXZ;1EA<]4AN5H:%_TA?9,$?M/ MB?S/7$8N6]KF&NN*]!AY3!)$9\_FN%?M+S_X=39Z=P_HB^,3=Y6\]JWFSU_A MV$7B3A:?Y;D,BWBX'\WF64H_-+\_/+X"1!6HO RK1\'@6ZLD&TC9SXC4RD;P MEK2>+VD](WGU(GPO+QVY-YI+;I33>LLU-PFQGJU:\F#2Y!F1VI6V]);.GCN= M;93"]&+].>N'B;;DL)%BYYF'P+:8]+WX#[;B^ME@U=-+R(U2&#:(R&Z:TK:E MJ\=U0FT4WFX@9]DD5:24"YR/>?DB+H/I?+J96(N3OZUA+/BQL-[[!/U&9/%> M<4Y!]+S.R5[O2SNG9JO9;/3PG/BO?_TB@F@7K@&F $PDD.F'Q8'(@&'0V1W% M:8!SI@_G&2:M'_J?X>.9L)JTY5^ B<,W_1XDDVU0+H]ZT=\7(8PUVC=&,P/A->F.X9L.-TJ5WE;N=1I_E+OYU#0[O M!JD;GRS23$Y3^/SU9'?T:9>@UF[V>]W-1-,UD6.MO3VD/._4&_WUY'GATOO5 MNXZ2&!Z0+7 Z8 8D@:UW9KBE#PM3E7SH^X&[X4V_UM@'8X"]F9>FK=WJ=#\) M-PAA6R_D?(O;>7DGO/:YPC73&#F@".&*+R+Y)K.-]]JL?% M'=.6CS[Y436V%/50Q]2XYV#'5H(]A02[YZC_NO2V98U/37.E9L];ZGLTZMO( M-M#;\W^:\]^49N];)>E%4?<-SQ1^?&$2><6^GH/5TC&D"7^M.>4%X7$@IGS) M"+;@20\VCQ=C (/;I^]'+N[G7.+5ZL:3^3BE](]L[QS^95Y3^GZSL>)Q)\.L M )G5?ZT*=G=_KWW&C.0W..@'8W&=]5D<77I;%C>/ B:1KX!"!A&GG)OT/DCC M3JO9?_?UY*.^7_^D/^,#JA[66GJ8VLE$)#*]Z=/:YFE>< ZX;5]S,)_BB)$X MN>7JE^['+S_**)X&4=5CU]U'X1%OBZN_9KN=)>"1*@7'&F4W!5VW\EG[P$N# M;(Z*V4T?V%MQLC/X\Z;/ZEP$FP<3[\: M<&^#RW> M_$\<67*'R=2>,2RX.7O?_C!<>!_/\'?3IHM0A Z/G",NB^F0;AX MY_SU%#AHZAS("^^MV:R^G@'/]7'<9;%4WC0[-*AM 5G' KW MF_D]BV?OG$[YQXEZ%T#C,M^[3__ K7#-61+/(Z]>_JD*!E.1G 51'>'XSA'S M+#9?)?P6^N[5V_<_(#3??SW8/]W[Z)R MWW=_'1W\LN?L'G[YLG]RLG]X\%,Z$U'AO)< N!KB@(OCY*T!Z5M\UON53VRL M]<0_1#H!*S&+HYKS<6=WQVDUNIUAU7L8:W/D9:RREE3^Z4$1;K *X3X='G]Q M?@)J _PB=A*X3B10I_-D\.YC[,ZG2NEY140.^G7V+SEP7=#KW%;;]SJ#H2>: M_6:O,QZW6N.>[,OA*T=)\V/I5_H?7KUO-NJ_$97G[WU_1V 52/KVH&I4@ZJ( M\ 305^]?H]_ .8SDFW77GF$I,9QK& *:N(!*/[]JO*+/,^%Y^O-M.=Q%X&43 M_-#XRQKL#MZ+.?$_O_IX&I!C5EL).?O _ST'/+=AZ*4EZ]'QTYK[XUS^,DY_77/E@E& M$HQV3_'GYK#=451D;:4 KQ_HBZ2 N\!]B=S>WXVC+!/^?>'HISAQLHET_""% MLW064B0.F7C7<^0CLI[VV*:RT'R,^^/A4'A"CEW7'[=[;;=]3WRZ\Y+Y M].GQZ.!DGQCREE>OR:LS@Y(.>[ O'!$"USY+Q&P2N"#*-N1<5M%& M:TUGQ=7'=RS/0/KCQ"L,"EA'V&S*0<\=^HTQ&"R]3GUW-]M[&& M('ROBB*<7V$CH-XXNW$R*Y^FHM+[<:-4.$Q>[UW";FC;3NP[B=FN(U(GG4D7 M@T:>$T1.D*6..Q$)'.V[+\\;#L1CX'5^V!AW?:PT&_F P]-KN M^#:*'P739DE\CFMBTR84%P+#!I46S2K%9K4J77$V[,,UHF[-)U4>LWG4\SCI M4W&YK\+ +IWVDE@:=OINM]=J@B;?Z+0&8^%UP* =-[MNSP=5O[<&3^OWZV 9 M-'JMP0T/L:2=OB@2?$UTY8 J&X,NFX#UD4\+0ZX;V#1(ER5G(@K^2Y_?;+%_ M/2#O[QSOG.PX>]-9&"\ RD5D=P[BG>M >3<+:2OLGAX)KF&!(\]+9)JJ_WP& MFZ=IL;_NN-UHM\2PW95>IR/[ Z\[!$5].)8]?]R1K3787[LQ<#[&22A F9LG M69D'U@I@GX[ Y%&W17D<#/9D' MP)=:6.A?8M;WIVCFI,8J[%I;WH4_#Y/3^"*R-NS!D8P;[9[OC67'[3?$H"O] M5F_0[W0\L)_D&AO^IYQ-%@DR!$K^NV MX2P&/; ,A">]H2\[4G8;K=O$,)94I -Y+CRQ59 >D#L?)]I<[8_[W3X-6L_]C"NI.""P] MCJ03D3530V4ZG),_!2Q) :OQY!5..A0T([BN1.N]=F?0:74ZK;;?ZK3=X:#A M^SZ80ATY;+0&C@-_[';; M;JOO R/J-(2_3M9'MS.H-_N#I?7IX ML_5Z_ ;I'KW[(S=[M_4I:5[3;N\TVZO933D;K642SHHD5^G:?8IP5Y"%Y%R4 MPIUP7/6V_+RYT[T*,)4[OA&;;W=V^E<(C6<'^D00)SQ93.&;U[<7I,V=5O=! M =\:[K3[+P?P!\J?3B@O+]T)]BYT@.U=3 +X)N>-#Z;\K6(B3Z7_7:%]*Z&Q M:+;&Q"OLM+!AJ]=H#(37[K<[S59_W!C[\''8;35;/:^SCO##N!T GHI3:LY, M),XY]EMU_MS8P3H9#"<[E+U_52!-G\U#L*W[95$;=K:* S$#L@]VW&WU>\UV M#\ZI(P8-L*K:_5Y'-EV_)T'A6B=\]NON?=G!5[.W^V5E&W9 FOCV%),JA3E[ M;K\E0.L=CYO]CI"@?WINL]?WW.&P(1IB'9_+P3].]NYF\SX7^^1Z[3?-M=^S MHO9[[ZKX 1@3]Y+:3=\$$7K3[SFY9S_RT#LOG?'"<2?2_8:)1-^<@,%BQ:*# MU!'.!:CX]6]1? %PDB*%[7GP0SI'HT^DCB?](.)0]?$<%,Y.HZL!;)T+P'K' M^0?\L0SP-9=.*T?[L]'\\7["\B;CC1ZF>,W5KJH_ !:_(2A.%"3V"1"%%!/9 M[7A>;S#H2C!C@8*%:':[+5]T!H-&O[\.X<9ELE5KNX?M]GZ\G[P?G VQOO,)\KVR]D"H:HFZV>-L+_'X3S*1$+Y M4$EJ:P)>'WT:0K8Z7L<==(<-O^6U>N-FHS?N-\?K: );1+T*42\FDJ+.)6Q] MW7SC3(!O(HIZC@A#@Z6<19&U<5BEI\5JL3B,5X$>:G.MX=F&%F7ZYEI*L\"!T%"$9U?C>-ZPU>\T!^U!"_WX8%]V0.5I M];W&H--HKI/'M*6T%T=I9$2$(@&A)%P7*"W!7AZ$=&A!1)7?8@%X??D'16/I M%,@4WI1HI@\[FP+L@'*!)."1(%"P,N+,.4OBBVRB?]X!42EI?62U4%T#!4'Q M.%N-'U>MDGYN_J@ON_:"U>O3%Z)\5!>O6*N^4MM5S=:XWM(ZJBWF=^XW@L,> MW^^\1\=E7EZ3[,(9G<7)PD[6:0ZZ;J,S],?==L<;]X9-T6Q+;]#TAL-VKW6; M='5NUD28X*H74D96E8 HZP[W@CIE4[0 ]@>+(ZWB7QC*RF0=6;C$/BD7B7@: MIK:W2FZANG;GTKFKT4^_^Q=Z]2Z_V79NM)L@TKK]EFRV.U*TA[U&1[8DYI1V M_?'0>\!RV0=C,AMS\">KM)OK# BZ\<,\#2*9VA9ZNSOH^V+LNFU_W!%#;S@> M-CW7;[7DN-%Q>VO8#;=N0O$0LJ J:O4@D97'4/7]*]1I3/I:TT>+YC89V<"I MT5D+%N@\954-$ 0S?&"YP"1O-)RE[TMR)D0J$Q7N5*<=H*AG)!'M'7S:[S=><$ M6UGU6SU,A7N#V\_WJB*'XQ#8EX5'?I!,V:TR@W<+O A0CZ)@'NU8S+T@4^O: MN1/.5%+NJ_?7YO'ONWXRPE7$R2@_D4^A."NVD>@UQI1@V>L,.[UQ=]#NRV&C M*YL]O]]Z2+FX-N:;>.I3<;V*WG#XP%:W6W/TO_1C=20Z0JB$^EFXZ-)WYR() M1&1=2:LGEH<051WOD.$:F9'F;GW N)LF=JYDSC:!YR1%%0_LAH^7(VR4V\M! M7KY-.>_]D'SZ\)4;)XDTE74H,Y($W?DQ4LQY$,_3<*$)INJM5W@?=7N43T%T MDDVS/7SPKGE="<-;@,6NUQ@WQYU69^CVANZXU_*Z[7Z[T1>M_GWI$E=C^)V0 MU[1GO '>%4ALAY<,EV]C=NSSZ>EZ*O)$%49HK@8]"$F MFIR6-.5;U$E2R'CR41B[,44K0.:&BS1(564K]TBNCP4J1Z@^R2AE(8W1!/B) M8HOF[3:]:Z%M*<+EVI DM0,4":AVY\@HS&*4 FF.FQV05V.W+QO=GN_WVVZS.W@XH7730-B5 MR1D;'[N\,1J%(W]L\*53Q13A>>7D>6(S)!/82SL M(&NW/Q:RUQP,VWZC,VSW!V+0ZP_;[F#<:LFF5^EA[;4;KQSL/$W?48]YP&PW M ),.=+C"CR/1K$=8C2?UKV8NE;AI:_>MX:U;K=?ZP^'&I'TXM\[+&CFLYA5 M1#>,4X3=#-#,@%AJV/G7BPIW4N!4ZN@ O8# MNC$U\B9#%*4DB*E,!.1-2+4LO?+$_%C)8^(0(+QF()37CJ\]43;G=6C$B?B4 MAW]"@#^<9^07@>.Q\&K0&_O>L \FH>QU^@- )\_O=7H#,?2:PZ&HP*M.H]T8 M%/&J9>/5_L&GM3&K7>L-FK5AO[&,6 9;U)%7ZRJ.76_@7("9Y,3Y/A4M?A&) M.W$&A%R=NY[KP^86A-?+G(SM)!Z1Y[&4AXS2@8C]JW6=+A.X%"D5P@TQCE[#=@-?K?4.Q8U M9D&R16VW8I6(HQI27R2-ZT( $H)/ $& J2VA\,.?\PU[VSU$R'/=<0%+$P'L M<0%+LP2>9EQ #L-''/Q@S7TH.-M4[]T/QT>?CL29_)!(\0V+M$TFB!M*D5"D M8V(VQ-"D%ZMOS+B&4J!ZY3O,\V?P37V,7]6)< !.X06043',M73^=166X9-; M7B.C OU:2$W11]ZR3UQ[7RI.7(/O;=E"6\M>NUY>E-MF")+.^P^Z$I&JPW3[H$_T72IK[1GC37&"=_11D!&E/L.+68]')+1%@]# 8<*>SQ97!PEZ]/P[2 M;P[:_''RD,>[-AOF0UT1]QX^F4!Z8![QX=DR"4*D#SM?(YQ@%Y[C %+A^V , MOWJ??^?0EV0B8]CJR=G(_6!CJ_6$^M$M$6UW WG1[F(L$Y7?L'CUOO#Q(5&E M4I:T7P(_:3UK=M("L:2F7P?RZ9E%-9YT-IO0VQM(Y[BP-ISM9WDF0@=.V)54 MR+CY>D=K>:S/RU \.L^:470 F;Z 8>*<"%]F"^=CD&*DD68>OPP-X^GP;L.\ M M=W@7I"VKLO2-TS:MW2HW7O+JT;$LYW[/O::"R_G83I/FL)TT4)PZE!NA]) M1?]CE6VP1RE!-;@BI$"T%9QUOF!A1,(A8VX3Y1S-$WX!+OY_QS*5R;GT_O_-UYE[+U1G[C]KCM8GCK94D86J\YRS5Y!% MC:ST\4^F0&,WCCPNR<-K !7G(5>(',XDSTUZ,6SKZ9#WUFBYJ6&&/H89_B\F M_@=8AG8N"7O@BU!_SNTV$)#C>)XY2N9B<&+C&5V[63UIYT4RO\&S97Z&C9V8 M\AG PY/Y[-7[G,/EOQ&2PJ^SD#Z+9$%=OYZ4-0V!,^U2 M^B;FD-*1 R\29XE42$!9GR,N_154#AGIC[HT($>>1W$_W0_/ZKY4A^;P@:3@ M(VEG0Y25NUSGSBR(W.0>BL8G9SW/'O5NC50/%)Z_.[I\ '0YI/J4_3S=?LM] MGHS[/%!X_;&XSRZ@4R[%T-4E$JJ8^10G$E;C_,T:FJNJCX\2>8[%$OL13BI_ M249@M[M1BOW65_W=1F2V(9DMFM]CMF'C64LI6#Y**6R*$2=IS=DSW2@.=3<* M5)QW=46@\PMVH4 C[:6D!72?7U"E^4!I\'?'IB9@4XY"NU9OE,W7HY\.#QZ8 M0SWO!,8F9C#JF5[.X44$/&D2S#!2LJNZ$'R0D01FA6XC_IUX5AZ841&6E8'D M+2=[,DZVJ:F53;(L!1/.DS-LO_FP MHO*>4.>EQI>;SSLIL]FA]&T]1][REG^2JF?"B4S.<:3\2V%B3QDLWAI+WZ=/ MX/>M2V"+Y?F._2N'AK-@B9M&ZBIM9/F$ZJ1S_54>8 MY=:C^/<[)\@ E]R*9J6H[5^:UHVBXI&5T0_QWBGOKXPL2\A3_/0_]?K1\2&V MU4) ',RQ&1;FM69_@;__TOS+7_Y2K]MH>974+/16:G=WABM[)Y?'1!_M[>Z/ M/CL'AZ=[SO'>+Z/CC_L'OSB?#H__@#^=SX>'O^'GD]/1Z1ZU7;M9OK)WFO.:+E!CQ?@"-45,3>3DUFC!5%+; M,?SO!?;!7,#_OTFGW&08?W#!9,R";)Y)_5P_3BY$XM7#./ZF1BRHN_3$,LR@ M"2*#&)A!/Y4BTOW+5)?P5G]4/2=:C2UMTW1I,>79$*_Q.K6"XN7%'9JG-_(>BY=K29NX.WPDX1GQ5/X*7_F#C">0J-$Y!!J\C9PG2Q. M4#5"+@5/P8.AALHKZ<0 0&/L&.[ SH2!'S#G0R#CB!@XZHL8)[C@E;-)0N4S M-+94&%Z78W1:'L5((#U?_CZGNO(/A&9+7R. (F_I:\+PI2\3B0D3%=_'_ZYZ M]D4 )S.6E5]KU*G\,0R^R1"%!*;E ^P+XR738!J$(D&Z@0M2/L1CTD&(2^4T M*8AB\LD\L"E ==!ZYM3:G3$?J&XUU]M!*7051XRD"VL020#+M49!)T'Z#;!S M'JE6OY13&L! M4;6QY7UIT5\#EIDQG+"/*!Q2J )U,7^!JW(5<-AIRZ8_?Q,:U5E5Y MJPI3>8$M4XWND/]H2>?B&Y95A("%F)Y2?O/>J 79O;>;RU(+&2TD9,YBF,LL MAJ=@VT(>)8*$18H2,XL%35"G#JKK0=QH-H+&#QDX*'%BGVH^1AD?;<&(V]#B MU&7$,USD6)*F!(OBH0PD,20H32QR!EJ,1%L1./0R4X:Y;J-4BFN4LMF &4:6%$B!H,0 M>(ZQ"]BLJ;*L$+][B&:;RD;\>'+TZ3/@RBG>=$]]-Q^^N6:KCR^M] (MO8K( MOK>^&XZ[YE8^NPH]UG$H+9M>AFYP"G46G#,C ZK!3O4R06\20)?XGU9[60\1 MU)T:$9RS+BY2EEGH7>!^IWG!-,MC"WI> M#CJ@.C5B&]D6:C!&=0%UY2P"Y<^E/OR:&0-3F1-9@RJXX_P:7\ W2:WP?&,0 MF+=HY1!6@J]P6U<;/,SSM78Z4QFOJQ>9ZE4^LH/N!ARSTBFR M]_?=O:-39W3B'._]WZ_[Q]Q?_O/H#T#*/>?KP<>]X]/1;WO.P:%S^.'S_B^C MT_W# ^?TT/EZ]'%TNN<<'L.-O^^?[#FC@W]H7TI]V9F";QC!I2=?/Y\ZAY^< M@[T_G/T#N/X+/;'F?/IZ^O5XS]G[G1K>PV,/3W_=._X#GEPA1^Z\;6?S_)[L M%2N\I,+]5>7V6W]>T=HCKEZ];U8.(]JZ;+\7E^UJ\7E]:^3U^9=%$MSM/.] MN]3P_(?GI5(5E*IJM6JE\M,9[O2N4ZVN#QN;9L1EE>L62M>2?G5S%,E;"B]1 MRXI(7$505?U1EI2WM3366?=I[C)\4(OF%A,Q0(^EH4:1LT\./)GIJ:$+)XW] M[()_!5O6J'9FO!F9\*S(RL(%J,C\4R:Q]>]=(/E\YU.YQ%.'#=>9#$$?D :%@5.C\6,VXH1 K"+"$;?S8+-@NEOP9TFH>\#%]9GU;7)C<\47^>D'=*1A/R3N/9&\Y'%(6%(>B2);=Q84D& MFVVL"H/H6\Z;[#WR9$CU[+I(ZZ*NP&H@8L"@1H3'&;KYUR7((AVR!];%CLAU MD8%%^DU1IGD)3G6\2$V4K>#FS%])+ 'Y R(640&H2!;-:F"!U9& B5,Z ? MA]=BM$HLX)GD1YPIOV2 852$*NT >MX$@FXR Y4CF?&(8ZPMH[J#- "A S: M]74,6=&\1=Q\!FJN4!Y[D8F:$W/'(73K+> A4X >[[GT^@(!X*1'L#WR%ZI0 M05B>GK4I5%^23;EP-.P@B<\#8@+"EXK("9_Q6W1<19PQ@(":JK%AMMC@B$ J MHY0GH!6E,ST0X& 1HY$:>144;Y$D0(+S92FQ\F4&VZPVH'X&RWT7O7&$G@/CICD2>-GV*(O MOP>6(AT5_R,.4%Z9BKL1OF<9#1R$*[5\(09Y1H5DICPC%!=Y%!_EAZM*-\X0 MXDB)>9P5MP>'Y7/L#8>=<_F:\4^%V!2YED]#9Q!,,<0!5_,Y42RH" 8\88Y^ M8!!7'97(Q;J:O(?KVD@,KU2V*M![3C.D+5[A4WX,J[EUUIB\53Q6!7"072FM M11KL4KDPL8D;YM%X9BPZ80,T%M9,=$2:1G1;'/:UW#G;J5%(C'@ZX3$=";HA MZO-9SJI^/SIXZ\.Q7 !:I&]V5D.!=R\ M!1W,57UVB'8MP.6)%TJ2H()?YZASD9D72+@:9$%Z%?TB$>:"LH9C:>>>2C.I MSX!*2HBC1;,^"<68#"R WYT%E"(!1#8CV@=J,&S3%M>/L9\I.RT,*J1334$-6ZY5)S*E/K*V5Y.L8 M#DG*R$@ZHYC+B-023\?;%1[]OG]\L'?Z=^=D;_?K\=Y'3='JK.F]%,G"6XRN M@"J5P(?M.'N&NK^ &F3FCUZH !BGO9'V/)]1/%3'<*X'_HXS8@EN);8Q/0,# M3;-XJFL<9R+)J."17CG&[8/^P)D^.F]!1%&,L?N-%%MW#1>BU IQ3C6FHLQX MSL7B'F*&!O /%3M<+U984K.6#5>,M#%Q:+0G>E'2%C$V!;PBJQ2! GPKUY)V MJ<'R+E:4\9L).*K"GT*3->=78'39Q(4;<[<*EP. O/O,:M9AP.F%OPBXX0LK M6?"CN'#VZ:OLFHFJ1+24,XE7AV%H9(:LR!S.8O.%3-./ [8;[/,[T'8 M%A.QD-.JQ&5,;[+_Z0 M!-X9I6C55'!#<^91FL8@:G7>!]:_DRYA0+!_,CH$37Q_M+O_AD4&*-]_B/ ; MV#7'(!0FJ+F@O7)&T*?LPP@= 5%,*?B)L LN./NZ9F>.:W&7FER8A ,Q11Z/ MJI2^0^L#RO91,L&C.GS,J8EK>+;HCA5)@F:3=5RPA;=HRW@Q>ZY!*IZ#XH:V ML4H?1U]X#2P!S//+,2%.I%+S4\G8YRCLVT0-*X@ H!G3$"BW*DZE9"4"7] Y M4X4?*U3!&57&:)-KM&_B4>QJT8HGDJQ.6)V2D)Z?J23VY6( '/20R;,%YYN2 M$:B5E]%^[@6+N:Z%\I[()5#=B_ D[(CU=8PPBZ54XXU(>6_V@%-Q9,\&0/((D"!@TS)93NG%2*B??FLBHW"V/WF3DA462$E M6N=4?&/LP+62*\T-4FU:YY%>=-GS3A*TC ,,AZ*=ZE/$ AYL@GJYRXA!0E9C M3,9.3"8$H,>4H?(-D DNQ2A\LF M'5U*#NQ;X:058[/"(4Q"06(1('L@<)&2C>:I8ZY2[D;VVW!6H3&@=YP/N(&< M&=*JT=X,,E4DP">I%RQ2$Z8!ZS%%<)R%\1C0P[6G;.9N,L,:*%X2@TE05\BJ MV.Q]A47HMTU0]M,#"E ?RER MB+PB6DI)@$LLAQ";N6PV1V@V)]IL5HA2HY 67[!,ZMKI6(IYE[V2=J !F2"9 MT@:%8\WCUK+Y/S-0')K]X5,% SSR<.^+Y<:YF,3 'J.,XXC 18C^U./-[J]V M+:0EHN X?8IV?Y"22[,BSX"1>QFLJ2HS5<_4%$F:*"&'!_I9&,_DFC'E$\W9 M/_)]Q*%_"S)N^$#;!IX.DH0$1")F02[%E")*>E:N(> K @QC,4,POK'<2S?5 MDP8X,6;3R P12$[)T6^<4>RF#V(&O@/-A]9!.*36-,6;S_'8#Y M%$-YZ$/("YCH472"*#@(%\^X$L6W=%OT_H"6*-$IM %*565,(E4_G!0L+&& M"1_&00M:D?1TF%'AAGJER4$ ?L$9$=_8Q>Y\EH$7IZSH"XFGLR9!];"8D%U^0=D1]_[5M5V+,4/FNTVHB UQ=;7JM@V M7O-6O:]PH\K<6*H6294"COH$J>#H"8\4.F!M'L+S@AX DGH_W=-[BG M5J/1VS@2^$,7K*N0O7$0AV*.E@NZ1SCSCQ*8O)P5:-,BK2TE?ZAS-5E=;.6I ME*MUQ!R2DL$),LJTBJ%"5,7(55XJI"6[Z8=AXIO$#[@>NPQ< +F.8.A%$Y!( M:N>B&6N0,BY,FL96W@MY8Y1K)D G#@VK2OG8L&[)SC8@;5D'(9 8DC/0T/_[ M>,*\G.VM>P()CH$E)?-DI*D^A"0[0? 9N%* M4A2#TJ'D5B?:A#6!+[B@VEM")0[(D1908UU+8%5W1ED,($*B M;*($N">GR@ZC1?"",'T!\":,T58R.**6#0^HR*OB4#(QWM(>23NB' /2$] > M)IW#\@PN+*]%B;NSJY$"RNBXI="\<4SI+.*:)@3B@A_^3TFJ;% O$?Q MR%&V-]L@TBV"2.W'"R*5PD04&UH&[ZH@TRUC2MLPTC+FWY'Y(6L! ];GEA86 MEU.](8"3Y2:B+4.T&8"9;E.9D8/L"5"#\/56YJJS /S5.?8FD6E99GV)5BTD,5U27JA*52@ MK@L,CXID77SY>3&'S4HMXW8>1CO+RX18O^?\[+20Q&-U8Z(,,]#M$Y\"'!]L M==-J6\4^&GX#]K P)0;*C\CYVQ<5*H(%) -4=1.R C:4J&D.ZYE(#[RG/[H QV1:Y]=!"^G.O87X;HX'8ZM?0FA<4[J%#4WW4?B$*RQ-I4-%\ MO3OZY?@--PC;Z?S%\=@H4QTFX'SQ3#$YU2ODOEB;223VW&%3U-%I[6ICA+L1 M-C"!U_M!GG&UPB9[Z#8:NZ2NH(-Y3MJ^XCG(B4B[P>@VJ=6HR*2%_%=;]2YC M8;D )K":1QQ%(RA6A:KUE,OV-6FZY5*RR#F$H+S?QF9[&U&D_2_4 M=V!6%(3 +!_[W3; =6PU2/.V9B7C JS>A#)I<7"[+)4VD3-79P4I_JIZ)'RK M(\;6)S$UT]%Z++YI(L,9OR>%.]&U:0D'HPK[8# JKF\Z()"XL;T;)M!$(3 ; MVGR2E#? /@"[%@*[RIED:;MZ*C]D!07,&;722#&N9C,:TKLG<:$Y#&YQ+!&G MT/U0(R=RD%K\.&!J4$V**+.8W/GKLIK\X-=G.3H84L+Z5>S'1H:<^Q3]3W_N MM'=ZJWG1L+73+W&C@>9&P&B(S[1OP&<*\0:B&ZS0L'"9ZX-*9ZB]B"LIM&A\ MZ/8_DYA] !@G)DRN M51J7G%L1QB6)$%0Z7[%V,N<^M9+?11.X"#5%*'<(>5(B:6H_4Y4]60AU>R8P M:)60Z+?N8",OI6"0LB6\CO@KS_E\NL>)OV U-,9OK?[B]'W M:@YLW6S9U+BH%EJ\.U5EAOJ0,2;)XIX&&3T63OX M/1,7"XIB%8!W8_+U:D5-*7&Y4]-2-744V6AO1*?X%$!Y%2#&@D0G+T@TI%I3 MF2WV=HW@!>)2K68*2HQN]X3)]H5\^#3GH!8NE*L13I=>Z))M7X0I\;-:WN0F MQXQ2G-#JHT;ABA EG:WO%4H:BR9 @;ZILC,$ 'NZ9(5:A1KQ9VFH2@I6.6P4 MZ[-=%5HWN;9&N]C;AQ4&P@U=/9P?NAW$XYYW%Z00,:&$%'8V=: -S$BR$?.PJCYS%4\?J^9)E8Y(@ZRW<$@J0Y[):.VX MQ-93>7-/96>;[K[U4]Z$/U7P(\.&/&!<:*V@DE%C$X(KQZN,"%8J"FU ']U$ M-# ZM#.TKC6#5 98V>&B:XMU.H^5PU>9[%?#%(S % B7'P<\F;++U\\D5#U+ M9K WRQ=FRI]9X@;)*D9-0AO?-HW'F,'"?I/T&S9N*"0DW%>G)):S)EDZ2%G! M)0O+TB5#(L^"YK!^;H-.FC0Y8JO@N7;G$(Y?Y^W3=?Y\1?1]Q_E-Y@X&&J-=T[-,OWJMMF _\):6YN?0F([5LYB6 M;ZR8B5/9#W55BQ2S3=6V0=Z M) '1-=E5B>Z3024<+L8/PKPG05Y]9)4MFGLQFO5L$?]$(?D2I9*Q7ECJH M56DL>3,O:F!A9\0K31R17BGCNK=$42&_04^QSW_?&U:M&6') <=N/I&",GI)-.*>:CPN5\?44 M"UKSAZJV,F\;7 POYKV5[9J Y9D@W+G'H4P9WFABIP^9+$EG MG,3?= /3<@_94F^O+0EN2?">K0O=P?2G%'M+KG#+X=OHO9CG4M>QF&;A!*D^ MAX)5IU\ ?O"X]Q5U#KHMB\KUT9,CK6D_U+&$-#-NMVV[VVMY>Q-.A:!^\VSV MUY8HD)7&%94YW.B7WVO)T-2JR[52'#2M-*UWIOJ M]W+2E27VTSD')14;LYKV;$?Z;6DV7\QR[+^$YE^Y>K\BVKSCJ P -9'%*NI6 MZ>N<2Q7%YYS]78H]WS8Z6FB?45"3RVEW^I_*UB2*,HKM1W/!^TWJ5+74RO+B MP1%SY9V/97H]@G2Z?*8$^Y0JYXM=.*88A]FA B7/)2Y.='%&[OPK=S8I2HVJ=J+41YC($%!&1>[SY^6= MSIA1&G;+60(!/!Q^PF;T1K>TFTB9+LQ+]&.UDK(+//>/ZL"IY&P21XL:)QM1 M)CZG'5'O,$Y *DHOC-E>2B__,8(SH>Z-K.C.(^X&7I)Y:%4J;K"EVRW=/A;= M_DJ#,:CT*Z&V--[J'D_8$\J0\2&W(5Q])>;)H:.NU.JFE6)Q(E9'S3/4@>K8IW*YER1U6S)92"IAJ5;HZ:HFU07GP%YP MNH<:KX--4:.%:4^TM/E$DF9@*GE4ES_SKKS=5NP)T-F/=(GXO^,@LIHHUE3T M!C:HP.5;+8M4]0174).J3D5@IL.8Z9!62 CEP2G5_:YT \B25IIW2ON0ET=) M4UYUOJS%S7R7UHC(^+A>RZ+ L]1+F6I9IC .Z+&+@M=DCZ#"?>Y;F M13O9PF">I@5&B#TWAZH2/AZ_C4J$#QZ-((RNGA8Z&NI-L MK5@:J77L/#?E;NW]"H6:R\5CY.FD0H=2G8,Y$SVAB%H4Z ;'%'.UQGI9U0[V MS*E"M<*FN9'W;A3;F1YKANA6FT@]NQ>$H#(_YD'[K>\ MJ,)*SJG8._=GIR[?F ?J6MT 2DM54XDO^+6Z-[JN>[]]$Y7E#=!3LOB"6O)3 M\T[3Z\5,;"KT?+%W43@ 1Q65&F$N<(PEK81WBQ/E"KI5[@"RX9:7FBQ#4$VS MTJ&SO->K.7N%-3A:33GBK*EIJ*%9 "U"O5@YF!4Z!BW##1OFV*O.!ZH:+ 0% M,ZHS>A4]2K/X@DC-;+]L>IJF\*8]?JT465']S[5M;E!#E<*:)OFJ"SHGW1<6 M@=5 ,LF76[,+H;C<_*&;))2F,%54FMJEVZB,ZY2YDE*ZGC^:?;;V;+ "0+3? MS8IT51:AT^@S[+Y7/$+=2%[8T1JJ0;5?HJOH56/2*@S"FGTL*--^78MCSKD- MN.+T!>[NZIDBQ??9;?6+DR%E58ZYU<72X);AKSP:1LWRI'$C9O??I)S9%5_E M>9]+[G(-";59&V2F4&G%QHE)^:&\#(J.*FZ'PZP@#E'XS*2+[6[R#'H@VKHK M2 82K#NA?R+'AKDK/Q MZT;-P?^]N4T/V5RQ,LD>MFE JFW1,+"_PJ44OJ J*OZF_I^L3N,>:"1]!-\J MQXK^"!<]_=@[2]6T2!MS7]Z??N&DE5HA)<;ZNAAW+_UX90)EX5I'EY \\D \ M:^OI_0S&>RX#\F397V\RK,S:NKC1V+)KQI7-5LOA M^]:B2>9A=S\XER,.86MOQ*@4;ANA#2&G@1 M)[\ 0PM!]"M%L/#;P=ZN_06A0OD[@-$(Q"[P:R" )>36@:5.8#=HH;XRW3\ MJVJ'LQOO.+_]PL2Q_(#RC;0OJW."9A2%X3@8X<.SQL-D) M%R"2%F8XMYIWQ!BFVR9P(LLL*,Q6T0OP3*X!CV+AL4^VST.OL&*NTOY17<51 MY.-UV%1F3BHEF8\^#[*RE6U_:1H1#??@N(K.9KUF]#AUW^%(+UHPDV"F_#3T MVT=N!J$CM4;OT-I$.L6N6QC717V>5 X\U%#,X*Z46OP8^([C^)MR\7#6AGI8 M;9U(,0>"G1M&@G5.2)[U4F@ EH_](1=-.E%S!32V)2;-Y&P>8(%E)%/=^^M" MCE.@2)YF#6B)SAMTY.1CI=3,@MR_Y$WTE"1F5M9#J2\?+F2*G=1H"I>4:L8V MVL!F(1>23;)Y*I=^LYZG9G8H]-4T&,FS. M6MO2X&7HZ]XGK!8_TLO,<3:)6 MMUMS]+_>5%EE]V- 5<4A^#LL.!>1%;'@G'D]<@"_CR1LYHM)."=6B3Q*N\ZO M;N[QY*-'ICQJD3H*)JCSU;1A7H\QC(?L;UK8'7-@XRX@)U#)A53L%VH,^YSX M5**M/\=XMI*@*B9LB.>8)N A4V-A](6<8[F3_TB/H[-DK=4C0'?,XYJB6[0( MJ#DR0^&<5P[,4^Y/PP,PJWUGUJP^,YCO#_(R1<2JM6JD6RA:#S$[SYN)7C4> MKG+:2%H:-U(<-@(<(M8C3CE/KICH8QF75EZ/M95M][6;QS-[VWCF-I[YT'S< M1/[R7N,E@XV&-!F7Z7(Y>^X@,U]<.8*[U!1ZR>OT.<;$&N-N,K JN)V.,"1# M%^V1R6XU;GTRGU0AOS)/JG0B8BL4(%OV2M56>RO-SMDSI>P?ZFN BCY/HZ(9 M5=C#>'DB%7>(#=E;F(\*TP);C;0-F<.#,J\F$]N=$69JD*W]JKPM@IH/"%(_ M[P"J$ZEL1=T']123MG+ILHG#U(1'\P>=M@ :=+.ES; "(U ;K)NZ"G/N'U%L!^.YL=.U!F,4%SZR M_2/G8T*Y5B)?GHI!L[85N/;2C-E72"@PM)P?U*BH]A1ZIA764QH1%\;4+ELYYLY-D$P[ M/-E175RAFAEF-L]O)=0JN*K,\MB$.C4#-,5PQ(TGW M7ST))RVO S/"T5(?4ZM"JM(EQQEH_!.14I=^ B":EJILN5?&S08RF^-]R,',A1W3R1<]0G+9'U38HF5(4.7U%90J5E"ZN8M"\;3N_TNR\<@0%1?6F8L'JFU4O53@$5JI9 M/[8&&%OP*9=?@*9!5 #L#%VPJ0EEV@=.;:O-L(BB;YDSWY J,F>29;-W;]]> M7%SLG)."=KD#SU;C\!32(/V9 13<"IL?:O9/;U;,@K(/D"Z1T2F%V+RY^,9Y M"JQX!S1]-7Q=[4/1+#V4@B5%_.18##U+N^$RDNS6' DU/((2%#'PC-!M-=J= MAZ;E@SA#P4$1137B+YNHT^5BB0B;^:"P)S.9Q[2J*A++HZ\G1Z:$9#T?C'..,T-3!%]%PB86:K4+MSLW!*8DLD M-WZ1:H8N3G%&4E:[(;W%B^FY%Q3VY015P,]Y(G#@HB81RG.CP"]H&YBIJG1Z M6FZ^3%6ADG!R,N8CA"+("Q'#0->)4&OT),%*1'1S3 .5MH G=.0<@[@/&B: MV"A%!V,HH$=]@%&\8"1V[N>ER%+UU) M+I56LT:SV?-T"')!E&/J^.45CQO-SW"B8K-%#^N2[ $A0>,( 0,.0#KQV]3+ M+)'LQ>Z$6CD4C!8M^*L.'Q2Y#;.N9OX9CO;QWS6\?\3=CL;W(!^F0R3?/L M(ZNLGC3/5/4<2K<-@[:5Y#>H)%84,M&0WNX,PXN,T%;\M$4D7;XXBI<_&';*F)+X/= X%J)!7S4%'UHA0H_ M!3(DO]G75!K2W_-]+M\OZ9,4JL!Z034 4C^P%("JY3F4(*1 3:=LFYD(,,=' M)C.)OKP:-^<"&"%5&7XBE_MN@@&@_,Z$RL08%*>A+YC>\&OMG8:7 $F2]6"6 MB.R%HD_$ECA>,A7?X.6<#"=H'5/*CL;81$V5'^D>HGK*01BN"$2[Z(4B4Z:F MF1<^'Y^9H [/GJ^X5F9IZN^E;9>LI=Q6*E@]:1RB1U!'?]E?H(YTOIT?LN4T MC\=IJ,4F$"DYD@['(7:U0.0U;&5$1<6(ITE>QUD2Q\H38].'ODKYY8$4XC%F M3Y=)(3>[38A7#7;.B5'E?!<*T/4_^CEFTK,K<*!;DN>3D[5]+D)L[*<21O0B MN.)6+9O&,,-BL/*)\C;FY#E5K_8D^D529SY3/K9L,2,O"CTY?[!J,:-3Q3'^ M&U,5"J5JS[EFA#9V&4SG4[M)7:Z2P%KV<1QOL\'E+)SZM[1W]0S#N'5NO (@ M_OTC3D;$^'A-08K\R>C0QLI/T.$\Y:$T*PX24*W0[ZER!D'#DBA4N)35RIL' M!HDYR"G)"+QRSJY__21B?3R -K5;NPO5YA'TNXPG:NC26!%$QE5M*5X.Z:#+ MS=79A?7H/5?N&J7+4YJPTF_.J3B/5"J0XY_VN*LTG1H6SZ#[%$,*8:W@K@_% MA6YGH)=;"%$Q%=GQCUD2G)/OENJ*K8X0^SXVS0XTUED.FLI M-(2V"%5JN\"I@40* ,?DIR"X-O,E2ETF/D-VG*U7*4)S7/6P6HS(R$ MT^^H4D"]QVS??A_&I,8<]4]F"34XIW&?E-)&+\ *-'H>KJ>#I.6K;Q BRLA>\5!JQ?2S*9'U447H3]T3&8_LH84UE0^SX4: M1$A]MN((JQNJAT_K+E[SB!F/9Z=_JVH?!,RYC/+T1)X/RU5MV)-LC',80HPC MAISB(USN//$U4@P,JT*H3"Z?9JY.QU1>F;.4>?(A]7XI;F8JL@P3+73@!_J#$-41['W2/?9$!5]%Z84NI?8)"6) ";H=T.J8@C9P:$$@YR/DI MDD7)1$&6KKGS&J$Q78N!HMR0QW$W;/SKI*.K3I?;XF$? "Y\H0#G+-,!X:OO MQ6K2\X T81WVK15(0WB8JH+P$&1E/2K>?^3$)3M4;I+O@ OCEG6UA9G>3K80 M4C\AE68:>?_@I5P6XB144RD]TH126*KY?D+F(V28,\/D(D"MTX:;;F+G^X%HMLPJ/;9 MH8@H6FKZCLRPAT\^60#?8@D/ZO.C:-)68 F4 =&F&^N>DH1'%]0"Z"IJTT4X MN 7CXZPI**$ XSKKF3)7'IPZ3[7/T2JC05&A%(Q0Q_#FH"8E)$G/BVDIG")" M#/3CP0FZ8>),)<^)Y*C2.52K M2H4-:3YB01&E+UP,RZM.'79QNVDYK'J*D6S)7__0YPO0/0'(JPCJ4(>#C:OY MH\F%+P",,^%:GFH:P-)A+-4*P @(YORU0(#;U)TIC2H@Q+I(<#"GY1J@+'K5#T_H:PHW'"UR@ZF(E"7C$45$*86M>@. 2 )?@ MAVGE5D+[,M#T 5(R"*,4;:QNMBR]IZM>LR=UN_)N[:[%C/L1JZ4K,=+CO28V543W3R M/^"RV=NA)A?KHI2"-Z)KTO-+D2J!O]Q3&'5S4J/57V*T $0D\_.[']<&,"$_@F]R]SVO*8U-++0R-\=%JI\JB[/*?.#N<1(CPW..!#=)/ ZFM3R6*EA'H*.< MDO:<+(#%XT&2"-=3$>T:F*(9@)6,1O$V7>!5[TVK*-%&71PO4)I$7[#?-4U'"M4=2SD,8FN$ MD65TLZY-\9SH+&>2=C-^ZOVL]NAD\R0B=POWDC&>%YKFP!M&*6YQ,_8?Y+NS MC#BR=;BR$A.,R$6 P:AS[GOQP/G6II1B/T^@?_C@BX^%97 L/@ 2AQ#G?N<9 M-ZW33M["/&0*R:C:=RZ$ !; K)$[4)G;L/$G[,;<;-1_JSG*YJ21)4N__]]:>=/FUP'>3!)/YUJKOBH*+\0 \ZP1* M.=LGRF?>;+\6;_"R9O>U]T9+!%VC80 P&"T)'KS:[I0A MHZNS CP_W1%@1+()BQ/4IV68W5MB7QRFBD4UUA$6'U%'N\AYW=2"([.J5X' MWDJ'7D*$0F=#?=0W@YMP N_G5_NPQ.9H!ZR/_ZG71Y$[B9-ZG>R3'[Z'#)_. M<*=W78).1=.O0N;-&XLUQD'YS/@GTHICN7YN1M< EO+E*R_Y9 MXW377O85"04)["M5==,Z)JI:GA03!G0IJ8?M:+#$=^V VXH00.[^S_F4I9=3 M8I"/V?8FV$YUQSSX.\BG&6'<0WFE5>,$@%[L?B,AZ*036B VFF&[26='J72G MRMV7-TN><4NSQ%LK6$\Q QK8\#$W@K5@";^HLKTOQB6NHX,&#!]-5UXNB\*! M!N@!U@/BB*N47>A*,U1'H,!^>@/ (E9B+2%!% 1?C@IH5U[@Y H,M5FI'*N> MC$_!,D*NY\9*]$AE.<4JFG%A%WR;<5=4$AE,C6A';8D; U\91';V?5T_JOHV M(H/PF4$X,99#UIP%(" 32(@DA%5VJ%_C:S@/#9:V(-4:OK1ZQ"U#. 5][;[: M=BA7Z/J<]F0.X$D63I$'WL-*6+S*5R',V@+9WHQD9'A'JJ)2[Z*JJ/YWS\U>XT?'Q84%H\#M=9C MOJ.W8<;[&5N"NL1X$J@&%6RF1A.GI"PC:\]:]21%IEJ-NJMZT]QI=N^)EV8NODU M$SBC7OW+>3NZIWJI,?D6U[>X_K2XCFDM$:G$)A^(4M2HVS'I&*;5#VKX"65" M8*;'%H6W*+P9*'QH&7$F1IMG0]JM!\>4DWLF5+=8M@+9>TKFV 2L(VY%234P ME)BITV^D-4?0M)7<4L']4<$]$$'G>Z:!//F@Z!?,TV*Q3^2EJ<-1)3FZ#D>[ MYM'NU'?S0,&\8Q-&':8S$7#;7?VM2LW&)FI!5,H=53T:MW2RE1:;02G[OJYR M1?>B4-FEW-*,DIGTU%ZK/:W=VK+8)]-V('*Z)\WNRD4,Y_A+[W$(X%X]496. MPV/RU1XKAS) #CG/!PT!ZEX.7^0^[6.=Y'!'9YH)E=QI6$PAJ;"T,ROD0ETS MV?N.&H3JN$>.PM1T\%,5.UZ R4M8MD<9^N3;H-]I"IZYV2":.^'QD0DPV32S M6Q-S)KAFJH7BQ+NZ(F\-O55@(?O8#[&+,B&"6BVU;/%8U])I;,K96FB'CY*& M>BYP7\5JL)/+WKQ#/Y9\EI@IC1 $ ST4>4Z@_2K.-\2$_3#F6=5_;O5WAIBF M%=I%])A!XW#T?BDYU*(B_BO3+S'SS'7GTSD3EBA!Y?E 53.FMGHV-F9I9IBD4#T]H%!*NT7S+9IO!IJCYI+/9-*\ M7?<>4S.:\B8U?X@DB>-I>:J5:N)KBN2V>+[%\\W"\Y'%Q:_GX..%-69H81?X M6)6YNF:EW#5BB_1;I-\,I+]%&%%9IAQI1[6]-$A/)8GJ$66Y_0"W4?:]%V_Q M?XO_FX'_1TF,19V V]*-HW@:N*5[S M"RXE*#N$:_F+EIW%YB4&7CYQ+$R<)H]S(1!2TVG%-N!3>N6E89]N&Y9HV+,-M&Y9M&Y;[C7&O$1TN M!2\O)#>3S0OVG?#Z%'==84?]-BDQH)K#/E7ER>FDL%[@RMF%I&ZL 54X&?N, MJDA/Q>MJY5VJG)O('X9@/L.HFP&J3[!:EA4-L!L?4?O=XOP6YZ]- M(C*8K;1[XM* &V2$D%:.RG]."EA08U77%DMOIC$8(0O5>5>/]2W.=N<>)&C% M@-$ #Z&6D44)LR61+8EL-(F,Y]X9MP+&Y$/0JP)=TI^!9H*MSWQ% WRE4H"V M>+W%ZTW!ZX\R!!.;73]4:+.$Y,IWARS^/."T+^R)J-$8T7V+REM4?GI4IB+V M@J')@S.LF1?4:B%/;[9;]FCM)4$C=@+D0(5GW(I%523H)'$]RZHP!D8Y*I^T MD,#XLY4;,6$?28^*M_27"'J#:K?P0E@]'VN5EE'93Z"RH/7D)#5'20\2L@G)+_ID*3&QIM.*/";_JXX3F9L#WC0!2K MFLWN30S3]';B>6CYL0011A<0^=6@LIHBC$*]60$ 2"LJ]5?-6LRX*Z)=3('" M@L4$-8?"Y&'LPT=]UC'(8#V;.@S3 ]"0QN8[2#'3>9@%LU#J/ 1TY@1>2F6? M<190HC&.A%8-"R]$DC=HUZZK._O?5I(),\Y[HI-/7'A /1:Q^V%:4\41N0.O MW$V^2#:I724HK.2\ MNA@A]".V118[F(K3%"J@<51O)VL']5"@=,W9@ 17S; MS<<3!E35%:PWA)U0.TAUY#4[&*.[5E4,$U'!\+$LQ,,K(D-YR=6C!^]NXE1^ MH$835N(9"-C.H/5C==*P.J7:7A>BDXNUI/LD+-<52-^0<#%;< M&*OT),T-FL8 "W@35L]@3RB:-+;T)IL_V02@^&N-N)&!5[&D0=5[P?6(WF=S M0<-^I1JYDAF'=-[N&U%_*GFL9"',N>-\$*8+.=P!V&#\%A7XP72C$0BVAQ,P M\(I<]Z"Q9%3*SM$'E Z^@G@^C>7P.LX*'KD0QP8XU7$/,WVD[P D+SO5^:@ MUU;4PDD]+QE09.M>WRK8[_=1)U)E/CEV6'WK5M0C>XN?6_R\#_P\LCL':4.8 MA#6Z2M5$5DQ"INP$9)+<;3G!+LV/U4ON_OTV!<>P:LX]PQ&LA9P+[4)@9Q;Z M2] G4FS.Y_C!)0Z_'KEN3/,\E!^1BKW(>W!64HMH9./ M5C2S!6DTM5+&A1B@5"G_.6O<6G,(X\Z M\S%%/8SG7GU,OO3B=,1\[*'S1D1-J3%5J^%G_Y-B$XGS^I]'HSAH*^H:X>KT^XO\$1#^[.[X!GI=^ MI*S-ORY>Q&@*2/B&-K8KK!50W[4+63'FE+&$IEY0#!]G00I=U:7"-6=!9/J2U_]*E<.6.\X>>!A)@+!8WJ(*!2$^F9#+0V;.,))K.:@I$J+L: M M*EBG>+1SHIKJE9D$GSTG6AAU/[86+;!EX(5,N#*1?L.-T4I1HVP9Z%PJ5'!2[7T\+6J-=BM#SU2*4?S:.E M+I48=*3F:N9![ Y:)>HT[*HZH!+.<$?ARD.XR.LB-!;C-Q?6]BO#BS3*BZ*S M*A7 C=.L;H>/H@BK3RG<:K!CJ;04WTUGIDZ+VR'GY1B)U!GK%'T2BYJ>L6HL M&!X&S9E@/C!ZLO,H_\B:_VQ-XR0914_ F-?4C \SL7IDS];VK;2HTK'R:W0J MFE<@8U>-$L(3")6:'JYE3YE#&BOBXWVJ1#?7?E8J!%9VG@=J#.!NA2CG[J2% M0<$7*F0Y-%2,YMX$LPTX_\WIMS@@-M@S$5[ MIC9/E=JC$RV2H1E=7;.G"->T%P/EPEDBC+*$4]I"4 ;2'9JWK1='H,Z$-:0B ')H'98.2B62Z;."=! _S//'"_*1YA<1[=;A*G M8Z$'D?+JR9,]CP*>G&A+-4HP!.F5>+3@2H\B\#JN>TH)SEMSV@F")\+-G21 M"CD-C_Q^EBH9YS0I\TP?[G*AAKD;ZN$&!GKR;]'96,BZ4::^.I/[!Q!L-U88 M:"T75HBO+X ,_/$SA5>H,=C\)5)9B:M).!D4J0EA[:GN2">79B9_ZT9OE'2LL__X6=Q$FQ/)"JP^5R]T/INJE,/.%$#@+J>L MZ[Q61@B\'E#C.]D"Q&&T0!:*1(T.B*O MD"2H%E&SS!]*E39D1ZPREV.%TZ.NV\0^"_(4=I\G=4=Q5)>78-FEQEV46G:# MQB-N:JXRP',8%9YL 8 ELNIQ4V6")$J\LH2IU(Y-ZJ[M:='9P$;_IVFFA*!U M[D186!)YX;,50%#>,)6!266;6GX0\@45!H9%8M9+K9T77Q-'Q3>8<>\JF[MH MG9;L.7>-L0RK'9=;]_YU[OWFUKW_O;OWG\:AOS3T2+F4\XP4>P88LE X;)EQ MO$\F"37]L*U1[D]%-JE*;$[D;,Y.@F*1@8%,U2#IIQW6<3U$=.T1->>BR"GH MMV%,51@VM!A$7*2!NP1A\1'D=T U-"D+4!(\ZD+5*LLL@*R_*%1C4E(7:W>D M9X$.98 PWBX]NHV+BL)0!667ZD9WG!$8-4N+LUZQM!)^E54F .*%:O;*OA'M M[[#\&Q6.##T(Q,J9_W_LO6ESW&:6)OJ]?@7:UYZ1;X!I+EK+W8Z@*V>;I!"5D#@KM#T$R#KFM8 =I>.D$5@?:_QI0%@*0I0R2U\/30$!C M^RU*F[L )=F&B6.S9&ZB2\Z%P#*D%8H"_^4O>KLI0'".#3&W>3;(R$='"U04 M58N%D2?*@NR6PMZ#]<<7]'%(*HY61&9Z%'KPD7VQH+F\+[>F?B87KA$>USPH M[D)0V!=$6NFSI9'T@AM!'C]/'E$>55@:>\4&%.>]FLY=V6VWRSG>YET)3-2J M/^,I_*:FFJ._!8=K? =3RN)LX1/-J33M![]< BA-Y$KKC_C>Z_1E: M^%6\(7*G/;/ S1JS/B,.]\K-YG-3[?,FBC"8[Z6Y=AVT%1\IHK&V@SD(]T2P M@>[ 8&YR1@'FEZ34;%K:QX?*RH'ELE+".UU#;)H0Y\AJ;2)&I*UD%L-&1A[$ M)PRMB>AXW5!W1H_&10/<^ODP%_,CGG\H:.GKIA+F;//?J49G=P] M(^6C]J&8?G W2\;T0-Q+%<5JB;:H&2V1 M MQ_L&]IR[VYT(P [?;5QB;..69%AISGDLA(3[#CU>62T,1*A]+N-PN)J:3DHF M%7T)%HO5-"!!^KS+N>-QD!Z":-+KFZA@]4Q0P33I-M=I88.) NX^'7E.'7%=S7E-AN[U>2W&F_O':1#\GK=\7/NX!> YAY M?)&7SQ=979#/N&^AP"AHI^BRX"T,'#.%Z#M=O#^'Z(5Q_AN#O MGNY%%9U_^U?5Y!:UN?4WNMU[J]OM-+M=N]V-]01L[52&]\[RIN%8BMS_HFVB M:&)A.K$(JRC6]E^N]K_U=, %%]CM@CN[N&0@TS\%F;[L-R>\BS7-X=^3"FF/ M_[G(/ILP!EZBB!<82GF3-:V E@ZT.M#J+='JGO5+3O)ZP1X!%W_6%0G-1"PO M+M)N,C)V>+;3"4I1R3N9L0%NX[>:$CT30'<@V(%@KTVP[X^7#:<($6 [AU0Y M-*TQWDSK^!SYHF@1&7VZ'<2$R-@/C0?DU-M&P2=F_MM([H$2W^0_A3-3V6:PJ5MXZ\G$(;Q_J.D/UAY M@VLW9ES]@#.6(@ S$;9S>7_B*5\7D';*K ^KK)[@(Q.RA,>NIX=1.V9<&&8: M?V]2S.7Z/:M.9FR4[$YLPS:Z^BRG3CH#<3-7\:.!47DY%RG0;RVC("WG3\ > MRXQ74J#/3'-L<<%"IE5%-HGGG[U28^Z(QY7)<_F930'[:@W&_:;3R)4P.[78 M=KHEW<>8P;FK;N:NMP%(3O4SPUQS0C.:X-DCT#+(K5FKV@\C/ALHM<6TM6FF*B&L:P55(&[&*1(%A];N^W=5,HR43 M30%R'81T>,408Z?90D"5\M#&M*WO24)\?_7I,(]X[<+_ M_S 5W<*$2ROK<( 8AB-SC6X6H7 OVK&VZ: U^TAR@,I#7%"SM,<8]#>EMM8N M0 #'.?+QL3J4?BN6'=Q!&FR?BP*Y#]QW>DTYIVXPAUD.*6, N81D?Y M!+OF"19FPBE>BQRS__Z# X[Q>C;P2@II(+) "5+H8U=X:'BPA3"%8GY)<93C MNFC+\GE%2A\EG\II=E+5MD[(E@,K0;AB]H JZ%.TXD;(0JE62$]RJ0%?1?L( M[[Z2!CT= *,&2<^8F%24,G]"5^)]DDB*X]@+>-X+0;\GK8?N+1;J8>]?7.X< MEQJ3NM0T=OP>VV9LL^1VU$#<=3I*7IV@:M_IGH"_HMWKLFU"_.R5<]&UK9)% M,X0"N#7:,?%SGJ5R4K:4K; MV;@HVYHQ'#0'G0F7?"K9,#S \!GDYLF_9+\MV+_4\C)L@ZA>>R"PAFI=I)ZY M-C_H&M;X1H+08"N:I4S<-Z?G?0OCWO>B,;) +>IOO7%\UJ7@B?O<9V[:#2NS M?-^IMOC9=L6L#(4^$3O&)2L 5,>48V]<,!:BBD5?7+&Z"3O2QTDTM$G+L48E M^)9[8/_9#1*;M:D=VA 6A8*K3GMEI^5Z/ MV7I'W0B_A\U7=G2$RG[2'U/>;ZY=F8*XKM->;30X+[G#+;0#UU4XVI]7**Q/ MRFS&X S -X"![_O5)&QDYP*%6MIB6)RQL' ]83-4!RC"3SP:8_H;$D2=#P6C M7-RTQ&RLH\LUD1&U)]2&]Z6[M%.Q?'11S2'I8V+P,\44EF]H,>+*&;G-V[/J M+U+T!:D=$]EU,=B@F"LK[2EX<5T2N$L/4&:[W%@LRGNIG$FLP1,Q1;="4ZLO00]\M:A14J X 5GSA MDPP-1,ZDL9%>E:9##+YA0<[3"KR5UD=/]&D/U8\<_F,'Q)$[Y'CV8LO]UG03WBRH\Z9DP>B M4>HPY%)7L9S_L-YC;P3)DG@$?C!4EBT3?$5\ I<^W8M"V M.(FK&DNI)2U_J:ZWU9/ M."X5G]OR@Z#@ %F,:A:V!H?U-'+H,Q@K:!P(+G]B7.'!(8:T,C>D"7J.!>-+ M?@G( X[5!-?)<9:&KJ[(ZC Y1JNGAYQPZ_"WGL>/H"(J5] JF_UJC]XN["3!-=\90#O44OSVRH5Z\$5_4NH MB4@W($#NBZX:[IZ3CLE4JT4=6^M<6YUD'PKS(&>41D(=$0MKP?3+=5E:9T*A M2Y:ED=!P!R )^28-5NV724ZU#++]EX"S!FN6@Z47VN=*D%ETVAHPJJJ.HFFB M7AU"E8?C,D4 ETIBGN-=2BYEU;(>XN\BSJ0Y0AX9+)+6!FOE&6@BDF'"XZJN MQ?)PN[>U!DXL<2P@?H"WOH&B4O>^5"C7VBN"]R^ZJ&)@Z0+1CXK-(N+->.FYJUI$ MBL:6W705@JT#79:(/'WH)2D,O0,\$05 10V[,<)K?Y M'H\IM'B;KBP-UC21\I7CQ2Q3N!S>L$V.51YB@I,&!1U;(Q RN*,@5]4U$GMV M4UE,&^/L&[6=G)8+>ZT\D,FTH\C=QF.SVJL)')1;C+T-EUT)*BU$8Y>&25UK MMFR%%;M-02Y'\P_SQ2%4+THKSL!9"@/Z) UR+YW.*-PZ%\8B/&2O^:8A@:I< M-GU((MQ\O__>GVS@5,?W5X